{"id": "10001234", "pair_id": "20001234", "similarity": 1.0, "text": "Patient 10001234  \nGender: Female  \nAge: 68  \nRace: WHITE  \n\nAdmission 30245871  \n    DRGs:  \n    - APR: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 3.0)  \n    - HCFA: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE W CC  \n\n    Medications:  \n    - Apixaban (Eliquis)  \n    - Heparin IV  \n    - Furosemide  \n    - Metoprolol Tartrate  \n    - Sodium Chloride 0.9% Flush  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Albuterol Inhaler  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Apixaban (Eliquis): PO, Discontinued via patient discharge  \n    - Heparin IV: Continuous infusion, Discontinued via patient discharge  \n    - Furosemide: PO, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 2L/min, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT Pulmonary Angiography  \n    - Lower Extremity Venous Doppler Ultrasound  \n\n---\n\nAdmission 30984212  \n    DRGs:  \n    - APR: RECURRENT PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 4.0)  \n    - HCFA: PULMONARY EMBOLISM REQUIRING THROMBOLYSIS  \n\n    Medications:  \n    - Alteplase (tPA)  \n    - Unfractionated Heparin  \n    - Apixaban (Eliquis)  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron  \n    - Acetaminophen  \n    - Metoprolol Tartrate  \n    - Oxygen Therapy  \n\n    Orders:  \n    - Alteplase (tPA): IV bolus + infusion, Completed  \n    - Unfractionated Heparin: IV infusion, Discontinued via patient discharge  \n    - Apixaban: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 4L/min, Discontinued via patient discharge  \n    \n    Procedures:  \n    - Systemic Thrombolysis with Alteplase  \n    - Repeat CT Pulmonary Angiography  \n    - Echocardiogram for right ventricular strain", "pair_text": "Patient 20001234  \nGender: Male  \nAge: 74  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 31274590  \n    DRGs:  \n    - APR: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 2.0)  \n    - HCFA: PULMONARY EMBOLISM W/O ACUTE COR PULMONALE, NO MCC  \n    Medications:  \n    - Rivaroxaban (Xarelto)  \n    - Enoxaparin (Lovenox)  \n    - Aspirin 81mg  \n    - Atorvastatin  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Ondansetron  \n    - Oxygen Therapy (PRN)  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Rivaroxaban (Xarelto): PO, Discontinued via patient discharge  \n    - Enoxaparin (Lovenox): SC, Discontinued after initiation of Rivaroxaban  \n    - Aspirin 81mg: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 2L/min, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT Pulmonary Angiography  \n    - Bilateral Lower Extremity Venous Doppler Ultrasound  \n\n---\n\nAdmission 31825644  \n    DRGs:  \n    - APR: PULMONARY EMBOLISM, READMISSION WITHOUT ACUTE COR PULMONALE (Severity 3.0)  \n    - HCFA: RECURRENT PULMONARY EMBOLISM REQUIRING INTENSIVE ANTICOAGULATION  \n\n    Medications:  \n    - Dabigatran (Pradaxa)  \n    - Heparin IV  \n    - Sodium Chloride 0.9% Flush  \n    - Metoprolol Succinate  \n    - Acetaminophen  \n    - Ondansetron  \n    - Albuterol Inhaler  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Dabigatran (Pradaxa): PO, Discontinued via patient discharge  \n    - Heparin IV: Continuous infusion, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Metoprolol Succinate: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Repeat CT Pulmonary Angiography  \n    - Echocardiogram to assess right heart function"}
{"id": "10001234", "pair_id": "30001234", "similarity": 0.75, "text": "Patient 10001234  \nGender: Female  \nAge: 68  \nRace: WHITE  \n\nAdmission 30245871  \n    DRGs:  \n    - APR: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 3.0)  \n    - HCFA: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE W CC  \n\n    Medications:  \n    - Apixaban (Eliquis)  \n    - Heparin IV  \n    - Furosemide  \n    - Metoprolol Tartrate  \n    - Sodium Chloride 0.9% Flush  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Albuterol Inhaler  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Apixaban (Eliquis): PO, Discontinued via patient discharge  \n    - Heparin IV: Continuous infusion, Discontinued via patient discharge  \n    - Furosemide: PO, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 2L/min, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT Pulmonary Angiography  \n    - Lower Extremity Venous Doppler Ultrasound  \n\n---\n\nAdmission 30984212  \n    DRGs:  \n    - APR: RECURRENT PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 4.0)  \n    - HCFA: PULMONARY EMBOLISM REQUIRING THROMBOLYSIS  \n\n    Medications:  \n    - Alteplase (tPA)  \n    - Unfractionated Heparin  \n    - Apixaban (Eliquis)  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron  \n    - Acetaminophen  \n    - Metoprolol Tartrate  \n    - Oxygen Therapy  \n\n    Orders:  \n    - Alteplase (tPA): IV bolus + infusion, Completed  \n    - Unfractionated Heparin: IV infusion, Discontinued via patient discharge  \n    - Apixaban: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 4L/min, Discontinued via patient discharge  \n    \n    Procedures:  \n    - Systemic Thrombolysis with Alteplase  \n    - Repeat CT Pulmonary Angiography  \n    - Echocardiogram for right ventricular strain", "pair_text": "Patient 30001234 \nGender: Female  \nAge: 59  \nRace: WHITE  \n\nAdmission 32145788  \n    DRGs:  \n    - APR: SEPTIC PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 4.0)  \n    - HCFA: PULMONARY EMBOLISM W SEPSIS, W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam (Zosyn)  \n    - Vancomycin IV  \n    - Heparin IV Drip  \n    - Rivaroxaban (Xarelto)  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Ondansetron  \n    - Norepinephrine IV (for hypotension)  \n    - Albuterol Inhaler  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV Q6H, Discontinued via patient discharge  \n    - Vancomycin: IV Q12H, Discontinued via patient discharge  \n    - Heparin Drip: IV infusion, Transitioned to Rivaroxaban  \n    - Rivaroxaban: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Norepinephrine: IV infusion, Discontinued prior to discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT Pulmonary Angiography  \n    - Transthoracic Echocardiogram (to rule out right heart strain and endocarditis)  \n    - Blood Cultures x2  \n    - Peripherally Inserted Central Catheter (PICC) line placement  \n\n---\n\nAdmission 32987124  \n    DRGs:  \n    - APR: RECURRENT SEPTIC PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 4.0)  \n    - HCFA: PULMONARY EMBOLISM W SEPSIS REQUIRING PROLONGED IV ANTIBIOTICS  \n\n    Medications:  \n    - Meropenem  \n    - Linezolid  \n    - Heparin IV Drip  \n    - Apixaban (Eliquis)  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron  \n    - Acetaminophen  \n    - Albuterol Nebulizer  \n\n    Orders:  \n    - Meropenem: IV Q8H, Discontinued via patient discharge  \n    - Linezolid: PO BID, Discontinued via patient discharge  \n    - Heparin Drip: IV infusion, Transitioned to Apixaban  \n    - Apixaban (Eliquis): PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Albuterol Nebulizer: IH, Discontinued via patient discharge  \n\n    Procedures:  \n    - Repeat CT Pulmonary Angiography  \n    - Transesophageal Echocardiogram (TEE) to evaluate for endocarditis  \n    - Central Venous Catheter Placement  \n    - Bronchoscopy with BAL (bronchoalveolar lavage)"}
{"id": "10001234", "pair_id": "40001234", "similarity": 0.5, "text": "Patient 10001234  \nGender: Female  \nAge: 68  \nRace: WHITE  \n\nAdmission 30245871  \n    DRGs:  \n    - APR: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 3.0)  \n    - HCFA: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE W CC  \n\n    Medications:  \n    - Apixaban (Eliquis)  \n    - Heparin IV  \n    - Furosemide  \n    - Metoprolol Tartrate  \n    - Sodium Chloride 0.9% Flush  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Albuterol Inhaler  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Apixaban (Eliquis): PO, Discontinued via patient discharge  \n    - Heparin IV: Continuous infusion, Discontinued via patient discharge  \n    - Furosemide: PO, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 2L/min, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT Pulmonary Angiography  \n    - Lower Extremity Venous Doppler Ultrasound  \n\n---\n\nAdmission 30984212  \n    DRGs:  \n    - APR: RECURRENT PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 4.0)  \n    - HCFA: PULMONARY EMBOLISM REQUIRING THROMBOLYSIS  \n\n    Medications:  \n    - Alteplase (tPA)  \n    - Unfractionated Heparin  \n    - Apixaban (Eliquis)  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron  \n    - Acetaminophen  \n    - Metoprolol Tartrate  \n    - Oxygen Therapy  \n\n    Orders:  \n    - Alteplase (tPA): IV bolus + infusion, Completed  \n    - Unfractionated Heparin: IV infusion, Discontinued via patient discharge  \n    - Apixaban: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 4L/min, Discontinued via patient discharge  \n    \n    Procedures:  \n    - Systemic Thrombolysis with Alteplase  \n    - Repeat CT Pulmonary Angiography  \n    - Echocardiogram for right ventricular strain", "pair_text": "Patient 40001234 \nGender: Female  \nAge: 66  \nRace: WHITE  \n\nAdmission 32741902  \n    DRGs:  \n    - APR: ACUTE VENOUS THROMBOEMBOLISM OF LOWER EXTREMITY (Severity 3.0)  \n    - HCFA: ACUTE DVT OF LOWER EXTREMITY W CC  \n\n    Medications:  \n    - Enoxaparin (Lovenox)  \n    - Warfarin  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Ondansetron  \n    - Influenza Vaccine Quadrivalent  \n    - Atorvastatin  \n    - Omeprazole  \n    - Bisacodyl  \n    - Albuterol Inhaler  \n\n    Orders:  \n    - Enoxaparin (Lovenox): SC, Discontinued via patient discharge  \n    - Warfarin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Omeprazole: PO, Discontinued via patient discharge  \n    - Bisacodyl: PO, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bilateral Lower Extremity Venous Doppler Ultrasound  \n    - INR Monitoring for Warfarin Adjustment  \n\n---\n\nAdmission 33452781  \n    DRGs:  \n    - APR: RECURRENT DEEP VEIN THROMBOSIS WITH EXTENSIVE CLOT BURDEN (Severity 4.0)  \n    - HCFA: COMPLICATED VENOUS THROMBOEMBOLISM WITH MCC  \n\n    Medications:  \n    - Apixaban (Eliquis)  \n    - Heparin IV  \n    - Sodium Chloride 0.9% Flush  \n    - Furosemide  \n    - Acetaminophen  \n    - Ondansetron  \n    - Metoprolol Tartrate  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Apixaban (Eliquis): PO, Discontinued via patient discharge  \n    - Heparin IV: Continuous infusion, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Furosemide: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Catheter-Directed Thrombolysis  \n    - Inferior Vena Cava (IVC) Filter Placement  \n    - Repeat Lower Extremity Venous Doppler"}
{"id": "10001234", "pair_id": "50001234", "similarity": 0.25, "text": "Patient 10001234  \nGender: Female  \nAge: 68  \nRace: WHITE  \n\nAdmission 30245871  \n    DRGs:  \n    - APR: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 3.0)  \n    - HCFA: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE W CC  \n\n    Medications:  \n    - Apixaban (Eliquis)  \n    - Heparin IV  \n    - Furosemide  \n    - Metoprolol Tartrate  \n    - Sodium Chloride 0.9% Flush  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Albuterol Inhaler  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Apixaban (Eliquis): PO, Discontinued via patient discharge  \n    - Heparin IV: Continuous infusion, Discontinued via patient discharge  \n    - Furosemide: PO, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 2L/min, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT Pulmonary Angiography  \n    - Lower Extremity Venous Doppler Ultrasound  \n\n---\n\nAdmission 30984212  \n    DRGs:  \n    - APR: RECURRENT PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 4.0)  \n    - HCFA: PULMONARY EMBOLISM REQUIRING THROMBOLYSIS  \n\n    Medications:  \n    - Alteplase (tPA)  \n    - Unfractionated Heparin  \n    - Apixaban (Eliquis)  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron  \n    - Acetaminophen  \n    - Metoprolol Tartrate  \n    - Oxygen Therapy  \n\n    Orders:  \n    - Alteplase (tPA): IV bolus + infusion, Completed  \n    - Unfractionated Heparin: IV infusion, Discontinued via patient discharge  \n    - Apixaban: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 4L/min, Discontinued via patient discharge  \n    \n    Procedures:  \n    - Systemic Thrombolysis with Alteplase  \n    - Repeat CT Pulmonary Angiography  \n    - Echocardiogram for right ventricular strain", "pair_text": "Patient 50001234  \nGender: Female  \nAge: 67  \nRace: WHITE  \n\nAdmission 31547812  \n    DRGs:  \n    - APR: CHRONIC VENOUS INSUFFICIENCY WITH LOWER LIMB EDEMA (Severity 2.0)  \n    - HCFA: PERIPHERAL VASCULAR DISORDERS W/O MCC  \n\n    Medications:  \n    - Furosemide PO  \n    - Compression Stockings  \n    - Pentoxifylline PO  \n    - Acetaminophen PO  \n    - Aspirin EC PO  \n    - Sodium Chloride 0.9% Flush IV  \n\n    Orders:  \n    - Furosemide: PO, Discontinued via patient discharge  \n    - Compression Stockings: Applied daily, Discontinued via patient discharge  \n    - Pentoxifylline: PO, Discontinued via patient discharge  \n    - Aspirin EC: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Venous Doppler ultrasound of lower extremities  \n    - Ankle-brachial index measurement  \n    - Education on leg elevation and exercise  \n\nAdmission 31890543  \n    DRGs:  \n    - APR: CHRONIC VENOUS INSUFFICIENCY WITH VARICOSE VEIN COMPLICATIONS (Severity 3.0)  \n    - HCFA: PERIPHERAL VASCULAR DISORDERS W CC  \n\n    Medications:  \n    - Furosemide PO  \n    - Aspirin EC PO  \n    - Rivaroxaban PO  \n    - Compression Stockings  \n    - Sodium Chloride 0.9% Flush IV  \n    - Acetaminophen PO  \n\n    Orders:  \n    - Furosemide: PO, Discontinued via patient discharge  \n    - Rivaroxaban: PO, Discontinued via patient discharge  \n    - Compression Stockings: Daily use, Discontinued via patient discharge  \n    - Aspirin EC: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Endovenous laser therapy (EVLT) for varicose veins  \n    - Duplex ultrasound for venous reflux mapping  \n    - Wound care for venous stasis ulcers  \n\nAdmission 32264128  \n    DRGs:  \n    - APR: SEVERE CHRONIC VENOUS INSUFFICIENCY WITH VENOUS ULCERATION (Severity 4.0)  \n    - HCFA: MAJOR PERIPHERAL VASCULAR DISORDERS W MCC  \n\n    Medications:  \n    - Furosemide IV  \n    - Rivaroxaban PO  \n    - Aspirin EC PO  \n    - Sodium Chloride 0.9% Flush IV  \n    - Oxycodone PO  \n    - Clindamycin PO  \n\n    Orders:  \n    - Furosemide: IV, Discontinued via patient discharge  \n    - Rivaroxaban: PO, Discontinued via patient discharge  \n    - Aspirin EC: PO, Discontinued via patient discharge  \n    - Clindamycin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Oxycodone: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Surgical debridement of venous ulcers  \n    - Skin grafting for chronic ulceration  \n    - Compression wrap therapy  \n    - Vascular consult for advanced venous bypass evaluation"}
{"id": "10001234", "pair_id": "60001234", "similarity": 0.0, "text": "Patient 10001234  \nGender: Female  \nAge: 68  \nRace: WHITE  \n\nAdmission 30245871  \n    DRGs:  \n    - APR: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 3.0)  \n    - HCFA: PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE W CC  \n\n    Medications:  \n    - Apixaban (Eliquis)  \n    - Heparin IV  \n    - Furosemide  \n    - Metoprolol Tartrate  \n    - Sodium Chloride 0.9% Flush  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Albuterol Inhaler  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Apixaban (Eliquis): PO, Discontinued via patient discharge  \n    - Heparin IV: Continuous infusion, Discontinued via patient discharge  \n    - Furosemide: PO, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 2L/min, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT Pulmonary Angiography  \n    - Lower Extremity Venous Doppler Ultrasound  \n\n---\n\nAdmission 30984212  \n    DRGs:  \n    - APR: RECURRENT PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE (Severity 4.0)  \n    - HCFA: PULMONARY EMBOLISM REQUIRING THROMBOLYSIS  \n\n    Medications:  \n    - Alteplase (tPA)  \n    - Unfractionated Heparin  \n    - Apixaban (Eliquis)  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron  \n    - Acetaminophen  \n    - Metoprolol Tartrate  \n    - Oxygen Therapy  \n\n    Orders:  \n    - Alteplase (tPA): IV bolus + infusion, Completed  \n    - Unfractionated Heparin: IV infusion, Discontinued via patient discharge  \n    - Apixaban: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Oxygen Therapy: NC 4L/min, Discontinued via patient discharge  \n    \n    Procedures:  \n    - Systemic Thrombolysis with Alteplase  \n    - Repeat CT Pulmonary Angiography  \n    - Echocardiogram for right ventricular strain", "pair_text": "Patient 60001234  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 51234678  \n    DRGs:  \n    - APR: MAJOR DEPRESSIVE DISORDERS (Severity 1.0)  \n    - HCFA: DEPRESSIVE NEUROSES W/O MCC  \n\n    Medications:  \n    - Sertraline (Zoloft) 50mg PO daily  \n    - Hydroxyzine 25mg PO PRN for anxiety  \n    - Trazodone 50mg PO HS PRN for sleep  \n    - Acetaminophen 500mg PO PRN for headache  \n    - Sodium Chloride 0.9% Flush IV  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Sertraline: PO, Scheduled, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Trazodone: PO, HS PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Initial psychiatric evaluation  \n    - Safety assessment and suicide risk screening  \n    - Cognitive Behavioral Therapy (CBT) session  \n\n---\n\nAdmission 52347901  \n    DRGs:  \n    - APR: MILD DEPRESSION W OUTPATIENT FOLLOW-UP (Severity 1.0)  \n    - HCFA: PSYCHIATRIC DISORDERS, MILD, W/O MCC  \n\n    Medications:  \n    - Escitalopram (Lexapro) 10mg PO daily  \n    - Lorazepam 0.5mg PO PRN for acute anxiety  \n    - Vitamin D3 1000 IU PO daily  \n    - Ibuprofen 400mg PO PRN for mild pain  \n    - Sodium Chloride 0.9% Flush IV  \n\n    Orders:  \n    - Escitalopram: PO, Scheduled, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Outpatient psychotherapy session  \n    - Depression screening via PHQ-9  \n    - Psychoeducation on lifestyle modifications  \n\n---\n\nAdmission 53452190  \n    DRGs:  \n    - APR: PSYCHOTHERAPY-FOCUSED CARE (Severity 1.0)  \n    - HCFA: PSYCHOTHERAPY FOR MILD MAJOR DEPRESSIVE EPISODE  \n\n    Medications:  \n    - Bupropion SR 150mg PO daily  \n    - Melatonin 3mg PO HS PRN for sleep  \n    - Multivitamin PO daily  \n    - Acetaminophen 650mg PO PRN  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Bupropion SR: PO, Scheduled, Discontinued via patient discharge  \n    - Melatonin: PO, HS PRN, Discontinued via patient discharge  \n    - Multivitamin: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Group Cognitive Behavioral Therapy  \n    - Mindfulness-Based Stress Reduction training  \n    - Discharge planning with outpatient follow-up"}
{"id": "10001278", "pair_id": "20001278", "similarity": 1.0, "text": "Patient 10001278   \nGender: Male  \nAge: 68  \nRace: WHITE  \n\nAdmission 31598273  \n    DRGs:  \n    - APR: LUNG MALIGNANCY WITHOUT COMPLICATIONS (Severity 2.0)  \n    - HCFA: PULMONARY NEOPLASMS W/O CC  \n\n    Medications:  \n    - Carboplatin  \n    - Paclitaxel  \n    - Ondansetron  \n    - Dexamethasone  \n    - Filgrastim  \n    - Morphine Sulfate  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Carboplatin: IV, Administered per chemotherapy cycle  \n    - Paclitaxel: IV, Administered per chemotherapy cycle  \n    - Ondansetron: IV, Pre-chemotherapy antiemetic  \n    - Dexamethasone: PO, Pre-chemotherapy antiemetic  \n    - Filgrastim: SC, Daily x5 days post-chemotherapy  \n    - Morphine Sulfate: PO, PRN for cancer-related pain  \n    - Oxygen Therapy: NC, Continuous, discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bronchoscopy with biopsy  \n    - CT-guided transthoracic lung biopsy  \n\n---\n\nAdmission 32254890  \n    DRGs:  \n    - APR: RESPIRATORY SYSTEM NEOPLASM WITH COMPLICATIONS (Severity 3.0)  \n    - HCFA: LUNG MALIGNANCY WITH CC  \n\n    Medications:  \n    - Pembrolizumab  \n    - Albuterol Inhaler  \n    - Tiotropium Bromide  \n    - Hydrocodone-Acetaminophen  \n    - Lorazepam  \n    - Heparin  \n    - Sodium Chloride 0.9% Flush  \n    - Famotidine  \n    - Ondansetron  \n    - Filgrastim  \n\n    Orders:  \n    - Pembrolizumab: IV, q3 weeks, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Hydrocodone-Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN for chemotherapy-related anxiety  \n    - Heparin: SC, Daily, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Famotidine: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Filgrastim: SC, Daily x5 days, Discontinued via patient discharge  \n\n    Procedures:  \n    - Mediport placement for chemotherapy access  \n    - PET-CT scan for staging  \n\n---\n\nAdmission 33462518  \n    DRGs:  \n    - APR: ACUTE RESPIRATORY FAILURE SECONDARY TO LUNG CANCER (Severity 4.0)  \n    - HCFA: RESPIRATORY FAILURE WITH CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam  \n    - Vancomycin  \n    - Methylprednisolone  \n    - Albuterol 0.083% Neb Soln  \n    - Tiotropium Bromide  \n    - Morphine Sulfate IV  \n    - Acetaminophen  \n    - Oxygen Therapy  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, q8h, Discontinued via patient discharge  \n    - Vancomycin: IV, q12h, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Daily, Discontinued via patient discharge  \n    - Albuterol 0.083% Neb Soln: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Morphine Sulfate IV: Continuous infusion for respiratory distress  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Oxygen Therapy: HFNC 50L, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Intubation and mechanical ventilation  \n    - Thoracentesis for malignant pleural effusion", "pair_text": "Patient 20001278  \nGender: Female  \nAge: 67  \nRace: WHITE  \n\nAdmission 31589274  \n    DRGs:  \n    - APR: LUNG CANCER - PULMONARY MALIGNANCY (Severity 3.0)  \n    - HCFA: RESPIRATORY NEOPLASMS W CC  \n\n    Medications:  \n    - Cisplatin  \n    - Pemetrexed  \n    - Dexamethasone  \n    - Ondansetron  \n    - Albuterol Inhaler  \n    - Tiotropium Bromide  \n    - Morphine Sulfate  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Cisplatin: IV, Scheduled, Discontinued via patient discharge  \n    - Pemetrexed: IV, Scheduled, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Discontinued via patient discharge  \n    - Morphine Sulfate: IV, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bronchoscopy with biopsy  \n    - CT-guided transthoracic lung biopsy  \n    - Port-a-cath insertion for chemotherapy  \n\n---\n\nAdmission 32278115  \n    DRGs:  \n    - APR: ACUTE RESPIRATORY FAILURE SECONDARY TO LUNG CANCER (Severity 4.0)  \n    - HCFA: RESPIRATORY FAILURE W MECHANICAL VENTILATION >96 HRS  \n\n    Medications:  \n    - Piperacillin-Tazobactam  \n    - Vancomycin  \n    - Furosemide  \n    - Hydrocortisone IV  \n    - Albuterol Nebulizer Solution  \n    - Sodium Chloride 0.9% Flush  \n    - Midazolam  \n    - Propofol Infusion  \n    - Heparin  \n    - Omeprazole IV  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, Scheduled, Discontinued via patient discharge  \n    - Vancomycin: IV, Scheduled, Discontinued via patient discharge  \n    - Furosemide: IV, PRN, Discontinued via patient discharge  \n    - Hydrocortisone IV: Scheduled, Discontinued via patient discharge  \n    - Albuterol Nebulizer Solution: IH, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Midazolam: IV Drip, Discontinued via patient discharge  \n    - Propofol Infusion: IV Drip, Discontinued via patient discharge  \n    - Heparin: SC, Discontinued via patient discharge  \n    - Omeprazole IV: Scheduled, Discontinued via patient discharge  \n\n    Procedures:  \n    - Endotracheal intubation  \n    - Mechanical ventilation management  \n    - Thoracentesis for malignant pleural effusion  \n\n---\n\nAdmission 33567492  \n    DRGs:  \n    - APR: LUNG CANCER WITH METASTASIS (Severity 4.0)  \n    - HCFA: SECONDARY MALIGNANCY W CC  \n\n    Medications:  \n    - Nivolumab (Opdivo)  \n    - Carboplatin  \n    - Folic Acid  \n    - Dexamethasone  \n    - Ondansetron  \n    - Oxycodone  \n    - Senna  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n    - Enoxaparin  \n\n    Orders:  \n    - Nivolumab (Opdivo): IV, Scheduled, Discontinued via patient discharge  \n    - Carboplatin: IV, Scheduled, Discontinued via patient discharge  \n    - Folic Acid: PO, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Senna: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - PET-CT scan for metastatic disease assessment  \n    - Thoracic lymph node biopsy  \n    - Palliative radiation therapy"}
{"id": "10001278", "pair_id": "30001278", "similarity": 0.75, "text": "Patient 10001278   \nGender: Male  \nAge: 68  \nRace: WHITE  \n\nAdmission 31598273  \n    DRGs:  \n    - APR: LUNG MALIGNANCY WITHOUT COMPLICATIONS (Severity 2.0)  \n    - HCFA: PULMONARY NEOPLASMS W/O CC  \n\n    Medications:  \n    - Carboplatin  \n    - Paclitaxel  \n    - Ondansetron  \n    - Dexamethasone  \n    - Filgrastim  \n    - Morphine Sulfate  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Carboplatin: IV, Administered per chemotherapy cycle  \n    - Paclitaxel: IV, Administered per chemotherapy cycle  \n    - Ondansetron: IV, Pre-chemotherapy antiemetic  \n    - Dexamethasone: PO, Pre-chemotherapy antiemetic  \n    - Filgrastim: SC, Daily x5 days post-chemotherapy  \n    - Morphine Sulfate: PO, PRN for cancer-related pain  \n    - Oxygen Therapy: NC, Continuous, discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bronchoscopy with biopsy  \n    - CT-guided transthoracic lung biopsy  \n\n---\n\nAdmission 32254890  \n    DRGs:  \n    - APR: RESPIRATORY SYSTEM NEOPLASM WITH COMPLICATIONS (Severity 3.0)  \n    - HCFA: LUNG MALIGNANCY WITH CC  \n\n    Medications:  \n    - Pembrolizumab  \n    - Albuterol Inhaler  \n    - Tiotropium Bromide  \n    - Hydrocodone-Acetaminophen  \n    - Lorazepam  \n    - Heparin  \n    - Sodium Chloride 0.9% Flush  \n    - Famotidine  \n    - Ondansetron  \n    - Filgrastim  \n\n    Orders:  \n    - Pembrolizumab: IV, q3 weeks, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Hydrocodone-Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN for chemotherapy-related anxiety  \n    - Heparin: SC, Daily, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Famotidine: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Filgrastim: SC, Daily x5 days, Discontinued via patient discharge  \n\n    Procedures:  \n    - Mediport placement for chemotherapy access  \n    - PET-CT scan for staging  \n\n---\n\nAdmission 33462518  \n    DRGs:  \n    - APR: ACUTE RESPIRATORY FAILURE SECONDARY TO LUNG CANCER (Severity 4.0)  \n    - HCFA: RESPIRATORY FAILURE WITH CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam  \n    - Vancomycin  \n    - Methylprednisolone  \n    - Albuterol 0.083% Neb Soln  \n    - Tiotropium Bromide  \n    - Morphine Sulfate IV  \n    - Acetaminophen  \n    - Oxygen Therapy  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, q8h, Discontinued via patient discharge  \n    - Vancomycin: IV, q12h, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Daily, Discontinued via patient discharge  \n    - Albuterol 0.083% Neb Soln: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Morphine Sulfate IV: Continuous infusion for respiratory distress  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Oxygen Therapy: HFNC 50L, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Intubation and mechanical ventilation  \n    - Thoracentesis for malignant pleural effusion", "pair_text": "Patient 30001278  \nGender: Male  \nAge: 69  \nRace: WHITE  \n\nAdmission 41256320  \n    DRGs:  \n    - APR: LUNG CANCER - MALIGNANT NEOPLASM, UPPER LOBE (Severity 3.0)  \n    - HCFA: PULMONARY NEOPLASMS W CC  \n\n    Medications:  \n    - Cisplatin  \n    - Pemetrexed  \n    - Dexamethasone  \n    - Ondansetron  \n    - Morphine Sulfate  \n    - Tiotropium Bromide  \n    - Albuterol Inhaler  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n    - Pantoprazole  \n\n    Orders:  \n    - Cisplatin: IV, Scheduled, Discontinued via patient discharge  \n    - Pemetrexed: IV, Scheduled, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, Discontinued via patient discharge  \n    - Morphine Sulfate: IV, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n    - Pantoprazole: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bronchoscopy with transbronchial biopsy  \n    - CT-guided upper lobe mass biopsy  \n    - Port-a-cath placement for chemotherapy  \n\n---\n\nAdmission 42178905  \n    DRGs:  \n    - APR: RESPIRATORY FAILURE SECONDARY TO LUNG CANCER (Severity 4.0)  \n    - HCFA: RESPIRATORY FAILURE W MECHANICAL VENTILATION >96 HRS  \n\n    Medications:  \n    - Piperacillin-Tazobactam  \n    - Vancomycin  \n    - Methylprednisolone IV  \n    - Albuterol Nebulizer  \n    - Midazolam IV Drip  \n    - Propofol Infusion  \n    - Sodium Chloride 0.9% Flush  \n    - Omeprazole IV  \n    - Heparin  \n    - Furosemide  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, Scheduled, Discontinued via patient discharge  \n    - Vancomycin: IV, Scheduled, Discontinued via patient discharge  \n    - Methylprednisolone IV: Scheduled, Discontinued via patient discharge  \n    - Albuterol Nebulizer: IH, Discontinued via patient discharge  \n    - Midazolam IV Drip: Continuous, Discontinued via patient discharge  \n    - Propofol Infusion: Continuous, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Omeprazole IV: Scheduled, Discontinued via patient discharge  \n    - Heparin: SC, Discontinued via patient discharge  \n    - Furosemide: IV, PRN, Discontinued via patient discharge  \n\n    Procedures:  \n    - Endotracheal intubation  \n    - Mechanical ventilation management  \n    - Thoracentesis for malignant pleural effusion  \n\n---\n\nAdmission 43789211  \n    DRGs:  \n    - APR: LUNG CANCER WITH METASTATIC PROGRESSION (Severity 4.0)  \n    - HCFA: SECONDARY MALIGNANCY W CC  \n\n    Medications:  \n    - Nivolumab (Opdivo)  \n    - Carboplatin  \n    - Folic Acid  \n    - Dexamethasone  \n    - Ondansetron  \n    - Oxycodone  \n    - Senna  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n    - Enoxaparin  \n\n    Orders:  \n    - Nivolumab (Opdivo): IV, Scheduled, Discontinued via patient discharge  \n    - Carboplatin: IV, Scheduled, Discontinued via patient discharge  \n    - Folic Acid: PO, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Senna: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - PET-CT scan for metastatic assessment  \n    - Supraclavicular lymph node excision  \n    - Palliative radiation therapy to upper lobe mass"}
{"id": "10001278", "pair_id": "40001278", "similarity": 0.5, "text": "Patient 10001278   \nGender: Male  \nAge: 68  \nRace: WHITE  \n\nAdmission 31598273  \n    DRGs:  \n    - APR: LUNG MALIGNANCY WITHOUT COMPLICATIONS (Severity 2.0)  \n    - HCFA: PULMONARY NEOPLASMS W/O CC  \n\n    Medications:  \n    - Carboplatin  \n    - Paclitaxel  \n    - Ondansetron  \n    - Dexamethasone  \n    - Filgrastim  \n    - Morphine Sulfate  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Carboplatin: IV, Administered per chemotherapy cycle  \n    - Paclitaxel: IV, Administered per chemotherapy cycle  \n    - Ondansetron: IV, Pre-chemotherapy antiemetic  \n    - Dexamethasone: PO, Pre-chemotherapy antiemetic  \n    - Filgrastim: SC, Daily x5 days post-chemotherapy  \n    - Morphine Sulfate: PO, PRN for cancer-related pain  \n    - Oxygen Therapy: NC, Continuous, discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bronchoscopy with biopsy  \n    - CT-guided transthoracic lung biopsy  \n\n---\n\nAdmission 32254890  \n    DRGs:  \n    - APR: RESPIRATORY SYSTEM NEOPLASM WITH COMPLICATIONS (Severity 3.0)  \n    - HCFA: LUNG MALIGNANCY WITH CC  \n\n    Medications:  \n    - Pembrolizumab  \n    - Albuterol Inhaler  \n    - Tiotropium Bromide  \n    - Hydrocodone-Acetaminophen  \n    - Lorazepam  \n    - Heparin  \n    - Sodium Chloride 0.9% Flush  \n    - Famotidine  \n    - Ondansetron  \n    - Filgrastim  \n\n    Orders:  \n    - Pembrolizumab: IV, q3 weeks, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Hydrocodone-Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN for chemotherapy-related anxiety  \n    - Heparin: SC, Daily, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Famotidine: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Filgrastim: SC, Daily x5 days, Discontinued via patient discharge  \n\n    Procedures:  \n    - Mediport placement for chemotherapy access  \n    - PET-CT scan for staging  \n\n---\n\nAdmission 33462518  \n    DRGs:  \n    - APR: ACUTE RESPIRATORY FAILURE SECONDARY TO LUNG CANCER (Severity 4.0)  \n    - HCFA: RESPIRATORY FAILURE WITH CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam  \n    - Vancomycin  \n    - Methylprednisolone  \n    - Albuterol 0.083% Neb Soln  \n    - Tiotropium Bromide  \n    - Morphine Sulfate IV  \n    - Acetaminophen  \n    - Oxygen Therapy  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, q8h, Discontinued via patient discharge  \n    - Vancomycin: IV, q12h, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Daily, Discontinued via patient discharge  \n    - Albuterol 0.083% Neb Soln: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Morphine Sulfate IV: Continuous infusion for respiratory distress  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Oxygen Therapy: HFNC 50L, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Intubation and mechanical ventilation  \n    - Thoracentesis for malignant pleural effusion", "pair_text": "Patient 40001278  \nGender: Female  \nAge: 62  \nRace: WHITE  \n\nAdmission 51278345  \n    DRGs:  \n    - APR: SECONDARY MALIGNANCY OF BONE (Severity 3.0)  \n    - HCFA: PATHOLOGICAL FRACTURES & BONE METASTASES W CC  \n\n    Medications:  \n    - Zoledronic Acid (Zometa)  \n    - Denosumab (Xgeva)  \n    - Dexamethasone  \n    - Oxycodone  \n    - Acetaminophen  \n    - Ondansetron  \n    - Calcium Carbonate  \n    - Vitamin D3 Supplement  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Zoledronic Acid (Zometa): IV, Monthly, Discontinued via patient discharge  \n    - Denosumab (Xgeva): SC, Monthly, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Ondansetron: PO, Discontinued via patient discharge  \n    - Calcium Carbonate: PO, Discontinued via patient discharge  \n    - Vitamin D3 Supplement: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Whole-body PET-CT scan  \n    - CT-guided biopsy of metastatic bone lesion  \n    - Port-a-cath placement for systemic therapy  \n\n---\n\nAdmission 52419781  \n    DRGs:  \n    - APR: PATHOLOGICAL FRACTURE DUE TO BONE METASTASIS (Severity 4.0)  \n    - HCFA: ORTHOPEDIC SURGERY FOR FRACTURES W CC  \n\n    Medications:  \n    - Hydromorphone PCA  \n    - Methadone  \n    - Ketorolac IV  \n    - Cefazolin IV  \n    - Zoledronic Acid  \n    - Ondansetron  \n    - Enoxaparin  \n    - Senna  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Hydromorphone PCA: IV Continuous, Discontinued via patient discharge  \n    - Methadone: PO, Scheduled, Discontinued via patient discharge  \n    - Ketorolac IV: Scheduled, Discontinued via patient discharge  \n    - Cefazolin IV: Perioperative, Discontinued via patient discharge  \n    - Zoledronic Acid: IV, Monthly, Discontinued via patient discharge  \n    - Ondansetron: IV, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n    - Senna: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Open reduction and internal fixation (ORIF) of femoral pathological fracture  \n    - Intraoperative fluoroscopy  \n    - Bone cement augmentation for stability  \n\n---\n\nAdmission 53968210  \n    DRGs:  \n    - APR: CANCER PAIN MANAGEMENT - SECONDARY BONE NEOPLASM (Severity 4.0)  \n    - HCFA: PALLIATIVE CARE W CC  \n\n    Medications:  \n    - Fentanyl Transdermal Patch  \n    - Hydromorphone IV  \n    - Gabapentin  \n    - Dexamethasone  \n    - Ondansetron  \n    - Lorazepam  \n    - Acetaminophen  \n    - Bisacodyl  \n    - Sodium Chloride 0.9% Flush  \n    - Zoledronic Acid  \n\n    Orders:  \n    - Fentanyl Transdermal Patch: TD, Scheduled, Discontinued via patient discharge  \n    - Hydromorphone IV: PRN, Discontinued via patient discharge  \n    - Gabapentin: PO, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Ondansetron: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Bisacodyl: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Zoledronic Acid: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Palliative radiation therapy to spine metastasis  \n    - MRI of thoracic and lumbar spine  \n    - Ultrasound-guided celiac plexus block for cancer-related pain"}
{"id": "10001278", "pair_id": "50001278", "similarity": 0.25, "text": "Patient 10001278   \nGender: Male  \nAge: 68  \nRace: WHITE  \n\nAdmission 31598273  \n    DRGs:  \n    - APR: LUNG MALIGNANCY WITHOUT COMPLICATIONS (Severity 2.0)  \n    - HCFA: PULMONARY NEOPLASMS W/O CC  \n\n    Medications:  \n    - Carboplatin  \n    - Paclitaxel  \n    - Ondansetron  \n    - Dexamethasone  \n    - Filgrastim  \n    - Morphine Sulfate  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Carboplatin: IV, Administered per chemotherapy cycle  \n    - Paclitaxel: IV, Administered per chemotherapy cycle  \n    - Ondansetron: IV, Pre-chemotherapy antiemetic  \n    - Dexamethasone: PO, Pre-chemotherapy antiemetic  \n    - Filgrastim: SC, Daily x5 days post-chemotherapy  \n    - Morphine Sulfate: PO, PRN for cancer-related pain  \n    - Oxygen Therapy: NC, Continuous, discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bronchoscopy with biopsy  \n    - CT-guided transthoracic lung biopsy  \n\n---\n\nAdmission 32254890  \n    DRGs:  \n    - APR: RESPIRATORY SYSTEM NEOPLASM WITH COMPLICATIONS (Severity 3.0)  \n    - HCFA: LUNG MALIGNANCY WITH CC  \n\n    Medications:  \n    - Pembrolizumab  \n    - Albuterol Inhaler  \n    - Tiotropium Bromide  \n    - Hydrocodone-Acetaminophen  \n    - Lorazepam  \n    - Heparin  \n    - Sodium Chloride 0.9% Flush  \n    - Famotidine  \n    - Ondansetron  \n    - Filgrastim  \n\n    Orders:  \n    - Pembrolizumab: IV, q3 weeks, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Hydrocodone-Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN for chemotherapy-related anxiety  \n    - Heparin: SC, Daily, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Famotidine: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Filgrastim: SC, Daily x5 days, Discontinued via patient discharge  \n\n    Procedures:  \n    - Mediport placement for chemotherapy access  \n    - PET-CT scan for staging  \n\n---\n\nAdmission 33462518  \n    DRGs:  \n    - APR: ACUTE RESPIRATORY FAILURE SECONDARY TO LUNG CANCER (Severity 4.0)  \n    - HCFA: RESPIRATORY FAILURE WITH CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam  \n    - Vancomycin  \n    - Methylprednisolone  \n    - Albuterol 0.083% Neb Soln  \n    - Tiotropium Bromide  \n    - Morphine Sulfate IV  \n    - Acetaminophen  \n    - Oxygen Therapy  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, q8h, Discontinued via patient discharge  \n    - Vancomycin: IV, q12h, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Daily, Discontinued via patient discharge  \n    - Albuterol 0.083% Neb Soln: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Morphine Sulfate IV: Continuous infusion for respiratory distress  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Oxygen Therapy: HFNC 50L, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Intubation and mechanical ventilation  \n    - Thoracentesis for malignant pleural effusion", "pair_text": "Patient 50001278\nGender: Male\nAge: 68\nRace: WHITE\n\nAdmission 33845721\n    DRGs:\n    - APR: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) (Severity 3.0)\n    - HCFA: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W MCC\n\n    Medications:\n    - Tiotropium Bromide (Spiriva)\n    - Albuterol 0.083% Neb Soln\n    - Ipratropium Bromide Neb\n    - Fluticasone-Salmeterol (Advair Diskus)\n    - Prednisone\n    - Azithromycin\n    - Montelukast\n    - Sodium Chloride 0.9% Flush\n    - Acetaminophen\n    - Influenza Vaccine Quadrivalent\n    - Heparin\n    - Oxygen Therapy (2L NC)\n\n    Orders:\n    - Tiotropium Bromide (Spiriva): IH, Discontinued via patient discharge\n    - Albuterol 0.083% Neb Soln: IH, Discontinued via patient discharge\n    - Ipratropium Bromide Neb: IH, Discontinued via patient discharge\n    - Fluticasone-Salmeterol (Advair Diskus): IH, Discontinued via patient discharge\n    - Prednisone: PO, Discontinued via patient discharge\n    - Azithromycin: PO, Discontinued via patient discharge\n    - Montelukast: PO, Discontinued via patient discharge\n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge\n    - Acetaminophen: PO, Discontinued via patient discharge\n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge\n    - Heparin: SC, Discontinued via patient discharge\n    - Oxygen Therapy: Continuous, Discontinued via patient discharge\n\n    Procedures:\n    - Chest X-Ray (portable)\n    - Arterial Blood Gas (ABG) analysis\n    - Pulse Oximetry monitoring\n    - Non-invasive ventilation initiation (BiPAP)\n\nAdmission 34572890\n    DRGs:\n    - APR: ACUTE EXACERBATION OF COPD (Severity 4.0)\n    - HCFA: ACUTE RESPIRATORY FAILURE W MCC\n\n    Medications:\n    - Methylprednisolone IV\n    - Piperacillin-Tazobactam (Zosyn)\n    - Albuterol Inhaler\n    - Tiotropium Bromide\n    - Budesonide Neb\n    - Levofloxacin\n    - Sodium Chloride 0.9% Flush\n    - Lorazepam\n    - Magnesium Sulfate IV\n    - Heparin\n    - Acetaminophen\n\n    Orders:\n    - Methylprednisolone IV: IV, Discontinued via patient discharge\n    - Piperacillin-Tazobactam (Zosyn): IV, Discontinued via patient discharge\n    - Albuterol Inhaler: IH, Discontinued via patient discharge\n    - Tiotropium Bromide: IH, Discontinued via patient discharge\n    - Budesonide Neb: IH, Discontinued via patient discharge\n    - Levofloxacin: PO, Discontinued via patient discharge\n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge\n    - Lorazepam: PO, Discontinued via patient discharge\n    - Magnesium Sulfate IV: IV, Discontinued via patient discharge\n    - Heparin: SC, Discontinued via patient discharge\n    - Acetaminophen: PO, Discontinued via patient discharge\n\n    Procedures:\n    - Endotracheal intubation with mechanical ventilation\n    - Continuous cardiac telemetry monitoring\n    - Bronchoscopy for airway clearance\n    - CT Chest without contrast\n\nAdmission 35698710\n    DRGs:\n    - APR: RESPIRATORY INFECTION WITH COPD (Severity 2.0)\n    - HCFA: SIMPLE PNEUMONIA & PLEURISY W CC\n\n    Medications:\n    - Amoxicillin-Clavulanate\n    - Tiotropium Bromide\n    - Albuterol Inhaler\n    - Fluticasone Propionate Nasal Spray\n    - Prednisone\n    - Oseltamivir\n    - Sodium Chloride 0.9% Flush\n    - Guaifenesin\n    - Influenza Vaccine Quadrivalent\n    - Heparin\n\n    Orders:\n    - Amoxicillin-Clavulanate: PO, Discontinued via patient discharge\n    - Tiotropium Bromide: IH, Discontinued via patient discharge\n    - Albuterol Inhaler: IH, Discontinued via patient discharge\n    - Fluticasone Propionate Nasal Spray: IH, Discontinued via patient discharge\n    - Prednisone: PO, Discontinued via patient discharge\n    - Oseltamivir: PO, Discontinued via patient discharge\n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge\n    - Guaifenesin: PO, Discontinued via patient discharge\n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge\n    - Heparin: SC, Discontinued via patient discharge\n\n    Procedures:\n    - Sputum culture and sensitivity\n    - High-resolution CT scan (HRCT)\n    - Spirometry"}
{"id": "10001278", "pair_id": "60001278", "similarity": 0.0, "text": "Patient 10001278   \nGender: Male  \nAge: 68  \nRace: WHITE  \n\nAdmission 31598273  \n    DRGs:  \n    - APR: LUNG MALIGNANCY WITHOUT COMPLICATIONS (Severity 2.0)  \n    - HCFA: PULMONARY NEOPLASMS W/O CC  \n\n    Medications:  \n    - Carboplatin  \n    - Paclitaxel  \n    - Ondansetron  \n    - Dexamethasone  \n    - Filgrastim  \n    - Morphine Sulfate  \n    - Oxygen Therapy  \n    - Acetaminophen  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Carboplatin: IV, Administered per chemotherapy cycle  \n    - Paclitaxel: IV, Administered per chemotherapy cycle  \n    - Ondansetron: IV, Pre-chemotherapy antiemetic  \n    - Dexamethasone: PO, Pre-chemotherapy antiemetic  \n    - Filgrastim: SC, Daily x5 days post-chemotherapy  \n    - Morphine Sulfate: PO, PRN for cancer-related pain  \n    - Oxygen Therapy: NC, Continuous, discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bronchoscopy with biopsy  \n    - CT-guided transthoracic lung biopsy  \n\n---\n\nAdmission 32254890  \n    DRGs:  \n    - APR: RESPIRATORY SYSTEM NEOPLASM WITH COMPLICATIONS (Severity 3.0)  \n    - HCFA: LUNG MALIGNANCY WITH CC  \n\n    Medications:  \n    - Pembrolizumab  \n    - Albuterol Inhaler  \n    - Tiotropium Bromide  \n    - Hydrocodone-Acetaminophen  \n    - Lorazepam  \n    - Heparin  \n    - Sodium Chloride 0.9% Flush  \n    - Famotidine  \n    - Ondansetron  \n    - Filgrastim  \n\n    Orders:  \n    - Pembrolizumab: IV, q3 weeks, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Hydrocodone-Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN for chemotherapy-related anxiety  \n    - Heparin: SC, Daily, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Famotidine: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Filgrastim: SC, Daily x5 days, Discontinued via patient discharge  \n\n    Procedures:  \n    - Mediport placement for chemotherapy access  \n    - PET-CT scan for staging  \n\n---\n\nAdmission 33462518  \n    DRGs:  \n    - APR: ACUTE RESPIRATORY FAILURE SECONDARY TO LUNG CANCER (Severity 4.0)  \n    - HCFA: RESPIRATORY FAILURE WITH CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam  \n    - Vancomycin  \n    - Methylprednisolone  \n    - Albuterol 0.083% Neb Soln  \n    - Tiotropium Bromide  \n    - Morphine Sulfate IV  \n    - Acetaminophen  \n    - Oxygen Therapy  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, q8h, Discontinued via patient discharge  \n    - Vancomycin: IV, q12h, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Daily, Discontinued via patient discharge  \n    - Albuterol 0.083% Neb Soln: IH, PRN, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Daily, Discontinued via patient discharge  \n    - Morphine Sulfate IV: Continuous infusion for respiratory distress  \n    - Acetaminophen: PO/NG, Discontinued via patient discharge  \n    - Oxygen Therapy: HFNC 50L, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Intubation and mechanical ventilation  \n    - Thoracentesis for malignant pleural effusion", "pair_text": "Patient 60001278  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 51890324  \n    DRGs:  \n    - APR: FOREARM FRACTURE - CLOSED REDUCTION / CASTING (Severity 2.0)  \n    - HCFA: UPPER EXTREMITY FRACTURE W/O MCC  \n\n    Medications:  \n    - Acetaminophen  \n    - Ibuprofen  \n    - Oxycodone  \n    - Ondansetron  \n    - Cefazolin  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Cefazolin: IV, Single dose pre-op, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Closed reduction of right distal radius fracture  \n    - Application of short-arm cast under conscious sedation  \n    - X-ray imaging of right forearm (pre- and post-reduction)  \n\n---\n\nAdmission 52678415  \n    DRGs:  \n    - APR: OPEN REDUCTION AND INTERNAL FIXATION OF RADIUS (Severity 3.0)  \n    - HCFA: OPEN TREATMENT OF FOREARM FRACTURE W CC  \n\n    Medications:  \n    - Cefazolin  \n    - Hydromorphone  \n    - Acetaminophen  \n    - Ibuprofen  \n    - Enoxaparin  \n    - Ondansetron  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Cefazolin: IV, Perioperative, Discontinued via patient discharge  \n    - Hydromorphone: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, Scheduled, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Open reduction and internal fixation (ORIF) of right distal radius  \n    - Placement of volar locking plate and screws  \n    - Intraoperative fluoroscopy for alignment confirmation  \n\n---\n\nAdmission 53429587  \n    DRGs:  \n    - APR: POSTOPERATIVE COMPLICATIONS FOLLOWING ORIF (Severity 2.0)  \n    - HCFA: POSTPROCEDURAL INFECTION W CC  \n\n    Medications:  \n    - Vancomycin  \n    - Piperacillin-Tazobactam  \n    - Acetaminophen  \n    - Oxycodone  \n    - Ondansetron  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Vancomycin: IV, Scheduled, Discontinued via patient discharge  \n    - Piperacillin-Tazobactam: IV, Scheduled, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bedside irrigation and debridement of surgical wound  \n    - Wound culture collection  \n    - Follow-up X-ray for hardware position verification"}
{"id": "10001279", "pair_id": "20001279", "similarity": 1.0, "text": "Patient 10001279  \nGender: Male  \nAge: 55  \nRace: HISPANIC  \n\nAdmission 41908751  \n    DRGs:  \n    - APR: TYPE 2 DIABETES MELLITUS W/O COMPLICATIONS (Severity 1.0)  \n    - HCFA: DIABETES MELLITUS W/O COMPLICATIONS  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Glimepiride 4 mg daily  \n    - Lisinopril 10 mg daily  \n    - Atorvastatin 20 mg nightly  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Glimepiride: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Fasting plasma glucose test  \n    - HbA1c measurement  \n    - Lipid panel  \n\n---\n\nAdmission 42569013  \n    DRGs:  \n    - APR: DIABETES WITH HYPERGLYCEMIA, NO COMPLICATIONS (Severity 2.0)  \n    - HCFA: TYPE 2 DM W UNCONTROLLED BLOOD GLUCOSE  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine (Lantus) 15 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Lisinopril 20 mg daily  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Sliding scale, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous glucose monitoring initiation  \n    - Comprehensive metabolic panel  \n    - Nutrition counseling with certified diabetes educator  \n\n---\n\nAdmission 43287145  \n    DRGs:  \n    - APR: ROUTINE DIABETES FOLLOW-UP VISIT (Severity 1.0)  \n    - HCFA: DIABETES MANAGEMENT, OUTPATIENT  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine 18 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Aspirin 81 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - HbA1c recheck  \n    - Retinal fundus photography for diabetic retinopathy screening  \n    - Urine microalbumin test  \n    - Blood pressure monitoring", "pair_text": "Patient 20001279  \nGender: Female  \nAge: 62  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 51234781  \n    DRGs:  \n    - APR: TYPE 2 DIABETES MELLITUS, NEWLY DIAGNOSED (Severity 1.0)  \n    - HCFA: DIABETES MELLITUS W/O COMPLICATIONS  \n\n    Medications:  \n    - Metformin 500 mg BID  \n    - Sitagliptin 100 mg daily  \n    - Atorvastatin 20 mg nightly  \n    - Lisinopril 5 mg daily  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Sitagliptin: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Oral glucose tolerance test  \n    - HbA1c measurement  \n    - Lipid profile screening  \n\n---\n\nAdmission 52650942  \n    DRGs:  \n    - APR: DIABETES WITH POOR GLYCEMIC CONTROL (Severity 2.0)  \n    - HCFA: TYPE 2 DIABETES WITH HYPERGLYCEMIA W/O COMPLICATIONS  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Empagliflozin 25 mg daily  \n    - Atorvastatin 40 mg nightly  \n    - Lisinopril 10 mg daily  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Empagliflozin: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - HbA1c follow-up test  \n    - Comprehensive metabolic panel  \n    - Diabetes education and lifestyle counseling session  \n\n---\n\nAdmission 53891276  \n    DRGs:  \n    - APR: DIABETES ANNUAL OUTPATIENT REVIEW (Severity 1.0)  \n    - HCFA: ROUTINE DIABETES MANAGEMENT, OUTPATIENT  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Empagliflozin 25 mg daily  \n    - Atorvastatin 40 mg nightly  \n    - Aspirin 81 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Empagliflozin: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - HbA1c recheck  \n    - Retinal fundus photography  \n    - Urine microalbumin screening  \n    - Diabetic foot exam  \n    - Blood pressure monitoring"}
{"id": "10001279", "pair_id": "30001279", "similarity": 0.75, "text": "Patient 10001279  \nGender: Male  \nAge: 55  \nRace: HISPANIC  \n\nAdmission 41908751  \n    DRGs:  \n    - APR: TYPE 2 DIABETES MELLITUS W/O COMPLICATIONS (Severity 1.0)  \n    - HCFA: DIABETES MELLITUS W/O COMPLICATIONS  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Glimepiride 4 mg daily  \n    - Lisinopril 10 mg daily  \n    - Atorvastatin 20 mg nightly  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Glimepiride: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Fasting plasma glucose test  \n    - HbA1c measurement  \n    - Lipid panel  \n\n---\n\nAdmission 42569013  \n    DRGs:  \n    - APR: DIABETES WITH HYPERGLYCEMIA, NO COMPLICATIONS (Severity 2.0)  \n    - HCFA: TYPE 2 DM W UNCONTROLLED BLOOD GLUCOSE  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine (Lantus) 15 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Lisinopril 20 mg daily  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Sliding scale, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous glucose monitoring initiation  \n    - Comprehensive metabolic panel  \n    - Nutrition counseling with certified diabetes educator  \n\n---\n\nAdmission 43287145  \n    DRGs:  \n    - APR: ROUTINE DIABETES FOLLOW-UP VISIT (Severity 1.0)  \n    - HCFA: DIABETES MANAGEMENT, OUTPATIENT  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine 18 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Aspirin 81 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - HbA1c recheck  \n    - Retinal fundus photography for diabetic retinopathy screening  \n    - Urine microalbumin test  \n    - Blood pressure monitoring", "pair_text": "Patient 30001279  \nGender: Male  \nAge: 59  \nRace: WHITE  \n\nAdmission 54821903  \n    DRGs:  \n    - APR: TYPE 2 DIABETES WITH HYPERGLYCEMIA - INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: DIABETES MELLITUS WITH HYPERGLYCEMIA W/O MCC  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Glimepiride 4 mg daily  \n    - Insulin Glargine 15 units nightly  \n    - Insulin Lispro sliding scale before meals  \n    - Atorvastatin 20 mg nightly  \n    - Lisinopril 10 mg daily  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Glimepiride: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Sliding scale, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - HbA1c measurement  \n    - Basic metabolic panel  \n    - Diabetes nutrition counseling session  \n\n---\n\nAdmission 55376421  \n    DRGs:  \n    - APR: DIABETES WITH ACUTE HYPERGLYCEMIC EXACERBATION (Severity 3.0)  \n    - HCFA: UNCONTROLLED TYPE 2 DIABETES W HYPERGLYCEMIA W CC  \n\n    Medications:  \n    - Insulin Glargine 25 units nightly  \n    - Insulin Lispro sliding scale pre-meals  \n    - Metformin 500 mg BID  \n    - Empagliflozin 25 mg daily  \n    - Atorvastatin 40 mg nightly  \n    - Losartan 50 mg daily  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Sliding scale, Discontinued via patient discharge  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Empagliflozin: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Losartan: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous glucose monitoring initiation  \n    - IV fluids for hyperglycemia management  \n    - Endocrinology consultation for insulin titration  \n\n---\n\nAdmission 56788134  \n    DRGs:  \n    - APR: FOLLOW-UP DIABETES MANAGEMENT - PERSISTENT HYPERGLYCEMIA (Severity 2.0)  \n    - HCFA: OUTPATIENT GLUCOSE CONTROL & DIABETES EDUCATION  \n\n    Medications:  \n    - Insulin Glargine 28 units nightly  \n    - Insulin Lispro sliding scale before meals  \n    - Metformin 1000 mg BID  \n    - Empagliflozin 25 mg daily  \n    - Atorvastatin 40 mg nightly  \n    - Aspirin 81 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Discontinued via patient discharge  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Empagliflozin: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - HbA1c recheck  \n    - Retinal fundus exam for diabetic retinopathy screening  \n    - Urine microalbumin test  \n    - Diabetes self-management education"}
{"id": "10001279", "pair_id": "40001279", "similarity": 0.5, "text": "Patient 10001279  \nGender: Male  \nAge: 55  \nRace: HISPANIC  \n\nAdmission 41908751  \n    DRGs:  \n    - APR: TYPE 2 DIABETES MELLITUS W/O COMPLICATIONS (Severity 1.0)  \n    - HCFA: DIABETES MELLITUS W/O COMPLICATIONS  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Glimepiride 4 mg daily  \n    - Lisinopril 10 mg daily  \n    - Atorvastatin 20 mg nightly  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Glimepiride: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Fasting plasma glucose test  \n    - HbA1c measurement  \n    - Lipid panel  \n\n---\n\nAdmission 42569013  \n    DRGs:  \n    - APR: DIABETES WITH HYPERGLYCEMIA, NO COMPLICATIONS (Severity 2.0)  \n    - HCFA: TYPE 2 DM W UNCONTROLLED BLOOD GLUCOSE  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine (Lantus) 15 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Lisinopril 20 mg daily  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Sliding scale, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous glucose monitoring initiation  \n    - Comprehensive metabolic panel  \n    - Nutrition counseling with certified diabetes educator  \n\n---\n\nAdmission 43287145  \n    DRGs:  \n    - APR: ROUTINE DIABETES FOLLOW-UP VISIT (Severity 1.0)  \n    - HCFA: DIABETES MANAGEMENT, OUTPATIENT  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine 18 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Aspirin 81 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - HbA1c recheck  \n    - Retinal fundus photography for diabetic retinopathy screening  \n    - Urine microalbumin test  \n    - Blood pressure monitoring", "pair_text": "Patient 40001279  \nGender: Female  \nAge: 57  \nRace: WHITE  \n\nAdmission 56278103  \n    DRGs:  \n    - APR: HYPERLIPIDEMIA, UNSPECIFIED - INITIAL MANAGEMENT (Severity 1.0)  \n    - HCFA: LIPID METABOLISM DISORDERS W/O MCC  \n\n    Medications:  \n    - Atorvastatin 20 mg nightly  \n    - Omega-3 Fish Oil 1g daily  \n    - Aspirin 81 mg daily  \n    - Vitamin D3 2000 IU daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Omega-3 Fish Oil: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Fasting lipid panel  \n    - HbA1c screening  \n    - Nutrition counseling for cholesterol reduction  \n\n---\n\nAdmission 57498322  \n    DRGs:  \n    - APR: HYPERLIPIDEMIA WITH ELEVATED CARDIOVASCULAR RISK (Severity 2.0)  \n    - HCFA: MIXED DYSLIPIDEMIA MANAGEMENT W CC  \n\n    Medications:  \n    - Rosuvastatin 40 mg nightly  \n    - Ezetimibe 10 mg daily  \n    - Aspirin 81 mg daily  \n    - Coenzyme Q10 100 mg daily  \n    - Lisinopril 10 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Rosuvastatin: PO, Discontinued via patient discharge  \n    - Ezetimibe: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Coenzyme Q10: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Coronary calcium scoring CT  \n    - Advanced lipid particle testing  \n    - Cardiovascular risk assessment and management planning  \n\n---\n\nAdmission 58900274  \n    DRGs:  \n    - APR: REFRACTORY HYPERLIPIDEMIA REQUIRING SPECIALIZED THERAPY (Severity 3.0)  \n    - HCFA: SEVERE DYSLIPIDEMIA W CC  \n\n    Medications:  \n    - Evolocumab (Repatha) 140 mg SC every 2 weeks  \n    - Rosuvastatin 40 mg nightly  \n    - Ezetimibe 10 mg daily  \n    - Aspirin 81 mg daily  \n    - Lisinopril 10 mg daily  \n    - Omega-3 Fish Oil 2g daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Evolocumab (Repatha): SC, Discontinued via patient discharge  \n    - Rosuvastatin: PO, Discontinued via patient discharge  \n    - Ezetimibe: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Omega-3 Fish Oil: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Referral to lipid specialist  \n    - LDL apheresis planning  \n    - Echocardiogram to evaluate cardiac function"}
{"id": "10001279", "pair_id": "50001279", "similarity": 0.25, "text": "Patient 10001279  \nGender: Male  \nAge: 55  \nRace: HISPANIC  \n\nAdmission 41908751  \n    DRGs:  \n    - APR: TYPE 2 DIABETES MELLITUS W/O COMPLICATIONS (Severity 1.0)  \n    - HCFA: DIABETES MELLITUS W/O COMPLICATIONS  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Glimepiride 4 mg daily  \n    - Lisinopril 10 mg daily  \n    - Atorvastatin 20 mg nightly  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Glimepiride: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Fasting plasma glucose test  \n    - HbA1c measurement  \n    - Lipid panel  \n\n---\n\nAdmission 42569013  \n    DRGs:  \n    - APR: DIABETES WITH HYPERGLYCEMIA, NO COMPLICATIONS (Severity 2.0)  \n    - HCFA: TYPE 2 DM W UNCONTROLLED BLOOD GLUCOSE  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine (Lantus) 15 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Lisinopril 20 mg daily  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Sliding scale, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous glucose monitoring initiation  \n    - Comprehensive metabolic panel  \n    - Nutrition counseling with certified diabetes educator  \n\n---\n\nAdmission 43287145  \n    DRGs:  \n    - APR: ROUTINE DIABETES FOLLOW-UP VISIT (Severity 1.0)  \n    - HCFA: DIABETES MANAGEMENT, OUTPATIENT  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine 18 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Aspirin 81 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - HbA1c recheck  \n    - Retinal fundus photography for diabetic retinopathy screening  \n    - Urine microalbumin test  \n    - Blood pressure monitoring", "pair_text": "Patient 50001279\nGender: Male\nAge: 64\nRace: WHITE\n\nAdmission 41239581\n    DRGs:\n    - APR: HYPERTENSION WITHOUT COMPLICATIONS (Severity 1.0)\n    - HCFA: HYPERTENSION W/O MCC\n\n    Medications:\n    - Lisinopril 10mg\n    - Hydrochlorothiazide 25mg\n    - Amlodipine 5mg\n    - Sodium Chloride 0.9% Flush\n    - Acetaminophen\n    - Aspirin EC 81mg\n    - Influenza Vaccine Quadrivalent\n\n    Orders:\n    - Lisinopril: PO, Discontinued via patient discharge\n    - Hydrochlorothiazide: PO, Discontinued via patient discharge\n    - Amlodipine: PO, Discontinued via patient discharge\n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge\n    - Acetaminophen: PO, Discontinued via patient discharge\n    - Aspirin EC 81mg: PO, Discontinued via patient discharge\n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge\n\n    Procedures:\n    - Basic Metabolic Panel (BMP)\n    - Electrocardiogram (ECG)\n    - Blood Pressure Monitoring\n\nAdmission 41876325\n    DRGs:\n    - APR: HYPERTENSIVE URGENCY / EMERGENCY (Severity 3.0)\n    - HCFA: HYPERTENSIVE CRISIS W MCC\n\n    Medications:\n    - Labetalol IV\n    - Nicardipine IV Drip\n    - Hydralazine IV\n    - Sodium Nitroprusside IV\n    - Aspirin 81mg\n    - Sodium Chloride 0.9% Flush\n    - Acetaminophen\n    - Atorvastatin 20mg\n    - Lorazepam PO\n    - Heparin SC\n\n    Orders:\n    - Labetalol IV: IV infusion, Discontinued via patient discharge\n    - Nicardipine IV Drip: Continuous IV, Discontinued via patient discharge\n    - Hydralazine IV: IV push, Discontinued via patient discharge\n    - Sodium Nitroprusside IV: Continuous IV, Discontinued via patient discharge\n    - Aspirin 81mg: PO, Discontinued via patient discharge\n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge\n    - Acetaminophen: PO, Discontinued via patient discharge\n    - Atorvastatin 20mg: PO, Discontinued via patient discharge\n    - Lorazepam: PO, Discontinued via patient discharge\n    - Heparin SC: SC, Discontinued via patient discharge\n\n    Procedures:\n    - Continuous cardiac telemetry monitoring\n    - CT Head without contrast (rule out hemorrhage)\n    - Renal Function Panel\n    - Chest X-Ray portable\n\nAdmission 42680412\n    DRGs:\n    - APR: HYPERTENSION WITH COMPLICATIONS (Severity 2.0)\n    - HCFA: HYPERTENSION W CC\n\n    Medications:\n    - Metoprolol Succinate 50mg\n    - Amlodipine 10mg\n    - Losartan 50mg\n    - Chlorthalidone 25mg\n    - Aspirin EC 81mg\n    - Sodium Chloride 0.9% Flush\n    - Influenza Vaccine Quadrivalent\n    - Atorvastatin 20mg\n    - Acetaminophen\n\n    Orders:\n    - Metoprolol Succinate: PO, Discontinued via patient discharge\n    - Amlodipine: PO, Discontinued via patient discharge\n    - Losartan: PO, Discontinued via patient discharge\n    - Chlorthalidone: PO, Discontinued via patient discharge\n    - Aspirin EC 81mg: PO, Discontinued via patient discharge\n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge\n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge\n    - Atorvastatin 20mg: PO, Discontinued via patient discharge\n    - Acetaminophen: PO, Discontinued via patient discharge\n\n    Procedures:\n    - Echocardiogram (TTE)\n    - 24-hour ambulatory BP monitoring\n    - Serum electrolytes\n    - Lipid panel"}
{"id": "10001279", "pair_id": "60001279", "similarity": 0.0, "text": "Patient 10001279  \nGender: Male  \nAge: 55  \nRace: HISPANIC  \n\nAdmission 41908751  \n    DRGs:  \n    - APR: TYPE 2 DIABETES MELLITUS W/O COMPLICATIONS (Severity 1.0)  \n    - HCFA: DIABETES MELLITUS W/O COMPLICATIONS  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Glimepiride 4 mg daily  \n    - Lisinopril 10 mg daily  \n    - Atorvastatin 20 mg nightly  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Glimepiride: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Fasting plasma glucose test  \n    - HbA1c measurement  \n    - Lipid panel  \n\n---\n\nAdmission 42569013  \n    DRGs:  \n    - APR: DIABETES WITH HYPERGLYCEMIA, NO COMPLICATIONS (Severity 2.0)  \n    - HCFA: TYPE 2 DM W UNCONTROLLED BLOOD GLUCOSE  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine (Lantus) 15 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Lisinopril 20 mg daily  \n    - Aspirin 81 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Sliding scale, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous glucose monitoring initiation  \n    - Comprehensive metabolic panel  \n    - Nutrition counseling with certified diabetes educator  \n\n---\n\nAdmission 43287145  \n    DRGs:  \n    - APR: ROUTINE DIABETES FOLLOW-UP VISIT (Severity 1.0)  \n    - HCFA: DIABETES MANAGEMENT, OUTPATIENT  \n\n    Medications:  \n    - Metformin 1000 mg BID  \n    - Insulin Glargine 18 units nightly  \n    - Insulin Lispro sliding scale  \n    - Atorvastatin 40 mg nightly  \n    - Aspirin 81 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Metformin: PO, Discontinued via patient discharge  \n    - Insulin Glargine: SC, Discontinued via patient discharge  \n    - Insulin Lispro: SC, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - HbA1c recheck  \n    - Retinal fundus photography for diabetic retinopathy screening  \n    - Urine microalbumin test  \n    - Blood pressure monitoring", "pair_text": "Patient 60001279  \nGender: Male  \nAge: 46  \nRace: WHITE  \n\nAdmission 61247853  \n    DRGs:  \n    - APR: TRAUMATIC SUBDURAL HEMORRHAGE WITHOUT LOSS OF CONSCIOUSNESS (Severity 3.0)  \n    - HCFA: INTRACRANIAL HEMORRHAGE W/O MCC  \n\n    Medications:  \n    - Levetiracetam 1000 mg BID  \n    - Acetaminophen 650 mg Q6H PRN  \n    - Mannitol IV 20%  \n    - Ondansetron 4 mg IV PRN  \n    - Sodium Chloride 0.9% Flush  \n    - Pantoprazole 40 mg IV daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Levetiracetam: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Mannitol: IV, PRN for ICP, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Pantoprazole: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT scan of head without contrast  \n    - Neurological monitoring every 2 hours  \n    - Intravenous hyperosmolar therapy initiation  \n\n---\n\nAdmission 62471329  \n    DRGs:  \n    - APR: POST-TRAUMATIC SUBDURAL HEMATOMA OBSERVATION (Severity 2.0)  \n    - HCFA: CLOSED TRAUMATIC BRAIN INJURY OBSERVATION  \n\n    Medications:  \n    - Levetiracetam 500 mg BID  \n    - Acetaminophen 500 mg PO PRN  \n    - Dexamethasone 4 mg IV Q8H  \n    - Ondansetron 4 mg IV PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Levetiracetam: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Dexamethasone: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - MRI brain with gradient susceptibility imaging  \n    - Repeat CT scan for hematoma progression  \n    - Neuro checks every 4 hours  \n\n---\n\nAdmission 63980244  \n    DRGs:  \n    - APR: SURGICAL MANAGEMENT OF TRAUMATIC SUBDURAL HEMORRHAGE (Severity 4.0)  \n    - HCFA: CRANIOTOMY FOR TRAUMATIC BRAIN INJURY W CC  \n\n    Medications:  \n    - Levetiracetam 1000 mg BID  \n    - Mannitol 20% IV bolus  \n    - Hypertonic Saline 3% IV infusion  \n    - Cefazolin 2 g IV prophylaxis  \n    - Fentanyl IV PRN  \n    - Ondansetron IV PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Levetiracetam: PO, Discontinued via patient discharge  \n    - Mannitol: IV, Discontinued via patient discharge  \n    - Hypertonic Saline: IV infusion, Discontinued via patient discharge  \n    - Cefazolin: IV, Discontinued via patient discharge  \n    - Fentanyl: IV, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Craniotomy for evacuation of subdural hematoma  \n    - Placement of ICP monitoring catheter  \n    - Postoperative ICU monitoring  \n    - Physical therapy evaluation prior to discharge"}
{"id": "10001280", "pair_id": "20001280", "similarity": 1.0, "text": "Patient 10001280  \nGender: Female  \nAge: 35  \nRace: HISPANIC  \n\nAdmission 61820347  \n    DRGs:  \n    - APR: ASTHMA EXACERBATION - UNSPECIFIED (Severity 2.0)  \n    - HCFA: ACUTE ASTHMA ATTACK W/O MCC  \n\n    Medications:  \n    - Albuterol Inhaler 90 mcg, 2 puffs q4h PRN  \n    - Ipratropium Bromide Neb 0.5 mg q6h  \n    - Prednisone 40 mg PO daily  \n    - Montelukast 10 mg nightly  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Ipratropium Bromide Neb: IH, Discontinued via patient discharge  \n    - Prednisone: PO, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Spirometry testing  \n    - Peak expiratory flow measurement  \n    - Chest X-ray to rule out pneumonia  \n\n---\n\nAdmission 62789415  \n    DRGs:  \n    - APR: MODERATE PERSISTENT ASTHMA EXACERBATION (Severity 3.0)  \n    - HCFA: ASTHMA W ACUTE RESPIRATORY DISTRESS W CC  \n\n    Medications:  \n    - Albuterol 2.5 mg Neb q4h  \n    - Budesonide Neb 0.5 mg BID  \n    - Methylprednisolone 60 mg IV q8h  \n    - Montelukast 10 mg nightly  \n    - Loratadine 10 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Albuterol Nebulizer: IH, Discontinued via patient discharge  \n    - Budesonide Neb: IH, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Arterial blood gas (ABG) analysis  \n    - Continuous pulse oximetry monitoring  \n    - Chest CT to evaluate airway inflammation  \n\n---\n\nAdmission 63917528  \n    DRGs:  \n    - APR: OUTPATIENT ASTHMA MANAGEMENT AND FOLLOW-UP (Severity 1.0)  \n    - HCFA: CHRONIC ASTHMA CONTROL - OUTPATIENT  \n\n    Medications:  \n    - Fluticasone-Salmeterol (Advair) 250/50 BID  \n    - Albuterol Inhaler PRN  \n    - Montelukast 10 mg nightly  \n    - Cetirizine 10 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Fluticasone-Salmeterol: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Pulmonary function testing (PFTs)  \n    - Asthma action plan counseling  \n    - Allergen skin testing referral", "pair_text": "Patient 20001280  \nGender: Male  \nAge: 42  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 62134781  \n    DRGs:  \n    - APR: ASTHMA EXACERBATION - UNSPECIFIED (Severity 2.0)  \n    - HCFA: ACUTE ASTHMA ATTACK W/O MCC  \n\n    Medications:  \n    - Albuterol Inhaler 90 mcg, 2 puffs q4h PRN  \n    - Ipratropium Bromide Neb 0.5 mg q6h  \n    - Prednisone 40 mg PO daily  \n    - Loratadine 10 mg PO daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Ipratropium Bromide Neb: IH, Discontinued via patient discharge  \n    - Prednisone: PO, Discontinued via patient discharge  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Peak expiratory flow measurement  \n    - Chest X-ray to rule out pneumonia  \n    - Spirometry testing  \n\n---\n\nAdmission 63391852  \n    DRGs:  \n    - APR: MODERATE PERSISTENT ASTHMA WITH ACUTE EXACERBATION (Severity 3.0)  \n    - HCFA: ACUTE RESPIRATORY DISTRESS DUE TO ASTHMA W CC  \n\n    Medications:  \n    - Albuterol 2.5 mg Neb q4h  \n    - Budesonide Neb 0.5 mg BID  \n    - Methylprednisolone 60 mg IV q8h  \n    - Montelukast 10 mg PO nightly  \n    - Cetirizine 10 mg PO daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Albuterol Nebulizer: IH, Discontinued via patient discharge  \n    - Budesonide Neb: IH, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Arterial blood gas (ABG) analysis  \n    - Continuous pulse oximetry  \n    - Chest CT scan for airway assessment  \n\n---\n\nAdmission 64752019  \n    DRGs:  \n    - APR: OUTPATIENT ASTHMA FOLLOW-UP MANAGEMENT (Severity 1.0)  \n    - HCFA: CHRONIC ASTHMA CONTROL - OUTPATIENT  \n\n    Medications:  \n    - Fluticasone-Salmeterol (Advair) 250/50 BID  \n    - Albuterol Inhaler PRN  \n    - Montelukast 10 mg nightly  \n    - Cetirizine 10 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Fluticasone-Salmeterol: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Pulmonary function testing (PFTs)  \n    - Allergy evaluation and skin testing referral  \n    - Asthma action plan counseling"}
{"id": "10001280", "pair_id": "30001280", "similarity": 0.75, "text": "Patient 10001280  \nGender: Female  \nAge: 35  \nRace: HISPANIC  \n\nAdmission 61820347  \n    DRGs:  \n    - APR: ASTHMA EXACERBATION - UNSPECIFIED (Severity 2.0)  \n    - HCFA: ACUTE ASTHMA ATTACK W/O MCC  \n\n    Medications:  \n    - Albuterol Inhaler 90 mcg, 2 puffs q4h PRN  \n    - Ipratropium Bromide Neb 0.5 mg q6h  \n    - Prednisone 40 mg PO daily  \n    - Montelukast 10 mg nightly  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Ipratropium Bromide Neb: IH, Discontinued via patient discharge  \n    - Prednisone: PO, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Spirometry testing  \n    - Peak expiratory flow measurement  \n    - Chest X-ray to rule out pneumonia  \n\n---\n\nAdmission 62789415  \n    DRGs:  \n    - APR: MODERATE PERSISTENT ASTHMA EXACERBATION (Severity 3.0)  \n    - HCFA: ASTHMA W ACUTE RESPIRATORY DISTRESS W CC  \n\n    Medications:  \n    - Albuterol 2.5 mg Neb q4h  \n    - Budesonide Neb 0.5 mg BID  \n    - Methylprednisolone 60 mg IV q8h  \n    - Montelukast 10 mg nightly  \n    - Loratadine 10 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Albuterol Nebulizer: IH, Discontinued via patient discharge  \n    - Budesonide Neb: IH, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Arterial blood gas (ABG) analysis  \n    - Continuous pulse oximetry monitoring  \n    - Chest CT to evaluate airway inflammation  \n\n---\n\nAdmission 63917528  \n    DRGs:  \n    - APR: OUTPATIENT ASTHMA MANAGEMENT AND FOLLOW-UP (Severity 1.0)  \n    - HCFA: CHRONIC ASTHMA CONTROL - OUTPATIENT  \n\n    Medications:  \n    - Fluticasone-Salmeterol (Advair) 250/50 BID  \n    - Albuterol Inhaler PRN  \n    - Montelukast 10 mg nightly  \n    - Cetirizine 10 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Fluticasone-Salmeterol: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Pulmonary function testing (PFTs)  \n    - Asthma action plan counseling  \n    - Allergen skin testing referral", "pair_text": "Patient 30001280  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 65321904  \n    DRGs:  \n    - APR: ACUTE ASTHMA EXACERBATION - UNSPECIFIED (Severity 3.0)  \n    - HCFA: ASTHMA WITH ACUTE EXACERBATION W/O MCC  \n\n    Medications:  \n    - Albuterol Inhaler 90 mcg, 2 puffs q4h PRN  \n    - Ipratropium Bromide Neb 0.5 mg q6h  \n    - Prednisone 60 mg PO daily  \n    - Montelukast 10 mg nightly  \n    - Cetirizine 10 mg daily  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Ipratropium Bromide Neb: IH, Discontinued via patient discharge  \n    - Prednisone: PO, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Peak expiratory flow measurement  \n    - Chest X-ray to rule out pneumonia  \n    - Spirometry pre- and post-bronchodilator  \n\n---\n\nAdmission 66738129  \n    DRGs:  \n    - APR: SEVERE ASTHMA EXACERBATION REQUIRING INPATIENT MANAGEMENT (Severity 4.0)  \n    - HCFA: STATUS ASTHMATICUS W CC  \n\n    Medications:  \n    - Albuterol 2.5 mg Neb continuous infusion  \n    - Budesonide Neb 0.5 mg BID  \n    - Methylprednisolone 80 mg IV q8h  \n    - Montelukast 10 mg nightly  \n    - Loratadine 10 mg daily  \n    - Magnesium Sulfate IV bolus  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Albuterol Continuous Neb: IH, Discontinued via patient discharge  \n    - Budesonide Neb: IH, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Magnesium Sulfate: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Arterial blood gas (ABG) monitoring  \n    - Continuous pulse oximetry and cardiac monitoring  \n    - High-resolution chest CT to evaluate airway inflammation  \n\n---\n\nAdmission 67542912  \n    DRGs:  \n    - APR: OUTPATIENT ASTHMA MANAGEMENT AND FOLLOW-UP (Severity 1.0)  \n    - HCFA: CHRONIC ASTHMA CONTROL - OUTPATIENT  \n\n    Medications:  \n    - Fluticasone-Salmeterol (Advair) 250/50 BID  \n    - Albuterol Inhaler PRN  \n    - Montelukast 10 mg nightly  \n    - Cetirizine 10 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Fluticasone-Salmeterol: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Pulmonary function testing (PFTs)  \n    - Personalized asthma action plan counseling  \n    - Allergy testing and referral for immunotherapy evaluation"}
{"id": "10001280", "pair_id": "40001280", "similarity": 0.5, "text": "Patient 10001280  \nGender: Female  \nAge: 35  \nRace: HISPANIC  \n\nAdmission 61820347  \n    DRGs:  \n    - APR: ASTHMA EXACERBATION - UNSPECIFIED (Severity 2.0)  \n    - HCFA: ACUTE ASTHMA ATTACK W/O MCC  \n\n    Medications:  \n    - Albuterol Inhaler 90 mcg, 2 puffs q4h PRN  \n    - Ipratropium Bromide Neb 0.5 mg q6h  \n    - Prednisone 40 mg PO daily  \n    - Montelukast 10 mg nightly  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Ipratropium Bromide Neb: IH, Discontinued via patient discharge  \n    - Prednisone: PO, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Spirometry testing  \n    - Peak expiratory flow measurement  \n    - Chest X-ray to rule out pneumonia  \n\n---\n\nAdmission 62789415  \n    DRGs:  \n    - APR: MODERATE PERSISTENT ASTHMA EXACERBATION (Severity 3.0)  \n    - HCFA: ASTHMA W ACUTE RESPIRATORY DISTRESS W CC  \n\n    Medications:  \n    - Albuterol 2.5 mg Neb q4h  \n    - Budesonide Neb 0.5 mg BID  \n    - Methylprednisolone 60 mg IV q8h  \n    - Montelukast 10 mg nightly  \n    - Loratadine 10 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Albuterol Nebulizer: IH, Discontinued via patient discharge  \n    - Budesonide Neb: IH, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Arterial blood gas (ABG) analysis  \n    - Continuous pulse oximetry monitoring  \n    - Chest CT to evaluate airway inflammation  \n\n---\n\nAdmission 63917528  \n    DRGs:  \n    - APR: OUTPATIENT ASTHMA MANAGEMENT AND FOLLOW-UP (Severity 1.0)  \n    - HCFA: CHRONIC ASTHMA CONTROL - OUTPATIENT  \n\n    Medications:  \n    - Fluticasone-Salmeterol (Advair) 250/50 BID  \n    - Albuterol Inhaler PRN  \n    - Montelukast 10 mg nightly  \n    - Cetirizine 10 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Fluticasone-Salmeterol: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Pulmonary function testing (PFTs)  \n    - Asthma action plan counseling  \n    - Allergen skin testing referral", "pair_text": "Patient 40001280  \nGender: Female  \nAge: 31  \nRace: ASIAN  \n\nAdmission 66237102  \n    DRGs:  \n    - APR: ALLERGIC RHINITIS, UNSPECIFIED - INITIAL MANAGEMENT (Severity 1.0)  \n    - HCFA: ALLERGIC RHINITIS W/O MCC  \n\n    Medications:  \n    - Loratadine 10 mg daily  \n    - Fluticasone Nasal Spray 50 mcg per nostril daily  \n    - Cetirizine 10 mg nightly  \n    - Sodium Chloride Nasal Spray PRN  \n    - Montelukast 10 mg nightly  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Fluticasone Nasal Spray: IN, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Sodium Chloride Nasal Spray: IN, PRN, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Nasal endoscopy for evaluation of airway inflammation  \n    - Peak nasal inspiratory flow measurement  \n    - Allergen blood panel  \n\n---\n\nAdmission 67849255  \n    DRGs:  \n    - APR: SEASONAL ALLERGIC RHINITIS WITH MODERATE SYMPTOMS (Severity 2.0)  \n    - HCFA: ALLERGIC RHINITIS WITH PERSISTENT CONGESTION  \n\n    Medications:  \n    - Fexofenadine 180 mg daily  \n    - Fluticasone Nasal Spray 2 sprays per nostril daily  \n    - Montelukast 10 mg nightly  \n    - Azelastine Nasal Spray BID  \n    - Cetirizine 10 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Fexofenadine: PO, Discontinued via patient discharge  \n    - Fluticasone Nasal Spray: IN, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Azelastine Nasal Spray: IN, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Skin prick allergy testing  \n    - Pulmonary function testing (PFTs) to rule out asthma overlap  \n    - Patient education on allergen avoidance strategies  \n\n---\n\nAdmission 69372891  \n    DRGs:  \n    - APR: CHRONIC ALLERGIC RHINITIS MANAGEMENT - FOLLOW-UP (Severity 1.0)  \n    - HCFA: OUTPATIENT ALLERGIC RHINITIS CONTROL  \n\n    Medications:  \n    - Fluticasone Nasal Spray 1 spray per nostril daily  \n    - Loratadine 10 mg daily  \n    - Montelukast 10 mg nightly  \n    - Cetirizine 10 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Fluticasone Nasal Spray: IN, Discontinued via patient discharge  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Repeat allergy testing for environmental triggers  \n    - Nasal cytology to evaluate eosinophilic inflammation  \n    - ENT referral for chronic nasal obstruction evaluation"}
{"id": "10001280", "pair_id": "50001280", "similarity": 0.25, "text": "Patient 10001280  \nGender: Female  \nAge: 35  \nRace: HISPANIC  \n\nAdmission 61820347  \n    DRGs:  \n    - APR: ASTHMA EXACERBATION - UNSPECIFIED (Severity 2.0)  \n    - HCFA: ACUTE ASTHMA ATTACK W/O MCC  \n\n    Medications:  \n    - Albuterol Inhaler 90 mcg, 2 puffs q4h PRN  \n    - Ipratropium Bromide Neb 0.5 mg q6h  \n    - Prednisone 40 mg PO daily  \n    - Montelukast 10 mg nightly  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Ipratropium Bromide Neb: IH, Discontinued via patient discharge  \n    - Prednisone: PO, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Spirometry testing  \n    - Peak expiratory flow measurement  \n    - Chest X-ray to rule out pneumonia  \n\n---\n\nAdmission 62789415  \n    DRGs:  \n    - APR: MODERATE PERSISTENT ASTHMA EXACERBATION (Severity 3.0)  \n    - HCFA: ASTHMA W ACUTE RESPIRATORY DISTRESS W CC  \n\n    Medications:  \n    - Albuterol 2.5 mg Neb q4h  \n    - Budesonide Neb 0.5 mg BID  \n    - Methylprednisolone 60 mg IV q8h  \n    - Montelukast 10 mg nightly  \n    - Loratadine 10 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Albuterol Nebulizer: IH, Discontinued via patient discharge  \n    - Budesonide Neb: IH, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Arterial blood gas (ABG) analysis  \n    - Continuous pulse oximetry monitoring  \n    - Chest CT to evaluate airway inflammation  \n\n---\n\nAdmission 63917528  \n    DRGs:  \n    - APR: OUTPATIENT ASTHMA MANAGEMENT AND FOLLOW-UP (Severity 1.0)  \n    - HCFA: CHRONIC ASTHMA CONTROL - OUTPATIENT  \n\n    Medications:  \n    - Fluticasone-Salmeterol (Advair) 250/50 BID  \n    - Albuterol Inhaler PRN  \n    - Montelukast 10 mg nightly  \n    - Cetirizine 10 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Fluticasone-Salmeterol: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Pulmonary function testing (PFTs)  \n    - Asthma action plan counseling  \n    - Allergen skin testing referral", "pair_text": "Patient 50001280  \nGender: Female  \nAge: 71  \nRace: WHITE  \n\nAdmission 50381247  \n    DRGs:  \n    - APR: RESPIRATORY SYMPTOMS & OTHER SIGNS (Severity 2.0)  \n    - HCFA: SHORTNESS OF BREATH / DYSPNEA W/O MCC  \n\n    Medications:  \n    - Albuterol 0.083% Neb Soln  \n    - Ipratropium Bromide Neb  \n    - Fluticasone-Salmeterol (Advair Diskus)  \n    - Montelukast  \n    - Prednisone  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Oxygen Therapy (2L NC)  \n    - Influenza Vaccine Quadrivalent  \n    - Lorazepam (for anxiety-related dyspnea)  \n\n    Orders:  \n    - Albuterol 0.083% Neb Soln: IH, Discontinued via patient discharge  \n    - Ipratropium Bromide Neb: IH, Discontinued via patient discharge  \n    - Fluticasone-Salmeterol (Advair Diskus): IH, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Prednisone: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Oxygen Therapy: Continuous, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n    - Lorazepam: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Pulse oximetry monitoring  \n    - Chest X-Ray (portable)  \n    - Basic Metabolic Panel (BMP)  \n    - Arterial Blood Gas (ABG)  \n\nAdmission 51243709  \n    DRGs:  \n    - APR: ACUTE DYSPNEA WITH EXACERBATION (Severity 3.0)  \n    - HCFA: RESPIRATORY DISTRESS W CC  \n\n    Medications:  \n    - Methylprednisolone IV  \n    - Budesonide Neb  \n    - Albuterol Inhaler  \n    - Tiotropium Bromide  \n    - Furosemide IV (for possible pulmonary edema)  \n    - Levofloxacin  \n    - Sodium Chloride 0.9% Flush  \n    - Atorvastatin  \n    - Heparin SC  \n    - Acetaminophen  \n\n    Orders:  \n    - Methylprednisolone IV: IV, Discontinued via patient discharge  \n    - Budesonide Neb: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Tiotropium Bromide: IH, Discontinued via patient discharge  \n    - Furosemide IV: IV, Discontinued via patient discharge  \n    - Levofloxacin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - High-resolution CT Chest (HRCT)  \n    - Bronchoscopy for airway evaluation  \n    - Non-invasive ventilation initiation (BiPAP)  \n    - Continuous cardiac telemetry monitoring  \n\nAdmission 52649803  \n    DRGs:  \n    - APR: RESPIRATORY SYMPTOMS SECONDARY TO CARDIAC DYSFUNCTION (Severity 4.0)  \n    - HCFA: RESPIRATORY FAILURE W MCC  \n\n    Medications:  \n    - Furosemide IV  \n    - Nitroglycerin Drip  \n    - Morphine IV (dyspnea relief in CHF)  \n    - Oxygen Therapy (high-flow)  \n    - Piperacillin-Tazobactam (Zosyn)  \n    - Metoprolol Tartrate  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Heparin SC  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Furosemide IV: IV bolus, Discontinued via patient discharge  \n    - Nitroglycerin Drip: Continuous IV, Discontinued via patient discharge  \n    - Morphine IV: IV, Discontinued via patient discharge  \n    - Oxygen Therapy: High-flow nasal cannula, Discontinued via patient discharge  \n    - Piperacillin-Tazobactam (Zosyn): IV, Discontinued via patient discharge  \n    - Metoprolol Tartrate: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Echocardiogram (TTE)  \n    - Pulmonary Function Testing (PFTs)  \n    - Arterial Line Placement  \n    - Endotracheal Intubation with Mechanical Ventilation"}
{"id": "10001280", "pair_id": "60001280", "similarity": 0.0, "text": "Patient 10001280  \nGender: Female  \nAge: 35  \nRace: HISPANIC  \n\nAdmission 61820347  \n    DRGs:  \n    - APR: ASTHMA EXACERBATION - UNSPECIFIED (Severity 2.0)  \n    - HCFA: ACUTE ASTHMA ATTACK W/O MCC  \n\n    Medications:  \n    - Albuterol Inhaler 90 mcg, 2 puffs q4h PRN  \n    - Ipratropium Bromide Neb 0.5 mg q6h  \n    - Prednisone 40 mg PO daily  \n    - Montelukast 10 mg nightly  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Ipratropium Bromide Neb: IH, Discontinued via patient discharge  \n    - Prednisone: PO, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Spirometry testing  \n    - Peak expiratory flow measurement  \n    - Chest X-ray to rule out pneumonia  \n\n---\n\nAdmission 62789415  \n    DRGs:  \n    - APR: MODERATE PERSISTENT ASTHMA EXACERBATION (Severity 3.0)  \n    - HCFA: ASTHMA W ACUTE RESPIRATORY DISTRESS W CC  \n\n    Medications:  \n    - Albuterol 2.5 mg Neb q4h  \n    - Budesonide Neb 0.5 mg BID  \n    - Methylprednisolone 60 mg IV q8h  \n    - Montelukast 10 mg nightly  \n    - Loratadine 10 mg daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Albuterol Nebulizer: IH, Discontinued via patient discharge  \n    - Budesonide Neb: IH, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Arterial blood gas (ABG) analysis  \n    - Continuous pulse oximetry monitoring  \n    - Chest CT to evaluate airway inflammation  \n\n---\n\nAdmission 63917528  \n    DRGs:  \n    - APR: OUTPATIENT ASTHMA MANAGEMENT AND FOLLOW-UP (Severity 1.0)  \n    - HCFA: CHRONIC ASTHMA CONTROL - OUTPATIENT  \n\n    Medications:  \n    - Fluticasone-Salmeterol (Advair) 250/50 BID  \n    - Albuterol Inhaler PRN  \n    - Montelukast 10 mg nightly  \n    - Cetirizine 10 mg daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Fluticasone-Salmeterol: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Montelukast: PO, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Pulmonary function testing (PFTs)  \n    - Asthma action plan counseling  \n    - Allergen skin testing referral", "pair_text": "Patient 60001280  \nGender: Male  \nAge: 24  \nRace: HISPANIC  \n\nAdmission 70125894  \n    DRGs:  \n    - APR: UNSPECIFIED ACUTE APPENDICITIS - INITIAL PRESENTATION (Severity 3.0)  \n    - HCFA: ACUTE APPENDICITIS W/O PERITONITIS W/O MCC  \n\n    Medications:  \n    - Piperacillin-Tazobactam 3.375 g IV q6h  \n    - Ondansetron 4 mg IV q6h PRN  \n    - Morphine 4 mg IV q4h PRN  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Sodium Chloride 0.9% Flush  \n    - Ceftriaxone 2 g IV q24h  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Morphine: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ceftriaxone: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT abdomen and pelvis with contrast  \n    - IV fluid bolus for resuscitation  \n    - Preoperative blood work and anesthesia clearance  \n\n---\n\nAdmission 71490312  \n    DRGs:  \n    - APR: LAPAROSCOPIC APPENDECTOMY FOR ACUTE APPENDICITIS (Severity 4.0)  \n    - HCFA: LAPAROSCOPIC APPENDECTOMY W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam 3.375 g IV q6h  \n    - Ceftriaxone 2 g IV q24h  \n    - Metronidazole 500 mg IV q8h  \n    - Hydromorphone 0.5 mg IV q4h PRN  \n    - Ondansetron 4 mg IV PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, Discontinued via patient discharge  \n    - Ceftriaxone: IV, Discontinued via patient discharge  \n    - Metronidazole: IV, Discontinued via patient discharge  \n    - Hydromorphone: IV, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Laparoscopic appendectomy  \n    - Intraoperative irrigation of peritoneal cavity  \n    - Placement of JP drain due to intraoperative findings  \n\n---\n\nAdmission 72844576  \n    DRGs:  \n    - APR: POSTOPERATIVE FOLLOW-UP FOR ACUTE APPENDICITIS (Severity 1.0)  \n    - HCFA: OUTPATIENT POST-SURGICAL CARE  \n\n    Medications:  \n    - Amoxicillin-Clavulanate 875/125 mg PO BID for 7 days  \n    - Ibuprofen 600 mg PO q6h PRN  \n    - Ondansetron 4 mg PO PRN  \n    - Acetaminophen 650 mg PO PRN  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Amoxicillin-Clavulanate: PO, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Ondansetron: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Wound check and dressing change  \n    - Removal of surgical staples  \n    - Postoperative ultrasound to rule out intra-abdominal abscess"}
{"id": "10001281", "pair_id": "20001281", "similarity": 1.0, "text": "Patient 10001281  \nGender: Female  \nAge: 54  \nRace: WHITE  \n\nAdmission 74125689  \n    DRGs:  \n    - APR: MALIGNANT NEOPLASM OF BREAST - INITIAL PRESENTATION (Severity 3.0)  \n    - HCFA: BREAST CANCER W/O MCC  \n\n    Medications:  \n    - Doxorubicin 60 mg/m² IV q21d (cycle-based)  \n    - Cyclophosphamide 600 mg/m² IV q21d  \n    - Ondansetron 8 mg IV q8h PRN for nausea  \n    - Dexamethasone 8 mg PO daily (chemo pre-medication)  \n    - Filgrastim 300 mcg SC daily x5 days post-chemo  \n    - Acetaminophen 650 mg PO PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Doxorubicin: IV, Discontinued via patient discharge  \n    - Cyclophosphamide: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Filgrastim: SC, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Ultrasound-guided core needle breast biopsy  \n    - Staging MRI of breast and axilla  \n    - Port-a-cath placement for chemotherapy administration  \n\n---\n\nAdmission 75438214  \n    DRGs:  \n    - APR: PARTIAL MASTECTOMY W AXILLARY NODE SAMPLING (Severity 4.0)  \n    - HCFA: BREAST SURGERY W CC  \n\n    Medications:  \n    - Cefazolin 2 g IV perioperatively  \n    - Morphine 2 mg IV q4h PRN  \n    - Ondansetron 4 mg IV PRN  \n    - Ketorolac 30 mg IV q6h  \n    - Acetaminophen 1 g PO q8h  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Cefazolin: IV, Discontinued via patient discharge  \n    - Morphine: IV, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Ketorolac: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Lumpectomy with sentinel lymph node biopsy  \n    - Axillary lymph node dissection  \n    - Intraoperative frozen section pathology  \n\n---\n\nAdmission 76901527  \n    DRGs:  \n    - APR: ADJUVANT RADIATION THERAPY FOR BREAST CANCER (Severity 2.0)  \n    - HCFA: RADIATION THERAPY - OUTPATIENT FOLLOW-UP  \n\n    Medications:  \n    - Tamoxifen 20 mg PO daily  \n    - Ondansetron 4 mg PO PRN  \n    - Lorazepam 1 mg PO PRN for treatment-related anxiety  \n    - Ibuprofen 600 mg PO q6h PRN  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Tamoxifen: PO, Discontinued via patient discharge  \n    - Ondansetron: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - External beam radiation therapy planning CT  \n    - Adjuvant radiation delivery to breast and axilla  \n    - Follow-up oncology evaluation for long-term treatment response", "pair_text": "Patient 20001281  \nGender: Female  \nAge: 49  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 78245109  \n    DRGs:  \n    - APR: MALIGNANT NEOPLASM OF BREAST - INITIAL DIAGNOSIS & WORKUP (Severity 3.0)  \n    - HCFA: BREAST CANCER W/O MCC  \n\n    Medications:  \n    - Paclitaxel 175 mg/m² IV q21d  \n    - Carboplatin AUC 5 IV q21d  \n    - Dexamethasone 8 mg PO daily (pre-medication)  \n    - Ondansetron 8 mg IV q8h PRN  \n    - Filgrastim 300 mcg SC daily x5 days post-chemo  \n    - Lorazepam 1 mg PO PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Paclitaxel: IV, Discontinued via patient discharge  \n    - Carboplatin: IV, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Filgrastim: SC, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Ultrasound-guided breast biopsy  \n    - MRI of bilateral breasts for staging  \n    - Port-a-cath placement for chemotherapy  \n\n---\n\nAdmission 79624587  \n    DRGs:  \n    - APR: MODIFIED RADICAL MASTECTOMY WITH AXILLARY DISSECTION (Severity 4.0)  \n    - HCFA: BREAST SURGERY W CC  \n\n    Medications:  \n    - Cefazolin 2 g IV perioperatively  \n    - Hydromorphone 0.5 mg IV q4h PRN  \n    - Acetaminophen 1 g PO q8h  \n    - Ondansetron 4 mg IV PRN  \n    - Ketorolac 30 mg IV q6h  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Cefazolin: IV, Discontinued via patient discharge  \n    - Hydromorphone: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Ketorolac: IV, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Right-sided modified radical mastectomy  \n    - Axillary lymph node dissection (level I & II nodes)  \n    - Intraoperative frozen pathology for nodal staging  \n\n---\n\nAdmission 81235967  \n    DRGs:  \n    - APR: POSTOPERATIVE FOLLOW-UP & ADJUVANT THERAPY INITIATION (Severity 2.0)  \n    - HCFA: OUTPATIENT BREAST CANCER MANAGEMENT  \n\n    Medications:  \n    - Letrozole 2.5 mg PO daily  \n    - Zoledronic acid 4 mg IV q6mo for bone protection  \n    - Ondansetron 4 mg PO PRN  \n    - Ibuprofen 600 mg PO q6h PRN  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Letrozole: PO, Discontinued via patient discharge  \n    - Zoledronic acid: IV, Discontinued via patient discharge  \n    - Ondansetron: PO, PRN, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Postoperative wound evaluation and dressing changes  \n    - Initiation of adjuvant endocrine therapy  \n    - Dual-energy X-ray absorptiometry (DEXA) scan for baseline bone density"}
{"id": "10001281", "pair_id": "30001281", "similarity": 0.75, "text": "Patient 10001281  \nGender: Female  \nAge: 54  \nRace: WHITE  \n\nAdmission 74125689  \n    DRGs:  \n    - APR: MALIGNANT NEOPLASM OF BREAST - INITIAL PRESENTATION (Severity 3.0)  \n    - HCFA: BREAST CANCER W/O MCC  \n\n    Medications:  \n    - Doxorubicin 60 mg/m² IV q21d (cycle-based)  \n    - Cyclophosphamide 600 mg/m² IV q21d  \n    - Ondansetron 8 mg IV q8h PRN for nausea  \n    - Dexamethasone 8 mg PO daily (chemo pre-medication)  \n    - Filgrastim 300 mcg SC daily x5 days post-chemo  \n    - Acetaminophen 650 mg PO PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Doxorubicin: IV, Discontinued via patient discharge  \n    - Cyclophosphamide: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Filgrastim: SC, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Ultrasound-guided core needle breast biopsy  \n    - Staging MRI of breast and axilla  \n    - Port-a-cath placement for chemotherapy administration  \n\n---\n\nAdmission 75438214  \n    DRGs:  \n    - APR: PARTIAL MASTECTOMY W AXILLARY NODE SAMPLING (Severity 4.0)  \n    - HCFA: BREAST SURGERY W CC  \n\n    Medications:  \n    - Cefazolin 2 g IV perioperatively  \n    - Morphine 2 mg IV q4h PRN  \n    - Ondansetron 4 mg IV PRN  \n    - Ketorolac 30 mg IV q6h  \n    - Acetaminophen 1 g PO q8h  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Cefazolin: IV, Discontinued via patient discharge  \n    - Morphine: IV, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Ketorolac: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Lumpectomy with sentinel lymph node biopsy  \n    - Axillary lymph node dissection  \n    - Intraoperative frozen section pathology  \n\n---\n\nAdmission 76901527  \n    DRGs:  \n    - APR: ADJUVANT RADIATION THERAPY FOR BREAST CANCER (Severity 2.0)  \n    - HCFA: RADIATION THERAPY - OUTPATIENT FOLLOW-UP  \n\n    Medications:  \n    - Tamoxifen 20 mg PO daily  \n    - Ondansetron 4 mg PO PRN  \n    - Lorazepam 1 mg PO PRN for treatment-related anxiety  \n    - Ibuprofen 600 mg PO q6h PRN  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Tamoxifen: PO, Discontinued via patient discharge  \n    - Ondansetron: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - External beam radiation therapy planning CT  \n    - Adjuvant radiation delivery to breast and axilla  \n    - Follow-up oncology evaluation for long-term treatment response", "pair_text": "Patient 30001281  \nGender: Female  \nAge: 57  \nRace: WHITE  \n\nAdmission 86420319  \n    DRGs:  \n    - APR: MALIGNANT NEOPLASM OF RIGHT BREAST - INITIAL STAGING & CHEMOTHERAPY (Severity 3.0)  \n    - HCFA: BREAST CANCER W/O MCC  \n\n    Medications:  \n    - Doxorubicin 60 mg/m² IV q21d  \n    - Cyclophosphamide 600 mg/m² IV q21d  \n    - Pegfilgrastim 6 mg SC once per cycle  \n    - Ondansetron 8 mg IV q8h PRN nausea  \n    - Dexamethasone 8 mg PO daily (chemo pre-med)  \n    - Lorazepam 1 mg PO PRN anxiety  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Doxorubicin: IV, Discontinued via patient discharge  \n    - Cyclophosphamide: IV, Discontinued via patient discharge  \n    - Pegfilgrastim: SC, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Ultrasound-guided core biopsy of right breast  \n    - PET-CT for staging and lymph node mapping  \n    - Port-a-cath placement for systemic therapy  \n\n---\n\nAdmission 87563427  \n    DRGs:  \n    - APR: RIGHT MODIFIED RADICAL MASTECTOMY WITH LYMPH NODE DISSECTION (Severity 4.0)  \n    - HCFA: BREAST SURGERY W CC  \n\n    Medications:  \n    - Cefazolin 2 g IV perioperatively  \n    - Morphine 2 mg IV q4h PRN  \n    - Ondansetron 4 mg IV PRN  \n    - Acetaminophen 1 g PO q8h  \n    - Ketorolac 30 mg IV q6h  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Cefazolin: IV, Discontinued via patient discharge  \n    - Morphine: IV, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ketorolac: IV, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Right modified radical mastectomy  \n    - Sentinel and axillary lymph node dissection  \n    - Intraoperative frozen section nodal pathology  \n\n---\n\nAdmission 89374251  \n    DRGs:  \n    - APR: ADJUVANT RADIATION THERAPY & HORMONAL TREATMENT INITIATION (Severity 2.0)  \n    - HCFA: RADIATION THERAPY OUTPATIENT FOLLOW-UP  \n\n    Medications:  \n    - Letrozole 2.5 mg PO daily  \n    - Zoledronic acid 4 mg IV q6mo  \n    - Ondansetron 4 mg PO PRN  \n    - Ibuprofen 600 mg PO q6h PRN  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Letrozole: PO, Discontinued via patient discharge  \n    - Zoledronic acid: IV, Discontinued via patient discharge  \n    - Ondansetron: PO, PRN, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Adjuvant external beam radiation therapy  \n    - CT-based treatment planning and simulation  \n    - Postoperative oncologic evaluation with breast MRI"}
{"id": "10001281", "pair_id": "40001281", "similarity": 0.5, "text": "Patient 10001281  \nGender: Female  \nAge: 54  \nRace: WHITE  \n\nAdmission 74125689  \n    DRGs:  \n    - APR: MALIGNANT NEOPLASM OF BREAST - INITIAL PRESENTATION (Severity 3.0)  \n    - HCFA: BREAST CANCER W/O MCC  \n\n    Medications:  \n    - Doxorubicin 60 mg/m² IV q21d (cycle-based)  \n    - Cyclophosphamide 600 mg/m² IV q21d  \n    - Ondansetron 8 mg IV q8h PRN for nausea  \n    - Dexamethasone 8 mg PO daily (chemo pre-medication)  \n    - Filgrastim 300 mcg SC daily x5 days post-chemo  \n    - Acetaminophen 650 mg PO PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Doxorubicin: IV, Discontinued via patient discharge  \n    - Cyclophosphamide: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Filgrastim: SC, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Ultrasound-guided core needle breast biopsy  \n    - Staging MRI of breast and axilla  \n    - Port-a-cath placement for chemotherapy administration  \n\n---\n\nAdmission 75438214  \n    DRGs:  \n    - APR: PARTIAL MASTECTOMY W AXILLARY NODE SAMPLING (Severity 4.0)  \n    - HCFA: BREAST SURGERY W CC  \n\n    Medications:  \n    - Cefazolin 2 g IV perioperatively  \n    - Morphine 2 mg IV q4h PRN  \n    - Ondansetron 4 mg IV PRN  \n    - Ketorolac 30 mg IV q6h  \n    - Acetaminophen 1 g PO q8h  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Cefazolin: IV, Discontinued via patient discharge  \n    - Morphine: IV, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Ketorolac: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Lumpectomy with sentinel lymph node biopsy  \n    - Axillary lymph node dissection  \n    - Intraoperative frozen section pathology  \n\n---\n\nAdmission 76901527  \n    DRGs:  \n    - APR: ADJUVANT RADIATION THERAPY FOR BREAST CANCER (Severity 2.0)  \n    - HCFA: RADIATION THERAPY - OUTPATIENT FOLLOW-UP  \n\n    Medications:  \n    - Tamoxifen 20 mg PO daily  \n    - Ondansetron 4 mg PO PRN  \n    - Lorazepam 1 mg PO PRN for treatment-related anxiety  \n    - Ibuprofen 600 mg PO q6h PRN  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Tamoxifen: PO, Discontinued via patient discharge  \n    - Ondansetron: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - External beam radiation therapy planning CT  \n    - Adjuvant radiation delivery to breast and axilla  \n    - Follow-up oncology evaluation for long-term treatment response", "pair_text": "Patient 40001281  \nGender: Male  \nAge: 66  \nRace: WHITE  \n\nAdmission 74591302  \n    DRGs:  \n    - APR: MALIGNANT NEOPLASM OF LUNG - INITIAL DIAGNOSIS & STAGING (Severity 3.0)  \n    - HCFA: LUNG CANCER W/O MCC  \n\n    Medications:  \n    - Cisplatin 75 mg/m² IV day 1 q21d  \n    - Pemetrexed 500 mg/m² IV day 1 q21d  \n    - Folic Acid 1 mg PO daily (pre-Pemetrexed)  \n    - Vitamin B12 1,000 mcg IM q9wks  \n    - Ondansetron 8 mg IV q8h PRN  \n    - Dexamethasone 8 mg PO BID day before & after chemo  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Cisplatin: IV, Discontinued via patient discharge  \n    - Pemetrexed: IV, Discontinued via patient discharge  \n    - Folic Acid: PO, Discontinued via patient discharge  \n    - Vitamin B12: IM, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT-guided lung mass biopsy  \n    - PET-CT for staging  \n    - Mediastinoscopy for nodal sampling  \n\n---\n\nAdmission 75942817  \n    DRGs:  \n    - APR: LOBECTOMY OF LUNG WITH MEDIASTINAL LYMPH NODE DISSECTION (Severity 4.0)  \n    - HCFA: THORACIC SURGERY W CC  \n\n    Medications:  \n    - Cefazolin 2 g IV perioperatively  \n    - Hydromorphone 0.5 mg IV q4h PRN  \n    - Acetaminophen 1 g PO q8h  \n    - Ketorolac 30 mg IV q6h  \n    - Ondansetron 4 mg IV PRN  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Cefazolin: IV, Discontinued via patient discharge  \n    - Hydromorphone: IV, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ketorolac: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Right upper lobectomy via VATS  \n    - Mediastinal lymph node dissection  \n    - Chest tube placement with postoperative drainage  \n\n---\n\nAdmission 77461594  \n    DRGs:  \n    - APR: ADJUVANT IMMUNOTHERAPY FOLLOW-UP (Severity 2.0)  \n    - HCFA: LUNG CANCER OUTPATIENT MANAGEMENT  \n\n    Medications:  \n    - Pembrolizumab 200 mg IV q3wks  \n    - Albuterol Inhaler PRN  \n    - Fluticasone-Salmeterol Inhaler BID  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Pembrolizumab: IV, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n    - Fluticasone-Salmeterol: IH, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT chest follow-up for tumor response  \n    - Pulmonary function testing  \n    - Oncology-directed surveillance planning"}
{"id": "10001281", "pair_id": "50001281", "similarity": 0.25, "text": "Patient 10001281  \nGender: Female  \nAge: 54  \nRace: WHITE  \n\nAdmission 74125689  \n    DRGs:  \n    - APR: MALIGNANT NEOPLASM OF BREAST - INITIAL PRESENTATION (Severity 3.0)  \n    - HCFA: BREAST CANCER W/O MCC  \n\n    Medications:  \n    - Doxorubicin 60 mg/m² IV q21d (cycle-based)  \n    - Cyclophosphamide 600 mg/m² IV q21d  \n    - Ondansetron 8 mg IV q8h PRN for nausea  \n    - Dexamethasone 8 mg PO daily (chemo pre-medication)  \n    - Filgrastim 300 mcg SC daily x5 days post-chemo  \n    - Acetaminophen 650 mg PO PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Doxorubicin: IV, Discontinued via patient discharge  \n    - Cyclophosphamide: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Filgrastim: SC, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Ultrasound-guided core needle breast biopsy  \n    - Staging MRI of breast and axilla  \n    - Port-a-cath placement for chemotherapy administration  \n\n---\n\nAdmission 75438214  \n    DRGs:  \n    - APR: PARTIAL MASTECTOMY W AXILLARY NODE SAMPLING (Severity 4.0)  \n    - HCFA: BREAST SURGERY W CC  \n\n    Medications:  \n    - Cefazolin 2 g IV perioperatively  \n    - Morphine 2 mg IV q4h PRN  \n    - Ondansetron 4 mg IV PRN  \n    - Ketorolac 30 mg IV q6h  \n    - Acetaminophen 1 g PO q8h  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Cefazolin: IV, Discontinued via patient discharge  \n    - Morphine: IV, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Ketorolac: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Lumpectomy with sentinel lymph node biopsy  \n    - Axillary lymph node dissection  \n    - Intraoperative frozen section pathology  \n\n---\n\nAdmission 76901527  \n    DRGs:  \n    - APR: ADJUVANT RADIATION THERAPY FOR BREAST CANCER (Severity 2.0)  \n    - HCFA: RADIATION THERAPY - OUTPATIENT FOLLOW-UP  \n\n    Medications:  \n    - Tamoxifen 20 mg PO daily  \n    - Ondansetron 4 mg PO PRN  \n    - Lorazepam 1 mg PO PRN for treatment-related anxiety  \n    - Ibuprofen 600 mg PO q6h PRN  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Tamoxifen: PO, Discontinued via patient discharge  \n    - Ondansetron: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - External beam radiation therapy planning CT  \n    - Adjuvant radiation delivery to breast and axilla  \n    - Follow-up oncology evaluation for long-term treatment response", "pair_text": "Patient 50001281  \nGender: Female  \nAge: 46  \nRace: WHITE  \n\nAdmission 61248390  \n    DRGs:  \n    - APR: BREAST DISORDERS EXCEPT MALIGNANCY (Severity 1.0)  \n    - HCFA: BENIGN MAMMARY DYSPLASIA W/O CC/MCC  \n\n    Medications:  \n    - Acetaminophen  \n    - Ibuprofen 600mg  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n    - Cephalexin 500mg  \n    - Lorazepam (for peri-procedural anxiety)  \n\n    Orders:  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ibuprofen 600mg: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n    - Cephalexin 500mg: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bilateral breast ultrasound  \n    - Mammography screening  \n    - Core needle aspiration biopsy  \n\nAdmission 62459127  \n    DRGs:  \n    - APR: BREAST BIOPSY & EXCISION PROCEDURES (Severity 2.0)  \n    - HCFA: BREAST BIOPSY W CC  \n\n    Medications:  \n    - Cefazolin IV (peri-operative prophylaxis)  \n    - Ketorolac IV  \n    - Acetaminophen  \n    - Oxycodone 5mg  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron IV  \n    - Heparin SC (DVT prophylaxis)  \n\n    Orders:  \n    - Cefazolin IV: IV, Once, Discontinued via patient discharge  \n    - Ketorolac IV: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Oxycodone 5mg: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Excisional biopsy of right breast lesion  \n    - Sentinel lymph node sampling  \n    - Pathology tissue analysis  \n\nAdmission 63710284  \n    DRGs:  \n    - APR: COMPLICATIONS OF BREAST PROCEDURES (Severity 2.0)  \n    - HCFA: POST-OPERATIVE BREAST COMPLICATIONS W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam (Zosyn) IV  \n    - Acetaminophen  \n    - Morphine IV PRN  \n    - Ondansetron IV  \n    - Sodium Chloride 0.9% Flush  \n    - Enoxaparin SC  \n    - Probiotic Supplement (Lactobacillus)  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Morphine IV: IV PRN, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Enoxaparin SC: SC, Discontinued via patient discharge  \n    - Probiotic Supplement: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Breast wound debridement  \n    - Ultrasound-guided seroma drainage  \n    - Repeat breast MRI for evaluation of healing"}
{"id": "10001281", "pair_id": "60001281", "similarity": 0.0, "text": "Patient 10001281  \nGender: Female  \nAge: 54  \nRace: WHITE  \n\nAdmission 74125689  \n    DRGs:  \n    - APR: MALIGNANT NEOPLASM OF BREAST - INITIAL PRESENTATION (Severity 3.0)  \n    - HCFA: BREAST CANCER W/O MCC  \n\n    Medications:  \n    - Doxorubicin 60 mg/m² IV q21d (cycle-based)  \n    - Cyclophosphamide 600 mg/m² IV q21d  \n    - Ondansetron 8 mg IV q8h PRN for nausea  \n    - Dexamethasone 8 mg PO daily (chemo pre-medication)  \n    - Filgrastim 300 mcg SC daily x5 days post-chemo  \n    - Acetaminophen 650 mg PO PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Doxorubicin: IV, Discontinued via patient discharge  \n    - Cyclophosphamide: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Dexamethasone: PO, Discontinued via patient discharge  \n    - Filgrastim: SC, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Ultrasound-guided core needle breast biopsy  \n    - Staging MRI of breast and axilla  \n    - Port-a-cath placement for chemotherapy administration  \n\n---\n\nAdmission 75438214  \n    DRGs:  \n    - APR: PARTIAL MASTECTOMY W AXILLARY NODE SAMPLING (Severity 4.0)  \n    - HCFA: BREAST SURGERY W CC  \n\n    Medications:  \n    - Cefazolin 2 g IV perioperatively  \n    - Morphine 2 mg IV q4h PRN  \n    - Ondansetron 4 mg IV PRN  \n    - Ketorolac 30 mg IV q6h  \n    - Acetaminophen 1 g PO q8h  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Cefazolin: IV, Discontinued via patient discharge  \n    - Morphine: IV, PRN, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Ketorolac: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Enoxaparin: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Lumpectomy with sentinel lymph node biopsy  \n    - Axillary lymph node dissection  \n    - Intraoperative frozen section pathology  \n\n---\n\nAdmission 76901527  \n    DRGs:  \n    - APR: ADJUVANT RADIATION THERAPY FOR BREAST CANCER (Severity 2.0)  \n    - HCFA: RADIATION THERAPY - OUTPATIENT FOLLOW-UP  \n\n    Medications:  \n    - Tamoxifen 20 mg PO daily  \n    - Ondansetron 4 mg PO PRN  \n    - Lorazepam 1 mg PO PRN for treatment-related anxiety  \n    - Ibuprofen 600 mg PO q6h PRN  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Tamoxifen: PO, Discontinued via patient discharge  \n    - Ondansetron: PO, PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - External beam radiation therapy planning CT  \n    - Adjuvant radiation delivery to breast and axilla  \n    - Follow-up oncology evaluation for long-term treatment response", "pair_text": "Patient 60001281  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 78542013  \n    DRGs:  \n    - APR: ACUTE UPPER RESPIRATORY INFECTION WITHOUT COMPLICATIONS (Severity 1.0)  \n    - HCFA: ACUTE URI W/O MCC  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h PRN fever  \n    - Ibuprofen 400 mg PO q6h PRN  \n    - Guaifenesin 600 mg PO BID  \n    - Loratadine 10 mg PO daily  \n    - Saline Nasal Spray PRN  \n    - Dextromethorphan 30 mg PO q12h PRN cough  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Guaifenesin: PO, Discontinued via patient discharge  \n    - Loratadine: PO, Discontinued via patient discharge  \n    - Saline Nasal Spray: IH, Discontinued via patient discharge  \n    - Dextromethorphan: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Rapid influenza A/B testing  \n    - COVID-19 PCR screening  \n    - Throat swab culture for bacterial pathogens  \n\n---\n\nAdmission 79268450  \n    DRGs:  \n    - APR: ACUTE URI WITH DEHYDRATION REQUIRING IV HYDRATION (Severity 2.0)  \n    - HCFA: ACUTE RESPIRATORY INFECTION W CC  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h  \n    - Ondansetron 4 mg IV PRN nausea  \n    - IV Fluids: Sodium Chloride 0.9% 1L bolus  \n    - Benzonatate 200 mg PO TID PRN cough  \n    - Oxymetazoline Nasal Spray BID x 3 days  \n    - Albuterol Inhaler PRN wheezing  \n\n    Orders:  \n    - Sodium Chloride IV Bolus: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Benzonatate: PO, PRN, Discontinued via patient discharge  \n    - Oxymetazoline Nasal Spray: IH, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, PRN, Discontinued via patient discharge  \n\n    Procedures:  \n    - Chest X-ray to rule out pneumonia  \n    - Pulse oximetry monitoring  \n    - Basic metabolic panel for hydration status  \n\n---\n\nAdmission 80413572  \n    DRGs:  \n    - APR: FOLLOW-UP VISIT FOR ACUTE URI RECOVERY (Severity 1.0)  \n    - HCFA: OUTPATIENT RESPIRATORY EVALUATION  \n\n    Medications:  \n    - Fluticasone Nasal Spray 2 sprays each nostril daily  \n    - Cetirizine 10 mg PO daily  \n    - Vitamin C 500 mg PO daily  \n    - Zinc Sulfate 50 mg PO daily  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Fluticasone Nasal Spray: IH, Discontinued via patient discharge  \n    - Cetirizine: PO, Discontinued via patient discharge  \n    - Vitamin C: PO, Discontinued via patient discharge  \n    - Zinc Sulfate: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Outpatient pulmonary function testing  \n    - Upper airway endoscopic evaluation  \n    - Preventive counseling on respiratory infection avoidance"}
{"id": "10001282", "pair_id": "20001282", "similarity": 1.0, "text": "Patient 10001282  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 81245739  \n    DRGs:  \n    - APR: MAJOR DEPRESSIVE DISORDER - INITIAL EVALUATION & MANAGEMENT (Severity 1.0)  \n    - HCFA: MILD MDD W/O PSYCHOSIS  \n\n    Medications:  \n    - Sertraline 25 mg PO daily  \n    - Hydroxyzine 25 mg PO q6h PRN anxiety  \n    - Trazodone 50 mg PO at bedtime PRN insomnia  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Initiate Sertraline 25 mg PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Trazodone: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Initial psychiatric evaluation  \n    - PHQ-9 screening for depression severity  \n    - Baseline labs (TSH, CMP, CBC) to rule out organic causes  \n\n---\n\nAdmission 82354107  \n    DRGs:  \n    - APR: OUTPATIENT COGNITIVE-BEHAVIORAL THERAPY (CBT) FOLLOW-UP (Severity 1.0)  \n    - HCFA: MILD MDD W/O MCC  \n\n    Medications:  \n    - Sertraline 50 mg PO daily (dose titrated)  \n    - Hydroxyzine 10 mg PO q8h PRN  \n    - Vitamin D3 2,000 IU PO daily  \n    - Melatonin 3 mg PO at bedtime  \n\n    Orders:  \n    - Sertraline titration to 50 mg daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Melatonin: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Weekly CBT therapy sessions  \n    - Structured journaling and mood monitoring  \n    - Lifestyle counseling: sleep hygiene, nutrition, exercise  \n\n---\n\nAdmission 83672058  \n    DRGs:  \n    - APR: PSYCHIATRIC MAINTENANCE FOLLOW-UP (Severity 1.0)  \n    - HCFA: DEPRESSION MEDICATION RESPONSE REVIEW  \n\n    Medications:  \n    - Sertraline 50 mg PO daily  \n    - Bupropion SR 100 mg PO QAM (added for persistent low energy)  \n    - Omega-3 Fatty Acids 1 g PO daily  \n    - Lorazepam 0.5 mg PO PRN severe anxiety  \n\n    Orders:  \n    - Continue Sertraline 50 mg PO, Discontinued via patient discharge  \n    - Start Bupropion SR 100 mg PO, Discontinued via patient discharge  \n    - Omega-3 supplementation: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n\n    Procedures:  \n    - Hamilton Depression Rating Scale reassessment  \n    - Medication adherence counseling  \n    - Follow-up telehealth appointment scheduling", "pair_text": "Patient 20001282  \nGender: Female  \nAge: 37  \nRace: WHITE  \n\nAdmission 84521096  \n    DRGs:  \n    - APR: MILD MAJOR DEPRESSIVE DISORDER - INITIAL DIAGNOSIS (Severity 1.0)  \n    - HCFA: SINGLE EPISODE MDD W/O PSYCHOSIS  \n\n    Medications:  \n    - Escitalopram 5 mg PO daily  \n    - Hydroxyzine 10 mg PO TID PRN anxiety  \n    - Acetaminophen 650 mg PO q6h PRN headaches  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Start Escitalopram 5 mg PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Comprehensive psychiatric evaluation  \n    - PHQ-9 screening  \n    - CBC, CMP, and TSH to rule out organic contributors  \n\n---\n\nAdmission 85634781  \n    DRGs:  \n    - APR: FOLLOW-UP FOR ANTIDEPRESSANT TITRATION (Severity 1.0)  \n    - HCFA: OUTPATIENT DEPRESSION MANAGEMENT W/O MCC  \n\n    Medications:  \n    - Escitalopram 10 mg PO daily (titrated dose)  \n    - Hydroxyzine 25 mg PO q8h PRN anxiety  \n    - Melatonin 3 mg PO nightly for sleep regulation  \n    - Omega-3 Fatty Acids 1 g PO daily  \n\n    Orders:  \n    - Escitalopram increased to 10 mg PO, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Melatonin: PO, Discontinued via patient discharge  \n    - Omega-3 Fatty Acids: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Cognitive Behavioral Therapy (CBT) initiation  \n    - Weekly mood tracking assignments  \n    - Sleep hygiene counseling  \n\n---\n\nAdmission 87269012  \n    DRGs:  \n    - APR: MAINTENANCE AND STABILITY FOLLOW-UP (Severity 1.0)  \n    - HCFA: DEPRESSION MEDICATION RESPONSE REVIEW  \n\n    Medications:  \n    - Escitalopram 10 mg PO daily  \n    - Bupropion XL 150 mg PO QAM (added for fatigue)  \n    - Vitamin D3 2,000 IU PO daily  \n    - Lorazepam 0.5 mg PO PRN severe anxiety  \n\n    Orders:  \n    - Continue Escitalopram 10 mg PO, Discontinued via patient discharge  \n    - Start Bupropion XL 150 mg PO, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n\n    Procedures:  \n    - Hamilton Depression Rating Scale reassessment  \n    - CBT progress evaluation  \n    - Telehealth follow-up scheduling"}
{"id": "10001282", "pair_id": "30001282", "similarity": 0.75, "text": "Patient 10001282  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 81245739  \n    DRGs:  \n    - APR: MAJOR DEPRESSIVE DISORDER - INITIAL EVALUATION & MANAGEMENT (Severity 1.0)  \n    - HCFA: MILD MDD W/O PSYCHOSIS  \n\n    Medications:  \n    - Sertraline 25 mg PO daily  \n    - Hydroxyzine 25 mg PO q6h PRN anxiety  \n    - Trazodone 50 mg PO at bedtime PRN insomnia  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Initiate Sertraline 25 mg PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Trazodone: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Initial psychiatric evaluation  \n    - PHQ-9 screening for depression severity  \n    - Baseline labs (TSH, CMP, CBC) to rule out organic causes  \n\n---\n\nAdmission 82354107  \n    DRGs:  \n    - APR: OUTPATIENT COGNITIVE-BEHAVIORAL THERAPY (CBT) FOLLOW-UP (Severity 1.0)  \n    - HCFA: MILD MDD W/O MCC  \n\n    Medications:  \n    - Sertraline 50 mg PO daily (dose titrated)  \n    - Hydroxyzine 10 mg PO q8h PRN  \n    - Vitamin D3 2,000 IU PO daily  \n    - Melatonin 3 mg PO at bedtime  \n\n    Orders:  \n    - Sertraline titration to 50 mg daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Melatonin: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Weekly CBT therapy sessions  \n    - Structured journaling and mood monitoring  \n    - Lifestyle counseling: sleep hygiene, nutrition, exercise  \n\n---\n\nAdmission 83672058  \n    DRGs:  \n    - APR: PSYCHIATRIC MAINTENANCE FOLLOW-UP (Severity 1.0)  \n    - HCFA: DEPRESSION MEDICATION RESPONSE REVIEW  \n\n    Medications:  \n    - Sertraline 50 mg PO daily  \n    - Bupropion SR 100 mg PO QAM (added for persistent low energy)  \n    - Omega-3 Fatty Acids 1 g PO daily  \n    - Lorazepam 0.5 mg PO PRN severe anxiety  \n\n    Orders:  \n    - Continue Sertraline 50 mg PO, Discontinued via patient discharge  \n    - Start Bupropion SR 100 mg PO, Discontinued via patient discharge  \n    - Omega-3 supplementation: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n\n    Procedures:  \n    - Hamilton Depression Rating Scale reassessment  \n    - Medication adherence counseling  \n    - Follow-up telehealth appointment scheduling", "pair_text": "Patient 30001282  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 90231458  \n    DRGs:  \n    - APR: MODERATE MAJOR DEPRESSIVE DISORDER - INITIAL EVALUATION (Severity 2.0)  \n    - HCFA: SINGLE EPISODE MDD W/O PSYCHOSIS  \n\n    Medications:  \n    - Fluoxetine 10 mg PO daily  \n    - Hydroxyzine 25 mg PO q8h PRN anxiety  \n    - Trazodone 50 mg PO at bedtime PRN insomnia  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Start Fluoxetine 10 mg PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Trazodone: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Psychiatric diagnostic evaluation  \n    - PHQ-9 depression screening  \n    - Baseline labs (CBC, CMP, TSH, Vitamin B12)  \n\n---\n\nAdmission 91854726  \n    DRGs:  \n    - APR: FOLLOW-UP FOR ANTIDEPRESSANT TITRATION & THERAPY INTEGRATION (Severity 2.0)  \n    - HCFA: OUTPATIENT MDD MANAGEMENT W/O MCC  \n\n    Medications:  \n    - Fluoxetine 20 mg PO daily (titrated dose)  \n    - Hydroxyzine 10 mg PO PRN anxiety  \n    - Vitamin D3 2000 IU PO daily  \n    - Melatonin 5 mg PO at bedtime  \n    - Omega-3 Fatty Acids 1 g PO daily  \n\n    Orders:  \n    - Increase Fluoxetine to 20 mg PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Melatonin: PO, Discontinued via patient discharge  \n    - Omega-3 Fatty Acids: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Cognitive Behavioral Therapy (CBT) initiation  \n    - Weekly group therapy sessions  \n    - Mood and sleep diary tracking  \n    - Lifestyle counseling for stress management  \n\n---\n\nAdmission 93462081  \n    DRGs:  \n    - APR: MAINTENANCE MANAGEMENT & AUGMENTATION THERAPY (Severity 2.0)  \n    - HCFA: RESPONSE TO DEPRESSION TREATMENT REVIEW  \n\n    Medications:  \n    - Fluoxetine 20 mg PO daily  \n    - Bupropion XL 150 mg PO every morning (augmentation for persistent low energy)  \n    - Lorazepam 0.5 mg PO PRN severe anxiety  \n    - Magnesium Glycinate 200 mg PO nightly for sleep  \n\n    Orders:  \n    - Continue Fluoxetine 20 mg PO daily, Discontinued via patient discharge  \n    - Start Bupropion XL 150 mg PO daily, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Magnesium Glycinate: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Hamilton Depression Rating Scale reassessment  \n    - Medication adherence counseling  \n    - CBT progress evaluation  \n    - Telepsychiatry follow-up appointment scheduling"}
{"id": "10001282", "pair_id": "40001282", "similarity": 0.5, "text": "Patient 10001282  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 81245739  \n    DRGs:  \n    - APR: MAJOR DEPRESSIVE DISORDER - INITIAL EVALUATION & MANAGEMENT (Severity 1.0)  \n    - HCFA: MILD MDD W/O PSYCHOSIS  \n\n    Medications:  \n    - Sertraline 25 mg PO daily  \n    - Hydroxyzine 25 mg PO q6h PRN anxiety  \n    - Trazodone 50 mg PO at bedtime PRN insomnia  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Initiate Sertraline 25 mg PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Trazodone: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Initial psychiatric evaluation  \n    - PHQ-9 screening for depression severity  \n    - Baseline labs (TSH, CMP, CBC) to rule out organic causes  \n\n---\n\nAdmission 82354107  \n    DRGs:  \n    - APR: OUTPATIENT COGNITIVE-BEHAVIORAL THERAPY (CBT) FOLLOW-UP (Severity 1.0)  \n    - HCFA: MILD MDD W/O MCC  \n\n    Medications:  \n    - Sertraline 50 mg PO daily (dose titrated)  \n    - Hydroxyzine 10 mg PO q8h PRN  \n    - Vitamin D3 2,000 IU PO daily  \n    - Melatonin 3 mg PO at bedtime  \n\n    Orders:  \n    - Sertraline titration to 50 mg daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Melatonin: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Weekly CBT therapy sessions  \n    - Structured journaling and mood monitoring  \n    - Lifestyle counseling: sleep hygiene, nutrition, exercise  \n\n---\n\nAdmission 83672058  \n    DRGs:  \n    - APR: PSYCHIATRIC MAINTENANCE FOLLOW-UP (Severity 1.0)  \n    - HCFA: DEPRESSION MEDICATION RESPONSE REVIEW  \n\n    Medications:  \n    - Sertraline 50 mg PO daily  \n    - Bupropion SR 100 mg PO QAM (added for persistent low energy)  \n    - Omega-3 Fatty Acids 1 g PO daily  \n    - Lorazepam 0.5 mg PO PRN severe anxiety  \n\n    Orders:  \n    - Continue Sertraline 50 mg PO, Discontinued via patient discharge  \n    - Start Bupropion SR 100 mg PO, Discontinued via patient discharge  \n    - Omega-3 supplementation: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n\n    Procedures:  \n    - Hamilton Depression Rating Scale reassessment  \n    - Medication adherence counseling  \n    - Follow-up telehealth appointment scheduling", "pair_text": "Patient 40001282  \nGender: Female  \nAge: 35  \nRace: WHITE  \n\nAdmission 77102546  \n    DRGs:  \n    - APR: GENERALIZED ANXIETY DISORDER - INITIAL EVALUATION (Severity 2.0)  \n    - HCFA: GAD W/O PSYCHOSIS OR SEVERE IMPAIRMENT  \n\n    Medications:  \n    - Sertraline 25 mg PO daily  \n    - Hydroxyzine 25 mg PO q8h PRN anxiety  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Start Sertraline 25 mg PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - GAD-7 anxiety assessment  \n    - Baseline labs (TSH, CBC, CMP, Vitamin D)  \n    - Initial mental health intake evaluation  \n\n---\n\nAdmission 78154092  \n    DRGs:  \n    - APR: FOLLOW-UP VISIT FOR MEDICATION TITRATION (Severity 2.0)  \n    - HCFA: OUTPATIENT MANAGEMENT OF ANXIETY DISORDERS  \n\n    Medications:  \n    - Sertraline 50 mg PO daily (titrated dose)  \n    - Buspirone 10 mg PO BID  \n    - Hydroxyzine 10 mg PO PRN  \n    - Vitamin D3 2000 IU PO daily  \n    - Melatonin 5 mg PO nightly for sleep support  \n\n    Orders:  \n    - Increase Sertraline to 50 mg PO daily, Discontinued via patient discharge  \n    - Start Buspirone 10 mg PO BID, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Melatonin: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Cognitive Behavioral Therapy (CBT) initiation  \n    - Breathing retraining and relaxation techniques  \n    - Sleep hygiene counseling  \n    - GAD-7 reassessment to evaluate treatment response  \n\n---\n\nAdmission 79561234  \n    DRGs:  \n    - APR: AUGMENTATION AND MAINTENANCE MANAGEMENT (Severity 2.0)  \n    - HCFA: LONG-TERM MANAGEMENT OF GAD WITH MEDICATION AND THERAPY  \n\n    Medications:  \n    - Sertraline 50 mg PO daily  \n    - Buspirone 10 mg PO BID  \n    - Propranolol 10 mg PO PRN for performance anxiety  \n    - Omega-3 Fatty Acids 1 g PO daily  \n    - Lorazepam 0.5 mg PO PRN severe anxiety (short-term use)  \n\n    Orders:  \n    - Continue Sertraline 50 mg PO daily, Discontinued via patient discharge  \n    - Continue Buspirone 10 mg PO BID, Discontinued via patient discharge  \n    - Start Propranolol 10 mg PO PRN, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n    - Omega-3 Fatty Acids: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - GAD-7 score monitoring  \n    - CBT progress evaluation  \n    - Mindfulness-based stress reduction (MBSR) therapy  \n    - Telepsychiatry follow-up appointment scheduling"}
{"id": "10001282", "pair_id": "50001282", "similarity": 0.25, "text": "Patient 10001282  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 81245739  \n    DRGs:  \n    - APR: MAJOR DEPRESSIVE DISORDER - INITIAL EVALUATION & MANAGEMENT (Severity 1.0)  \n    - HCFA: MILD MDD W/O PSYCHOSIS  \n\n    Medications:  \n    - Sertraline 25 mg PO daily  \n    - Hydroxyzine 25 mg PO q6h PRN anxiety  \n    - Trazodone 50 mg PO at bedtime PRN insomnia  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Initiate Sertraline 25 mg PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Trazodone: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Initial psychiatric evaluation  \n    - PHQ-9 screening for depression severity  \n    - Baseline labs (TSH, CMP, CBC) to rule out organic causes  \n\n---\n\nAdmission 82354107  \n    DRGs:  \n    - APR: OUTPATIENT COGNITIVE-BEHAVIORAL THERAPY (CBT) FOLLOW-UP (Severity 1.0)  \n    - HCFA: MILD MDD W/O MCC  \n\n    Medications:  \n    - Sertraline 50 mg PO daily (dose titrated)  \n    - Hydroxyzine 10 mg PO q8h PRN  \n    - Vitamin D3 2,000 IU PO daily  \n    - Melatonin 3 mg PO at bedtime  \n\n    Orders:  \n    - Sertraline titration to 50 mg daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Melatonin: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Weekly CBT therapy sessions  \n    - Structured journaling and mood monitoring  \n    - Lifestyle counseling: sleep hygiene, nutrition, exercise  \n\n---\n\nAdmission 83672058  \n    DRGs:  \n    - APR: PSYCHIATRIC MAINTENANCE FOLLOW-UP (Severity 1.0)  \n    - HCFA: DEPRESSION MEDICATION RESPONSE REVIEW  \n\n    Medications:  \n    - Sertraline 50 mg PO daily  \n    - Bupropion SR 100 mg PO QAM (added for persistent low energy)  \n    - Omega-3 Fatty Acids 1 g PO daily  \n    - Lorazepam 0.5 mg PO PRN severe anxiety  \n\n    Orders:  \n    - Continue Sertraline 50 mg PO, Discontinued via patient discharge  \n    - Start Bupropion SR 100 mg PO, Discontinued via patient discharge  \n    - Omega-3 supplementation: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n\n    Procedures:  \n    - Hamilton Depression Rating Scale reassessment  \n    - Medication adherence counseling  \n    - Follow-up telehealth appointment scheduling", "pair_text": "Patient 50001282  \nGender: Female  \nAge: 39  \nRace: WHITE  \n\nAdmission 70124852  \n    DRGs:  \n    - APR: ANXIETY, STRESS & ADJUSTMENT DISORDERS (Severity 2.0)  \n    - HCFA: POST-TRAUMATIC STRESS DISORDER W/O MCC  \n\n    Medications:  \n    - Sertraline 50mg  \n    - Hydroxyzine 25mg  \n    - Trazodone 50mg  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Sertraline: PO, Discontinued via patient discharge  \n    - Hydroxyzine: PO, Discontinued via patient discharge  \n    - Trazodone: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Psychiatric evaluation  \n    - Screening for comorbid depression (PHQ-9)  \n    - Sleep hygiene counseling  \n\nAdmission 71365907  \n    DRGs:  \n    - APR: ACUTE EXACERBATION OF PTSD SYMPTOMS (Severity 3.0)  \n    - HCFA: POST-TRAUMATIC STRESS DISORDER W CC  \n\n    Medications:  \n    - Sertraline 100mg  \n    - Prazosin 2mg (for nightmares)  \n    - Lorazepam 1mg PRN  \n    - Quetiapine 25mg  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron IV  \n    - Diphenhydramine 25mg  \n\n    Orders:  \n    - Sertraline: PO, Discontinued via patient discharge  \n    - Prazosin: PO, Discontinued via patient discharge  \n    - Lorazepam: PO PRN, Discontinued via patient discharge  \n    - Quetiapine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Diphenhydramine 25mg: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Intensive psychiatric monitoring  \n    - Trauma-focused cognitive behavioral therapy (TF-CBT)  \n    - Sleep study for insomnia  \n\nAdmission 72638415  \n    DRGs:  \n    - APR: SEVERE PTSD WITH COMORBIDITIES (Severity 4.0)  \n    - HCFA: POST-TRAUMATIC STRESS DISORDER W MCC  \n\n    Medications:  \n    - Venlafaxine XR 150mg  \n    - Clonazepam 0.5mg BID  \n    - Gabapentin 300mg  \n    - Zolpidem 10mg (for insomnia)  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Propranolol 10mg (for autonomic symptoms)  \n\n    Orders:  \n    - Venlafaxine XR: PO, Discontinued via patient discharge  \n    - Clonazepam: PO, Discontinued via patient discharge  \n    - Gabapentin: PO, Discontinued via patient discharge  \n    - Zolpidem: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Propranolol: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Inpatient psychiatric stabilization  \n    - Group trauma therapy sessions  \n    - Biofeedback and relaxation training  \n    - Continuous sleep monitoring"}
{"id": "10001282", "pair_id": "60001282", "similarity": 0.0, "text": "Patient 10001282  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 81245739  \n    DRGs:  \n    - APR: MAJOR DEPRESSIVE DISORDER - INITIAL EVALUATION & MANAGEMENT (Severity 1.0)  \n    - HCFA: MILD MDD W/O PSYCHOSIS  \n\n    Medications:  \n    - Sertraline 25 mg PO daily  \n    - Hydroxyzine 25 mg PO q6h PRN anxiety  \n    - Trazodone 50 mg PO at bedtime PRN insomnia  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Initiate Sertraline 25 mg PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Trazodone: PO, PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Initial psychiatric evaluation  \n    - PHQ-9 screening for depression severity  \n    - Baseline labs (TSH, CMP, CBC) to rule out organic causes  \n\n---\n\nAdmission 82354107  \n    DRGs:  \n    - APR: OUTPATIENT COGNITIVE-BEHAVIORAL THERAPY (CBT) FOLLOW-UP (Severity 1.0)  \n    - HCFA: MILD MDD W/O MCC  \n\n    Medications:  \n    - Sertraline 50 mg PO daily (dose titrated)  \n    - Hydroxyzine 10 mg PO q8h PRN  \n    - Vitamin D3 2,000 IU PO daily  \n    - Melatonin 3 mg PO at bedtime  \n\n    Orders:  \n    - Sertraline titration to 50 mg daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Melatonin: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Weekly CBT therapy sessions  \n    - Structured journaling and mood monitoring  \n    - Lifestyle counseling: sleep hygiene, nutrition, exercise  \n\n---\n\nAdmission 83672058  \n    DRGs:  \n    - APR: PSYCHIATRIC MAINTENANCE FOLLOW-UP (Severity 1.0)  \n    - HCFA: DEPRESSION MEDICATION RESPONSE REVIEW  \n\n    Medications:  \n    - Sertraline 50 mg PO daily  \n    - Bupropion SR 100 mg PO QAM (added for persistent low energy)  \n    - Omega-3 Fatty Acids 1 g PO daily  \n    - Lorazepam 0.5 mg PO PRN severe anxiety  \n\n    Orders:  \n    - Continue Sertraline 50 mg PO, Discontinued via patient discharge  \n    - Start Bupropion SR 100 mg PO, Discontinued via patient discharge  \n    - Omega-3 supplementation: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, PRN, Discontinued via patient discharge  \n\n    Procedures:  \n    - Hamilton Depression Rating Scale reassessment  \n    - Medication adherence counseling  \n    - Follow-up telehealth appointment scheduling", "pair_text": "Patient 60001282  \nGender: Female  \nAge: 28  \nRace: WHITE  \n\nAdmission 65091824  \n    DRGs:  \n    - APR: UNSPECIFIED CONJUNCTIVITIS - INITIAL EVALUATION (Severity 1.0)  \n    - HCFA: ACUTE CONJUNCTIVITIS W/O COMPLICATIONS  \n\n    Medications:  \n    - Erythromycin Ophthalmic Ointment 0.5%, Apply to affected eye QID x 7 days  \n    - Artificial Tears Ophthalmic Solution, 1 drop OU QID PRN dryness  \n    - Loratadine 10 mg PO daily for associated allergic symptoms  \n    - Acetaminophen 500 mg PO PRN mild discomfort  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Erythromycin Ophthalmic Ointment: Topical, Discontinued via patient discharge  \n    - Artificial Tears: Ophthalmic, PRN, Discontinued via patient discharge  \n    - Loratadine: PO daily, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Slit-lamp examination of both eyes  \n    - Fluorescein staining for corneal involvement  \n    - Conjunctival swab for bacterial culture  \n\n---\n\nAdmission 66143709  \n    DRGs:  \n    - APR: PERSISTENT CONJUNCTIVITIS FOLLOW-UP (Severity 1.0)  \n    - HCFA: FOLLOW-UP CARE FOR UNSPECIFIED CONJUNCTIVITIS  \n\n    Medications:  \n    - Tobramycin Ophthalmic Drops 0.3%, 1 drop OD q4h x 7 days  \n    - Cetirizine 10 mg PO daily for itching and watery eyes  \n    - Warm Compress Therapy BID  \n    - Ibuprofen 400 mg PO PRN eye pain  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Start Tobramycin Ophthalmic Drops: Topical, Discontinued via patient discharge  \n    - Cetirizine: PO daily, Discontinued via patient discharge  \n    - Warm Compresses: Apply BID, Discontinued via patient discharge  \n    - Ibuprofen: PO, PRN, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Visual acuity testing  \n    - Ocular pH testing (negative for chemical injury)  \n    - Patient education on hygiene and avoiding eye touching  \n\n---\n\nAdmission 67458230  \n    DRGs:  \n    - APR: RECURRENT CONJUNCTIVITIS WITH DIFFERENTIAL ASSESSMENT (Severity 2.0)  \n    - HCFA: CONJUNCTIVITIS - RULE OUT VIRAL VS ALLERGIC  \n\n    Medications:  \n    - Olopatadine Ophthalmic Drops 0.2%, 1 drop OU daily for allergic relief  \n    - Prednisolone Acetate Ophthalmic Suspension 1%, 1 drop OS BID x 5 days (short course)  \n    - Diphenhydramine 25 mg PO at bedtime PRN itching  \n    - Sodium Chloride 0.9% Flush  \n    - Vitamin D3 1000 IU PO daily  \n\n    Orders:  \n    - Start Olopatadine Ophthalmic Drops: Ophthalmic, Discontinued via patient discharge  \n    - Prednisolone Ophthalmic Suspension: Topical, Discontinued via patient discharge  \n    - Diphenhydramine: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - PCR testing for adenovirus and HSV  \n    - Tear osmolarity testing  \n    - Education on avoiding contact lenses until symptoms resolve  \n    - Scheduled follow-up with ophthalmology in 1 week"}
{"id": "10001283", "pair_id": "20001283", "similarity": 1.0, "text": "Patient 10001283  \nGender: Female  \nAge: 63  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: SEPSIS DUE TO OTHER GRAM-NEGATIVE ORGANISMS (Severity 4.0)  \n    - HCFA: SEVERE SEPSIS W/ ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Vancomycin IV per pharmacy dosing protocol  \n    - Norepinephrine IV infusion (titrated for MAP > 65 mmHg)  \n    - Acetaminophen 650 mg PO q6h PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Insulin Regular IV infusion per sliding scale  \n    - Pantoprazole 40 mg IV daily  \n    - Heparin 5000 units SC q8h for DVT prophylaxis  \n\n    Orders:  \n    - Start broad-spectrum antibiotics (Piperacillin-Tazobactam + Vancomycin), Discontinued via patient discharge  \n    - Initiate norepinephrine infusion for hypotension, Discontinued via patient discharge  \n    - Blood cultures x2 before antibiotic administration, Completed  \n    - Insert central venous catheter for pressor support, Completed  \n    - Sodium Chloride 0.9% IV: Continuous infusion, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Pantoprazole: IV, Discontinued via patient discharge  \n    - Heparin prophylaxis: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Central venous catheter placement  \n    - Arterial blood gas analysis  \n    - Continuous cardiac telemetry monitoring  \n    - Initial sepsis resuscitation bundle initiation (30 mL/kg crystalloid bolus)  \n\n---\n\nAdmission 79243681  \n    DRGs:  \n    - APR: SEPTIC SHOCK MANAGEMENT AND ORGAN SUPPORT (Severity 4.0)  \n    - HCFA: GRAM-NEGATIVE BACTEREMIA WITH RENAL FAILURE  \n\n    Medications:  \n    - Meropenem 1 g IV q8h (switched from Piperacillin-Tazobactam based on cultures)  \n    - Gentamicin 5 mg/kg IV q24h (synergy for multidrug-resistant E. coli)  \n    - Hydrocortisone 50 mg IV q6h for refractory septic shock  \n    - Norepinephrine IV infusion  \n    - Midodrine 10 mg PO TID for weaning from pressors  \n    - Furosemide 40 mg IV PRN for volume overload  \n    - Calcium Gluconate IV PRN for electrolyte correction  \n\n    Orders:  \n    - Switch antibiotic coverage to Meropenem + Gentamicin based on culture sensitivity, Discontinued via patient discharge  \n    - Start hydrocortisone IV for refractory shock, Discontinued via patient discharge  \n    - Blood cultures: Repeat x2, Completed  \n    - Initiate continuous renal replacement therapy (CRRT), Completed  \n    - Insert arterial line for blood pressure monitoring, Completed  \n    - Midodrine: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous renal replacement therapy initiation  \n    - Arterial line placement  \n    - Serial lactate monitoring q4h  \n    - Echocardiography to rule out septic cardiomyopathy  \n\n---\n\nAdmission 80529344  \n    DRGs:  \n    - APR: POST-SEPSIS REHABILITATION & LONG-TERM FOLLOW-UP (Severity 2.0)  \n    - HCFA: POST-SEPTIC SYNDROME WITH PERSISTENT INFLAMMATION  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID x 7 days (step-down therapy)  \n    - Probiotic supplement PO daily to restore gut microbiota  \n    - Vitamin C 1000 mg PO daily  \n    - Gabapentin 300 mg PO BID for neuropathy  \n    - Acetaminophen 500 mg PO PRN mild pain  \n\n    Orders:  \n    - Start Ciprofloxacin PO for outpatient therapy, Discontinued via patient discharge  \n    - Begin probiotic supplementation, Discontinued via patient discharge  \n    - Physical therapy referral for post-ICU syndrome, Completed  \n    - Dietitian consult for nutritional optimization, Completed  \n\n    Procedures:  \n    - Follow-up blood cultures to ensure clearance of bacteremia  \n    - Pulmonary function testing due to prolonged mechanical ventilation  \n    - Outpatient nephrology follow-up scheduling for renal recovery assessment", "pair_text": "Patient 20001283  \nGender: Male  \nAge: 70  \nRace: WHITE  \n\nAdmission 80321542  \n    DRGs:  \n    - APR: SEPSIS DUE TO OTHER GRAM-NEGATIVE ORGANISMS (Severity 4.0)  \n    - HCFA: GRAM-NEGATIVE SEPTICEMIA WITH ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Vancomycin IV dosed per pharmacy protocol  \n    - Norepinephrine IV infusion titrated for MAP > 65 mmHg  \n    - Acetaminophen 650 mg PO q6h PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Insulin Regular IV per sliding scale protocol  \n    - Pantoprazole 40 mg IV daily  \n    - Heparin 5000 units SC q8h for DVT prophylaxis  \n\n    Orders:  \n    - Start broad-spectrum antibiotics (Piperacillin-Tazobactam + Vancomycin), Discontinued via patient discharge  \n    - Initiate norepinephrine infusion for refractory hypotension, Discontinued via patient discharge  \n    - Obtain blood cultures x2 prior to antibiotic initiation, Completed  \n    - Insert central venous catheter for vasopressor administration, Completed  \n    - Start pantoprazole IV for GI prophylaxis, Discontinued via patient discharge  \n    - Heparin prophylaxis: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Central venous catheter placement  \n    - Initial sepsis resuscitation bundle with 30 mL/kg fluid bolus  \n    - Continuous cardiac telemetry  \n    - Arterial blood gas (ABG) assessment  \n\n---\n\nAdmission 81546327  \n    DRGs:  \n    - APR: SEPTIC SHOCK MANAGEMENT WITH MULTI-ORGAN FAILURE (Severity 4.0)  \n    - HCFA: GRAM-NEGATIVE SEPSIS WITH ACUTE RENAL FAILURE  \n\n    Medications:  \n    - Meropenem 1 g IV q8h (de-escalation based on cultures)  \n    - Tobramycin IV once daily for synergy against multidrug-resistant Klebsiella  \n    - Hydrocortisone 50 mg IV q6h for refractory septic shock  \n    - Norepinephrine IV infusion  \n    - Midodrine 10 mg PO TID for vasopressor weaning  \n    - Furosemide 40 mg IV PRN for pulmonary edema  \n    - Calcium Gluconate IV PRN electrolyte correction  \n\n    Orders:  \n    - De-escalate antibiotics to Meropenem + Tobramycin based on susceptibility results, Discontinued via patient discharge  \n    - Start hydrocortisone IV for persistent hypotension, Discontinued via patient discharge  \n    - Obtain repeat blood cultures x2, Completed  \n    - Initiate continuous renal replacement therapy (CRRT) for AKI, Completed  \n    - Place arterial line for invasive blood pressure monitoring, Completed  \n    - Midodrine: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous renal replacement therapy initiation  \n    - Arterial line placement  \n    - Serial lactate monitoring every 4 hours  \n    - Transthoracic echocardiogram to assess septic cardiomyopathy  \n\n---\n\nAdmission 82751604  \n    DRGs:  \n    - APR: POST-SEPSIS REHABILITATION AND FOLLOW-UP (Severity 2.0)  \n    - HCFA: RECOVERY PHASE AFTER GRAM-NEGATIVE SEPSIS  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID x 10 days (oral step-down therapy)  \n    - Probiotic supplement PO daily  \n    - Vitamin D3 2000 IU PO daily  \n    - Gabapentin 300 mg PO BID for neuropathic pain from critical illness polyneuropathy  \n    - Acetaminophen 500 mg PO PRN mild pain  \n\n    Orders:  \n    - Start Ciprofloxacin PO for outpatient therapy, Discontinued via patient discharge  \n    - Start probiotics for gut microbiome restoration, Discontinued via patient discharge  \n    - Refer to physical therapy for post-ICU weakness, Completed  \n    - Dietitian consult for high-protein nutritional recovery, Completed  \n\n    Procedures:  \n    - Follow-up blood cultures to confirm clearance of bacteremia  \n    - Pulmonary function testing after mechanical ventilation  \n    - Outpatient nephrology follow-up for renal recovery  \n    - Functional assessment and mental health screening for post-sepsis syndrome"}
{"id": "10001283", "pair_id": "30001283", "similarity": 0.75, "text": "Patient 10001283  \nGender: Female  \nAge: 63  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: SEPSIS DUE TO OTHER GRAM-NEGATIVE ORGANISMS (Severity 4.0)  \n    - HCFA: SEVERE SEPSIS W/ ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Vancomycin IV per pharmacy dosing protocol  \n    - Norepinephrine IV infusion (titrated for MAP > 65 mmHg)  \n    - Acetaminophen 650 mg PO q6h PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Insulin Regular IV infusion per sliding scale  \n    - Pantoprazole 40 mg IV daily  \n    - Heparin 5000 units SC q8h for DVT prophylaxis  \n\n    Orders:  \n    - Start broad-spectrum antibiotics (Piperacillin-Tazobactam + Vancomycin), Discontinued via patient discharge  \n    - Initiate norepinephrine infusion for hypotension, Discontinued via patient discharge  \n    - Blood cultures x2 before antibiotic administration, Completed  \n    - Insert central venous catheter for pressor support, Completed  \n    - Sodium Chloride 0.9% IV: Continuous infusion, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Pantoprazole: IV, Discontinued via patient discharge  \n    - Heparin prophylaxis: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Central venous catheter placement  \n    - Arterial blood gas analysis  \n    - Continuous cardiac telemetry monitoring  \n    - Initial sepsis resuscitation bundle initiation (30 mL/kg crystalloid bolus)  \n\n---\n\nAdmission 79243681  \n    DRGs:  \n    - APR: SEPTIC SHOCK MANAGEMENT AND ORGAN SUPPORT (Severity 4.0)  \n    - HCFA: GRAM-NEGATIVE BACTEREMIA WITH RENAL FAILURE  \n\n    Medications:  \n    - Meropenem 1 g IV q8h (switched from Piperacillin-Tazobactam based on cultures)  \n    - Gentamicin 5 mg/kg IV q24h (synergy for multidrug-resistant E. coli)  \n    - Hydrocortisone 50 mg IV q6h for refractory septic shock  \n    - Norepinephrine IV infusion  \n    - Midodrine 10 mg PO TID for weaning from pressors  \n    - Furosemide 40 mg IV PRN for volume overload  \n    - Calcium Gluconate IV PRN for electrolyte correction  \n\n    Orders:  \n    - Switch antibiotic coverage to Meropenem + Gentamicin based on culture sensitivity, Discontinued via patient discharge  \n    - Start hydrocortisone IV for refractory shock, Discontinued via patient discharge  \n    - Blood cultures: Repeat x2, Completed  \n    - Initiate continuous renal replacement therapy (CRRT), Completed  \n    - Insert arterial line for blood pressure monitoring, Completed  \n    - Midodrine: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous renal replacement therapy initiation  \n    - Arterial line placement  \n    - Serial lactate monitoring q4h  \n    - Echocardiography to rule out septic cardiomyopathy  \n\n---\n\nAdmission 80529344  \n    DRGs:  \n    - APR: POST-SEPSIS REHABILITATION & LONG-TERM FOLLOW-UP (Severity 2.0)  \n    - HCFA: POST-SEPTIC SYNDROME WITH PERSISTENT INFLAMMATION  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID x 7 days (step-down therapy)  \n    - Probiotic supplement PO daily to restore gut microbiota  \n    - Vitamin C 1000 mg PO daily  \n    - Gabapentin 300 mg PO BID for neuropathy  \n    - Acetaminophen 500 mg PO PRN mild pain  \n\n    Orders:  \n    - Start Ciprofloxacin PO for outpatient therapy, Discontinued via patient discharge  \n    - Begin probiotic supplementation, Discontinued via patient discharge  \n    - Physical therapy referral for post-ICU syndrome, Completed  \n    - Dietitian consult for nutritional optimization, Completed  \n\n    Procedures:  \n    - Follow-up blood cultures to ensure clearance of bacteremia  \n    - Pulmonary function testing due to prolonged mechanical ventilation  \n    - Outpatient nephrology follow-up scheduling for renal recovery assessment", "pair_text": "Patient 30001283  \nGender: Female  \nAge: 66  \nRace: WHITE  \n\nAdmission 84201934  \n    DRGs:  \n    - APR: SEPSIS DUE TO ANAEROBIC ORGANISMS (Severity 4.0)  \n    - HCFA: ANAEROBIC SEPTICEMIA WITH ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Metronidazole 500 mg IV q8h  \n    - Vancomycin IV dosed per pharmacy protocol  \n    - Norepinephrine IV infusion titrated to maintain MAP > 65 mmHg  \n    - Acetaminophen 650 mg PO/NG q6h PRN fever  \n    - Sodium Bicarbonate infusion PRN for metabolic acidosis  \n    - Heparin 5000 units SC q8h for DVT prophylaxis  \n    - Pantoprazole 40 mg IV daily for GI protection  \n\n    Orders:  \n    - Initiate Piperacillin-Tazobactam + Metronidazole combination therapy, Discontinued via patient discharge  \n    - Add Vancomycin empirically for MRSA coverage, Discontinued via patient discharge  \n    - Insert central venous catheter for pressor and antibiotic administration, Completed  \n    - Start norepinephrine infusion for persistent hypotension, Discontinued via patient discharge  \n    - Obtain blood cultures x2 prior to antibiotic initiation, Completed  \n    - Pantoprazole IV: Discontinued via patient discharge  \n    - Heparin SC: Discontinued via patient discharge  \n\n    Procedures:  \n    - Central venous catheter placement  \n    - Initial sepsis bundle activation (30 mL/kg IV fluids)  \n    - Arterial blood gas (ABG) assessment  \n    - Continuous cardiac monitoring  \n\n---\n\nAdmission 85236719  \n    DRGs:  \n    - APR: ANAEROBIC SEPSIS WITH MULTI-ORGAN FAILURE (Severity 4.0)  \n    - HCFA: SEVERE SEPSIS WITH ACUTE KIDNEY INJURY AND RESPIRATORY FAILURE  \n\n    Medications:  \n    - Meropenem 1 g IV q8h (escalated therapy)  \n    - Clindamycin 900 mg IV q8h (to inhibit toxin production)  \n    - Hydrocortisone 50 mg IV q6h for refractory shock  \n    - Norepinephrine IV infusion  \n    - Vasopressin 0.03 units/min IV infusion for septic shock  \n    - Insulin infusion for hyperglycemia management  \n    - Calcium Gluconate IV PRN electrolyte stabilization  \n    - Albuterol-Ipratropium Neb q6h PRN for ventilated bronchospasm  \n\n    Orders:  \n    - Switch to Meropenem + Clindamycin for extended anaerobic coverage, Discontinued via patient discharge  \n    - Start Hydrocortisone IV for refractory hypotension, Discontinued via patient discharge  \n    - Initiate Vasopressin infusion for persistent hypotension, Discontinued via patient discharge  \n    - Initiate mechanical ventilation due to acute hypoxemic respiratory failure, Completed  \n    - Start CRRT for AKI, Completed  \n    - Obtain repeat blood and urine cultures, Completed  \n\n    Procedures:  \n    - Endotracheal intubation and initiation of mechanical ventilation  \n    - Arterial line placement for invasive blood pressure monitoring  \n    - Continuous renal replacement therapy (CRRT)  \n    - Serial lactate monitoring q4h  \n    - Chest X-ray to confirm ETT and central line position  \n\n---\n\nAdmission 86452033  \n    DRGs:  \n    - APR: POST-SEPSIS OUTPATIENT MANAGEMENT (Severity 2.0)  \n    - HCFA: RECOVERY PHASE AFTER ANAEROBIC SEPSIS  \n\n    Medications:  \n    - Amoxicillin-Clavulanate 875/125 mg PO BID x10 days (oral step-down)  \n    - Probiotics PO daily for microbiome support  \n    - Vitamin C 1000 mg PO daily  \n    - Gabapentin 300 mg PO BID for critical illness neuropathy  \n    - Acetaminophen 500 mg PO PRN mild pain  \n\n    Orders:  \n    - Start Amoxicillin-Clavulanate for step-down therapy, Discontinued via patient discharge  \n    - Start probiotics for gut health, Discontinued via patient discharge  \n    - Referral to physical therapy for post-ICU weakness, Completed  \n    - Nutrition consult for calorie and protein optimization, Completed  \n\n    Procedures:  \n    - Pulmonary function testing after ventilator weaning  \n    - Follow-up echocardiogram to assess septic cardiomyopathy recovery  \n    - Outpatient infectious disease follow-up  \n    - Functional status evaluation for rehabilitation planning"}
{"id": "10001283", "pair_id": "40001283", "similarity": 0.5, "text": "Patient 10001283  \nGender: Female  \nAge: 63  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: SEPSIS DUE TO OTHER GRAM-NEGATIVE ORGANISMS (Severity 4.0)  \n    - HCFA: SEVERE SEPSIS W/ ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Vancomycin IV per pharmacy dosing protocol  \n    - Norepinephrine IV infusion (titrated for MAP > 65 mmHg)  \n    - Acetaminophen 650 mg PO q6h PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Insulin Regular IV infusion per sliding scale  \n    - Pantoprazole 40 mg IV daily  \n    - Heparin 5000 units SC q8h for DVT prophylaxis  \n\n    Orders:  \n    - Start broad-spectrum antibiotics (Piperacillin-Tazobactam + Vancomycin), Discontinued via patient discharge  \n    - Initiate norepinephrine infusion for hypotension, Discontinued via patient discharge  \n    - Blood cultures x2 before antibiotic administration, Completed  \n    - Insert central venous catheter for pressor support, Completed  \n    - Sodium Chloride 0.9% IV: Continuous infusion, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Pantoprazole: IV, Discontinued via patient discharge  \n    - Heparin prophylaxis: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Central venous catheter placement  \n    - Arterial blood gas analysis  \n    - Continuous cardiac telemetry monitoring  \n    - Initial sepsis resuscitation bundle initiation (30 mL/kg crystalloid bolus)  \n\n---\n\nAdmission 79243681  \n    DRGs:  \n    - APR: SEPTIC SHOCK MANAGEMENT AND ORGAN SUPPORT (Severity 4.0)  \n    - HCFA: GRAM-NEGATIVE BACTEREMIA WITH RENAL FAILURE  \n\n    Medications:  \n    - Meropenem 1 g IV q8h (switched from Piperacillin-Tazobactam based on cultures)  \n    - Gentamicin 5 mg/kg IV q24h (synergy for multidrug-resistant E. coli)  \n    - Hydrocortisone 50 mg IV q6h for refractory septic shock  \n    - Norepinephrine IV infusion  \n    - Midodrine 10 mg PO TID for weaning from pressors  \n    - Furosemide 40 mg IV PRN for volume overload  \n    - Calcium Gluconate IV PRN for electrolyte correction  \n\n    Orders:  \n    - Switch antibiotic coverage to Meropenem + Gentamicin based on culture sensitivity, Discontinued via patient discharge  \n    - Start hydrocortisone IV for refractory shock, Discontinued via patient discharge  \n    - Blood cultures: Repeat x2, Completed  \n    - Initiate continuous renal replacement therapy (CRRT), Completed  \n    - Insert arterial line for blood pressure monitoring, Completed  \n    - Midodrine: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous renal replacement therapy initiation  \n    - Arterial line placement  \n    - Serial lactate monitoring q4h  \n    - Echocardiography to rule out septic cardiomyopathy  \n\n---\n\nAdmission 80529344  \n    DRGs:  \n    - APR: POST-SEPSIS REHABILITATION & LONG-TERM FOLLOW-UP (Severity 2.0)  \n    - HCFA: POST-SEPTIC SYNDROME WITH PERSISTENT INFLAMMATION  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID x 7 days (step-down therapy)  \n    - Probiotic supplement PO daily to restore gut microbiota  \n    - Vitamin C 1000 mg PO daily  \n    - Gabapentin 300 mg PO BID for neuropathy  \n    - Acetaminophen 500 mg PO PRN mild pain  \n\n    Orders:  \n    - Start Ciprofloxacin PO for outpatient therapy, Discontinued via patient discharge  \n    - Begin probiotic supplementation, Discontinued via patient discharge  \n    - Physical therapy referral for post-ICU syndrome, Completed  \n    - Dietitian consult for nutritional optimization, Completed  \n\n    Procedures:  \n    - Follow-up blood cultures to ensure clearance of bacteremia  \n    - Pulmonary function testing due to prolonged mechanical ventilation  \n    - Outpatient nephrology follow-up scheduling for renal recovery assessment", "pair_text": "Patient 40001283  \nGender: Female  \nAge: 54  \nRace: HISPANIC  \n\nAdmission 74502814  \n    DRGs:  \n    - APR: INFECTIOUS GASTROENTERITIS WITH DEHYDRATION (Severity 2.0)  \n    - HCFA: ACUTE INFECTIOUS ENTEROCOLITIS WITHOUT MCC  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID x5 days  \n    - Ondansetron 4 mg IV q8h PRN nausea  \n    - Loperamide 2 mg PO PRN diarrhea (used cautiously)  \n    - Oral Rehydration Solution (ORS) 250 mL PO q2h  \n    - Acetaminophen 650 mg PO q6h PRN fever  \n    - Sodium Chloride 0.9% IV infusion at 125 mL/hr  \n\n    Orders:  \n    - Start Ciprofloxacin PO, Discontinued via patient discharge  \n    - Initiate IV fluids for dehydration, Discontinued via patient discharge  \n    - Ondansetron: IV, PRN, Discontinued via patient discharge  \n    - Oral Rehydration Solution: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Stool culture and sensitivity, Completed  \n    - Test for *Clostridioides difficile* toxin, Completed  \n\n    Procedures:  \n    - IV fluid bolus (2L NS)  \n    - Stool PCR testing for bacterial pathogens  \n    - Isolation precautions initiated  \n\n---\n\nAdmission 76103955  \n    DRGs:  \n    - APR: INFECTIOUS GASTROENTERITIS WITH HYPOVOLEMIC SHOCK (Severity 3.0)  \n    - HCFA: SEVERE ENTERIC INFECTION WITH ELECTROLYTE IMBALANCE  \n\n    Medications:  \n    - Azithromycin 500 mg PO daily x3 days  \n    - Rifaximin 550 mg PO BID x7 days  \n    - Lactobacillus probiotics PO daily  \n    - IV Potassium Chloride 20 mEq in NS for hypokalemia  \n    - Pantoprazole 40 mg IV daily for stress ulcer prophylaxis  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Switch from Ciprofloxacin to Azithromycin due to resistance, Discontinued via patient discharge  \n    - Add Rifaximin for suspected *E. coli*-associated gastroenteritis, Discontinued via patient discharge  \n    - Start probiotics PO, Discontinued via patient discharge  \n    - Potassium Chloride IV replacement, Completed  \n    - Pantoprazole IV: Discontinued via patient discharge  \n    - Enoxaparin SC: Discontinued via patient discharge  \n    - Serial electrolyte panels q6h, Completed  \n\n    Procedures:  \n    - Nasogastric tube placement for severe vomiting  \n    - Abdominal ultrasound to rule out colitis complications  \n    - Central venous line insertion for hydration and antibiotics  \n\n---\n\nAdmission 77461588  \n    DRGs:  \n    - APR: OUTPATIENT MANAGEMENT OF POST-INFECTIOUS IBS (Severity 1.0)  \n    - HCFA: FOLLOW-UP FOR GASTROENTERITIS RECOVERY  \n\n    Medications:  \n    - Dicyclomine 20 mg PO TID for abdominal cramping  \n    - Probiotics PO daily  \n    - Vitamin D3 2000 IU PO daily  \n    - Zinc Sulfate 220 mg PO daily  \n    - Oral Rehydration Solution 250 mL PO PRN  \n\n    Orders:  \n    - Start Dicyclomine for IBS-like post-infectious abdominal pain, Discontinued via patient discharge  \n    - Continue probiotics PO, Discontinued via patient discharge  \n    - Nutrition consult for hydration recovery, Completed  \n    - Referral to gastroenterology for follow-up, Completed  \n\n    Procedures:  \n    - Lactose tolerance testing  \n    - Small bowel ultrasound for persistent bloating  \n    - Dietary consultation for low-FODMAP transition plan"}
{"id": "10001283", "pair_id": "50001283", "similarity": 0.25, "text": "Patient 10001283  \nGender: Female  \nAge: 63  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: SEPSIS DUE TO OTHER GRAM-NEGATIVE ORGANISMS (Severity 4.0)  \n    - HCFA: SEVERE SEPSIS W/ ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Vancomycin IV per pharmacy dosing protocol  \n    - Norepinephrine IV infusion (titrated for MAP > 65 mmHg)  \n    - Acetaminophen 650 mg PO q6h PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Insulin Regular IV infusion per sliding scale  \n    - Pantoprazole 40 mg IV daily  \n    - Heparin 5000 units SC q8h for DVT prophylaxis  \n\n    Orders:  \n    - Start broad-spectrum antibiotics (Piperacillin-Tazobactam + Vancomycin), Discontinued via patient discharge  \n    - Initiate norepinephrine infusion for hypotension, Discontinued via patient discharge  \n    - Blood cultures x2 before antibiotic administration, Completed  \n    - Insert central venous catheter for pressor support, Completed  \n    - Sodium Chloride 0.9% IV: Continuous infusion, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Pantoprazole: IV, Discontinued via patient discharge  \n    - Heparin prophylaxis: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Central venous catheter placement  \n    - Arterial blood gas analysis  \n    - Continuous cardiac telemetry monitoring  \n    - Initial sepsis resuscitation bundle initiation (30 mL/kg crystalloid bolus)  \n\n---\n\nAdmission 79243681  \n    DRGs:  \n    - APR: SEPTIC SHOCK MANAGEMENT AND ORGAN SUPPORT (Severity 4.0)  \n    - HCFA: GRAM-NEGATIVE BACTEREMIA WITH RENAL FAILURE  \n\n    Medications:  \n    - Meropenem 1 g IV q8h (switched from Piperacillin-Tazobactam based on cultures)  \n    - Gentamicin 5 mg/kg IV q24h (synergy for multidrug-resistant E. coli)  \n    - Hydrocortisone 50 mg IV q6h for refractory septic shock  \n    - Norepinephrine IV infusion  \n    - Midodrine 10 mg PO TID for weaning from pressors  \n    - Furosemide 40 mg IV PRN for volume overload  \n    - Calcium Gluconate IV PRN for electrolyte correction  \n\n    Orders:  \n    - Switch antibiotic coverage to Meropenem + Gentamicin based on culture sensitivity, Discontinued via patient discharge  \n    - Start hydrocortisone IV for refractory shock, Discontinued via patient discharge  \n    - Blood cultures: Repeat x2, Completed  \n    - Initiate continuous renal replacement therapy (CRRT), Completed  \n    - Insert arterial line for blood pressure monitoring, Completed  \n    - Midodrine: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous renal replacement therapy initiation  \n    - Arterial line placement  \n    - Serial lactate monitoring q4h  \n    - Echocardiography to rule out septic cardiomyopathy  \n\n---\n\nAdmission 80529344  \n    DRGs:  \n    - APR: POST-SEPSIS REHABILITATION & LONG-TERM FOLLOW-UP (Severity 2.0)  \n    - HCFA: POST-SEPTIC SYNDROME WITH PERSISTENT INFLAMMATION  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID x 7 days (step-down therapy)  \n    - Probiotic supplement PO daily to restore gut microbiota  \n    - Vitamin C 1000 mg PO daily  \n    - Gabapentin 300 mg PO BID for neuropathy  \n    - Acetaminophen 500 mg PO PRN mild pain  \n\n    Orders:  \n    - Start Ciprofloxacin PO for outpatient therapy, Discontinued via patient discharge  \n    - Begin probiotic supplementation, Discontinued via patient discharge  \n    - Physical therapy referral for post-ICU syndrome, Completed  \n    - Dietitian consult for nutritional optimization, Completed  \n\n    Procedures:  \n    - Follow-up blood cultures to ensure clearance of bacteremia  \n    - Pulmonary function testing due to prolonged mechanical ventilation  \n    - Outpatient nephrology follow-up scheduling for renal recovery assessment", "pair_text": "Patient 50001283  \nGender: Male  \nAge: 67  \nRace: WHITE  \n\nAdmission 80127643  \n    DRGs:  \n    - APR: PNEUMONIA, UNSPECIFIED ORGANISM (Severity 2.0)  \n    - HCFA: SIMPLE PNEUMONIA & PLEURISY W CC  \n\n    Medications:  \n    - Ceftriaxone IV  \n    - Azithromycin PO  \n    - Albuterol 0.083% Neb Soln  \n    - Acetaminophen  \n    - Sodium Chloride 0.9% Flush  \n    - Guaifenesin  \n    - Oxygen Therapy (2L NC)  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Ceftriaxone IV: IV, Discontinued via patient discharge  \n    - Azithromycin PO: PO, Discontinued via patient discharge  \n    - Albuterol 0.083% Neb Soln: IH, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Guaifenesin: PO, Discontinued via patient discharge  \n    - Oxygen Therapy: Continuous, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Chest X-ray  \n    - Sputum culture and sensitivity  \n    - Pulse oximetry monitoring  \n    - Blood cultures  \n\nAdmission 81459207  \n    DRGs:  \n    - APR: PNEUMONIA WITH RESPIRATORY DISTRESS (Severity 3.0)  \n    - HCFA: PNEUMONIA W ACUTE RESPIRATORY FAILURE W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam (Zosyn) IV  \n    - Levofloxacin IV  \n    - Methylprednisolone IV  \n    - Albuterol Inhaler  \n    - Budesonide Neb  \n    - Sodium Chloride 0.9% Flush  \n    - Heparin SC (DVT prophylaxis)  \n    - Ondansetron IV  \n    - Acetaminophen  \n\n    Orders:  \n    - Piperacillin-Tazobactam IV: IV, Discontinued via patient discharge  \n    - Levofloxacin IV: IV, Discontinued via patient discharge  \n    - Methylprednisolone IV: IV, Discontinued via patient discharge  \n    - Albuterol Inhaler: IH, Discontinued via patient discharge  \n    - Budesonide Neb: IH, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Arterial blood gas (ABG)  \n    - High-resolution CT Chest (HRCT)  \n    - Continuous cardiac telemetry monitoring  \n    - Bronchoscopy for airway clearance  \n\nAdmission 82937411  \n    DRGs:  \n    - APR: SEVERE PNEUMONIA WITH COMPLICATIONS (Severity 4.0)  \n    - HCFA: PNEUMONIA W MCC  \n\n    Medications:  \n    - Meropenem IV  \n    - Vancomycin IV  \n    - Methylprednisolone IV  \n    - Oxygen Therapy (high-flow nasal cannula)  \n    - Morphine IV (for dyspnea relief)  \n    - Sodium Chloride 0.9% Flush  \n    - Enoxaparin SC  \n    - Acetaminophen  \n    - Oseltamivir PO (empiric for viral coverage)  \n\n    Orders:  \n    - Meropenem IV: IV, Discontinued via patient discharge  \n    - Vancomycin IV: IV, Discontinued via patient discharge  \n    - Methylprednisolone IV: IV, Discontinued via patient discharge  \n    - Oxygen Therapy: High-flow, Discontinued via patient discharge  \n    - Morphine IV: IV PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Enoxaparin SC: SC, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Oseltamivir PO: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Endotracheal intubation with mechanical ventilation  \n    - Chest ultrasound for pleural effusion  \n    - Thoracentesis  \n    - Repeat chest CT scan for evaluation of progression"}
{"id": "10001283", "pair_id": "60001283", "similarity": 0.0, "text": "Patient 10001283  \nGender: Female  \nAge: 63  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: SEPSIS DUE TO OTHER GRAM-NEGATIVE ORGANISMS (Severity 4.0)  \n    - HCFA: SEVERE SEPSIS W/ ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Vancomycin IV per pharmacy dosing protocol  \n    - Norepinephrine IV infusion (titrated for MAP > 65 mmHg)  \n    - Acetaminophen 650 mg PO q6h PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Insulin Regular IV infusion per sliding scale  \n    - Pantoprazole 40 mg IV daily  \n    - Heparin 5000 units SC q8h for DVT prophylaxis  \n\n    Orders:  \n    - Start broad-spectrum antibiotics (Piperacillin-Tazobactam + Vancomycin), Discontinued via patient discharge  \n    - Initiate norepinephrine infusion for hypotension, Discontinued via patient discharge  \n    - Blood cultures x2 before antibiotic administration, Completed  \n    - Insert central venous catheter for pressor support, Completed  \n    - Sodium Chloride 0.9% IV: Continuous infusion, Discontinued via patient discharge  \n    - Acetaminophen: PO, PRN, Discontinued via patient discharge  \n    - Pantoprazole: IV, Discontinued via patient discharge  \n    - Heparin prophylaxis: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Central venous catheter placement  \n    - Arterial blood gas analysis  \n    - Continuous cardiac telemetry monitoring  \n    - Initial sepsis resuscitation bundle initiation (30 mL/kg crystalloid bolus)  \n\n---\n\nAdmission 79243681  \n    DRGs:  \n    - APR: SEPTIC SHOCK MANAGEMENT AND ORGAN SUPPORT (Severity 4.0)  \n    - HCFA: GRAM-NEGATIVE BACTEREMIA WITH RENAL FAILURE  \n\n    Medications:  \n    - Meropenem 1 g IV q8h (switched from Piperacillin-Tazobactam based on cultures)  \n    - Gentamicin 5 mg/kg IV q24h (synergy for multidrug-resistant E. coli)  \n    - Hydrocortisone 50 mg IV q6h for refractory septic shock  \n    - Norepinephrine IV infusion  \n    - Midodrine 10 mg PO TID for weaning from pressors  \n    - Furosemide 40 mg IV PRN for volume overload  \n    - Calcium Gluconate IV PRN for electrolyte correction  \n\n    Orders:  \n    - Switch antibiotic coverage to Meropenem + Gentamicin based on culture sensitivity, Discontinued via patient discharge  \n    - Start hydrocortisone IV for refractory shock, Discontinued via patient discharge  \n    - Blood cultures: Repeat x2, Completed  \n    - Initiate continuous renal replacement therapy (CRRT), Completed  \n    - Insert arterial line for blood pressure monitoring, Completed  \n    - Midodrine: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous renal replacement therapy initiation  \n    - Arterial line placement  \n    - Serial lactate monitoring q4h  \n    - Echocardiography to rule out septic cardiomyopathy  \n\n---\n\nAdmission 80529344  \n    DRGs:  \n    - APR: POST-SEPSIS REHABILITATION & LONG-TERM FOLLOW-UP (Severity 2.0)  \n    - HCFA: POST-SEPTIC SYNDROME WITH PERSISTENT INFLAMMATION  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID x 7 days (step-down therapy)  \n    - Probiotic supplement PO daily to restore gut microbiota  \n    - Vitamin C 1000 mg PO daily  \n    - Gabapentin 300 mg PO BID for neuropathy  \n    - Acetaminophen 500 mg PO PRN mild pain  \n\n    Orders:  \n    - Start Ciprofloxacin PO for outpatient therapy, Discontinued via patient discharge  \n    - Begin probiotic supplementation, Discontinued via patient discharge  \n    - Physical therapy referral for post-ICU syndrome, Completed  \n    - Dietitian consult for nutritional optimization, Completed  \n\n    Procedures:  \n    - Follow-up blood cultures to ensure clearance of bacteremia  \n    - Pulmonary function testing due to prolonged mechanical ventilation  \n    - Outpatient nephrology follow-up scheduling for renal recovery assessment", "pair_text": "Patient 60001283  \nGender: Female  \nAge: 32  \nRace: ASIAN  \n\nAdmission 81239041  \n    DRGs:  \n    - APR: ATOPIC DERMATITIS - INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: ATOPIC DERMATITIS W/O MCC  \n\n    Medications:  \n    - Hydrocortisone 2.5% Cream, Apply to affected areas BID x 7 days  \n    - Cetirizine 10 mg PO daily for itching  \n    - Aquaphor Ointment, Apply liberally to dry skin PRN  \n    - Diphenhydramine 25 mg PO at bedtime PRN pruritus  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Hydrocortisone 2.5% Cream: Topical, Discontinued via patient discharge  \n    - Cetirizine: PO daily, Discontinued via patient discharge  \n    - Aquaphor Ointment: Topical, Discontinued via patient discharge  \n    - Diphenhydramine: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Skin patch allergy testing ordered, Completed  \n\n    Procedures:  \n    - Dermatology consult for initial management  \n    - Skin barrier assessment  \n    - Moisture level testing  \n\n---\n\nAdmission 82458177  \n    DRGs:  \n    - APR: ATOPIC DERMATITIS WITH FLARE-UP (Severity 3.0)  \n    - HCFA: SEVERE ATOPIC DERMATITIS WITH SECONDARY INFECTION  \n\n    Medications:  \n    - Prednisone 40 mg PO daily x5 days (short steroid taper)  \n    - Tacrolimus 0.1% Ointment, Apply to affected areas BID  \n    - Cephalexin 500 mg PO QID x7 days for suspected bacterial superinfection  \n    - Loratadine 10 mg PO daily  \n    - Hydroxyzine 25 mg PO at bedtime PRN itching  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Prednisone taper: PO, Discontinued via patient discharge  \n    - Tacrolimus Ointment: Topical, Discontinued via patient discharge  \n    - Cephalexin: PO, Discontinued via patient discharge  \n    - Loratadine: PO daily, Discontinued via patient discharge  \n    - Hydroxyzine: PO, PRN, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Skin culture and sensitivity: Completed  \n\n    Procedures:  \n    - Wound culture from eczematous lesion  \n    - Dermatology follow-up for tacrolimus titration  \n    - Education on infection prevention  \n\n---\n\nAdmission 83945710  \n    DRGs:  \n    - APR: CHRONIC ATOPIC DERMATITIS MANAGEMENT (Severity 1.0)  \n    - HCFA: LONG-TERM MANAGEMENT OF ATOPIC DERMATITIS  \n\n    Medications:  \n    - Dupilumab 300 mg SC every 2 weeks  \n    - Fexofenadine 180 mg PO daily  \n    - Hydrating Cream with Ceramides, Apply to entire body BID  \n    - Vitamin D3 2000 IU PO daily  \n    - Zinc Oxide Ointment for flare areas PRN  \n\n    Orders:  \n    - Start Dupilumab SC therapy, Ongoing  \n    - Fexofenadine: PO daily, Discontinued via patient discharge  \n    - Ceramide Hydrating Cream: Topical, Discontinued via patient discharge  \n    - Vitamin D3: PO, Discontinued via patient discharge  \n    - Zinc Oxide: Topical, Discontinued via patient discharge  \n    - Referral to allergy/immunology for further workup, Completed  \n\n    Procedures:  \n    - Spirometry testing to assess associated atopic asthma  \n    - Patch testing to identify triggers  \n    - Education on allergen avoidance and skincare routines  \n    - Scheduled follow-up every 3 months"}
{"id": "10001284", "pair_id": "20001284", "similarity": 1.0, "text": "Patient 10001284  \nGender: Female  \nAge: 67  \nRace: WHITE  \n\nAdmission 78541230  \n    DRGs:  \n    - APR: OSTEOARTHRITIS - RIGHT KNEE (Severity 2.0)  \n    - HCFA: UNILATERAL PRIMARY OSTEOARTHRITIS OF RIGHT KNEE W/O MCC  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Ibuprofen 400 mg PO q8h PRN inflammation  \n    - Diclofenac 1% Topical Gel, Apply to right knee QID  \n    - Glucosamine-Chondroitin 500 mg PO daily  \n    - Vitamin D3 2000 IU PO daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Diclofenac Gel: Topical, Discontinued via patient discharge  \n    - Ibuprofen PO: PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Referral to physical therapy for strengthening program, Completed  \n    - Knee X-ray ordered, Completed  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Diagnostic knee X-ray  \n    - Gait and stability assessment  \n    - Physical therapy consultation  \n\n---\n\nAdmission 79658022  \n    DRGs:  \n    - APR: OSTEOARTHRITIS FLARE WITH EFFUSION (Severity 3.0)  \n    - HCFA: OSTEOARTHRITIS OF RIGHT KNEE WITH SYNOVITIS  \n\n    Medications:  \n    - Methylprednisolone 40 mg IA injection (intra-articular)  \n    - Naproxen 500 mg PO BID x10 days  \n    - Pantoprazole 40 mg PO daily (GI protection)  \n    - Tramadol 50 mg PO q6h PRN moderate pain  \n    - Ice therapy protocol, Applied BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Methylprednisolone IA injection: Completed  \n    - Naproxen PO: BID, Discontinued via patient discharge  \n    - Pantoprazole PO: Discontinued via patient discharge  \n    - Tramadol: PO PRN, Discontinued via patient discharge  \n    - Joint aspiration for analysis of synovial effusion, Completed  \n    - Referral for MRI of right knee, Completed  \n\n    Procedures:  \n    - Intra-articular corticosteroid injection  \n    - Synovial fluid aspiration  \n    - MRI of right knee to assess cartilage integrity  \n\n---\n\nAdmission 80234591  \n    DRGs:  \n    - APR: KNEE JOINT REPLACEMENT - RIGHT KNEE (Severity 4.0)  \n    - HCFA: TOTAL KNEE ARTHROPLASTY W/O MCC  \n\n    Medications:  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n    - Cefazolin 2 g IV pre-op and q8h post-op x24h  \n    - Oxycodone 5 mg PO q6h PRN severe pain  \n    - Acetaminophen 1000 mg PO q6h scheduled  \n    - Ondansetron 4 mg IV q8h PRN nausea  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Start Enoxaparin SC post-op, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Cefazolin IV prophylaxis: Completed  \n    - Physical therapy: Start POD#1, Discontinued via patient discharge  \n    - Continuous passive motion (CPM) device ordered, Completed  \n    - Wound care instructions reviewed, Completed  \n\n    Procedures:  \n    - Right total knee arthroplasty performed under spinal anesthesia  \n    - Post-op wound closure with staples  \n    - Early mobilization with physical therapy team  \n    - DVT prophylaxis initiated immediately post-op  \n\n---\n\nAdmission 81426078  \n    DRGs:  \n    - APR: POST-ARTHROPLASTY REHABILITATION (Severity 1.0)  \n    - HCFA: POST-OP KNEE FUNCTIONAL RECOVERY  \n\n    Medications:  \n    - Celecoxib 200 mg PO daily  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Diclofenac Patch, Apply to right knee PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Continue Celecoxib PO, Discontinued via patient discharge  \n    - Transition to home-based physical therapy, Completed  \n    - Schedule follow-up orthopedic evaluation in 6 weeks, Completed  \n    - CPM therapy discontinued, Completed  \n\n    Procedures:  \n    - Supervised functional training  \n    - Gait training with assistive device  \n    - Assessment of range of motion (ROM) milestones  \n    - Counseling for long-term osteoarthritis management", "pair_text": "Patient 20001284  \nGender: Female  \nAge: 70  \nRace: WHITE  \n\nAdmission 87234510  \n    DRGs:  \n    - APR: OSTEOARTHRITIS OF RIGHT KNEE (Severity 2.0)  \n    - HCFA: UNILATERAL PRIMARY OSTEOARTHRITIS RIGHT KNEE W/O MCC  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h PRN mild pain  \n    - Ibuprofen 400 mg PO q8h PRN inflammation  \n    - Diclofenac 1% Gel, Apply to right knee BID  \n    - Vitamin D3 2000 IU PO daily  \n    - Calcium Carbonate 500 mg PO BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Initiate Diclofenac 1% Gel: Topical, Discontinued via patient discharge  \n    - Start Ibuprofen PO: PRN, Discontinued via patient discharge  \n    - Physical therapy referral for strengthening and ROM, Completed  \n    - Knee X-ray ordered, Completed  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Right knee diagnostic X-ray  \n    - Gait and mobility assessment  \n    - Physical therapy initiation for knee stabilization  \n\n---\n\nAdmission 88347926  \n    DRGs:  \n    - APR: OSTEOARTHRITIS FLARE WITH SWELLING (Severity 3.0)  \n    - HCFA: UNILATERAL OSTEOARTHRITIS RIGHT KNEE W SYNOVITIS  \n\n    Medications:  \n    - Methylprednisolone 40 mg intra-articular injection  \n    - Naproxen 500 mg PO BID x14 days  \n    - Pantoprazole 40 mg PO daily (for GI protection)  \n    - Tramadol 50 mg PO q6h PRN moderate pain  \n    - Ice compression therapy BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Intra-articular steroid injection: Completed  \n    - Naproxen PO: BID, Discontinued via patient discharge  \n    - Pantoprazole PO: Discontinued via patient discharge  \n    - Tramadol PO: PRN, Discontinued via patient discharge  \n    - Joint aspiration to rule out infection, Completed  \n    - MRI ordered for cartilage evaluation, Completed  \n\n    Procedures:  \n    - Intra-articular corticosteroid injection  \n    - Synovial fluid aspiration and analysis  \n    - MRI of right knee joint performed  \n\n---\n\nAdmission 89562478  \n    DRGs:  \n    - APR: VISCOSUPPLEMENTATION THERAPY FOR OSTEOARTHRITIS (Severity 2.0)  \n    - HCFA: HYALURONIC ACID INJECTION SERIES  \n\n    Medications:  \n    - Hyaluronan (Hyalgan) 20 mg IA weekly x3 doses  \n    - Acetaminophen 500 mg PO q6h PRN post-injection soreness  \n    - Ice therapy PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Hyaluronan IA therapy: Completed (3 weekly injections)  \n    - Continue home-based physical therapy, Completed  \n    - Follow-up scheduled for post-injection assessment, Completed  \n\n    Procedures:  \n    - Hyaluronic acid intra-articular injections  \n    - Post-injection ROM evaluation  \n    - Counseling for weight management and strengthening exercises  \n\n---\n\nAdmission 90837615  \n    DRGs:  \n    - APR: PRP THERAPY FOR KNEE OSTEOARTHRITIS (Severity 2.0)  \n    - HCFA: PLATELET-RICH PLASMA JOINT INJECTION  \n\n    Medications:  \n    - Platelet-rich plasma (PRP) intra-articular injection performed  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Celecoxib 200 mg PO daily  \n    - Vitamin D + Calcium supplement PO daily  \n\n    Orders:  \n    - PRP knee injection performed under ultrasound guidance, Completed  \n    - Celecoxib PO: Daily, Discontinued via patient discharge  \n    - Continue strengthening and low-impact mobility program, Completed  \n\n    Procedures:  \n    - PRP extraction and knee injection  \n    - Ultrasound-guided intra-articular placement  \n    - Functional outcome evaluation with orthopedic follow-up"}
{"id": "10001284", "pair_id": "30001284", "similarity": 0.75, "text": "Patient 10001284  \nGender: Female  \nAge: 67  \nRace: WHITE  \n\nAdmission 78541230  \n    DRGs:  \n    - APR: OSTEOARTHRITIS - RIGHT KNEE (Severity 2.0)  \n    - HCFA: UNILATERAL PRIMARY OSTEOARTHRITIS OF RIGHT KNEE W/O MCC  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Ibuprofen 400 mg PO q8h PRN inflammation  \n    - Diclofenac 1% Topical Gel, Apply to right knee QID  \n    - Glucosamine-Chondroitin 500 mg PO daily  \n    - Vitamin D3 2000 IU PO daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Diclofenac Gel: Topical, Discontinued via patient discharge  \n    - Ibuprofen PO: PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Referral to physical therapy for strengthening program, Completed  \n    - Knee X-ray ordered, Completed  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Diagnostic knee X-ray  \n    - Gait and stability assessment  \n    - Physical therapy consultation  \n\n---\n\nAdmission 79658022  \n    DRGs:  \n    - APR: OSTEOARTHRITIS FLARE WITH EFFUSION (Severity 3.0)  \n    - HCFA: OSTEOARTHRITIS OF RIGHT KNEE WITH SYNOVITIS  \n\n    Medications:  \n    - Methylprednisolone 40 mg IA injection (intra-articular)  \n    - Naproxen 500 mg PO BID x10 days  \n    - Pantoprazole 40 mg PO daily (GI protection)  \n    - Tramadol 50 mg PO q6h PRN moderate pain  \n    - Ice therapy protocol, Applied BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Methylprednisolone IA injection: Completed  \n    - Naproxen PO: BID, Discontinued via patient discharge  \n    - Pantoprazole PO: Discontinued via patient discharge  \n    - Tramadol: PO PRN, Discontinued via patient discharge  \n    - Joint aspiration for analysis of synovial effusion, Completed  \n    - Referral for MRI of right knee, Completed  \n\n    Procedures:  \n    - Intra-articular corticosteroid injection  \n    - Synovial fluid aspiration  \n    - MRI of right knee to assess cartilage integrity  \n\n---\n\nAdmission 80234591  \n    DRGs:  \n    - APR: KNEE JOINT REPLACEMENT - RIGHT KNEE (Severity 4.0)  \n    - HCFA: TOTAL KNEE ARTHROPLASTY W/O MCC  \n\n    Medications:  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n    - Cefazolin 2 g IV pre-op and q8h post-op x24h  \n    - Oxycodone 5 mg PO q6h PRN severe pain  \n    - Acetaminophen 1000 mg PO q6h scheduled  \n    - Ondansetron 4 mg IV q8h PRN nausea  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Start Enoxaparin SC post-op, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Cefazolin IV prophylaxis: Completed  \n    - Physical therapy: Start POD#1, Discontinued via patient discharge  \n    - Continuous passive motion (CPM) device ordered, Completed  \n    - Wound care instructions reviewed, Completed  \n\n    Procedures:  \n    - Right total knee arthroplasty performed under spinal anesthesia  \n    - Post-op wound closure with staples  \n    - Early mobilization with physical therapy team  \n    - DVT prophylaxis initiated immediately post-op  \n\n---\n\nAdmission 81426078  \n    DRGs:  \n    - APR: POST-ARTHROPLASTY REHABILITATION (Severity 1.0)  \n    - HCFA: POST-OP KNEE FUNCTIONAL RECOVERY  \n\n    Medications:  \n    - Celecoxib 200 mg PO daily  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Diclofenac Patch, Apply to right knee PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Continue Celecoxib PO, Discontinued via patient discharge  \n    - Transition to home-based physical therapy, Completed  \n    - Schedule follow-up orthopedic evaluation in 6 weeks, Completed  \n    - CPM therapy discontinued, Completed  \n\n    Procedures:  \n    - Supervised functional training  \n    - Gait training with assistive device  \n    - Assessment of range of motion (ROM) milestones  \n    - Counseling for long-term osteoarthritis management", "pair_text": "Patient 30001284  \nGender: Female  \nAge: 68  \nRace: WHITE  \n\nAdmission 81456231  \n    DRGs:  \n    - APR: BILATERAL PRIMARY KNEE OSTEOARTHRITIS — INITIAL MANAGEMENT (Severity 2.0)  \n    - HCFA: OSTEOARTHRITIS OF BOTH KNEES WITHOUT MCC  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Naproxen 500 mg PO BID x14 days  \n    - Diclofenac 1% Gel, Apply to both knees BID  \n    - Calcium + Vitamin D3 500 mg PO daily  \n    - Glucosamine-Chondroitin 1500 mg PO daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Naproxen PO BID, Discontinued via patient discharge  \n    - Apply Diclofenac Gel, Discontinued via patient discharge  \n    - Referral to physical therapy for quadriceps strengthening, Completed  \n    - Bilateral knee X-rays ordered, Completed  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Bilateral knee X-ray  \n    - Physical therapy evaluation for gait optimization  \n    - Weight-bearing analysis for joint alignment  \n\n---\n\nAdmission 82790422  \n    DRGs:  \n    - APR: OSTEOARTHRITIS EXACERBATION WITH FUNCTIONAL LIMITATION (Severity 3.0)  \n    - HCFA: BILATERAL OSTEOARTHRITIS OF KNEES WITH SWELLING  \n\n    Medications:  \n    - Methylprednisolone 40 mg IA injection (each knee)  \n    - Ibuprofen 600 mg PO q8h x10 days  \n    - Pantoprazole 40 mg PO daily for gastric protection  \n    - Tramadol 50 mg PO q6h PRN moderate pain  \n    - Compression wraps for bilateral knees  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Perform bilateral intra-articular corticosteroid injections, Completed  \n    - Ibuprofen PO q8h, Discontinued via patient discharge  \n    - Pantoprazole PO daily, Discontinued via patient discharge  \n    - Tramadol PO PRN, Discontinued via patient discharge  \n    - MRI of both knees ordered for cartilage damage assessment, Completed  \n\n    Procedures:  \n    - Bilateral steroid injections under ultrasound guidance  \n    - Joint aspiration for inflammatory markers  \n    - MRI of bilateral knees for OA staging  \n\n---\n\nAdmission 83976512  \n    DRGs:  \n    - APR: VISCOSUPPLEMENTATION FOR SEVERE BILATERAL KNEE OA (Severity 3.0)  \n    - HCFA: HYALURONAN INJECTION SERIES — BILATERAL  \n\n    Medications:  \n    - Hyaluronic Acid (Synvisc-One) 6 mL IA injection per knee, Single dose  \n    - Acetaminophen 500 mg PO q6h PRN soreness  \n    - Cold compress therapy BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Synvisc-One injections for bilateral knees, Completed  \n    - Recommend home exercise program for ROM improvement, Completed  \n    - Schedule follow-up in 4 weeks for reassessment, Completed  \n\n    Procedures:  \n    - Ultrasound-guided Synvisc-One injections  \n    - Post-procedure flexion-extension ROM assessment  \n    - Functional mobility testing  \n\n---\n\nAdmission 85123477  \n    DRGs:  \n    - APR: ROBOT-ASSISTED TOTAL KNEE ARTHROPLASTY (Severity 4.0)  \n    - HCFA: BILATERAL KNEE REPLACEMENT WITH MAJOR COMPLICATION RISK  \n\n    Medications:  \n    - Cefazolin 2 g IV pre-op for infection prophylaxis  \n    - Oxycodone 5 mg PO q4h PRN post-op pain  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n    - Celecoxib 200 mg PO daily for post-op inflammation  \n    - Acetaminophen 650 mg PO q6h scheduled  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Preoperative antibiotics administered, Completed  \n    - Bilateral robot-assisted total knee arthroplasty performed, Completed  \n    - Start DVT prophylaxis with Enoxaparin, Discontinued via patient discharge  \n    - Start inpatient rehabilitation protocol, Completed  \n    - Outpatient physical therapy referral, Completed  \n\n    Procedures:  \n    - Bilateral robot-assisted total knee arthroplasty  \n    - Continuous passive motion (CPM) therapy initiated  \n    - Postoperative wound care and dressing change  \n    - Inpatient rehabilitation for early ambulation"}
{"id": "10001284", "pair_id": "40001284", "similarity": 0.5, "text": "Patient 10001284  \nGender: Female  \nAge: 67  \nRace: WHITE  \n\nAdmission 78541230  \n    DRGs:  \n    - APR: OSTEOARTHRITIS - RIGHT KNEE (Severity 2.0)  \n    - HCFA: UNILATERAL PRIMARY OSTEOARTHRITIS OF RIGHT KNEE W/O MCC  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Ibuprofen 400 mg PO q8h PRN inflammation  \n    - Diclofenac 1% Topical Gel, Apply to right knee QID  \n    - Glucosamine-Chondroitin 500 mg PO daily  \n    - Vitamin D3 2000 IU PO daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Diclofenac Gel: Topical, Discontinued via patient discharge  \n    - Ibuprofen PO: PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Referral to physical therapy for strengthening program, Completed  \n    - Knee X-ray ordered, Completed  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Diagnostic knee X-ray  \n    - Gait and stability assessment  \n    - Physical therapy consultation  \n\n---\n\nAdmission 79658022  \n    DRGs:  \n    - APR: OSTEOARTHRITIS FLARE WITH EFFUSION (Severity 3.0)  \n    - HCFA: OSTEOARTHRITIS OF RIGHT KNEE WITH SYNOVITIS  \n\n    Medications:  \n    - Methylprednisolone 40 mg IA injection (intra-articular)  \n    - Naproxen 500 mg PO BID x10 days  \n    - Pantoprazole 40 mg PO daily (GI protection)  \n    - Tramadol 50 mg PO q6h PRN moderate pain  \n    - Ice therapy protocol, Applied BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Methylprednisolone IA injection: Completed  \n    - Naproxen PO: BID, Discontinued via patient discharge  \n    - Pantoprazole PO: Discontinued via patient discharge  \n    - Tramadol: PO PRN, Discontinued via patient discharge  \n    - Joint aspiration for analysis of synovial effusion, Completed  \n    - Referral for MRI of right knee, Completed  \n\n    Procedures:  \n    - Intra-articular corticosteroid injection  \n    - Synovial fluid aspiration  \n    - MRI of right knee to assess cartilage integrity  \n\n---\n\nAdmission 80234591  \n    DRGs:  \n    - APR: KNEE JOINT REPLACEMENT - RIGHT KNEE (Severity 4.0)  \n    - HCFA: TOTAL KNEE ARTHROPLASTY W/O MCC  \n\n    Medications:  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n    - Cefazolin 2 g IV pre-op and q8h post-op x24h  \n    - Oxycodone 5 mg PO q6h PRN severe pain  \n    - Acetaminophen 1000 mg PO q6h scheduled  \n    - Ondansetron 4 mg IV q8h PRN nausea  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Start Enoxaparin SC post-op, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Cefazolin IV prophylaxis: Completed  \n    - Physical therapy: Start POD#1, Discontinued via patient discharge  \n    - Continuous passive motion (CPM) device ordered, Completed  \n    - Wound care instructions reviewed, Completed  \n\n    Procedures:  \n    - Right total knee arthroplasty performed under spinal anesthesia  \n    - Post-op wound closure with staples  \n    - Early mobilization with physical therapy team  \n    - DVT prophylaxis initiated immediately post-op  \n\n---\n\nAdmission 81426078  \n    DRGs:  \n    - APR: POST-ARTHROPLASTY REHABILITATION (Severity 1.0)  \n    - HCFA: POST-OP KNEE FUNCTIONAL RECOVERY  \n\n    Medications:  \n    - Celecoxib 200 mg PO daily  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Diclofenac Patch, Apply to right knee PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Continue Celecoxib PO, Discontinued via patient discharge  \n    - Transition to home-based physical therapy, Completed  \n    - Schedule follow-up orthopedic evaluation in 6 weeks, Completed  \n    - CPM therapy discontinued, Completed  \n\n    Procedures:  \n    - Supervised functional training  \n    - Gait training with assistive device  \n    - Assessment of range of motion (ROM) milestones  \n    - Counseling for long-term osteoarthritis management", "pair_text": "Patient 40001284  \nGender: Male  \nAge: 54  \nRace: WHITE  \n\nAdmission 74120531  \n    DRGs:  \n    - APR: ACUTE RIGHT KNEE PAIN — INITIAL ASSESSMENT (Severity 1.0)  \n    - HCFA: KNEE PAIN WITHOUT TRAUMATIC INJURY  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h PRN mild pain  \n    - Ibuprofen 600 mg PO q8h PRN swelling/pain  \n    - Diclofenac 1% Gel, Apply to right knee BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Right knee X-ray ordered, Completed  \n    - Apply cold compresses to right knee, Completed  \n    - Start Diclofenac topical treatment, Discontinued via patient discharge  \n    - Ibuprofen PO q8h PRN, Discontinued via patient discharge  \n    - Physical therapy referral for ROM and gait training, Completed  \n\n    Procedures:  \n    - Right knee X-ray  \n    - Physical therapy evaluation for strengthening and mobility  \n\n---\n\nAdmission 75284629  \n    DRGs:  \n    - APR: CHRONIC KNEE PAIN EXACERBATION (Severity 2.0)  \n    - HCFA: FUNCTIONAL LIMITATION DUE TO RIGHT KNEE PAIN  \n\n    Medications:  \n    - Naproxen 500 mg PO BID x14 days  \n    - Tramadol 50 mg PO q6h PRN moderate pain  \n    - Pantoprazole 40 mg PO daily for gastric protection  \n    - Lidocaine 5% Patch, Apply to right knee q24h  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - MRI of right knee ordered, Completed  \n    - Naproxen PO BID, Discontinued via patient discharge  \n    - Tramadol PO PRN, Discontinued via patient discharge  \n    - Pantoprazole PO daily, Discontinued via patient discharge  \n    - Initiate home exercise plan for knee stability, Completed  \n\n    Procedures:  \n    - MRI of right knee for meniscal and ligament evaluation  \n    - Joint aspiration to rule out inflammatory or septic causes  \n    - Gait analysis and correction via physical therapy  \n\n---\n\nAdmission 76895104  \n    DRGs:  \n    - APR: INTERVENTIONAL MANAGEMENT OF PERSISTENT KNEE PAIN (Severity 3.0)  \n    - HCFA: INTRA-ARTICULAR INJECTION FOR PAIN CONTROL  \n\n    Medications:  \n    - Methylprednisolone 40 mg IA injection to right knee  \n    - Celecoxib 200 mg PO daily  \n    - Acetaminophen 650 mg PO q6h scheduled  \n    - Cold compresses PRN swelling  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Perform corticosteroid injection to right knee under ultrasound guidance, Completed  \n    - Start Celecoxib PO daily, Discontinued via patient discharge  \n    - Continue physical therapy plan, Completed  \n    - Follow-up in 4 weeks for reassessment, Completed  \n\n    Procedures:  \n    - Right knee ultrasound-guided steroid injection  \n    - Post-injection ROM and functional assessment  \n    - Physical therapy strengthening session  \n\n---\n\nAdmission 78264012  \n    DRGs:  \n    - APR: SURGICAL INTERVENTION FOR CHRONIC KNEE PAIN (Severity 4.0)  \n    - HCFA: RIGHT KNEE ARTHROSCOPY WITH MENISCAL DEBRIDEMENT  \n\n    Medications:  \n    - Cefazolin 2 g IV pre-op for infection prophylaxis  \n    - Oxycodone 5 mg PO q4h PRN post-op pain  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n    - Celecoxib 200 mg PO daily for inflammation  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Perform right knee arthroscopy, Completed  \n    - Start DVT prophylaxis with Enoxaparin, Discontinued via patient discharge  \n    - Initiate inpatient rehabilitation post-op, Completed  \n    - Outpatient PT referral for recovery, Completed  \n\n    Procedures:  \n    - Arthroscopic right knee meniscal debridement  \n    - Postoperative wound care and dressing changes  \n    - Continuous passive motion (CPM) therapy  \n    - Physical therapy for quadriceps and hamstring strengthening"}
{"id": "10001284", "pair_id": "50001284", "similarity": 0.25, "text": "Patient 10001284  \nGender: Female  \nAge: 67  \nRace: WHITE  \n\nAdmission 78541230  \n    DRGs:  \n    - APR: OSTEOARTHRITIS - RIGHT KNEE (Severity 2.0)  \n    - HCFA: UNILATERAL PRIMARY OSTEOARTHRITIS OF RIGHT KNEE W/O MCC  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Ibuprofen 400 mg PO q8h PRN inflammation  \n    - Diclofenac 1% Topical Gel, Apply to right knee QID  \n    - Glucosamine-Chondroitin 500 mg PO daily  \n    - Vitamin D3 2000 IU PO daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Diclofenac Gel: Topical, Discontinued via patient discharge  \n    - Ibuprofen PO: PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Referral to physical therapy for strengthening program, Completed  \n    - Knee X-ray ordered, Completed  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Diagnostic knee X-ray  \n    - Gait and stability assessment  \n    - Physical therapy consultation  \n\n---\n\nAdmission 79658022  \n    DRGs:  \n    - APR: OSTEOARTHRITIS FLARE WITH EFFUSION (Severity 3.0)  \n    - HCFA: OSTEOARTHRITIS OF RIGHT KNEE WITH SYNOVITIS  \n\n    Medications:  \n    - Methylprednisolone 40 mg IA injection (intra-articular)  \n    - Naproxen 500 mg PO BID x10 days  \n    - Pantoprazole 40 mg PO daily (GI protection)  \n    - Tramadol 50 mg PO q6h PRN moderate pain  \n    - Ice therapy protocol, Applied BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Methylprednisolone IA injection: Completed  \n    - Naproxen PO: BID, Discontinued via patient discharge  \n    - Pantoprazole PO: Discontinued via patient discharge  \n    - Tramadol: PO PRN, Discontinued via patient discharge  \n    - Joint aspiration for analysis of synovial effusion, Completed  \n    - Referral for MRI of right knee, Completed  \n\n    Procedures:  \n    - Intra-articular corticosteroid injection  \n    - Synovial fluid aspiration  \n    - MRI of right knee to assess cartilage integrity  \n\n---\n\nAdmission 80234591  \n    DRGs:  \n    - APR: KNEE JOINT REPLACEMENT - RIGHT KNEE (Severity 4.0)  \n    - HCFA: TOTAL KNEE ARTHROPLASTY W/O MCC  \n\n    Medications:  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n    - Cefazolin 2 g IV pre-op and q8h post-op x24h  \n    - Oxycodone 5 mg PO q6h PRN severe pain  \n    - Acetaminophen 1000 mg PO q6h scheduled  \n    - Ondansetron 4 mg IV q8h PRN nausea  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Start Enoxaparin SC post-op, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Cefazolin IV prophylaxis: Completed  \n    - Physical therapy: Start POD#1, Discontinued via patient discharge  \n    - Continuous passive motion (CPM) device ordered, Completed  \n    - Wound care instructions reviewed, Completed  \n\n    Procedures:  \n    - Right total knee arthroplasty performed under spinal anesthesia  \n    - Post-op wound closure with staples  \n    - Early mobilization with physical therapy team  \n    - DVT prophylaxis initiated immediately post-op  \n\n---\n\nAdmission 81426078  \n    DRGs:  \n    - APR: POST-ARTHROPLASTY REHABILITATION (Severity 1.0)  \n    - HCFA: POST-OP KNEE FUNCTIONAL RECOVERY  \n\n    Medications:  \n    - Celecoxib 200 mg PO daily  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Diclofenac Patch, Apply to right knee PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Continue Celecoxib PO, Discontinued via patient discharge  \n    - Transition to home-based physical therapy, Completed  \n    - Schedule follow-up orthopedic evaluation in 6 weeks, Completed  \n    - CPM therapy discontinued, Completed  \n\n    Procedures:  \n    - Supervised functional training  \n    - Gait training with assistive device  \n    - Assessment of range of motion (ROM) milestones  \n    - Counseling for long-term osteoarthritis management", "pair_text": "Patient 50001284  \nGender: Female  \nAge: 73  \nRace: WHITE  \n\nAdmission 90128463  \n    DRGs:  \n    - APR: GAIT & MOBILITY DISORDERS (Severity 2.0)  \n    - HCFA: DIFFICULTY IN WALKING W/O MCC  \n\n    Medications:  \n    - Acetaminophen  \n    - Ibuprofen 600mg  \n    - Vitamin D3 Supplement  \n    - Calcium Carbonate  \n    - Sodium Chloride 0.9% Flush  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ibuprofen 600mg: PO, Discontinued via patient discharge  \n    - Vitamin D3 Supplement: PO, Discontinued via patient discharge  \n    - Calcium Carbonate: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Physical therapy evaluation  \n    - Gait assessment and balance testing  \n    - MRI of lumbar spine (rule out neurological cause)  \n\nAdmission 91348752  \n    DRGs:  \n    - APR: GAIT DISTURBANCES W MUSCULOSKELETAL DISORDERS (Severity 3.0)  \n    - HCFA: DIFFICULTY IN WALKING W CC  \n\n    Medications:  \n    - Naproxen 500mg  \n    - Cyclobenzaprine 5mg  \n    - Acetaminophen  \n    - Sodium Chloride 0.9% Flush  \n    - Heparin SC (DVT prophylaxis)  \n    - Calcium + Vitamin D Supplement  \n    - Ondansetron IV  \n\n    Orders:  \n    - Naproxen 500mg: PO, Discontinued via patient discharge  \n    - Cyclobenzaprine 5mg: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n    - Calcium + Vitamin D Supplement: PO, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Nerve conduction studies (EMG/NCV)  \n    - CT scan of hips and pelvis  \n    - Assistive device fitting (walker)  \n\nAdmission 92751008  \n    DRGs:  \n    - APR: SEVERE GAIT IMPAIRMENT DUE TO NEUROLOGICAL DISORDERS (Severity 4.0)  \n    - HCFA: DIFFICULTY IN WALKING W MCC  \n\n    Medications:  \n    - Methylprednisolone IV (suspected inflammatory cause)  \n    - Gabapentin 300mg  \n    - Baclofen 10mg  \n    - Acetaminophen  \n    - Sodium Chloride 0.9% Flush  \n    - Enoxaparin SC  \n    - Lorazepam 1mg (for anxiety related to gait training)  \n\n    Orders:  \n    - Methylprednisolone IV: IV, Discontinued via patient discharge  \n    - Gabapentin 300mg: PO, Discontinued via patient discharge  \n    - Baclofen 10mg: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Enoxaparin SC: SC, Discontinued via patient discharge  \n    - Lorazepam 1mg: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Brain MRI with contrast  \n    - Comprehensive neurological evaluation  \n    - Intensive inpatient rehabilitation therapy  \n    - Fall risk assessment and mobility training"}
{"id": "10001284", "pair_id": "60001284", "similarity": 0.0, "text": "Patient 10001284  \nGender: Female  \nAge: 67  \nRace: WHITE  \n\nAdmission 78541230  \n    DRGs:  \n    - APR: OSTEOARTHRITIS - RIGHT KNEE (Severity 2.0)  \n    - HCFA: UNILATERAL PRIMARY OSTEOARTHRITIS OF RIGHT KNEE W/O MCC  \n\n    Medications:  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Ibuprofen 400 mg PO q8h PRN inflammation  \n    - Diclofenac 1% Topical Gel, Apply to right knee QID  \n    - Glucosamine-Chondroitin 500 mg PO daily  \n    - Vitamin D3 2000 IU PO daily  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Start Diclofenac Gel: Topical, Discontinued via patient discharge  \n    - Ibuprofen PO: PRN, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Referral to physical therapy for strengthening program, Completed  \n    - Knee X-ray ordered, Completed  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Diagnostic knee X-ray  \n    - Gait and stability assessment  \n    - Physical therapy consultation  \n\n---\n\nAdmission 79658022  \n    DRGs:  \n    - APR: OSTEOARTHRITIS FLARE WITH EFFUSION (Severity 3.0)  \n    - HCFA: OSTEOARTHRITIS OF RIGHT KNEE WITH SYNOVITIS  \n\n    Medications:  \n    - Methylprednisolone 40 mg IA injection (intra-articular)  \n    - Naproxen 500 mg PO BID x10 days  \n    - Pantoprazole 40 mg PO daily (GI protection)  \n    - Tramadol 50 mg PO q6h PRN moderate pain  \n    - Ice therapy protocol, Applied BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Methylprednisolone IA injection: Completed  \n    - Naproxen PO: BID, Discontinued via patient discharge  \n    - Pantoprazole PO: Discontinued via patient discharge  \n    - Tramadol: PO PRN, Discontinued via patient discharge  \n    - Joint aspiration for analysis of synovial effusion, Completed  \n    - Referral for MRI of right knee, Completed  \n\n    Procedures:  \n    - Intra-articular corticosteroid injection  \n    - Synovial fluid aspiration  \n    - MRI of right knee to assess cartilage integrity  \n\n---\n\nAdmission 80234591  \n    DRGs:  \n    - APR: KNEE JOINT REPLACEMENT - RIGHT KNEE (Severity 4.0)  \n    - HCFA: TOTAL KNEE ARTHROPLASTY W/O MCC  \n\n    Medications:  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n    - Cefazolin 2 g IV pre-op and q8h post-op x24h  \n    - Oxycodone 5 mg PO q6h PRN severe pain  \n    - Acetaminophen 1000 mg PO q6h scheduled  \n    - Ondansetron 4 mg IV q8h PRN nausea  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Start Enoxaparin SC post-op, Discontinued via patient discharge  \n    - Oxycodone: PO, PRN, Discontinued via patient discharge  \n    - Cefazolin IV prophylaxis: Completed  \n    - Physical therapy: Start POD#1, Discontinued via patient discharge  \n    - Continuous passive motion (CPM) device ordered, Completed  \n    - Wound care instructions reviewed, Completed  \n\n    Procedures:  \n    - Right total knee arthroplasty performed under spinal anesthesia  \n    - Post-op wound closure with staples  \n    - Early mobilization with physical therapy team  \n    - DVT prophylaxis initiated immediately post-op  \n\n---\n\nAdmission 81426078  \n    DRGs:  \n    - APR: POST-ARTHROPLASTY REHABILITATION (Severity 1.0)  \n    - HCFA: POST-OP KNEE FUNCTIONAL RECOVERY  \n\n    Medications:  \n    - Celecoxib 200 mg PO daily  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Diclofenac Patch, Apply to right knee PRN  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Continue Celecoxib PO, Discontinued via patient discharge  \n    - Transition to home-based physical therapy, Completed  \n    - Schedule follow-up orthopedic evaluation in 6 weeks, Completed  \n    - CPM therapy discontinued, Completed  \n\n    Procedures:  \n    - Supervised functional training  \n    - Gait training with assistive device  \n    - Assessment of range of motion (ROM) milestones  \n    - Counseling for long-term osteoarthritis management", "pair_text": "Patient 60001284  \nGender: Female  \nAge: 48  \nRace: WHITE  \n\nAdmission 78124563  \n    DRGs:  \n    - APR: BILATERAL HYPERMETROPIA WITH REFRACTIVE ERROR MANAGEMENT (Severity 1.0)  \n    - HCFA: HYPERMETROPIA, BILATERAL — REFRACTION & CORRECTIVE LENS FITTING  \n\n    Medications:  \n    - Artificial Tears (Carboxymethylcellulose) 1 drop OU QID  \n    - Ketotifen 0.025% Ophthalmic Drops 1 drop OU BID (for ocular itching)  \n    - Sodium Chloride 0.9% Flush (eye irrigation PRN)  \n\n    Orders:  \n    - Comprehensive eye exam with dilated fundus evaluation, Completed  \n    - Manifest and cycloplegic refraction testing, Completed  \n    - Fitting of corrective prescription lenses (hyperopic correction), Completed  \n    - Ketotifen eye drops initiated, Discontinued via patient discharge  \n    - Patient education on eye strain reduction techniques, Completed  \n\n    Procedures:  \n    - Automated keratometry and refraction  \n    - Optical coherence tomography (OCT) for baseline retinal assessment  \n\n---\n\nAdmission 79265428  \n    DRGs:  \n    - APR: REFRACTIVE ERROR MANAGEMENT WITH PERSISTENT VISUAL STRAIN (Severity 1.0)  \n    - HCFA: BILATERAL HYPERMETROPIA WITH ASTHENOPIA — FOLLOW-UP EXAM  \n\n    Medications:  \n    - Artificial Tears (Preservative-Free) 1 drop OU Q4H PRN dryness  \n    - Low-dose Pilocarpine 1% Ophthalmic Drops (trial for accommodative support)  \n    - Ketorolac 0.5% Ophthalmic Drops 1 drop OU BID PRN irritation  \n\n    Orders:  \n    - Binocular vision assessment, Completed  \n    - Updated corrective lens prescription with progressive lenses, Completed  \n    - Start artificial tears PRN dryness, Discontinued via patient discharge  \n    - Trial of low-dose pilocarpine drops for near vision, Discontinued via patient discharge  \n    - Patient counseling on reducing prolonged near-work strain, Completed  \n\n    Procedures:  \n    - Humphrey Visual Field testing  \n    - Non-contact tonometry for intraocular pressure monitoring  \n\n---\n\nAdmission 80395142  \n    DRGs:  \n    - APR: REFRACTIVE SURGERY EVALUATION FOR BILATERAL HYPERMETROPIA (Severity 2.0)  \n    - HCFA: CANDIDACY ASSESSMENT FOR LASIK/PRK  \n\n    Medications:  \n    - Moxifloxacin 0.5% Ophthalmic Drops 1 drop OU QID (pre-op prophylaxis)  \n    - Prednisolone Acetate 1% Ophthalmic Drops 1 drop OU QID (post-eval inflammation control)  \n    - Preservative-Free Lubricating Drops QID  \n\n    Orders:  \n    - Corneal topography for LASIK/PRK candidacy, Completed  \n    - Pachymetry to assess corneal thickness, Completed  \n    - Moxifloxacin drops initiated, Discontinued via patient discharge  \n    - Prednisolone acetate eye drops post-evaluation, Discontinued via patient discharge  \n    - Follow-up scheduled for surgical planning, Completed  \n\n    Procedures:  \n    - Corneal pachymetry  \n    - Anterior segment OCT for corneal mapping  \n    - LASIK surgical candidacy consultation  \n\n---\n\nAdmission 81402653  \n    DRGs:  \n    - APR: POST-CORRECTIVE LENS ADJUSTMENT & SYMPTOM MANAGEMENT (Severity 1.0)  \n    - HCFA: BILATERAL HYPERMETROPIA WITH ADAPTATION ISSUES  \n\n    Medications:  \n    - Artificial Tears Gel QHS  \n    - Cyclosporine Ophthalmic Emulsion 0.05% 1 drop OU BID  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Lens refit with updated prescription for intermediate and near vision, Completed  \n    - Initiate Cyclosporine ophthalmic drops for chronic dryness, Discontinued via patient discharge  \n    - Patient advised to follow visual ergonomics strategies, Completed  \n    - Annual follow-up scheduled, Completed  \n\n    Procedures:  \n    - Trial fitting of multifocal contact lenses  \n    - Near-point convergence testing  \n    - Contrast sensitivity testing for low-light vision"}
{"id": "10001285", "pair_id": "20001285", "similarity": 1.0, "text": "Patient 10001285  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 77231845  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — ACUTE EXACERBATION (Severity 3.0)  \n    - HCFA: ULCERATIVE COLITIS W RECTAL BLEEDING — MAJOR GASTROINTESTINAL DISORDERS  \n\n    Medications:  \n    - Mesalamine (Asacol) 1.6 g PO TID  \n    - Methylprednisolone IV 40 mg q12h  \n    - Pantoprazole 40 mg PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n    - Ondansetron 4 mg IV q6h PRN nausea  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Heparin 5000 units SC q12h for DVT prophylaxis  \n\n    Orders:  \n    - Admit to inpatient GI service  \n    - Colonoscopy with biopsies, Completed  \n    - Start Mesalamine, Discontinued via patient discharge  \n    - IV Methylprednisolone initiated, Discontinued via patient discharge  \n    - Ondansetron IV for nausea, Discontinued via patient discharge  \n    - Start clear liquid diet advancing as tolerated, Completed  \n    - GI consult requested, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsy of inflamed rectal mucosa  \n    - Abdominal ultrasound to rule out megacolon  \n\n---\n\nAdmission 78249302  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — STEROID-DEPENDENT FLARE (Severity 3.0)  \n    - HCFA: GASTROINTESTINAL DISORDERS — REFRACTORY UC  \n\n    Medications:  \n    - Mesalamine 1.6 g PO TID  \n    - Prednisone taper starting at 60 mg PO daily  \n    - Infliximab (Remicade) IV 5 mg/kg at weeks 0, 2, and 6  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Pantoprazole 40 mg PO daily  \n    - Hydrocortisone rectal suppository 25 mg BID  \n\n    Orders:  \n    - Initiate Infliximab infusion therapy, Completed  \n    - Prednisone taper protocol, Discontinued via patient discharge  \n    - Continue Mesalamine PO therapy, Discontinued via patient discharge  \n    - CBC, CMP, CRP monitoring, Completed  \n    - Nutritional consult for low-residue diet, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to assess disease extent  \n    - CT abdomen/pelvis for complications  \n\n---\n\nAdmission 79516478  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — MAINTENANCE PHASE (Severity 2.0)  \n    - HCFA: LONG-TERM UC MANAGEMENT ON BIOLOGIC THERAPY  \n\n    Medications:  \n    - Infliximab 5 mg/kg IV every 8 weeks  \n    - Mesalamine 1.2 g PO daily  \n    - Probiotic Supplement BID  \n    - Ferrous Sulfate 325 mg PO daily  \n    - Loperamide 2 mg PO PRN diarrhea  \n\n    Orders:  \n    - Continue scheduled Infliximab infusions, Discontinued via patient discharge  \n    - Maintain Mesalamine oral therapy, Discontinued via patient discharge  \n    - Annual colonoscopy surveillance recommended, Scheduled  \n    - Dietician follow-up for anti-inflammatory diet, Completed  \n    - Order fecal calprotectin for relapse monitoring, Completed  \n\n    Procedures:  \n    - Colonoscopy surveillance  \n    - Infliximab infusion under observation  \n\n---\n\nAdmission 80647911  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS — ACUTE RECTAL BLEEDING REQUIRING SURGICAL CONSULT (Severity 4.0)  \n    - HCFA: GASTROINTESTINAL BLEEDING MANAGEMENT  \n\n    Medications:  \n    - IV Hydrocortisone 100 mg q8h  \n    - Infliximab 10 mg/kg IV (rescue dose)  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Tranexamic Acid IV 1 g once  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Admit to step-down ICU for hemodynamic monitoring  \n    - Start high-dose IV steroids, Discontinued via patient discharge  \n    - Escalate Infliximab dosing, Discontinued via patient discharge  \n    - Start broad-spectrum antibiotics, Discontinued via patient discharge  \n    - Surgical consult for possible colectomy, Completed  \n    - Crossmatch blood for possible transfusion, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to localize active bleeding  \n    - Red blood cell transfusion x2 units  \n    - Central line placement for rapid access", "pair_text": "Patient 20001285  \nGender: Male  \nAge: 51  \nRace: WHITE  \n\nAdmission 88316421  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — INITIAL SEVERE FLARE (Severity 3.0)  \n    - HCFA: ULCERATIVE COLITIS — GASTROINTESTINAL BLEEDING MANAGEMENT  \n\n    Medications:  \n    - Mesalamine 2.4 g PO daily  \n    - Methylprednisolone IV 60 mg daily  \n    - Pantoprazole 40 mg PO daily  \n    - Ondansetron 4 mg IV q8h PRN nausea  \n    - Sodium Chloride 0.9% IV flush PRN  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Heparin 5000 units SC q12h for DVT prophylaxis  \n\n    Orders:  \n    - Start Mesalamine PO, Discontinued via patient discharge  \n    - IV Methylprednisolone for acute flare, Discontinued via patient discharge  \n    - Start clear liquid diet progressing to soft diet, Completed  \n    - Ondansetron IV for nausea, Discontinued via patient discharge  \n    - GI consult initiated, Completed  \n    - Order CBC, CMP, ESR, and CRP labs, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsy confirming ulcerative colitis  \n    - Abdominal X-ray to assess for toxic megacolon  \n\n---\n\nAdmission 89647208  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — STEROID-REFRACTORY FLARE (Severity 3.0)  \n    - HCFA: GASTROINTESTINAL INFLAMMATORY DISEASES — REFRACTORY UC  \n\n    Medications:  \n    - Mesalamine 2.4 g PO daily  \n    - Prednisone taper starting at 60 mg PO daily  \n    - Infliximab IV 5 mg/kg at weeks 0, 2, and 6  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Pantoprazole 40 mg PO daily  \n    - Hydrocortisone rectal foam 10% BID  \n\n    Orders:  \n    - Initiate Infliximab infusion, Completed  \n    - Prednisone taper protocol, Discontinued via patient discharge  \n    - Continue Mesalamine, Discontinued via patient discharge  \n    - Weekly CRP monitoring, Completed  \n    - Dietician consult for low-residue diet, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to assess disease severity  \n    - CT abdomen/pelvis for complication screening  \n\n---\n\nAdmission 90834297  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS — MAINTENANCE PHASE (Severity 2.0)  \n    - HCFA: LONG-TERM MANAGEMENT OF BIOLOGIC-RESPONSIVE UC  \n\n    Medications:  \n    - Infliximab 5 mg/kg IV every 8 weeks  \n    - Mesalamine 1.6 g PO daily  \n    - Probiotic supplement BID  \n    - Ferrous Sulfate 325 mg PO daily for anemia  \n    - Loperamide 2 mg PO PRN diarrhea  \n\n    Orders:  \n    - Continue scheduled Infliximab infusions, Discontinued via patient discharge  \n    - Maintain Mesalamine therapy, Discontinued via patient discharge  \n    - Fecal calprotectin ordered for monitoring inflammation, Completed  \n    - Nutrition counseling for maintenance diet, Completed  \n    - Annual colonoscopy surveillance recommended, Scheduled  \n\n    Procedures:  \n    - Infliximab infusion with monitoring  \n    - Colonoscopy for long-term disease surveillance  \n\n---\n\nAdmission 91953762  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS — ACUTE MASSIVE RECTAL BLEEDING (Severity 4.0)  \n    - HCFA: GI BLEEDING REQUIRING SURGICAL CONSULT  \n\n    Medications:  \n    - IV Hydrocortisone 100 mg q8h  \n    - Infliximab 10 mg/kg IV rescue dose  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Tranexamic Acid 1 g IV once  \n    - Pantoprazole 40 mg IV daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Admit to ICU for hemodynamic monitoring  \n    - Start high-dose IV steroids, Discontinued via patient discharge  \n    - Escalate Infliximab dosing, Discontinued via patient discharge  \n    - Start broad-spectrum antibiotics, Discontinued via patient discharge  \n    - Surgical consult requested for potential colectomy, Completed  \n    - Blood transfusion consent obtained, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to localize active bleeding  \n    - RBC transfusion x3 units  \n    - Central venous catheter placement for rapid infusion access"}
{"id": "10001285", "pair_id": "30001285", "similarity": 0.75, "text": "Patient 10001285  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 77231845  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — ACUTE EXACERBATION (Severity 3.0)  \n    - HCFA: ULCERATIVE COLITIS W RECTAL BLEEDING — MAJOR GASTROINTESTINAL DISORDERS  \n\n    Medications:  \n    - Mesalamine (Asacol) 1.6 g PO TID  \n    - Methylprednisolone IV 40 mg q12h  \n    - Pantoprazole 40 mg PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n    - Ondansetron 4 mg IV q6h PRN nausea  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Heparin 5000 units SC q12h for DVT prophylaxis  \n\n    Orders:  \n    - Admit to inpatient GI service  \n    - Colonoscopy with biopsies, Completed  \n    - Start Mesalamine, Discontinued via patient discharge  \n    - IV Methylprednisolone initiated, Discontinued via patient discharge  \n    - Ondansetron IV for nausea, Discontinued via patient discharge  \n    - Start clear liquid diet advancing as tolerated, Completed  \n    - GI consult requested, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsy of inflamed rectal mucosa  \n    - Abdominal ultrasound to rule out megacolon  \n\n---\n\nAdmission 78249302  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — STEROID-DEPENDENT FLARE (Severity 3.0)  \n    - HCFA: GASTROINTESTINAL DISORDERS — REFRACTORY UC  \n\n    Medications:  \n    - Mesalamine 1.6 g PO TID  \n    - Prednisone taper starting at 60 mg PO daily  \n    - Infliximab (Remicade) IV 5 mg/kg at weeks 0, 2, and 6  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Pantoprazole 40 mg PO daily  \n    - Hydrocortisone rectal suppository 25 mg BID  \n\n    Orders:  \n    - Initiate Infliximab infusion therapy, Completed  \n    - Prednisone taper protocol, Discontinued via patient discharge  \n    - Continue Mesalamine PO therapy, Discontinued via patient discharge  \n    - CBC, CMP, CRP monitoring, Completed  \n    - Nutritional consult for low-residue diet, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to assess disease extent  \n    - CT abdomen/pelvis for complications  \n\n---\n\nAdmission 79516478  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — MAINTENANCE PHASE (Severity 2.0)  \n    - HCFA: LONG-TERM UC MANAGEMENT ON BIOLOGIC THERAPY  \n\n    Medications:  \n    - Infliximab 5 mg/kg IV every 8 weeks  \n    - Mesalamine 1.2 g PO daily  \n    - Probiotic Supplement BID  \n    - Ferrous Sulfate 325 mg PO daily  \n    - Loperamide 2 mg PO PRN diarrhea  \n\n    Orders:  \n    - Continue scheduled Infliximab infusions, Discontinued via patient discharge  \n    - Maintain Mesalamine oral therapy, Discontinued via patient discharge  \n    - Annual colonoscopy surveillance recommended, Scheduled  \n    - Dietician follow-up for anti-inflammatory diet, Completed  \n    - Order fecal calprotectin for relapse monitoring, Completed  \n\n    Procedures:  \n    - Colonoscopy surveillance  \n    - Infliximab infusion under observation  \n\n---\n\nAdmission 80647911  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS — ACUTE RECTAL BLEEDING REQUIRING SURGICAL CONSULT (Severity 4.0)  \n    - HCFA: GASTROINTESTINAL BLEEDING MANAGEMENT  \n\n    Medications:  \n    - IV Hydrocortisone 100 mg q8h  \n    - Infliximab 10 mg/kg IV (rescue dose)  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Tranexamic Acid IV 1 g once  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Admit to step-down ICU for hemodynamic monitoring  \n    - Start high-dose IV steroids, Discontinued via patient discharge  \n    - Escalate Infliximab dosing, Discontinued via patient discharge  \n    - Start broad-spectrum antibiotics, Discontinued via patient discharge  \n    - Surgical consult for possible colectomy, Completed  \n    - Crossmatch blood for possible transfusion, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to localize active bleeding  \n    - Red blood cell transfusion x2 units  \n    - Central line placement for rapid access", "pair_text": "Patient 30001285  \nGender: Female  \nAge: 38  \nRace: WHITE  \n\nAdmission 77198204  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITHOUT COMPLICATIONS — INITIAL DIAGNOSIS (Severity 2.0)  \n    - HCFA: ULCERATIVE COLITIS — NON-COMPLICATED MANAGEMENT  \n\n    Medications:  \n    - Mesalamine 2.4 g PO daily  \n    - Budesonide 9 mg PO daily  \n    - Pantoprazole 40 mg PO daily  \n    - Ondansetron 4 mg PO q8h PRN nausea  \n    - Sodium Chloride 0.9% IV flush PRN  \n    - Acetaminophen 650 mg PO q6h PRN abdominal pain  \n\n    Orders:  \n    - Start Mesalamine PO, Discontinued via patient discharge  \n    - Budesonide PO for anti-inflammatory effect, Discontinued via patient discharge  \n    - Begin low-residue diet, Completed  \n    - Ondansetron PO PRN nausea, Discontinued via patient discharge  \n    - Labs ordered: CBC, CMP, CRP, ESR, Completed  \n    - Stool studies ordered to rule out infectious causes, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsy showing mild ulcerative inflammation  \n    - Abdominal ultrasound to rule out secondary pathology  \n\n---\n\nAdmission 78513472  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITHOUT COMPLICATIONS — SYMPTOM FLARE (Severity 2.0)  \n    - HCFA: ULCERATIVE COLITIS — NON-SEVERE DISEASE MANAGEMENT  \n\n    Medications:  \n    - Mesalamine 3.6 g PO daily  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Probiotic supplement 2 capsules PO daily  \n    - Calcium Carbonate + Vitamin D daily  \n    - Pantoprazole 40 mg PO daily  \n    - Simethicone 80 mg PO PRN bloating  \n\n    Orders:  \n    - Adjust Mesalamine dose to 3.6 g PO daily, Discontinued via patient discharge  \n    - Begin short-course prednisone taper, Discontinued via patient discharge  \n    - Initiate probiotic supplementation, Discontinued via patient discharge  \n    - Nutrition counseling for anti-inflammatory diet, Completed  \n    - Schedule follow-up with GI clinic in 4 weeks, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy showing mild proctosigmoid involvement  \n    - CRP re-evaluation for flare monitoring  \n\n---\n\nAdmission 80236954  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS — MAINTENANCE THERAPY (Severity 1.0)  \n    - HCFA: LONG-TERM DISEASE MONITORING  \n\n    Medications:  \n    - Mesalamine 2.4 g PO daily  \n    - Vitamin D3 2000 IU PO daily  \n    - Omega-3 Fatty Acids 1 g PO daily  \n    - Ferrous Sulfate 325 mg PO daily  \n    - Loperamide 2 mg PO PRN diarrhea  \n\n    Orders:  \n    - Continue maintenance Mesalamine therapy, Discontinued via patient discharge  \n    - Fecal calprotectin ordered to monitor mucosal healing, Completed  \n    - Annual surveillance colonoscopy recommended, Scheduled  \n    - Nutritional counseling for high-fiber diet during remission, Completed  \n    - Refer to patient support group for chronic UC management, Completed  \n\n    Procedures:  \n    - Routine colonoscopy showing mild mucosal improvement  \n    - Mesalamine adherence review by clinical pharmacist  \n\n---\n\nAdmission 81925743  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS — ASYMPTOMATIC FOLLOW-UP (Severity 1.0)  \n    - HCFA: LOW-RISK MAINTENANCE MANAGEMENT  \n\n    Medications:  \n    - Mesalamine 2.4 g PO daily  \n    - Probiotic supplement daily  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Continue stable Mesalamine regimen, Discontinued via patient discharge  \n    - Schedule annual GI follow-up, Completed  \n    - Monitor CBC and CRP yearly, Completed  \n    - Educate patient on early flare recognition, Completed  \n\n    Procedures:  \n    - Surveillance colonoscopy performed, no active disease detected  \n    - Nutritional assessment performed during outpatient visit"}
{"id": "10001285", "pair_id": "40001285", "similarity": 0.5, "text": "Patient 10001285  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 77231845  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — ACUTE EXACERBATION (Severity 3.0)  \n    - HCFA: ULCERATIVE COLITIS W RECTAL BLEEDING — MAJOR GASTROINTESTINAL DISORDERS  \n\n    Medications:  \n    - Mesalamine (Asacol) 1.6 g PO TID  \n    - Methylprednisolone IV 40 mg q12h  \n    - Pantoprazole 40 mg PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n    - Ondansetron 4 mg IV q6h PRN nausea  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Heparin 5000 units SC q12h for DVT prophylaxis  \n\n    Orders:  \n    - Admit to inpatient GI service  \n    - Colonoscopy with biopsies, Completed  \n    - Start Mesalamine, Discontinued via patient discharge  \n    - IV Methylprednisolone initiated, Discontinued via patient discharge  \n    - Ondansetron IV for nausea, Discontinued via patient discharge  \n    - Start clear liquid diet advancing as tolerated, Completed  \n    - GI consult requested, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsy of inflamed rectal mucosa  \n    - Abdominal ultrasound to rule out megacolon  \n\n---\n\nAdmission 78249302  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — STEROID-DEPENDENT FLARE (Severity 3.0)  \n    - HCFA: GASTROINTESTINAL DISORDERS — REFRACTORY UC  \n\n    Medications:  \n    - Mesalamine 1.6 g PO TID  \n    - Prednisone taper starting at 60 mg PO daily  \n    - Infliximab (Remicade) IV 5 mg/kg at weeks 0, 2, and 6  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Pantoprazole 40 mg PO daily  \n    - Hydrocortisone rectal suppository 25 mg BID  \n\n    Orders:  \n    - Initiate Infliximab infusion therapy, Completed  \n    - Prednisone taper protocol, Discontinued via patient discharge  \n    - Continue Mesalamine PO therapy, Discontinued via patient discharge  \n    - CBC, CMP, CRP monitoring, Completed  \n    - Nutritional consult for low-residue diet, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to assess disease extent  \n    - CT abdomen/pelvis for complications  \n\n---\n\nAdmission 79516478  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — MAINTENANCE PHASE (Severity 2.0)  \n    - HCFA: LONG-TERM UC MANAGEMENT ON BIOLOGIC THERAPY  \n\n    Medications:  \n    - Infliximab 5 mg/kg IV every 8 weeks  \n    - Mesalamine 1.2 g PO daily  \n    - Probiotic Supplement BID  \n    - Ferrous Sulfate 325 mg PO daily  \n    - Loperamide 2 mg PO PRN diarrhea  \n\n    Orders:  \n    - Continue scheduled Infliximab infusions, Discontinued via patient discharge  \n    - Maintain Mesalamine oral therapy, Discontinued via patient discharge  \n    - Annual colonoscopy surveillance recommended, Scheduled  \n    - Dietician follow-up for anti-inflammatory diet, Completed  \n    - Order fecal calprotectin for relapse monitoring, Completed  \n\n    Procedures:  \n    - Colonoscopy surveillance  \n    - Infliximab infusion under observation  \n\n---\n\nAdmission 80647911  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS — ACUTE RECTAL BLEEDING REQUIRING SURGICAL CONSULT (Severity 4.0)  \n    - HCFA: GASTROINTESTINAL BLEEDING MANAGEMENT  \n\n    Medications:  \n    - IV Hydrocortisone 100 mg q8h  \n    - Infliximab 10 mg/kg IV (rescue dose)  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Tranexamic Acid IV 1 g once  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Admit to step-down ICU for hemodynamic monitoring  \n    - Start high-dose IV steroids, Discontinued via patient discharge  \n    - Escalate Infliximab dosing, Discontinued via patient discharge  \n    - Start broad-spectrum antibiotics, Discontinued via patient discharge  \n    - Surgical consult for possible colectomy, Completed  \n    - Crossmatch blood for possible transfusion, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to localize active bleeding  \n    - Red blood cell transfusion x2 units  \n    - Central line placement for rapid access", "pair_text": "Patient 40001285  \nGender: Male  \nAge: 62  \nRace: WHITE  \n\nAdmission 78845312  \n    DRGs:  \n    - APR: LOWER GI BLEED — INITIAL EPISODE (Severity 3.0)  \n    - HCFA: HEMORRHAGE OF ANUS AND RECTUM — NON-VARICEAL SOURCE  \n\n    Medications:  \n    - Pantoprazole 40 mg IV BID  \n    - Octreotide infusion 50 mcg/hr  \n    - Sodium Chloride 0.9% IV at 100 mL/hr  \n    - Ceftriaxone 1 g IV daily (prophylaxis for infection risk)  \n    - Acetaminophen 650 mg PO q6h PRN pain  \n    - Ondansetron 4 mg IV q8h PRN nausea  \n\n    Orders:  \n    - Start Pantoprazole IV, Discontinued via patient discharge  \n    - Start Octreotide IV drip for bleeding control, Discontinued via patient discharge  \n    - Begin IV fluids for hypovolemia, Discontinued via patient discharge  \n    - Ceftriaxone prophylaxis initiated, Discontinued via patient discharge  \n    - Monitor hemoglobin and hematocrit q6h, Completed  \n    - Type and crossmatch blood for potential transfusion, Completed  \n    - Colonoscopy scheduled for evaluation, Completed  \n\n    Procedures:  \n    - Colonoscopy with epinephrine injection and thermal coagulation at bleeding site  \n    - Rectal anoscopy to identify bleeding source  \n    - IV fluid resuscitation  \n\n---\n\nAdmission 79902461  \n    DRGs:  \n    - APR: LOWER GI BLEED — READMISSION FOR RECURRENT BLEEDING (Severity 2.0)  \n    - HCFA: HEMORRHAGE OF ANUS AND RECTUM — NON-SURGICAL MANAGEMENT  \n\n    Medications:  \n    - Pantoprazole 40 mg PO daily  \n    - Mesalamine suppository 1 g PR nightly (for associated rectal inflammation)  \n    - Sucralfate 1 g PO TID  \n    - Ferrous Sulfate 325 mg PO daily for anemia  \n    - Polyethylene Glycol PO daily for stool softening  \n    - Ondansetron 4 mg PO PRN nausea  \n\n    Orders:  \n    - Transition Pantoprazole IV to PO, Discontinued via patient discharge  \n    - Mesalamine rectal suppository initiated, Discontinued via patient discharge  \n    - Sucralfate started for mucosal healing, Discontinued via patient discharge  \n    - Iron supplementation ordered for anemia recovery, Discontinued via patient discharge  \n    - Polyethylene Glycol PRN for constipation prevention, Discontinued via patient discharge  \n    - Schedule follow-up with GI clinic in 2 weeks, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy revealing small internal hemorrhoids with recent bleeding  \n    - No active bleeding at time of evaluation  \n    - Nutrition consult for high-fiber diet  \n\n---\n\nAdmission 81173584  \n    DRGs:  \n    - APR: LOWER GI BLEED — ELECTIVE SURVEILLANCE (Severity 1.0)  \n    - HCFA: CHRONIC ANORECTAL BLEEDING — LONG-TERM MANAGEMENT  \n\n    Medications:  \n    - Pantoprazole 40 mg PO daily  \n    - Hydrocortisone rectal cream BID PRN irritation  \n    - Vitamin C 500 mg PO daily  \n    - Zinc Sulfate 220 mg PO daily  \n    - Probiotic supplement PO daily  \n\n    Orders:  \n    - Continue oral Pantoprazole for prophylaxis, Discontinued via patient discharge  \n    - Start hydrocortisone rectal cream PRN irritation, Discontinued via patient discharge  \n    - Recommend high-fiber diet and hydration, Completed  \n    - Surveillance colonoscopy scheduled yearly, Completed  \n\n    Procedures:  \n    - Annual surveillance colonoscopy — stable mucosa, no new bleeding  \n    - Anorectal ultrasound confirming mucosal healing  \n\n---\n\nAdmission 82519670  \n    DRGs:  \n    - APR: LOWER GI BLEED — OUTPATIENT FOLLOW-UP (Severity 1.0)  \n    - HCFA: POST-BLEEDING RECOVERY MONITORING  \n\n    Medications:  \n    - Pantoprazole 40 mg PO daily  \n    - Ferrous Sulfate 325 mg PO every other day  \n    - Multivitamin with folate PO daily  \n\n    Orders:  \n    - Continue long-term Pantoprazole PO, Discontinued via patient discharge  \n    - Monitor CBC q6 months, Completed  \n    - Nutritional counseling for bleeding prevention, Completed  \n    - Patient education provided on early warning signs of recurrent bleeding, Completed  \n\n    Procedures:  \n    - Surveillance sigmoidoscopy performed — no active bleeding  \n    - Dietary and hydration counseling session"}
{"id": "10001285", "pair_id": "50001285", "similarity": 0.25, "text": "Patient 10001285  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 77231845  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — ACUTE EXACERBATION (Severity 3.0)  \n    - HCFA: ULCERATIVE COLITIS W RECTAL BLEEDING — MAJOR GASTROINTESTINAL DISORDERS  \n\n    Medications:  \n    - Mesalamine (Asacol) 1.6 g PO TID  \n    - Methylprednisolone IV 40 mg q12h  \n    - Pantoprazole 40 mg PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n    - Ondansetron 4 mg IV q6h PRN nausea  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Heparin 5000 units SC q12h for DVT prophylaxis  \n\n    Orders:  \n    - Admit to inpatient GI service  \n    - Colonoscopy with biopsies, Completed  \n    - Start Mesalamine, Discontinued via patient discharge  \n    - IV Methylprednisolone initiated, Discontinued via patient discharge  \n    - Ondansetron IV for nausea, Discontinued via patient discharge  \n    - Start clear liquid diet advancing as tolerated, Completed  \n    - GI consult requested, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsy of inflamed rectal mucosa  \n    - Abdominal ultrasound to rule out megacolon  \n\n---\n\nAdmission 78249302  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — STEROID-DEPENDENT FLARE (Severity 3.0)  \n    - HCFA: GASTROINTESTINAL DISORDERS — REFRACTORY UC  \n\n    Medications:  \n    - Mesalamine 1.6 g PO TID  \n    - Prednisone taper starting at 60 mg PO daily  \n    - Infliximab (Remicade) IV 5 mg/kg at weeks 0, 2, and 6  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Pantoprazole 40 mg PO daily  \n    - Hydrocortisone rectal suppository 25 mg BID  \n\n    Orders:  \n    - Initiate Infliximab infusion therapy, Completed  \n    - Prednisone taper protocol, Discontinued via patient discharge  \n    - Continue Mesalamine PO therapy, Discontinued via patient discharge  \n    - CBC, CMP, CRP monitoring, Completed  \n    - Nutritional consult for low-residue diet, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to assess disease extent  \n    - CT abdomen/pelvis for complications  \n\n---\n\nAdmission 79516478  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — MAINTENANCE PHASE (Severity 2.0)  \n    - HCFA: LONG-TERM UC MANAGEMENT ON BIOLOGIC THERAPY  \n\n    Medications:  \n    - Infliximab 5 mg/kg IV every 8 weeks  \n    - Mesalamine 1.2 g PO daily  \n    - Probiotic Supplement BID  \n    - Ferrous Sulfate 325 mg PO daily  \n    - Loperamide 2 mg PO PRN diarrhea  \n\n    Orders:  \n    - Continue scheduled Infliximab infusions, Discontinued via patient discharge  \n    - Maintain Mesalamine oral therapy, Discontinued via patient discharge  \n    - Annual colonoscopy surveillance recommended, Scheduled  \n    - Dietician follow-up for anti-inflammatory diet, Completed  \n    - Order fecal calprotectin for relapse monitoring, Completed  \n\n    Procedures:  \n    - Colonoscopy surveillance  \n    - Infliximab infusion under observation  \n\n---\n\nAdmission 80647911  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS — ACUTE RECTAL BLEEDING REQUIRING SURGICAL CONSULT (Severity 4.0)  \n    - HCFA: GASTROINTESTINAL BLEEDING MANAGEMENT  \n\n    Medications:  \n    - IV Hydrocortisone 100 mg q8h  \n    - Infliximab 10 mg/kg IV (rescue dose)  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Tranexamic Acid IV 1 g once  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Admit to step-down ICU for hemodynamic monitoring  \n    - Start high-dose IV steroids, Discontinued via patient discharge  \n    - Escalate Infliximab dosing, Discontinued via patient discharge  \n    - Start broad-spectrum antibiotics, Discontinued via patient discharge  \n    - Surgical consult for possible colectomy, Completed  \n    - Crossmatch blood for possible transfusion, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to localize active bleeding  \n    - Red blood cell transfusion x2 units  \n    - Central line placement for rapid access", "pair_text": "Patient 50001285  \nGender: Female  \nAge: 55  \nRace: WHITE  \n\nAdmission 10023761  \n    DRGs:  \n    - APR: IRON DEFICIENCY ANEMIA W/O MCC (Severity 2.0)  \n    - HCFA: ANEMIA & NUTRITIONAL DISORDERS W/O CC/MCC  \n\n    Medications:  \n    - Ferrous Sulfate 325mg PO  \n    - Folic Acid 1mg PO  \n    - Vitamin B12 (Cyanocobalamin) 1000mcg IM  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Ondansetron 4mg IV  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Ferrous Sulfate: PO, Discontinued via patient discharge  \n    - Folic Acid: PO, Discontinued via patient discharge  \n    - Vitamin B12: IM, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Complete blood count (CBC)  \n    - Iron studies (serum iron, TIBC, ferritin)  \n    - Peripheral smear review  \n\nAdmission 10194523  \n    DRGs:  \n    - APR: IRON DEFICIENCY ANEMIA W BLOOD LOSS (Severity 3.0)  \n    - HCFA: ANEMIA W CC  \n\n    Medications:  \n    - IV Iron Sucrose (Venofer) 200mg  \n    - Pantoprazole 40mg PO  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Lorazepam 1mg PO  \n    - Ondansetron IV  \n    - Heparin SC (DVT prophylaxis)  \n\n    Orders:  \n    - IV Iron Sucrose: IV, Discontinued via patient discharge  \n    - Pantoprazole: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Upper GI endoscopy (to rule out bleeding source)  \n    - Colonoscopy screening  \n    - Serum folate & vitamin B12 panel  \n    - Abdominal ultrasound  \n\nAdmission 10385742  \n    DRGs:  \n    - APR: SEVERE IRON DEFICIENCY ANEMIA W TRANSFUSION (Severity 4.0)  \n    - HCFA: ANEMIA W MCC  \n\n    Medications:  \n    - Packed Red Blood Cell (PRBC) transfusion  \n    - IV Iron Dextran 1000mg  \n    - Pantoprazole IV  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Diphenhydramine 25mg IV (pre-medication for transfusion)  \n    - Ceftriaxone IV (empiric coverage)  \n    - Multivitamin Supplement  \n\n    Orders:  \n    - PRBC Transfusion: IV, Completed  \n    - IV Iron Dextran: IV, Discontinued via patient discharge  \n    - Pantoprazole IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Diphenhydramine: IV, Discontinued via patient discharge  \n    - Ceftriaxone IV: IV, Discontinued via patient discharge  \n    - Multivitamin Supplement: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Packed red blood cell transfusion (2 units)  \n    - Bone marrow aspiration and biopsy  \n    - Ferritin and transferrin saturation studies  \n    - Continuous pulse oximetry monitoring"}
{"id": "10001285", "pair_id": "60001285", "similarity": 0.0, "text": "Patient 10001285  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 77231845  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — ACUTE EXACERBATION (Severity 3.0)  \n    - HCFA: ULCERATIVE COLITIS W RECTAL BLEEDING — MAJOR GASTROINTESTINAL DISORDERS  \n\n    Medications:  \n    - Mesalamine (Asacol) 1.6 g PO TID  \n    - Methylprednisolone IV 40 mg q12h  \n    - Pantoprazole 40 mg PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n    - Ondansetron 4 mg IV q6h PRN nausea  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Heparin 5000 units SC q12h for DVT prophylaxis  \n\n    Orders:  \n    - Admit to inpatient GI service  \n    - Colonoscopy with biopsies, Completed  \n    - Start Mesalamine, Discontinued via patient discharge  \n    - IV Methylprednisolone initiated, Discontinued via patient discharge  \n    - Ondansetron IV for nausea, Discontinued via patient discharge  \n    - Start clear liquid diet advancing as tolerated, Completed  \n    - GI consult requested, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsy of inflamed rectal mucosa  \n    - Abdominal ultrasound to rule out megacolon  \n\n---\n\nAdmission 78249302  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — STEROID-DEPENDENT FLARE (Severity 3.0)  \n    - HCFA: GASTROINTESTINAL DISORDERS — REFRACTORY UC  \n\n    Medications:  \n    - Mesalamine 1.6 g PO TID  \n    - Prednisone taper starting at 60 mg PO daily  \n    - Infliximab (Remicade) IV 5 mg/kg at weeks 0, 2, and 6  \n    - Calcium Carbonate + Vitamin D PO daily  \n    - Pantoprazole 40 mg PO daily  \n    - Hydrocortisone rectal suppository 25 mg BID  \n\n    Orders:  \n    - Initiate Infliximab infusion therapy, Completed  \n    - Prednisone taper protocol, Discontinued via patient discharge  \n    - Continue Mesalamine PO therapy, Discontinued via patient discharge  \n    - CBC, CMP, CRP monitoring, Completed  \n    - Nutritional consult for low-residue diet, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to assess disease extent  \n    - CT abdomen/pelvis for complications  \n\n---\n\nAdmission 79516478  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS WITH RECTAL BLEEDING — MAINTENANCE PHASE (Severity 2.0)  \n    - HCFA: LONG-TERM UC MANAGEMENT ON BIOLOGIC THERAPY  \n\n    Medications:  \n    - Infliximab 5 mg/kg IV every 8 weeks  \n    - Mesalamine 1.2 g PO daily  \n    - Probiotic Supplement BID  \n    - Ferrous Sulfate 325 mg PO daily  \n    - Loperamide 2 mg PO PRN diarrhea  \n\n    Orders:  \n    - Continue scheduled Infliximab infusions, Discontinued via patient discharge  \n    - Maintain Mesalamine oral therapy, Discontinued via patient discharge  \n    - Annual colonoscopy surveillance recommended, Scheduled  \n    - Dietician follow-up for anti-inflammatory diet, Completed  \n    - Order fecal calprotectin for relapse monitoring, Completed  \n\n    Procedures:  \n    - Colonoscopy surveillance  \n    - Infliximab infusion under observation  \n\n---\n\nAdmission 80647911  \n    DRGs:  \n    - APR: ULCERATIVE COLITIS — ACUTE RECTAL BLEEDING REQUIRING SURGICAL CONSULT (Severity 4.0)  \n    - HCFA: GASTROINTESTINAL BLEEDING MANAGEMENT  \n\n    Medications:  \n    - IV Hydrocortisone 100 mg q8h  \n    - Infliximab 10 mg/kg IV (rescue dose)  \n    - Piperacillin-Tazobactam 4.5 g IV q6h  \n    - Tranexamic Acid IV 1 g once  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Admit to step-down ICU for hemodynamic monitoring  \n    - Start high-dose IV steroids, Discontinued via patient discharge  \n    - Escalate Infliximab dosing, Discontinued via patient discharge  \n    - Start broad-spectrum antibiotics, Discontinued via patient discharge  \n    - Surgical consult for possible colectomy, Completed  \n    - Crossmatch blood for possible transfusion, Completed  \n\n    Procedures:  \n    - Flexible sigmoidoscopy to localize active bleeding  \n    - Red blood cell transfusion x2 units  \n    - Central line placement for rapid access", "pair_text": "Patient 60001285  \nGender: Female  \nAge: 45  \nRace: WHITE  \n\nAdmission 78563214  \n    DRGs:  \n    - APR: PSORIASIS VULGARIS — INITIAL DIAGNOSIS AND MANAGEMENT (Severity 2.0)  \n    - HCFA: PSORIASIS WITHOUT SYSTEMIC COMPLICATIONS  \n\n    Medications:  \n    - Clobetasol propionate 0.05% topical cream BID  \n    - Calcipotriol (Vitamin D analog) 50 mcg/g topical BID  \n    - Cetirizine 10 mg PO daily for pruritus  \n    - Aquaphor ointment topical PRN for dryness  \n    - Acetaminophen 650 mg PO PRN mild discomfort  \n\n    Orders:  \n    - Initiate clobetasol topical therapy, Discontinued via patient discharge  \n    - Start calcipotriol BID for plaque control, Discontinued via patient discharge  \n    - Recommend daily emollient use, Completed  \n    - Patient education provided on trigger avoidance, Completed  \n    - Schedule dermatology follow-up in 4 weeks, Completed  \n\n    Procedures:  \n    - Wood’s lamp exam to rule out fungal coinfections  \n    - Initial PASI (Psoriasis Area and Severity Index) scoring for baseline disease severity  \n\n---\n\nAdmission 79620485  \n    DRGs:  \n    - APR: PSORIASIS VULGARIS — SYSTEMIC TREATMENT INITIATION (Severity 3.0)  \n    - HCFA: MODERATE TO SEVERE PSORIASIS WITH SYSTEMIC THERAPY  \n\n    Medications:  \n    - Methotrexate 15 mg PO weekly  \n    - Folic acid 1 mg PO daily  \n    - Clobetasol propionate 0.05% topical cream PRN  \n    - Hydroxyzine 25 mg PO nightly for pruritus  \n    - Ibuprofen 400 mg PO PRN mild pain  \n    - Vitamin D3 2000 IU PO daily  \n\n    Orders:  \n    - Start methotrexate PO weekly, Discontinued via patient discharge  \n    - Initiate folic acid supplementation, Discontinued via patient discharge  \n    - CBC, LFTs, and renal function monitoring ordered, Completed  \n    - Continue high-potency topical steroid PRN, Discontinued via patient discharge  \n    - Counseling on alcohol avoidance and infection risk, Completed  \n\n    Procedures:  \n    - Liver function panel and kidney function testing pre-methotrexate  \n    - Repeat PASI scoring to assess response after 8 weeks  \n    - Phototherapy counseling performed  \n\n---\n\nAdmission 81259732  \n    DRGs:  \n    - APR: PSORIASIS VULGARIS — BIOLOGIC THERAPY MANAGEMENT (Severity 3.0)  \n    - HCFA: MODERATE TO SEVERE PLAQUE PSORIASIS WITH BIOLOGIC INITIATION  \n\n    Medications:  \n    - Adalimumab (Humira) 40 mg SC every other week  \n    - Methotrexate 10 mg PO weekly  \n    - Folic acid 1 mg PO daily  \n    - Moisturizing ointments topical PRN dryness  \n    - Cetirizine 10 mg PO daily  \n    - Influenza Vaccine Quadrivalent IM once  \n\n    Orders:  \n    - Start adalimumab SC per dermatology, Discontinued via patient discharge  \n    - Reduce methotrexate dose for dual therapy, Discontinued via patient discharge  \n    - Tuberculosis and hepatitis B screening ordered before biologic initiation, Completed  \n    - Annual influenza vaccine administered, Completed  \n    - Patient counseling on biologic safety, Completed  \n\n    Procedures:  \n    - Subcutaneous injection training for adalimumab self-administration  \n    - Regular follow-up visits scheduled every 12 weeks  \n    - PASI and DLQI (Dermatology Life Quality Index) monitoring for treatment effectiveness  \n\n---\n\nAdmission 82956340  \n    DRGs:  \n    - APR: PSORIASIS VULGARIS — LONG-TERM DISEASE MONITORING (Severity 1.0)  \n    - HCFA: STABLE CHRONIC PSORIASIS ON MAINTENANCE THERAPY  \n\n    Medications:  \n    - Adalimumab (Humira) 40 mg SC every other week  \n    - Folic acid 1 mg PO daily  \n    - Calcipotriol topical PRN  \n    - Multivitamin with zinc and omega-3s PO daily  \n\n    Orders:  \n    - Continue biologic therapy per dermatology protocol, Discontinued via patient discharge  \n    - Annual labs for LFTs, CBC, and creatinine clearance, Completed  \n    - Patient education provided on maintaining moisturization and trigger avoidance, Completed  \n    - Recommend yearly dermatology check-up, Completed  \n\n    Procedures:  \n    - Full skin assessment and photographic documentation  \n    - Updated PASI score showing >85% improvement from baseline  \n    - Nutrition counseling for anti-inflammatory diet"}
{"id": "10001286", "pair_id": "20001286", "similarity": 1.0, "text": "Patient 10001286  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 77543210  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL EPISODE (Severity 2.0)  \n    - HCFA: ACUTE LOWER URINARY TRACT INFECTION WITH BLOOD IN URINE  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO PRN pain  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n\n    Orders:  \n    - Start nitrofurantoin 100 mg PO BID × 7 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 2 days for dysuria, Discontinued via patient discharge  \n    - Urine culture and sensitivity ordered, Completed  \n    - Encourage oral hydration (>2L daily), Completed  \n    - Acetaminophen PRN for discomfort, Discontinued via patient discharge  \n\n    Procedures:  \n    - Urinalysis with microscopy  \n    - Urine culture and antibiotic sensitivity testing  \n\n---\n\nAdmission 78905421  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — RECURRENT EPISODE (Severity 3.0)  \n    - HCFA: RECURRENT LOWER URINARY TRACT INFECTION WITH GROSS HEMATURIA  \n\n    Medications:  \n    - Cefdinir 300 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 3 days  \n    - Ibuprofen 400 mg PO PRN mild pelvic pain  \n    - Lactobacillus probiotic PO daily  \n    - Estradiol 10 mcg vaginal tablet twice weekly (for UTI prevention)  \n\n    Orders:  \n    - Start cefdinir 300 mg PO BID × 10 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 3 days, Discontinued via patient discharge  \n    - Urine microscopy and culture ordered, Completed  \n    - Post-void residual ultrasound ordered, Completed  \n    - Counsel patient on voiding after intercourse, Completed  \n\n    Procedures:  \n    - Bladder ultrasound  \n    - Renal ultrasound to rule out upper urinary tract involvement  \n    - Repeat urine culture 7 days post-antibiotics  \n\n---\n\nAdmission 80123976  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — MULTIDRUG-RESISTANT ORGANISM (Severity 4.0)  \n    - HCFA: COMPLEX URINARY TRACT INFECTION WITH GROSS BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-tazobactam 4.5 g IV q8h × 7 days  \n    - Fluconazole 150 mg PO weekly × 2 doses (antifungal prophylaxis)  \n    - Acetaminophen 650 mg PO PRN fever  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Probiotic supplementation PO daily  \n\n    Orders:  \n    - Start IV piperacillin-tazobactam based on urine culture resistance, Discontinued via patient discharge  \n    - Fluconazole prophylaxis ordered, Discontinued via patient discharge  \n    - Insert peripheral IV line, Completed  \n    - Monitor CBC, CMP, and renal function daily, Completed  \n    - Schedule follow-up with urology, Completed  \n\n    Procedures:  \n    - CT abdomen/pelvis with contrast to rule out obstructive uropathy  \n    - Cystoscopy to evaluate hematuria origin  \n    - Post-treatment urine analysis and sensitivity testing", "pair_text": "Patient 20001286  \nGender: Female  \nAge: 37  \nRace: ASIAN  \n\nAdmission 76543122  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL DIAGNOSIS (Severity 2.0)  \n    - HCFA: ACUTE LOWER URINARY TRACT INFECTION WITH BLOOD IN URINE  \n\n    Medications:  \n    - Cephalexin 500 mg PO Q6H × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO PRN fever or pelvic pain  \n    - Sodium Chloride 0.9% IV PRN hydration  \n    - Cranberry extract supplement PO daily  \n\n    Orders:  \n    - Start cephalexin 500 mg PO Q6H × 7 days, Discontinued via patient discharge  \n    - Phenazopyridine PO TID for dysuria, Discontinued via patient discharge  \n    - Urinalysis and urine culture ordered, Completed  \n    - Encourage oral hydration ≥2.5 L/day, Completed  \n    - Schedule follow-up in 7 days, Completed  \n\n    Procedures:  \n    - Urinalysis with microscopy  \n    - Urine culture and sensitivity testing  \n\n---\n\nAdmission 78204915  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — RECURRENT EPISODE (Severity 3.0)  \n    - HCFA: RECURRENT LOWER UTI WITH BLOOD IN URINE  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 3 days  \n    - Ibuprofen 400 mg PO PRN suprapubic pain  \n    - Lactobacillus probiotic PO daily  \n    - Vitamin C 500 mg PO daily  \n\n    Orders:  \n    - Start ciprofloxacin 500 mg PO BID × 7 days, Discontinued via patient discharge  \n    - Phenazopyridine PO TID × 3 days, Discontinued via patient discharge  \n    - Bladder scan for residual urine volume, Completed  \n    - Renal ultrasound ordered, Completed  \n    - Patient counseled on UTI prevention strategies, Completed  \n\n    Procedures:  \n    - Bladder ultrasound for incomplete emptying  \n    - Renal ultrasound to rule out upper tract involvement  \n    - Repeat urine culture 7 days post-antibiotic therapy  \n\n---\n\nAdmission 80361740  \n    DRGs:  \n    - APR: COMPLICATED CYSTITIS WITH GROSS HEMATURIA — IV THERAPY REQUIRED (Severity 4.0)  \n    - HCFA: ACUTE LOWER UTI WITH SIGNIFICANT BLOOD LOSS AND SYSTEMIC SYMPTOMS  \n\n    Medications:  \n    - Ceftriaxone 1 g IV q24h × 5 days  \n    - Fluconazole 150 mg PO weekly × 2 doses  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Acetaminophen 650 mg PO PRN fever  \n    - Sodium Chloride 0.9% IV continuous for hydration  \n\n    Orders:  \n    - Start ceftriaxone IV therapy, Discontinued via patient discharge  \n    - Initiate antifungal prophylaxis with fluconazole, Discontinued via patient discharge  \n    - Monitor vital signs q4h for sepsis risk, Completed  \n    - Insert peripheral IV line, Completed  \n    - Urology consult ordered, Completed  \n\n    Procedures:  \n    - CT urography to assess for urinary tract obstruction  \n    - Cystoscopy to evaluate source of bleeding  \n    - Post-discharge urine culture to confirm clearance"}
{"id": "10001286", "pair_id": "30001286", "similarity": 0.75, "text": "Patient 10001286  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 77543210  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL EPISODE (Severity 2.0)  \n    - HCFA: ACUTE LOWER URINARY TRACT INFECTION WITH BLOOD IN URINE  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO PRN pain  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n\n    Orders:  \n    - Start nitrofurantoin 100 mg PO BID × 7 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 2 days for dysuria, Discontinued via patient discharge  \n    - Urine culture and sensitivity ordered, Completed  \n    - Encourage oral hydration (>2L daily), Completed  \n    - Acetaminophen PRN for discomfort, Discontinued via patient discharge  \n\n    Procedures:  \n    - Urinalysis with microscopy  \n    - Urine culture and antibiotic sensitivity testing  \n\n---\n\nAdmission 78905421  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — RECURRENT EPISODE (Severity 3.0)  \n    - HCFA: RECURRENT LOWER URINARY TRACT INFECTION WITH GROSS HEMATURIA  \n\n    Medications:  \n    - Cefdinir 300 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 3 days  \n    - Ibuprofen 400 mg PO PRN mild pelvic pain  \n    - Lactobacillus probiotic PO daily  \n    - Estradiol 10 mcg vaginal tablet twice weekly (for UTI prevention)  \n\n    Orders:  \n    - Start cefdinir 300 mg PO BID × 10 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 3 days, Discontinued via patient discharge  \n    - Urine microscopy and culture ordered, Completed  \n    - Post-void residual ultrasound ordered, Completed  \n    - Counsel patient on voiding after intercourse, Completed  \n\n    Procedures:  \n    - Bladder ultrasound  \n    - Renal ultrasound to rule out upper urinary tract involvement  \n    - Repeat urine culture 7 days post-antibiotics  \n\n---\n\nAdmission 80123976  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — MULTIDRUG-RESISTANT ORGANISM (Severity 4.0)  \n    - HCFA: COMPLEX URINARY TRACT INFECTION WITH GROSS BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-tazobactam 4.5 g IV q8h × 7 days  \n    - Fluconazole 150 mg PO weekly × 2 doses (antifungal prophylaxis)  \n    - Acetaminophen 650 mg PO PRN fever  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Probiotic supplementation PO daily  \n\n    Orders:  \n    - Start IV piperacillin-tazobactam based on urine culture resistance, Discontinued via patient discharge  \n    - Fluconazole prophylaxis ordered, Discontinued via patient discharge  \n    - Insert peripheral IV line, Completed  \n    - Monitor CBC, CMP, and renal function daily, Completed  \n    - Schedule follow-up with urology, Completed  \n\n    Procedures:  \n    - CT abdomen/pelvis with contrast to rule out obstructive uropathy  \n    - Cystoscopy to evaluate hematuria origin  \n    - Post-treatment urine analysis and sensitivity testing", "pair_text": "Patient 30001286  \nGender: Female  \nAge: 45  \nRace: WHITE  \n\nAdmission 76843211  \n    DRGs:  \n    - APR: INTERSTITIAL CYSTITIS / CHRONIC BLADDER PAIN SYNDROME — INITIAL DIAGNOSIS (Severity 2.0)  \n    - HCFA: CHRONIC BLADDER INFLAMMATORY DISORDERS W/O OBSTRUCTION  \n\n    Medications:  \n    - Pentosan Polysulfate Sodium (Elmiron) 100 mg PO TID  \n    - Amitriptyline 25 mg PO QHS  \n    - Hydroxyzine 25 mg PO QHS  \n    - Acetaminophen 650 mg PO PRN pelvic pain  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n\n    Orders:  \n    - Start Elmiron 100 mg PO TID, Continued  \n    - Amitriptyline 25 mg PO nightly for neuropathic bladder pain, Continued  \n    - Hydroxyzine 25 mg PO nightly for mast cell stabilization, Continued  \n    - Bladder diary instructed for symptom monitoring, Completed  \n    - Urinalysis and urine culture ordered to rule out infection, Completed  \n\n    Procedures:  \n    - Baseline cystoscopy to evaluate bladder wall integrity  \n    - Post-void residual urine ultrasound  \n\n---\n\nAdmission 78403129  \n    DRGs:  \n    - APR: INTERSTITIAL CYSTITIS WITH PERSISTENT PAIN — FLARE MANAGEMENT (Severity 3.0)  \n    - HCFA: CHRONIC BLADDER PAIN SYNDROME WITH URGENCY AND FREQUENCY  \n\n    Medications:  \n    - Intravesical Heparin 40,000 units + Lidocaine 2% + Sodium Bicarbonate instillation weekly × 6  \n    - Gabapentin 300 mg PO BID for pelvic nerve pain  \n    - Phenazopyridine 200 mg PO TID × 2 days for flare-associated dysuria  \n    - Ibuprofen 400 mg PO PRN pelvic cramping  \n    - Lactobacillus probiotic PO daily  \n\n    Orders:  \n    - Weekly bladder instillation therapy × 6 sessions, Completed  \n    - Initiate gabapentin 300 mg PO BID, Continued  \n    - Urine cytology to rule out atypical cells, Completed  \n    - Physical therapy referral for pelvic floor relaxation, Completed  \n    - Patient counseled on anti-inflammatory diet, Completed  \n\n    Procedures:  \n    - Intravesical bladder instillation therapy  \n    - Urodynamic testing to evaluate bladder compliance and capacity  \n\n---\n\nAdmission 81294567  \n    DRGs:  \n    - APR: REFRACTORY INTERSTITIAL CYSTITIS WITH SEVERE PERSISTENT SYMPTOMS (Severity 4.0)  \n    - HCFA: COMPLEX BLADDER PAIN SYNDROME REQUIRING ADVANCED INTERVENTION  \n\n    Medications:  \n    - Cyclosporine A 75 mg PO BID (immunomodulator for refractory disease)  \n    - Diazepam 5 mg PO BID for pelvic floor muscle spasm  \n    - Tramadol 50 mg PO PRN severe pain  \n    - Sodium Bicarbonate 650 mg PO daily (urine alkalization)  \n    - Hydrocodone-acetaminophen 5/325 mg PO PRN breakthrough pain  \n\n    Orders:  \n    - Start cyclosporine PO BID with CBC and renal monitoring, Continued  \n    - Schedule hydrodistension under anesthesia, Completed  \n    - Insert peripheral IV for peri-procedural hydration, Completed  \n    - Referral to urology pain specialist, Completed  \n    - Follow-up cystoscopy scheduled in 3 months, Pending  \n\n    Procedures:  \n    - Cystoscopy with bladder hydrodistension under anesthesia  \n    - Bladder biopsy to evaluate for Hunner lesions  \n    - Pelvic MRI to exclude secondary causes of chronic pain"}
{"id": "10001286", "pair_id": "40001286", "similarity": 0.5, "text": "Patient 10001286  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 77543210  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL EPISODE (Severity 2.0)  \n    - HCFA: ACUTE LOWER URINARY TRACT INFECTION WITH BLOOD IN URINE  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO PRN pain  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n\n    Orders:  \n    - Start nitrofurantoin 100 mg PO BID × 7 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 2 days for dysuria, Discontinued via patient discharge  \n    - Urine culture and sensitivity ordered, Completed  \n    - Encourage oral hydration (>2L daily), Completed  \n    - Acetaminophen PRN for discomfort, Discontinued via patient discharge  \n\n    Procedures:  \n    - Urinalysis with microscopy  \n    - Urine culture and antibiotic sensitivity testing  \n\n---\n\nAdmission 78905421  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — RECURRENT EPISODE (Severity 3.0)  \n    - HCFA: RECURRENT LOWER URINARY TRACT INFECTION WITH GROSS HEMATURIA  \n\n    Medications:  \n    - Cefdinir 300 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 3 days  \n    - Ibuprofen 400 mg PO PRN mild pelvic pain  \n    - Lactobacillus probiotic PO daily  \n    - Estradiol 10 mcg vaginal tablet twice weekly (for UTI prevention)  \n\n    Orders:  \n    - Start cefdinir 300 mg PO BID × 10 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 3 days, Discontinued via patient discharge  \n    - Urine microscopy and culture ordered, Completed  \n    - Post-void residual ultrasound ordered, Completed  \n    - Counsel patient on voiding after intercourse, Completed  \n\n    Procedures:  \n    - Bladder ultrasound  \n    - Renal ultrasound to rule out upper urinary tract involvement  \n    - Repeat urine culture 7 days post-antibiotics  \n\n---\n\nAdmission 80123976  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — MULTIDRUG-RESISTANT ORGANISM (Severity 4.0)  \n    - HCFA: COMPLEX URINARY TRACT INFECTION WITH GROSS BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-tazobactam 4.5 g IV q8h × 7 days  \n    - Fluconazole 150 mg PO weekly × 2 doses (antifungal prophylaxis)  \n    - Acetaminophen 650 mg PO PRN fever  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Probiotic supplementation PO daily  \n\n    Orders:  \n    - Start IV piperacillin-tazobactam based on urine culture resistance, Discontinued via patient discharge  \n    - Fluconazole prophylaxis ordered, Discontinued via patient discharge  \n    - Insert peripheral IV line, Completed  \n    - Monitor CBC, CMP, and renal function daily, Completed  \n    - Schedule follow-up with urology, Completed  \n\n    Procedures:  \n    - CT abdomen/pelvis with contrast to rule out obstructive uropathy  \n    - Cystoscopy to evaluate hematuria origin  \n    - Post-treatment urine analysis and sensitivity testing", "pair_text": "Patient 40001286  \nGender: Male  \nAge: 49  \nRace: WHITE  \n\nAdmission 77451203  \n    DRGs:  \n    - APR: KIDNEY STONES — INITIAL EPISODE WITH HYDRATION MANAGEMENT (Severity 2.0)  \n    - HCFA: URINARY CALCULUS WITHOUT OBSTRUCTION  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ketorolac 15 mg IV q6h PRN flank pain  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Acetaminophen 650 mg PO PRN mild pain  \n    - Sodium Chloride 0.9% IV continuous for hydration  \n\n    Orders:  \n    - Start tamsulosin PO daily, Continued  \n    - Initiate IV hydration with normal saline, Discontinued via patient discharge  \n    - Non-contrast CT scan abdomen/pelvis to confirm stone location, Completed  \n    - Strain urine for stone passage, Completed  \n    - Encourage oral hydration ≥3 L/day, Completed  \n\n    Procedures:  \n    - Non-contrast abdominal CT scan  \n    - Urinalysis and metabolic panel  \n\n---\n\nAdmission 79283155  \n    DRGs:  \n    - APR: OBSTRUCTING KIDNEY STONE WITH ACUTE FLARE (Severity 3.0)  \n    - HCFA: KIDNEY STONES WITH URINARY TRACT OBSTRUCTION  \n\n    Medications:  \n    - Morphine 2 mg IV q4h PRN severe renal colic  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ceftriaxone 1 g IV q24h (prophylaxis against infection)  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Ibuprofen 600 mg PO q8h for inflammation  \n\n    Orders:  \n    - Place peripheral IV for fluid resuscitation, Completed  \n    - Start ceftriaxone IV prophylaxis, Discontinued via patient discharge  \n    - Renal ultrasound to evaluate obstruction severity, Completed  \n    - Urology consult for potential intervention, Completed  \n    - Patient education on stone prevention, Completed  \n\n    Procedures:  \n    - Renal ultrasound  \n    - Intravenous pyelogram (IVP) to evaluate obstruction  \n    - Stone analysis ordered post-passage  \n\n---\n\nAdmission 82193704  \n    DRGs:  \n    - APR: COMPLICATED KIDNEY STONES REQUIRING SURGICAL MANAGEMENT (Severity 4.0)  \n    - HCFA: CALCULUS OF KIDNEY WITH PERSISTENT OBSTRUCTION  \n\n    Medications:  \n    - Ceftriaxone 1 g IV pre-op prophylaxis  \n    - Ketorolac 15 mg IV PRN postoperative pain  \n    - Acetaminophen 650 mg PO PRN pain  \n    - Tamsulosin 0.4 mg PO daily for stone passage support  \n    - Sodium Bicarbonate 650 mg PO daily (alkalinization of urine)  \n\n    Orders:  \n    - Schedule ureteroscopy with laser lithotripsy, Completed  \n    - Insert ureteral stent post-procedure, Completed  \n    - Continuous IV fluids for 24 hours post-op, Discontinued via patient discharge  \n    - Repeat abdominal X-ray (KUB) to confirm stone clearance, Completed  \n    - 24-hour urine collection ordered for metabolic stone workup, Pending  \n\n    Procedures:  \n    - Ureteroscopy with laser lithotripsy  \n    - Ureteral stent placement  \n    - 24-hour urine analysis for stone recurrence prevention"}
{"id": "10001286", "pair_id": "50001286", "similarity": 0.25, "text": "Patient 10001286  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 77543210  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL EPISODE (Severity 2.0)  \n    - HCFA: ACUTE LOWER URINARY TRACT INFECTION WITH BLOOD IN URINE  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO PRN pain  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n\n    Orders:  \n    - Start nitrofurantoin 100 mg PO BID × 7 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 2 days for dysuria, Discontinued via patient discharge  \n    - Urine culture and sensitivity ordered, Completed  \n    - Encourage oral hydration (>2L daily), Completed  \n    - Acetaminophen PRN for discomfort, Discontinued via patient discharge  \n\n    Procedures:  \n    - Urinalysis with microscopy  \n    - Urine culture and antibiotic sensitivity testing  \n\n---\n\nAdmission 78905421  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — RECURRENT EPISODE (Severity 3.0)  \n    - HCFA: RECURRENT LOWER URINARY TRACT INFECTION WITH GROSS HEMATURIA  \n\n    Medications:  \n    - Cefdinir 300 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 3 days  \n    - Ibuprofen 400 mg PO PRN mild pelvic pain  \n    - Lactobacillus probiotic PO daily  \n    - Estradiol 10 mcg vaginal tablet twice weekly (for UTI prevention)  \n\n    Orders:  \n    - Start cefdinir 300 mg PO BID × 10 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 3 days, Discontinued via patient discharge  \n    - Urine microscopy and culture ordered, Completed  \n    - Post-void residual ultrasound ordered, Completed  \n    - Counsel patient on voiding after intercourse, Completed  \n\n    Procedures:  \n    - Bladder ultrasound  \n    - Renal ultrasound to rule out upper urinary tract involvement  \n    - Repeat urine culture 7 days post-antibiotics  \n\n---\n\nAdmission 80123976  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — MULTIDRUG-RESISTANT ORGANISM (Severity 4.0)  \n    - HCFA: COMPLEX URINARY TRACT INFECTION WITH GROSS BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-tazobactam 4.5 g IV q8h × 7 days  \n    - Fluconazole 150 mg PO weekly × 2 doses (antifungal prophylaxis)  \n    - Acetaminophen 650 mg PO PRN fever  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Probiotic supplementation PO daily  \n\n    Orders:  \n    - Start IV piperacillin-tazobactam based on urine culture resistance, Discontinued via patient discharge  \n    - Fluconazole prophylaxis ordered, Discontinued via patient discharge  \n    - Insert peripheral IV line, Completed  \n    - Monitor CBC, CMP, and renal function daily, Completed  \n    - Schedule follow-up with urology, Completed  \n\n    Procedures:  \n    - CT abdomen/pelvis with contrast to rule out obstructive uropathy  \n    - Cystoscopy to evaluate hematuria origin  \n    - Post-treatment urine analysis and sensitivity testing", "pair_text": "Patient 50001286  \nGender: Male  \nAge: 61  \nRace: WHITE  \n\nAdmission 11023958  \n    DRGs:  \n    - APR: HEMATURIA W/O MAJOR COMPLICATIONS (Severity 2.0)  \n    - HCFA: HEMATURIA, UNSPECIFIED W/O CC/MCC  \n\n    Medications:  \n    - Acetaminophen  \n    - Sodium Chloride 0.9% Flush  \n    - Ciprofloxacin 500mg PO (empiric coverage)  \n    - Phenazopyridine 200mg PO  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ciprofloxacin 500mg: PO, Discontinued via patient discharge  \n    - Phenazopyridine 200mg: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Urinalysis with microscopy  \n    - Urine culture and sensitivity  \n    - Renal ultrasound  \n\nAdmission 11148723  \n    DRGs:  \n    - APR: HEMATURIA WITH UROLOGIC EVALUATION (Severity 3.0)  \n    - HCFA: GROSS HEMATURIA W CC  \n\n    Medications:  \n    - Ceftriaxone IV  \n    - Tamsulosin 0.4mg PO  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Ondansetron IV  \n    - Heparin SC (DVT prophylaxis)  \n\n    Orders:  \n    - Ceftriaxone IV: IV, Discontinued via patient discharge  \n    - Tamsulosin 0.4mg: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT Urogram  \n    - Flexible cystoscopy with bladder inspection  \n    - Uroflowmetry and post-void residual measurement  \n\nAdmission 11287591  \n    DRGs:  \n    - APR: SEVERE HEMATURIA WITH OBSTRUCTION OR BLEEDING SOURCE (Severity 4.0)  \n    - HCFA: HEMATURIA W MCC  \n\n    Medications:  \n    - Piperacillin-Tazobactam (Zosyn) IV  \n    - Aminocaproic Acid IV (for bleeding control)  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Phenazopyridine 200mg PO  \n    - Enoxaparin SC (DVT prophylaxis held peri-procedure)  \n    - Hydromorphone IV (for pain control)  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, Discontinued via patient discharge  \n    - Aminocaproic Acid IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Phenazopyridine 200mg: PO, Discontinued via patient discharge  \n    - Enoxaparin SC: SC, Discontinued via patient discharge  \n    - Hydromorphone IV: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Cystoscopy with clot evacuation  \n    - Bilateral retrograde pyelogram  \n    - Ureteroscopic evaluation  \n    - Bladder fulguration for bleeding source control"}
{"id": "10001286", "pair_id": "60001286", "similarity": 0.0, "text": "Patient 10001286  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 77543210  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL EPISODE (Severity 2.0)  \n    - HCFA: ACUTE LOWER URINARY TRACT INFECTION WITH BLOOD IN URINE  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO PRN pain  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n\n    Orders:  \n    - Start nitrofurantoin 100 mg PO BID × 7 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 2 days for dysuria, Discontinued via patient discharge  \n    - Urine culture and sensitivity ordered, Completed  \n    - Encourage oral hydration (>2L daily), Completed  \n    - Acetaminophen PRN for discomfort, Discontinued via patient discharge  \n\n    Procedures:  \n    - Urinalysis with microscopy  \n    - Urine culture and antibiotic sensitivity testing  \n\n---\n\nAdmission 78905421  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — RECURRENT EPISODE (Severity 3.0)  \n    - HCFA: RECURRENT LOWER URINARY TRACT INFECTION WITH GROSS HEMATURIA  \n\n    Medications:  \n    - Cefdinir 300 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 3 days  \n    - Ibuprofen 400 mg PO PRN mild pelvic pain  \n    - Lactobacillus probiotic PO daily  \n    - Estradiol 10 mcg vaginal tablet twice weekly (for UTI prevention)  \n\n    Orders:  \n    - Start cefdinir 300 mg PO BID × 10 days, Discontinued via patient discharge  \n    - Start phenazopyridine 200 mg PO TID × 3 days, Discontinued via patient discharge  \n    - Urine microscopy and culture ordered, Completed  \n    - Post-void residual ultrasound ordered, Completed  \n    - Counsel patient on voiding after intercourse, Completed  \n\n    Procedures:  \n    - Bladder ultrasound  \n    - Renal ultrasound to rule out upper urinary tract involvement  \n    - Repeat urine culture 7 days post-antibiotics  \n\n---\n\nAdmission 80123976  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — MULTIDRUG-RESISTANT ORGANISM (Severity 4.0)  \n    - HCFA: COMPLEX URINARY TRACT INFECTION WITH GROSS BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-tazobactam 4.5 g IV q8h × 7 days  \n    - Fluconazole 150 mg PO weekly × 2 doses (antifungal prophylaxis)  \n    - Acetaminophen 650 mg PO PRN fever  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Probiotic supplementation PO daily  \n\n    Orders:  \n    - Start IV piperacillin-tazobactam based on urine culture resistance, Discontinued via patient discharge  \n    - Fluconazole prophylaxis ordered, Discontinued via patient discharge  \n    - Insert peripheral IV line, Completed  \n    - Monitor CBC, CMP, and renal function daily, Completed  \n    - Schedule follow-up with urology, Completed  \n\n    Procedures:  \n    - CT abdomen/pelvis with contrast to rule out obstructive uropathy  \n    - Cystoscopy to evaluate hematuria origin  \n    - Post-treatment urine analysis and sensitivity testing", "pair_text": "Patient 60001286  \nGender: Female  \nAge: 32  \nRace: ASIAN  \n\nAdmission 77510392  \n    DRGs:  \n    - APR: UNSPECIFIED CONJUNCTIVITIS — INITIAL EVALUATION (Severity 1.0)  \n    - HCFA: ACUTE EYE INFLAMMATION W/O COMPLICATIONS  \n\n    Medications:  \n    - Artificial Tears (Carboxymethylcellulose) 1 drop OU QID  \n    - Olopatadine 0.1% Ophthalmic Drops, 1 drop OU BID  \n    - Acetaminophen 500 mg PO PRN eye discomfort  \n    - Sodium Chloride 0.9% Flush PRN eye irrigation  \n\n    Orders:  \n    - Start olopatadine drops BID, Continued  \n    - Artificial tears QID for lubrication, Continued  \n    - Visual acuity assessment, Completed  \n    - Slit-lamp eye exam ordered, Completed  \n    - Educate patient on avoiding eye rubbing and allergen exposure, Completed  \n\n    Procedures:  \n    - Slit-lamp examination to rule out corneal involvement  \n\n---\n\nAdmission 78492316  \n    DRGs:  \n    - APR: UNSPECIFIED CONJUNCTIVITIS — RECURRENT FLARE (Severity 2.0)  \n    - HCFA: CHRONIC CONJUNCTIVAL INFLAMMATION W/O VISION LOSS  \n\n    Medications:  \n    - Tobramycin Ophthalmic Drops 0.3% 1 drop OU Q6H × 7 days  \n    - Prednisolone Acetate 1% Ophthalmic Drops, 1 drop OU BID (short course)  \n    - Cetirizine 10 mg PO daily for allergic control  \n    - Ibuprofen 400 mg PO PRN swelling or irritation  \n\n    Orders:  \n    - Bacterial culture from conjunctival swab ordered, Completed  \n    - Start Tobramycin drops Q6H × 7 days, Discontinued via patient discharge  \n    - Prednisolone drops BID for 5 days, Discontinued via patient discharge  \n    - Patient educated on warm compresses twice daily, Completed  \n    - Ophthalmology follow-up scheduled in 1 week, Completed  \n\n    Procedures:  \n    - Conjunctival swab and bacterial culture  \n    - Fundoscopic exam to rule out posterior eye involvement  \n\n---\n\nAdmission 80123741  \n    DRGs:  \n    - APR: RECURRENT BILATERAL CONJUNCTIVITIS — SEVERE INFLAMMATORY FLARE (Severity 3.0)  \n    - HCFA: EYE INFLAMMATION WITH SEVERE SWELLING BUT NO VISION THREAT  \n\n    Medications:  \n    - Moxifloxacin Ophthalmic Drops 0.5% 1 drop OU Q8H × 10 days  \n    - Cyclosporine Ophthalmic Drops 0.05% 1 drop OU BID  \n    - Loratadine 10 mg PO daily for allergic triggers  \n    - Hydrocortisone 0.5% Ophthalmic Ointment nightly OU × 5 days  \n    - Sodium Chloride 0.9% Flush PRN eye irrigation  \n\n    Orders:  \n    - Initiate moxifloxacin ophthalmic therapy, Discontinued via patient discharge  \n    - Start cyclosporine drops BID for recurrent inflammation, Continued  \n    - Perform fluorescein staining to rule out corneal abrasions, Completed  \n    - Provide patient education on hand hygiene and eye protection, Completed  \n    - Referral to ophthalmology subspecialty clinic, Completed  \n\n    Procedures:  \n    - Fluorescein staining for corneal integrity  \n    - Schirmer’s test to evaluate tear production  \n    - High-resolution anterior segment OCT for inflammation monitoring"}
{"id": "10001287", "pair_id": "20001287", "similarity": 1.0, "text": "Patient 10001287  \nGender: Female  \nAge: 31  \nRace: HISPANIC  \n\nAdmission 78145210  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION — THIRD TRIMESTER (Severity 3.0)  \n    - HCFA: PREGNANCY-INDUCED HYPERTENSION W/O SEVERE FEATURES  \n\n    Medications:  \n    - Labetalol 100 mg PO BID  \n    - Nifedipine ER 30 mg PO daily  \n    - Prenatal Vitamins 1 tab PO daily  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Sodium Chloride 0.9% Flush PRN IV access maintenance  \n\n    Orders:  \n    - Daily blood pressure monitoring, Continued  \n    - Non-stress test (NST) for fetal heart rate monitoring, Completed  \n    - Start labetalol PO BID, Continued  \n    - Low-sodium diet counseling, Completed  \n    - Educate patient on signs of worsening preeclampsia, Completed  \n\n    Procedures:  \n    - Non-stress test  \n    - Urine protein-to-creatinine ratio testing  \n\n---\n\nAdmission 79382467  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION WITH ELEVATED RISK (Severity 4.0)  \n    - HCFA: GESTATIONAL HYPERTENSION REQUIRING CLOSE SURVEILLANCE  \n\n    Medications:  \n    - Labetalol 200 mg PO BID  \n    - Nifedipine ER 60 mg PO daily  \n    - Magnesium Sulfate 4 g IV loading dose, then 1 g/hr continuous infusion  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Aspirin 81 mg PO daily (low-dose prophylaxis)  \n\n    Orders:  \n    - Start magnesium sulfate infusion for seizure prophylaxis, Discontinued via patient discharge  \n    - Continuous fetal heart monitoring, Completed  \n    - Weekly biophysical profile (BPP) ordered, Completed  \n    - Serial lab monitoring: CBC, CMP, uric acid, Completed  \n    - Consult maternal-fetal medicine specialist, Completed  \n\n    Procedures:  \n    - Biophysical profile ultrasound  \n    - Serial fetal growth assessments  \n    - Non-stress testing ×2 per week  \n\n---\n\nAdmission 81693240  \n    DRGs:  \n    - APR: SEVERE PREECLAMPSIA — THIRD TRIMESTER (Severity 5.0)  \n    - HCFA: PREGNANCY-RELATED HYPERTENSION WITH MULTIORGAN INVOLVEMENT  \n\n    Medications:  \n    - Magnesium Sulfate 4 g IV loading + 1 g/hr continuous  \n    - Hydralazine 10 mg IV PRN severe hypertension  \n    - Betamethasone 12 mg IM Q24H × 2 doses for fetal lung maturity  \n    - Labetalol 300 mg PO BID  \n    - Lactated Ringer’s IV fluids  \n\n    Orders:  \n    - Admit to Labor & Delivery for close maternal and fetal monitoring, Completed  \n    - Initiate magnesium sulfate therapy, Discontinued via patient discharge  \n    - Prepare for possible induction of labor, Completed  \n    - Continuous electronic fetal monitoring, Completed  \n    - Neonatal ICU team alerted for potential preterm delivery, Completed  \n\n    Procedures:  \n    - Induction of labor using oxytocin  \n    - Epidural anesthesia administered  \n    - Spontaneous vaginal delivery achieved at 36 weeks  \n    - Placental pathology sent for evaluation", "pair_text": "Patient 20001287  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 81156392  \n    DRGs:  \n    - APR: PREGNANCY-INDUCED HYPERTENSION — THIRD TRIMESTER (Severity 3.0)  \n    - HCFA: GESTATIONAL HYPERTENSION WITHOUT SEVERE FEATURES  \n\n    Medications:  \n    - Labetalol 100 mg PO BID  \n    - Nifedipine ER 30 mg PO daily  \n    - Prenatal Vitamins 1 tab PO daily  \n    - Low-dose Aspirin 81 mg PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Start labetalol PO BID, Continued  \n    - Daily blood pressure monitoring, Continued  \n    - Non-stress test (NST) for fetal heart rate, Completed  \n    - Educate patient on diet and warning signs of preeclampsia, Completed  \n    - Follow-up growth ultrasound ordered, Completed  \n\n    Procedures:  \n    - Non-stress test  \n    - Basic metabolic panel to assess renal function  \n\n---\n\nAdmission 82547913  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION WITH LAB ELEVATIONS (Severity 4.0)  \n    - HCFA: GESTATIONAL HYPERTENSION REQUIRING CLOSE SURVEILLANCE  \n\n    Medications:  \n    - Labetalol 200 mg PO BID  \n    - Nifedipine ER 60 mg PO daily  \n    - Magnesium Sulfate 4 g IV loading, then 1 g/hr continuous  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Betamethasone 12 mg IM Q24H × 2 doses for fetal lung maturity  \n\n    Orders:  \n    - Initiate magnesium sulfate infusion for seizure prophylaxis, Discontinued via patient discharge  \n    - Continuous fetal monitoring, Completed  \n    - Weekly biophysical profile (BPP) ordered, Completed  \n    - Serial CBC, CMP, and urine protein-to-creatinine ratio, Completed  \n    - Maternal-fetal medicine consult requested, Completed  \n\n    Procedures:  \n    - Biophysical profile ultrasound  \n    - 24-hour urine protein collection  \n    - Serial Doppler velocimetry for placental flow  \n\n---\n\nAdmission 84231977  \n    DRGs:  \n    - APR: SEVERE PREECLAMPSIA WITH DELIVERY — THIRD TRIMESTER (Severity 5.0)  \n    - HCFA: PREGNANCY-RELATED HYPERTENSION WITH COMPLICATIONS  \n\n    Medications:  \n    - Magnesium Sulfate 4 g IV bolus + 1 g/hr continuous infusion  \n    - Hydralazine 10 mg IV Q6H PRN severe BP elevation  \n    - Labetalol 300 mg PO BID  \n    - Oxytocin infusion for induction of labor  \n    - Acetaminophen 650 mg PO PRN postpartum discomfort  \n\n    Orders:  \n    - Admit to Labor & Delivery for induction, Completed  \n    - Magnesium sulfate infusion initiated, Discontinued via patient discharge  \n    - Continuous electronic fetal monitoring, Completed  \n    - NICU team alerted for possible preterm delivery, Completed  \n    - Postpartum follow-up for blood pressure monitoring scheduled, Completed  \n\n    Procedures:  \n    - Induction of labor using oxytocin  \n    - Epidural anesthesia administered  \n    - Vaginal delivery achieved at 35 weeks  \n    - Placental pathology sent for evaluation"}
{"id": "10001287", "pair_id": "30001287", "similarity": 0.75, "text": "Patient 10001287  \nGender: Female  \nAge: 31  \nRace: HISPANIC  \n\nAdmission 78145210  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION — THIRD TRIMESTER (Severity 3.0)  \n    - HCFA: PREGNANCY-INDUCED HYPERTENSION W/O SEVERE FEATURES  \n\n    Medications:  \n    - Labetalol 100 mg PO BID  \n    - Nifedipine ER 30 mg PO daily  \n    - Prenatal Vitamins 1 tab PO daily  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Sodium Chloride 0.9% Flush PRN IV access maintenance  \n\n    Orders:  \n    - Daily blood pressure monitoring, Continued  \n    - Non-stress test (NST) for fetal heart rate monitoring, Completed  \n    - Start labetalol PO BID, Continued  \n    - Low-sodium diet counseling, Completed  \n    - Educate patient on signs of worsening preeclampsia, Completed  \n\n    Procedures:  \n    - Non-stress test  \n    - Urine protein-to-creatinine ratio testing  \n\n---\n\nAdmission 79382467  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION WITH ELEVATED RISK (Severity 4.0)  \n    - HCFA: GESTATIONAL HYPERTENSION REQUIRING CLOSE SURVEILLANCE  \n\n    Medications:  \n    - Labetalol 200 mg PO BID  \n    - Nifedipine ER 60 mg PO daily  \n    - Magnesium Sulfate 4 g IV loading dose, then 1 g/hr continuous infusion  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Aspirin 81 mg PO daily (low-dose prophylaxis)  \n\n    Orders:  \n    - Start magnesium sulfate infusion for seizure prophylaxis, Discontinued via patient discharge  \n    - Continuous fetal heart monitoring, Completed  \n    - Weekly biophysical profile (BPP) ordered, Completed  \n    - Serial lab monitoring: CBC, CMP, uric acid, Completed  \n    - Consult maternal-fetal medicine specialist, Completed  \n\n    Procedures:  \n    - Biophysical profile ultrasound  \n    - Serial fetal growth assessments  \n    - Non-stress testing ×2 per week  \n\n---\n\nAdmission 81693240  \n    DRGs:  \n    - APR: SEVERE PREECLAMPSIA — THIRD TRIMESTER (Severity 5.0)  \n    - HCFA: PREGNANCY-RELATED HYPERTENSION WITH MULTIORGAN INVOLVEMENT  \n\n    Medications:  \n    - Magnesium Sulfate 4 g IV loading + 1 g/hr continuous  \n    - Hydralazine 10 mg IV PRN severe hypertension  \n    - Betamethasone 12 mg IM Q24H × 2 doses for fetal lung maturity  \n    - Labetalol 300 mg PO BID  \n    - Lactated Ringer’s IV fluids  \n\n    Orders:  \n    - Admit to Labor & Delivery for close maternal and fetal monitoring, Completed  \n    - Initiate magnesium sulfate therapy, Discontinued via patient discharge  \n    - Prepare for possible induction of labor, Completed  \n    - Continuous electronic fetal monitoring, Completed  \n    - Neonatal ICU team alerted for potential preterm delivery, Completed  \n\n    Procedures:  \n    - Induction of labor using oxytocin  \n    - Epidural anesthesia administered  \n    - Spontaneous vaginal delivery achieved at 36 weeks  \n    - Placental pathology sent for evaluation", "pair_text": "Patient 30001287  \nGender: Female  \nAge: 33  \nRace: ASIAN  \n\nAdmission 76231480  \n    DRGs:  \n    - APR: GESTATIONAL HYPERTENSION WITHOUT PROTEINURIA — THIRD TRIMESTER (Severity 2.0)  \n    - HCFA: HYPERTENSION COMPLICATING PREGNANCY — NO PROTEINURIA  \n\n    Medications:  \n    - Labetalol 100 mg PO BID  \n    - Nifedipine ER 30 mg PO daily  \n    - Prenatal Vitamins 1 tab PO daily  \n    - Aspirin 81 mg PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Start labetalol PO BID, Continued  \n    - Daily BP monitoring, Completed  \n    - Non-stress test (NST) for fetal heart rate, Completed  \n    - Dietary counseling for low-sodium intake, Completed  \n    - Fetal growth ultrasound scheduled, Completed  \n\n    Procedures:  \n    - Non-stress test  \n    - Basic labs: CBC, CMP, urine dipstick  \n\n---\n\nAdmission 78520433  \n    DRGs:  \n    - APR: GESTATIONAL HYPERTENSION REQUIRING CLOSE MONITORING (Severity 3.0)  \n    - HCFA: HIGH-RISK OBSTETRICAL OBSERVATION WITHOUT PROTEINURIA  \n\n    Medications:  \n    - Labetalol 200 mg PO BID  \n    - Nifedipine ER 60 mg PO daily  \n    - Betamethasone 12 mg IM Q24H × 2 doses for fetal lung maturity  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Prenatal Vitamins PO daily  \n\n    Orders:  \n    - Serial BP monitoring Q4H, Completed  \n    - Weekly biophysical profile (BPP) ordered, Completed  \n    - Non-stress test twice weekly, Completed  \n    - Labs: urine protein-to-creatinine ratio, CBC, CMP, Completed  \n    - Maternal-fetal medicine (MFM) consult requested, Completed  \n\n    Procedures:  \n    - Biophysical profile ultrasound  \n    - Doppler assessment for placental perfusion  \n    - Fetal monitoring ×2 per week  \n\n---\n\nAdmission 80296751  \n    DRGs:  \n    - APR: GESTATIONAL HYPERTENSION — INDUCTION OF LABOR (Severity 4.0)  \n    - HCFA: DELIVERY-ASSOCIATED HYPERTENSION MANAGEMENT  \n\n    Medications:  \n    - Labetalol 300 mg PO BID  \n    - Hydralazine 10 mg IV PRN SBP >160 mmHg  \n    - Oxytocin infusion for induction of labor  \n    - Magnesium Sulfate 4 g IV bolus + 1 g/hr continuous infusion  \n    - Acetaminophen 650 mg PO PRN postpartum discomfort  \n\n    Orders:  \n    - Admit to Labor & Delivery, Completed  \n    - Initiate induction protocol with oxytocin, Completed  \n    - Continuous fetal monitoring, Completed  \n    - NICU team alerted for potential late preterm delivery, Completed  \n    - Postpartum BP monitoring and follow-up, Completed  \n\n    Procedures:  \n    - Induction of labor using oxytocin  \n    - Epidural anesthesia administered  \n    - Spontaneous vaginal delivery achieved at 37 weeks  \n    - Placenta evaluated and sent to pathology"}
{"id": "10001287", "pair_id": "40001287", "similarity": 0.5, "text": "Patient 10001287  \nGender: Female  \nAge: 31  \nRace: HISPANIC  \n\nAdmission 78145210  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION — THIRD TRIMESTER (Severity 3.0)  \n    - HCFA: PREGNANCY-INDUCED HYPERTENSION W/O SEVERE FEATURES  \n\n    Medications:  \n    - Labetalol 100 mg PO BID  \n    - Nifedipine ER 30 mg PO daily  \n    - Prenatal Vitamins 1 tab PO daily  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Sodium Chloride 0.9% Flush PRN IV access maintenance  \n\n    Orders:  \n    - Daily blood pressure monitoring, Continued  \n    - Non-stress test (NST) for fetal heart rate monitoring, Completed  \n    - Start labetalol PO BID, Continued  \n    - Low-sodium diet counseling, Completed  \n    - Educate patient on signs of worsening preeclampsia, Completed  \n\n    Procedures:  \n    - Non-stress test  \n    - Urine protein-to-creatinine ratio testing  \n\n---\n\nAdmission 79382467  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION WITH ELEVATED RISK (Severity 4.0)  \n    - HCFA: GESTATIONAL HYPERTENSION REQUIRING CLOSE SURVEILLANCE  \n\n    Medications:  \n    - Labetalol 200 mg PO BID  \n    - Nifedipine ER 60 mg PO daily  \n    - Magnesium Sulfate 4 g IV loading dose, then 1 g/hr continuous infusion  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Aspirin 81 mg PO daily (low-dose prophylaxis)  \n\n    Orders:  \n    - Start magnesium sulfate infusion for seizure prophylaxis, Discontinued via patient discharge  \n    - Continuous fetal heart monitoring, Completed  \n    - Weekly biophysical profile (BPP) ordered, Completed  \n    - Serial lab monitoring: CBC, CMP, uric acid, Completed  \n    - Consult maternal-fetal medicine specialist, Completed  \n\n    Procedures:  \n    - Biophysical profile ultrasound  \n    - Serial fetal growth assessments  \n    - Non-stress testing ×2 per week  \n\n---\n\nAdmission 81693240  \n    DRGs:  \n    - APR: SEVERE PREECLAMPSIA — THIRD TRIMESTER (Severity 5.0)  \n    - HCFA: PREGNANCY-RELATED HYPERTENSION WITH MULTIORGAN INVOLVEMENT  \n\n    Medications:  \n    - Magnesium Sulfate 4 g IV loading + 1 g/hr continuous  \n    - Hydralazine 10 mg IV PRN severe hypertension  \n    - Betamethasone 12 mg IM Q24H × 2 doses for fetal lung maturity  \n    - Labetalol 300 mg PO BID  \n    - Lactated Ringer’s IV fluids  \n\n    Orders:  \n    - Admit to Labor & Delivery for close maternal and fetal monitoring, Completed  \n    - Initiate magnesium sulfate therapy, Discontinued via patient discharge  \n    - Prepare for possible induction of labor, Completed  \n    - Continuous electronic fetal monitoring, Completed  \n    - Neonatal ICU team alerted for potential preterm delivery, Completed  \n\n    Procedures:  \n    - Induction of labor using oxytocin  \n    - Epidural anesthesia administered  \n    - Spontaneous vaginal delivery achieved at 36 weeks  \n    - Placental pathology sent for evaluation", "pair_text": "Patient 40001287  \nGender: Female  \nAge: 27  \nRace: HISPANIC  \n\nAdmission 73126489  \n    DRGs:  \n    - APR: HYPEREMESIS GRAVIDARUM — UNSPECIFIED, FIRST TRIMESTER (Severity 2.0)  \n    - HCFA: EXCESSIVE VOMITING IN PREGNANCY — INITIAL MANAGEMENT  \n\n    Medications:  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n    - Doxylamine-Pyridoxine 10-10 mg PO BID  \n    - Promethazine 12.5 mg IV Q6H PRN  \n    - Sodium Chloride 0.9% IV bolus 1L, then continuous hydration  \n    - Prenatal Vitamins 1 tab PO daily  \n    - Thiamine 100 mg IV daily  \n\n    Orders:  \n    - Initiate IV fluids for dehydration, Completed  \n    - Ondansetron IV PRN, Continued  \n    - Diet consult for bland, high-calorie meal plan, Completed  \n    - Monitor electrolytes and ketones daily, Completed  \n    - Schedule follow-up with obstetrics clinic, Completed  \n\n    Procedures:  \n    - IV hydration therapy  \n    - Basic labs: CMP, CBC, urine ketones  \n\n---\n\nAdmission 74598311  \n    DRGs:  \n    - APR: HYPEREMESIS GRAVIDARUM WITH MODERATE COMPLICATIONS (Severity 3.0)  \n    - HCFA: REFRACTORY PERSISTENT VOMITING IN PREGNANCY  \n\n    Medications:  \n    - Metoclopramide 10 mg IV Q6H  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Diphenhydramine 25 mg PO Q8H PRN  \n    - Pantoprazole 40 mg IV daily  \n    - Sodium Chloride 0.9% IV + Dextrose 5% infusion  \n    - Thiamine 100 mg IV daily  \n    - Folic Acid 1 mg PO daily  \n\n    Orders:  \n    - Admit for uncontrolled vomiting and dehydration, Completed  \n    - Initiate IV multivitamin supplementation, Completed  \n    - Daily weight monitoring, Completed  \n    - Abdominal ultrasound ordered to evaluate fetal growth, Completed  \n    - Consider home ondansetron pump, Pending  \n\n    Procedures:  \n    - IV hydration and electrolyte replacement  \n    - Ultrasound for fetal viability and growth  \n    - Nutritional assessment  \n\n---\n\nAdmission 76834122  \n    DRGs:  \n    - APR: SEVERE HYPEREMESIS GRAVIDARUM WITH COMPLICATIONS (Severity 4.0)  \n    - HCFA: ADVANCED MANAGEMENT OF INTRACTABLE PREGNANCY-RELATED VOMITING  \n\n    Medications:  \n    - Ondansetron continuous infusion at 8 mg/hr IV  \n    - Metoclopramide 10 mg IV Q6H  \n    - Methylprednisolone 16 mg IV Q12H for refractory nausea  \n    - Potassium Chloride 40 mEq IV daily  \n    - Thiamine 100 mg IV + Multivitamin infusion  \n    - Parenteral Nutrition (TPN) initiated via PICC line  \n\n    Orders:  \n    - Place PICC line for TPN initiation, Completed  \n    - Daily metabolic panel and electrolyte replacement, Completed  \n    - Serial weight and hydration status monitoring, Completed  \n    - Fetal non-stress test ordered, Completed  \n    - Post-discharge plan for home health TPN support, Completed  \n\n    Procedures:  \n    - PICC line placement for long-term nutrition  \n    - Initiation of total parenteral nutrition (TPN)  \n    - Fetal monitoring with NST and BPP"}
{"id": "10001287", "pair_id": "50001287", "similarity": 0.25, "text": "Patient 10001287  \nGender: Female  \nAge: 31  \nRace: HISPANIC  \n\nAdmission 78145210  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION — THIRD TRIMESTER (Severity 3.0)  \n    - HCFA: PREGNANCY-INDUCED HYPERTENSION W/O SEVERE FEATURES  \n\n    Medications:  \n    - Labetalol 100 mg PO BID  \n    - Nifedipine ER 30 mg PO daily  \n    - Prenatal Vitamins 1 tab PO daily  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Sodium Chloride 0.9% Flush PRN IV access maintenance  \n\n    Orders:  \n    - Daily blood pressure monitoring, Continued  \n    - Non-stress test (NST) for fetal heart rate monitoring, Completed  \n    - Start labetalol PO BID, Continued  \n    - Low-sodium diet counseling, Completed  \n    - Educate patient on signs of worsening preeclampsia, Completed  \n\n    Procedures:  \n    - Non-stress test  \n    - Urine protein-to-creatinine ratio testing  \n\n---\n\nAdmission 79382467  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION WITH ELEVATED RISK (Severity 4.0)  \n    - HCFA: GESTATIONAL HYPERTENSION REQUIRING CLOSE SURVEILLANCE  \n\n    Medications:  \n    - Labetalol 200 mg PO BID  \n    - Nifedipine ER 60 mg PO daily  \n    - Magnesium Sulfate 4 g IV loading dose, then 1 g/hr continuous infusion  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Aspirin 81 mg PO daily (low-dose prophylaxis)  \n\n    Orders:  \n    - Start magnesium sulfate infusion for seizure prophylaxis, Discontinued via patient discharge  \n    - Continuous fetal heart monitoring, Completed  \n    - Weekly biophysical profile (BPP) ordered, Completed  \n    - Serial lab monitoring: CBC, CMP, uric acid, Completed  \n    - Consult maternal-fetal medicine specialist, Completed  \n\n    Procedures:  \n    - Biophysical profile ultrasound  \n    - Serial fetal growth assessments  \n    - Non-stress testing ×2 per week  \n\n---\n\nAdmission 81693240  \n    DRGs:  \n    - APR: SEVERE PREECLAMPSIA — THIRD TRIMESTER (Severity 5.0)  \n    - HCFA: PREGNANCY-RELATED HYPERTENSION WITH MULTIORGAN INVOLVEMENT  \n\n    Medications:  \n    - Magnesium Sulfate 4 g IV loading + 1 g/hr continuous  \n    - Hydralazine 10 mg IV PRN severe hypertension  \n    - Betamethasone 12 mg IM Q24H × 2 doses for fetal lung maturity  \n    - Labetalol 300 mg PO BID  \n    - Lactated Ringer’s IV fluids  \n\n    Orders:  \n    - Admit to Labor & Delivery for close maternal and fetal monitoring, Completed  \n    - Initiate magnesium sulfate therapy, Discontinued via patient discharge  \n    - Prepare for possible induction of labor, Completed  \n    - Continuous electronic fetal monitoring, Completed  \n    - Neonatal ICU team alerted for potential preterm delivery, Completed  \n\n    Procedures:  \n    - Induction of labor using oxytocin  \n    - Epidural anesthesia administered  \n    - Spontaneous vaginal delivery achieved at 36 weeks  \n    - Placental pathology sent for evaluation", "pair_text": "Patient 50001287  \nGender: Male  \nAge: 59  \nRace: WHITE  \n\nAdmission 12034125  \n    DRGs:  \n    - APR: HYPERTENSION WITHOUT COMPLICATIONS (Severity 1.0)  \n    - HCFA: ESSENTIAL HYPERTENSION W/O MCC  \n\n    Medications:  \n    - Lisinopril 10mg PO  \n    - Hydrochlorothiazide 25mg PO  \n    - Amlodipine 5mg PO  \n    - Sodium Chloride 0.9% Flush  \n    - Aspirin EC 81mg PO  \n    - Acetaminophen  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Lisinopril: PO, Discontinued via patient discharge  \n    - Hydrochlorothiazide: PO, Discontinued via patient discharge  \n    - Amlodipine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Aspirin EC 81mg: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Electrocardiogram (ECG)  \n    - Basic metabolic panel  \n    - Blood pressure monitoring  \n\nAdmission 12149867  \n    DRGs:  \n    - APR: HYPERTENSIVE URGENCY / EMERGENCY (Severity 3.0)  \n    - HCFA: MALIGNANT HYPERTENSION W CC  \n\n    Medications:  \n    - Labetalol IV  \n    - Nicardipine IV Drip  \n    - Hydralazine IV  \n    - Sodium Nitroprusside IV  \n    - Aspirin EC 81mg  \n    - Atorvastatin 20mg  \n    - Lorazepam 1mg PO  \n    - Sodium Chloride 0.9% Flush  \n    - Heparin SC  \n    - Acetaminophen  \n\n    Orders:  \n    - Labetalol IV: IV, Discontinued via patient discharge  \n    - Nicardipine IV Drip: IV, Discontinued via patient discharge  \n    - Hydralazine IV: IV, Discontinued via patient discharge  \n    - Sodium Nitroprusside IV: IV, Discontinued via patient discharge  \n    - Aspirin EC 81mg: PO, Discontinued via patient discharge  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Lorazepam: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous cardiac telemetry monitoring  \n    - CT Head without contrast (rule out intracranial hemorrhage)  \n    - Renal function panel  \n    - Chest X-ray portable  \n\nAdmission 12287504  \n    DRGs:  \n    - APR: HYPERTENSION WITH ORGAN DAMAGE (Severity 4.0)  \n    - HCFA: ESSENTIAL HYPERTENSION W MCC  \n\n    Medications:  \n    - Losartan 50mg PO  \n    - Metoprolol Succinate 50mg PO  \n    - Chlorthalidone 25mg PO  \n    - Amlodipine 10mg PO  \n    - Sodium Chloride 0.9% Flush  \n    - Atorvastatin 20mg  \n    - Aspirin EC 81mg  \n    - Clonidine 0.1mg PO  \n    - Acetaminophen  \n\n    Orders:  \n    - Losartan: PO, Discontinued via patient discharge  \n    - Metoprolol Succinate: PO, Discontinued via patient discharge  \n    - Chlorthalidone: PO, Discontinued via patient discharge  \n    - Amlodipine: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Atorvastatin 20mg: PO, Discontinued via patient discharge  \n    - Aspirin EC 81mg: PO, Discontinued via patient discharge  \n    - Clonidine: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Echocardiogram (TTE)  \n    - 24-hour ambulatory BP monitoring  \n    - Serum electrolytes  \n    - Microalbuminuria screening"}
{"id": "10001287", "pair_id": "60001287", "similarity": 0.0, "text": "Patient 10001287  \nGender: Female  \nAge: 31  \nRace: HISPANIC  \n\nAdmission 78145210  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION — THIRD TRIMESTER (Severity 3.0)  \n    - HCFA: PREGNANCY-INDUCED HYPERTENSION W/O SEVERE FEATURES  \n\n    Medications:  \n    - Labetalol 100 mg PO BID  \n    - Nifedipine ER 30 mg PO daily  \n    - Prenatal Vitamins 1 tab PO daily  \n    - Acetaminophen 650 mg PO PRN mild headache  \n    - Sodium Chloride 0.9% Flush PRN IV access maintenance  \n\n    Orders:  \n    - Daily blood pressure monitoring, Continued  \n    - Non-stress test (NST) for fetal heart rate monitoring, Completed  \n    - Start labetalol PO BID, Continued  \n    - Low-sodium diet counseling, Completed  \n    - Educate patient on signs of worsening preeclampsia, Completed  \n\n    Procedures:  \n    - Non-stress test  \n    - Urine protein-to-creatinine ratio testing  \n\n---\n\nAdmission 79382467  \n    DRGs:  \n    - APR: PREGNANCY-RELATED HYPERTENSION WITH ELEVATED RISK (Severity 4.0)  \n    - HCFA: GESTATIONAL HYPERTENSION REQUIRING CLOSE SURVEILLANCE  \n\n    Medications:  \n    - Labetalol 200 mg PO BID  \n    - Nifedipine ER 60 mg PO daily  \n    - Magnesium Sulfate 4 g IV loading dose, then 1 g/hr continuous infusion  \n    - Ondansetron 4 mg IV PRN nausea  \n    - Aspirin 81 mg PO daily (low-dose prophylaxis)  \n\n    Orders:  \n    - Start magnesium sulfate infusion for seizure prophylaxis, Discontinued via patient discharge  \n    - Continuous fetal heart monitoring, Completed  \n    - Weekly biophysical profile (BPP) ordered, Completed  \n    - Serial lab monitoring: CBC, CMP, uric acid, Completed  \n    - Consult maternal-fetal medicine specialist, Completed  \n\n    Procedures:  \n    - Biophysical profile ultrasound  \n    - Serial fetal growth assessments  \n    - Non-stress testing ×2 per week  \n\n---\n\nAdmission 81693240  \n    DRGs:  \n    - APR: SEVERE PREECLAMPSIA — THIRD TRIMESTER (Severity 5.0)  \n    - HCFA: PREGNANCY-RELATED HYPERTENSION WITH MULTIORGAN INVOLVEMENT  \n\n    Medications:  \n    - Magnesium Sulfate 4 g IV loading + 1 g/hr continuous  \n    - Hydralazine 10 mg IV PRN severe hypertension  \n    - Betamethasone 12 mg IM Q24H × 2 doses for fetal lung maturity  \n    - Labetalol 300 mg PO BID  \n    - Lactated Ringer’s IV fluids  \n\n    Orders:  \n    - Admit to Labor & Delivery for close maternal and fetal monitoring, Completed  \n    - Initiate magnesium sulfate therapy, Discontinued via patient discharge  \n    - Prepare for possible induction of labor, Completed  \n    - Continuous electronic fetal monitoring, Completed  \n    - Neonatal ICU team alerted for potential preterm delivery, Completed  \n\n    Procedures:  \n    - Induction of labor using oxytocin  \n    - Epidural anesthesia administered  \n    - Spontaneous vaginal delivery achieved at 36 weeks  \n    - Placental pathology sent for evaluation", "pair_text": "Patient 60001287  \nGender: Female  \nAge: 29  \nRace: WHITE  \n\nAdmission 71234019  \n    DRGs:  \n    - APR: ASTHMA EXACERBATION WITHOUT STATUS ASTHMATICUS (Severity 2.0)  \n    - HCFA: UNSPECIFIED ASTHMA WITHOUT COMPLICATIONS  \n\n    Medications:  \n    - Albuterol Inhaler 90 mcg: 2 puffs Q4H PRN  \n    - Fluticasone Propionate 110 mcg: 1 puff BID  \n    - Montelukast 10 mg PO QHS  \n    - Cetirizine 10 mg PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Initiate albuterol inhaler PRN, Completed  \n    - Spirometry testing for baseline control, Completed  \n    - Patient education on asthma action plan, Completed  \n    - Environmental allergen reduction counseling, Completed  \n    - Follow-up scheduled with primary care and pulmonology, Completed  \n\n    Procedures:  \n    - Pulmonary function testing (PFT)  \n    - Peak flow measurement  \n\n---\n\nAdmission 73451288  \n    DRGs:  \n    - APR: ACUTE ASTHMA EXACERBATION — MODERATE SEVERITY (Severity 3.0)  \n    - HCFA: ASTHMA WITH RESPIRATORY DISTRESS — NON-ICU  \n\n    Medications:  \n    - Albuterol 2.5 mg Nebulizer Q2H PRN  \n    - Ipratropium Bromide 0.5 mg Nebulizer Q4H PRN  \n    - Prednisone 40 mg PO daily × 5 days  \n    - Fluticasone-Salmeterol 250/50 mcg Diskus: 1 puff BID  \n    - Montelukast 10 mg PO daily  \n\n    Orders:  \n    - Admit for acute asthma exacerbation, Completed  \n    - Initiate DuoNeb treatments Q4H, Completed  \n    - Oxygen therapy initiated for SpO₂ < 94%, Completed  \n    - Chest X-ray to rule out pneumonia, Completed  \n    - Daily peak expiratory flow monitoring, Completed  \n\n    Procedures:  \n    - Nebulizer therapy  \n    - Chest X-ray imaging  \n    - Continuous oxygen saturation monitoring  \n\n---\n\nAdmission 75268043  \n    DRGs:  \n    - APR: ASTHMA STABILIZATION FOLLOW-UP (Severity 1.0)  \n    - HCFA: ASTHMA MAINTENANCE — NO COMPLICATIONS  \n\n    Medications:  \n    - Fluticasone-Salmeterol 250/50 mcg Diskus: 1 puff BID  \n    - Montelukast 10 mg PO QHS  \n    - Albuterol Inhaler 90 mcg: 2 puffs PRN  \n    - Loratadine 10 mg PO daily  \n    - Influenza Vaccine Quadrivalent: IM once  \n\n    Orders:  \n    - Continue asthma controller medications, Completed  \n    - Asthma education and inhaler technique check, Completed  \n    - Influenza vaccine administered, Completed  \n    - Schedule 3-month follow-up for medication review, Completed  \n\n    Procedures:  \n    - Peak flow monitoring  \n    - Allergy panel ordered for environmental triggers"}
{"id": "10001288", "pair_id": "20001288", "similarity": 1.0, "text": "Patient 10001288  \nGender: Male  \nAge: 56  \nRace: WHITE  \n\nAdmission 61247890  \n    DRGs:  \n    - APR: SEPSIS DUE TO MRSA INFECTION (Severity 4.0)  \n    - HCFA: MRSA-ASSOCIATED BLOODSTREAM INFECTION WITH ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Vancomycin IV 1.25g Q12H (dose-adjusted per trough levels)  \n    - Piperacillin-Tazobactam 4.5g IV Q6H  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Lactated Ringer’s IV bolus 500 mL PRN hypotension  \n    - Heparin 5000 U SC Q8H for DVT prophylaxis  \n\n    Orders:  \n    - Blood cultures ×2 from separate sites before antibiotics, Completed  \n    - Initiate Vancomycin per infectious disease protocol, Completed  \n    - Daily renal function monitoring due to nephrotoxic risk, Completed  \n    - MRSA nasal screening ordered, Completed  \n    - ID consultation ordered, Completed  \n\n    Procedures:  \n    - Central venous catheter placement for IV therapy  \n    - Ultrasound-guided fluid resuscitation  \n    - Serial lactate monitoring  \n\n---\n\nAdmission 64321754  \n    DRGs:  \n    - APR: COMPLICATED MRSA SOFT-TISSUE INFECTION (Severity 3.0)  \n    - HCFA: CELLULITIS AND ABSCESS SECONDARY TO MRSA  \n\n    Medications:  \n    - Linezolid 600 mg PO Q12H  \n    - Vancomycin IV 1g Q12H (discontinued after 48 hrs due to nephrotoxicity)  \n    - Daptomycin 6 mg/kg IV Q24H started after renal function decline  \n    - Ibuprofen 600 mg PO Q8H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Wound culture with MRSA sensitivity panel, Completed  \n    - ID re-consultation for therapy adjustment, Completed  \n    - Switch from vancomycin to daptomycin per nephrology recommendations, Completed  \n    - Daily CBC and CMP monitoring, Completed  \n    - Wound care nurse evaluation, Completed  \n\n    Procedures:  \n    - Surgical incision & drainage (I&D) of left thigh abscess  \n    - Negative pressure wound therapy (VAC dressing)  \n    - Bedside wound debridement performed twice  \n\n---\n\nAdmission 67230987  \n    DRGs:  \n    - APR: RECURRENT MRSA INFECTION — CHRONIC MANAGEMENT (Severity 2.0)  \n    - HCFA: MRSA-RELATED OSTEOARTICULAR INVOLVEMENT  \n\n    Medications:  \n    - Doxycycline 100 mg PO BID × 6 weeks (suppressive therapy)  \n    - Rifampin 600 mg PO daily for biofilm coverage  \n    - Probiotic supplementation PO daily to reduce antibiotic-associated GI effects  \n    - Acetaminophen 500 mg PO Q6H PRN  \n    - Influenza Vaccine Quadrivalent IM once  \n\n    Orders:  \n    - Outpatient infectious disease follow-up scheduled, Completed  \n    - MRI ordered to evaluate for MRSA-associated osteomyelitis, Completed  \n    - PICC line placed for prolonged IV antibiotic therapy, Completed  \n    - Weekly labs for monitoring ESR, CRP, renal function, Completed  \n\n    Procedures:  \n    - PICC line placement for long-term IV antibiotics  \n    - MRI of right ankle showing early MRSA-related osteomyelitis  \n    - Outpatient wound care and physical therapy referral", "pair_text": "Patient 20001288  \nGender: Female  \nAge: 62  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 78124566  \n    DRGs:  \n    - APR: MRSA SEPTICEMIA WITH ACUTE ORGAN DYSFUNCTION (Severity 4.0)  \n    - HCFA: SEVERE MRSA BLOODSTREAM INFECTION WITH MULTI-SYSTEM INVOLVEMENT  \n\n    Medications:  \n    - Vancomycin IV 1.25 g Q12H (dose-adjusted based on trough levels)  \n    - Piperacillin-Tazobactam IV 4.5 g Q6H  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Norepinephrine IV infusion for septic shock, titrated per MAP  \n    - Sodium Chloride 0.9% IV continuous  \n    - Heparin 5000 U SC Q8H for DVT prophylaxis  \n\n    Orders:  \n    - Obtain blood cultures ×2 prior to starting antibiotics, Completed  \n    - Infectious disease (ID) consult for MRSA bacteremia, Completed  \n    - Vancomycin trough level monitoring ordered, Completed  \n    - Strict I/O monitoring and fluid resuscitation plan, Completed  \n    - Daily renal panel monitoring due to nephrotoxic risk, Completed  \n\n    Procedures:  \n    - Central venous line placement  \n    - Serial lactate monitoring  \n    - Continuous telemetry monitoring  \n\n---\n\nAdmission 79431025  \n    DRGs:  \n    - APR: COMPLICATED MRSA SKIN AND SOFT-TISSUE INFECTION (Severity 3.0)  \n    - HCFA: CELLULITIS AND DEEP ABSCESS SECONDARY TO MRSA  \n\n    Medications:  \n    - Linezolid 600 mg PO Q12H  \n    - Clindamycin 600 mg IV Q8H for toxin suppression  \n    - Ibuprofen 600 mg PO Q8H PRN pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Wound cultures for MRSA with sensitivity testing, Completed  \n    - Consult wound care for dressing changes, Completed  \n    - Switch from Vancomycin to Linezolid per ID recommendations, Completed  \n    - Daily CBC, ESR, and CRP ordered to track inflammation, Completed  \n\n    Procedures:  \n    - Incision and drainage (I&D) of right lower extremity abscess  \n    - Negative pressure wound therapy initiated  \n    - Bedside wound debridement performed twice  \n\n---\n\nAdmission 81249537  \n    DRGs:  \n    - APR: RECURRENT MRSA OSTEOMYELITIS — CHRONIC MANAGEMENT (Severity 2.0)  \n    - HCFA: MRSA BONE AND JOINT INVOLVEMENT — NON-ACUTE  \n\n    Medications:  \n    - Daptomycin IV 6 mg/kg Q24H × 6 weeks via PICC  \n    - Rifampin 600 mg PO daily for biofilm penetration  \n    - Doxycycline 100 mg PO BID as suppressive therapy after IV course  \n    - Probiotic PO daily to minimize antibiotic-associated diarrhea  \n    - Influenza Vaccine Quadrivalent IM once  \n\n    Orders:  \n    - MRI of left tibia to evaluate for chronic MRSA osteomyelitis, Completed  \n    - PICC line placement for extended IV therapy, Completed  \n    - Weekly ESR, CRP, and renal function monitoring, Completed  \n    - Outpatient ID follow-up scheduled, Completed  \n\n    Procedures:  \n    - PICC line insertion  \n    - MRI confirming MRSA-related osteomyelitis  \n    - Outpatient wound care follow-up"}
{"id": "10001288", "pair_id": "30001288", "similarity": 0.75, "text": "Patient 10001288  \nGender: Male  \nAge: 56  \nRace: WHITE  \n\nAdmission 61247890  \n    DRGs:  \n    - APR: SEPSIS DUE TO MRSA INFECTION (Severity 4.0)  \n    - HCFA: MRSA-ASSOCIATED BLOODSTREAM INFECTION WITH ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Vancomycin IV 1.25g Q12H (dose-adjusted per trough levels)  \n    - Piperacillin-Tazobactam 4.5g IV Q6H  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Lactated Ringer’s IV bolus 500 mL PRN hypotension  \n    - Heparin 5000 U SC Q8H for DVT prophylaxis  \n\n    Orders:  \n    - Blood cultures ×2 from separate sites before antibiotics, Completed  \n    - Initiate Vancomycin per infectious disease protocol, Completed  \n    - Daily renal function monitoring due to nephrotoxic risk, Completed  \n    - MRSA nasal screening ordered, Completed  \n    - ID consultation ordered, Completed  \n\n    Procedures:  \n    - Central venous catheter placement for IV therapy  \n    - Ultrasound-guided fluid resuscitation  \n    - Serial lactate monitoring  \n\n---\n\nAdmission 64321754  \n    DRGs:  \n    - APR: COMPLICATED MRSA SOFT-TISSUE INFECTION (Severity 3.0)  \n    - HCFA: CELLULITIS AND ABSCESS SECONDARY TO MRSA  \n\n    Medications:  \n    - Linezolid 600 mg PO Q12H  \n    - Vancomycin IV 1g Q12H (discontinued after 48 hrs due to nephrotoxicity)  \n    - Daptomycin 6 mg/kg IV Q24H started after renal function decline  \n    - Ibuprofen 600 mg PO Q8H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Wound culture with MRSA sensitivity panel, Completed  \n    - ID re-consultation for therapy adjustment, Completed  \n    - Switch from vancomycin to daptomycin per nephrology recommendations, Completed  \n    - Daily CBC and CMP monitoring, Completed  \n    - Wound care nurse evaluation, Completed  \n\n    Procedures:  \n    - Surgical incision & drainage (I&D) of left thigh abscess  \n    - Negative pressure wound therapy (VAC dressing)  \n    - Bedside wound debridement performed twice  \n\n---\n\nAdmission 67230987  \n    DRGs:  \n    - APR: RECURRENT MRSA INFECTION — CHRONIC MANAGEMENT (Severity 2.0)  \n    - HCFA: MRSA-RELATED OSTEOARTICULAR INVOLVEMENT  \n\n    Medications:  \n    - Doxycycline 100 mg PO BID × 6 weeks (suppressive therapy)  \n    - Rifampin 600 mg PO daily for biofilm coverage  \n    - Probiotic supplementation PO daily to reduce antibiotic-associated GI effects  \n    - Acetaminophen 500 mg PO Q6H PRN  \n    - Influenza Vaccine Quadrivalent IM once  \n\n    Orders:  \n    - Outpatient infectious disease follow-up scheduled, Completed  \n    - MRI ordered to evaluate for MRSA-associated osteomyelitis, Completed  \n    - PICC line placed for prolonged IV antibiotic therapy, Completed  \n    - Weekly labs for monitoring ESR, CRP, renal function, Completed  \n\n    Procedures:  \n    - PICC line placement for long-term IV antibiotics  \n    - MRI of right ankle showing early MRSA-related osteomyelitis  \n    - Outpatient wound care and physical therapy referral", "pair_text": "Patient 30001288  \nGender: Male  \nAge: 64  \nRace: WHITE  \n\nAdmission 71528491  \n    DRGs:  \n    - APR: MSSA BACTEREMIA WITH ACUTE ORGAN DYSFUNCTION (Severity 4.0)  \n    - HCFA: STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTION WITH SYSTEMIC COMPLICATIONS  \n\n    Medications:  \n    - Nafcillin IV 2 g Q4H (first-line MSSA treatment)  \n    - Piperacillin-Tazobactam IV 4.5 g Q6H until susceptibilities finalized  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Norepinephrine IV infusion for hypotension, titrated per MAP  \n    - Sodium Chloride 0.9% IV continuous for fluid resuscitation  \n    - Heparin 5000 U SC Q8H for DVT prophylaxis  \n\n    Orders:  \n    - Obtain blood cultures ×2 from separate sites, Completed  \n    - Initiate Nafcillin after MSSA confirmed, Completed  \n    - ID consultation for treatment duration planning, Completed  \n    - Daily renal and hepatic function monitoring, Completed  \n    - Echocardiogram ordered to rule out endocarditis, Completed  \n\n    Procedures:  \n    - Central venous line insertion for IV antibiotics  \n    - Serial lactate monitoring  \n    - Echocardiography performed — negative for vegetations  \n\n---\n\nAdmission 73862540  \n    DRGs:  \n    - APR: COMPLICATED MSSA SKIN AND SOFT-TISSUE INFECTION (Severity 3.0)  \n    - HCFA: CELLULITIS AND ABSCESS SECONDARY TO MSSA  \n\n    Medications:  \n    - Cefazolin IV 2 g Q8H (narrowed after susceptibility testing)  \n    - Clindamycin 600 mg IV Q8H for toxin suppression  \n    - Ibuprofen 600 mg PO Q8H PRN pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Wound culture and Gram stain, Completed  \n    - Surgical consult for abscess drainage, Completed  \n    - Daily wound dressing changes ordered, Completed  \n    - ID re-evaluation for narrowing therapy to Cefazolin, Completed  \n    - CBC and CRP monitored daily, Completed  \n\n    Procedures:  \n    - Incision and drainage (I&D) of left forearm abscess  \n    - Placement of negative pressure wound VAC therapy  \n    - Bedside wound debridement performed once  \n\n---\n\nAdmission 76423812  \n    DRGs:  \n    - APR: MSSA SEPTIC ARTHRITIS OF THE KNEE (Severity 3.0)  \n    - HCFA: ACUTE SEPTIC JOINT SECONDARY TO MSSA  \n\n    Medications:  \n    - Cefazolin IV 2 g Q8H × 6 weeks via PICC line  \n    - Rifampin 600 mg PO daily for biofilm penetration  \n    - Naproxen 500 mg PO BID PRN joint pain  \n    - Acetaminophen 500 mg PO Q6H PRN  \n    - Influenza Vaccine Quadrivalent IM once  \n\n    Orders:  \n    - Joint aspiration for synovial fluid analysis and MSSA culture, Completed  \n    - PICC line placed for prolonged IV antibiotics, Completed  \n    - Daily ESR and CRP ordered to monitor resolution, Completed  \n    - Physical therapy consult initiated, Completed  \n\n    Procedures:  \n    - Arthroscopic irrigation and debridement of the right knee  \n    - PICC line placement for long-term IV therapy  \n    - Synovial fluid drainage performed successfully"}
{"id": "10001288", "pair_id": "40001288", "similarity": 0.5, "text": "Patient 10001288  \nGender: Male  \nAge: 56  \nRace: WHITE  \n\nAdmission 61247890  \n    DRGs:  \n    - APR: SEPSIS DUE TO MRSA INFECTION (Severity 4.0)  \n    - HCFA: MRSA-ASSOCIATED BLOODSTREAM INFECTION WITH ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Vancomycin IV 1.25g Q12H (dose-adjusted per trough levels)  \n    - Piperacillin-Tazobactam 4.5g IV Q6H  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Lactated Ringer’s IV bolus 500 mL PRN hypotension  \n    - Heparin 5000 U SC Q8H for DVT prophylaxis  \n\n    Orders:  \n    - Blood cultures ×2 from separate sites before antibiotics, Completed  \n    - Initiate Vancomycin per infectious disease protocol, Completed  \n    - Daily renal function monitoring due to nephrotoxic risk, Completed  \n    - MRSA nasal screening ordered, Completed  \n    - ID consultation ordered, Completed  \n\n    Procedures:  \n    - Central venous catheter placement for IV therapy  \n    - Ultrasound-guided fluid resuscitation  \n    - Serial lactate monitoring  \n\n---\n\nAdmission 64321754  \n    DRGs:  \n    - APR: COMPLICATED MRSA SOFT-TISSUE INFECTION (Severity 3.0)  \n    - HCFA: CELLULITIS AND ABSCESS SECONDARY TO MRSA  \n\n    Medications:  \n    - Linezolid 600 mg PO Q12H  \n    - Vancomycin IV 1g Q12H (discontinued after 48 hrs due to nephrotoxicity)  \n    - Daptomycin 6 mg/kg IV Q24H started after renal function decline  \n    - Ibuprofen 600 mg PO Q8H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Wound culture with MRSA sensitivity panel, Completed  \n    - ID re-consultation for therapy adjustment, Completed  \n    - Switch from vancomycin to daptomycin per nephrology recommendations, Completed  \n    - Daily CBC and CMP monitoring, Completed  \n    - Wound care nurse evaluation, Completed  \n\n    Procedures:  \n    - Surgical incision & drainage (I&D) of left thigh abscess  \n    - Negative pressure wound therapy (VAC dressing)  \n    - Bedside wound debridement performed twice  \n\n---\n\nAdmission 67230987  \n    DRGs:  \n    - APR: RECURRENT MRSA INFECTION — CHRONIC MANAGEMENT (Severity 2.0)  \n    - HCFA: MRSA-RELATED OSTEOARTICULAR INVOLVEMENT  \n\n    Medications:  \n    - Doxycycline 100 mg PO BID × 6 weeks (suppressive therapy)  \n    - Rifampin 600 mg PO daily for biofilm coverage  \n    - Probiotic supplementation PO daily to reduce antibiotic-associated GI effects  \n    - Acetaminophen 500 mg PO Q6H PRN  \n    - Influenza Vaccine Quadrivalent IM once  \n\n    Orders:  \n    - Outpatient infectious disease follow-up scheduled, Completed  \n    - MRI ordered to evaluate for MRSA-associated osteomyelitis, Completed  \n    - PICC line placed for prolonged IV antibiotic therapy, Completed  \n    - Weekly labs for monitoring ESR, CRP, renal function, Completed  \n\n    Procedures:  \n    - PICC line placement for long-term IV antibiotics  \n    - MRI of right ankle showing early MRSA-related osteomyelitis  \n    - Outpatient wound care and physical therapy referral", "pair_text": "Patient 40001288  \nGender: Female  \nAge: 58  \nRace: HISPANIC  \n\nAdmission 67124890  \n    DRGs:  \n    - APR: SEVERE E. COLI SEPTICEMIA WITH ACUTE ORGAN DYSFUNCTION (Severity 4.0)  \n    - HCFA: E. COLI BLOODSTREAM INFECTION WITH MULTI-SYSTEM INVOLVEMENT  \n\n    Medications:  \n    - Ceftriaxone IV 2 g Q24H (empiric treatment, adjusted per culture)  \n    - Piperacillin-Tazobactam IV 4.5 g Q6H until sensitivities returned  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Norepinephrine IV infusion titrated for hypotension  \n    - Sodium Chloride 0.9% IV continuous for resuscitation  \n    - Heparin 5000 U SC Q8H for DVT prophylaxis  \n\n    Orders:  \n    - Obtain blood and urine cultures ×2 before antibiotics, Completed  \n    - Infectious disease (ID) consultation initiated, Completed  \n    - Start broad-spectrum coverage, then narrow to Ceftriaxone once sensitivities available, Completed  \n    - Daily renal panel monitoring due to risk of AKI, Completed  \n    - Foley catheter inserted for strict urine output monitoring, Completed  \n\n    Procedures:  \n    - Central venous line placement  \n    - Serial lactate monitoring  \n    - Continuous telemetry monitoring  \n\n---\n\nAdmission 68195743  \n    DRGs:  \n    - APR: COMPLICATED PYELONEPHRITIS WITH E. COLI BACTEREMIA (Severity 3.0)  \n    - HCFA: E. COLI-ASSOCIATED ACUTE PYELONEPHRITIS WITH SYSTEMIC RESPONSE  \n\n    Medications:  \n    - Levofloxacin IV 750 mg Q24H (based on susceptibility results)  \n    - Acetaminophen 650 mg PO Q6H PRN pain or fever  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Sodium Chloride 0.9% Flush IV PRN  \n    - Probiotic PO daily to reduce antibiotic-associated diarrhea  \n\n    Orders:  \n    - CT abdomen/pelvis ordered to assess for obstruction or perinephric abscess, Completed  \n    - Daily urinalysis and urine cultures, Completed  \n    - Urology consult to evaluate for possible stent placement, Completed  \n    - Transition from IV Levofloxacin to oral Ciprofloxacin after discharge, Completed  \n    - Renal ultrasound scheduled to assess for hydronephrosis, Completed  \n\n    Procedures:  \n    - CT imaging confirmed left-sided pyelonephritis  \n    - Foley catheter removed after 48 hours  \n    - IV-to-PO switch therapy coordinated with ID  \n\n---\n\nAdmission 69931428  \n    DRGs:  \n    - APR: E. COLI-RELATED INFECTIVE ENDOCARDITIS (Severity 4.0)  \n    - HCFA: COMPLICATED E. COLI ENDOVASCULAR INFECTION  \n\n    Medications:  \n    - Meropenem IV 1 g Q8H (chosen due to ESBL-producing E. coli)  \n    - Gentamicin IV 3 mg/kg daily for synergistic effect, dose adjusted per levels  \n    - Aspirin 81 mg PO daily for endocarditis-related embolic risk  \n    - Pantoprazole 40 mg PO daily for GI prophylaxis  \n    - Influenza Vaccine Quadrivalent IM once  \n\n    Orders:  \n    - Transesophageal echocardiography (TEE) ordered to confirm vegetations, Completed  \n    - PICC line placed for prolonged IV therapy, Completed  \n    - Weekly ESR and CRP monitoring to track infection clearance, Completed  \n    - Blood cultures repeated every 48 hours until negative, Completed  \n    - Outpatient ID follow-up arranged for continuation of therapy, Completed  \n\n    Procedures:  \n    - TEE confirmed aortic valve vegetation  \n    - PICC line successfully inserted for 6-week IV antibiotic course  \n    - Regular outpatient bloodwork arranged to monitor drug levels and kidney function"}
{"id": "10001288", "pair_id": "50001288", "similarity": 0.25, "text": "Patient 10001288  \nGender: Male  \nAge: 56  \nRace: WHITE  \n\nAdmission 61247890  \n    DRGs:  \n    - APR: SEPSIS DUE TO MRSA INFECTION (Severity 4.0)  \n    - HCFA: MRSA-ASSOCIATED BLOODSTREAM INFECTION WITH ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Vancomycin IV 1.25g Q12H (dose-adjusted per trough levels)  \n    - Piperacillin-Tazobactam 4.5g IV Q6H  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Lactated Ringer’s IV bolus 500 mL PRN hypotension  \n    - Heparin 5000 U SC Q8H for DVT prophylaxis  \n\n    Orders:  \n    - Blood cultures ×2 from separate sites before antibiotics, Completed  \n    - Initiate Vancomycin per infectious disease protocol, Completed  \n    - Daily renal function monitoring due to nephrotoxic risk, Completed  \n    - MRSA nasal screening ordered, Completed  \n    - ID consultation ordered, Completed  \n\n    Procedures:  \n    - Central venous catheter placement for IV therapy  \n    - Ultrasound-guided fluid resuscitation  \n    - Serial lactate monitoring  \n\n---\n\nAdmission 64321754  \n    DRGs:  \n    - APR: COMPLICATED MRSA SOFT-TISSUE INFECTION (Severity 3.0)  \n    - HCFA: CELLULITIS AND ABSCESS SECONDARY TO MRSA  \n\n    Medications:  \n    - Linezolid 600 mg PO Q12H  \n    - Vancomycin IV 1g Q12H (discontinued after 48 hrs due to nephrotoxicity)  \n    - Daptomycin 6 mg/kg IV Q24H started after renal function decline  \n    - Ibuprofen 600 mg PO Q8H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Wound culture with MRSA sensitivity panel, Completed  \n    - ID re-consultation for therapy adjustment, Completed  \n    - Switch from vancomycin to daptomycin per nephrology recommendations, Completed  \n    - Daily CBC and CMP monitoring, Completed  \n    - Wound care nurse evaluation, Completed  \n\n    Procedures:  \n    - Surgical incision & drainage (I&D) of left thigh abscess  \n    - Negative pressure wound therapy (VAC dressing)  \n    - Bedside wound debridement performed twice  \n\n---\n\nAdmission 67230987  \n    DRGs:  \n    - APR: RECURRENT MRSA INFECTION — CHRONIC MANAGEMENT (Severity 2.0)  \n    - HCFA: MRSA-RELATED OSTEOARTICULAR INVOLVEMENT  \n\n    Medications:  \n    - Doxycycline 100 mg PO BID × 6 weeks (suppressive therapy)  \n    - Rifampin 600 mg PO daily for biofilm coverage  \n    - Probiotic supplementation PO daily to reduce antibiotic-associated GI effects  \n    - Acetaminophen 500 mg PO Q6H PRN  \n    - Influenza Vaccine Quadrivalent IM once  \n\n    Orders:  \n    - Outpatient infectious disease follow-up scheduled, Completed  \n    - MRI ordered to evaluate for MRSA-associated osteomyelitis, Completed  \n    - PICC line placed for prolonged IV antibiotic therapy, Completed  \n    - Weekly labs for monitoring ESR, CRP, renal function, Completed  \n\n    Procedures:  \n    - PICC line placement for long-term IV antibiotics  \n    - MRI of right ankle showing early MRSA-related osteomyelitis  \n    - Outpatient wound care and physical therapy referral", "pair_text": "Patient 50001288  \nGender: Female  \nAge: 62  \nRace: WHITE  \n\nAdmission 13028754  \n    DRGs:  \n    - APR: INFECTION FOLLOWING SURGICAL PROCEDURE (Severity 3.0)  \n    - HCFA: POSTOPERATIVE WOUND INFECTION W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam (Zosyn) IV  \n    - Vancomycin IV  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Ondansetron IV  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Piperacillin-Tazobactam IV: IV, Discontinued via patient discharge  \n    - Vancomycin IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Wound culture and sensitivity  \n    - Bedside wound debridement  \n    - Blood cultures  \n\nAdmission 13195428  \n    DRGs:  \n    - APR: SEVERE INFECTION FOLLOWING PROCEDURE WITH DRAINAGE (Severity 4.0)  \n    - HCFA: POSTOPERATIVE SEPSIS W MCC  \n\n    Medications:  \n    - Meropenem IV  \n    - Linezolid IV  \n    - Sodium Chloride 0.9% Flush  \n    - Enoxaparin SC  \n    - Acetaminophen  \n    - Fluconazole IV (fungal coverage)  \n    - Ondansetron IV  \n\n    Orders:  \n    - Meropenem IV: IV, Discontinued via patient discharge  \n    - Linezolid IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Enoxaparin SC: SC, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Fluconazole IV: IV, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Surgical incision and drainage  \n    - Placement of negative pressure wound therapy (VAC)  \n    - CT abdomen/pelvis to evaluate abscess  \n    - Repeat wound cultures  \n\nAdmission 13367294  \n    DRGs:  \n    - APR: POSTOPERATIVE INFECTION WITH COMPLICATIONS (Severity 2.0)  \n    - HCFA: INFECTION FOLLOWING PROCEDURE W/O CC/MCC  \n\n    Medications:  \n    - Cefepime IV  \n    - Daptomycin IV  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Probiotic Supplement  \n    - Ondansetron PO  \n\n    Orders:  \n    - Cefepime IV: IV, Discontinued via patient discharge  \n    - Daptomycin IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Probiotic Supplement: PO, Discontinued via patient discharge  \n    - Ondansetron PO: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Ultrasound-guided aspiration of fluid collection  \n    - Wound vacuum dressing change  \n    - Follow-up MRI to evaluate healing status"}
{"id": "10001288", "pair_id": "60001288", "similarity": 0.0, "text": "Patient 10001288  \nGender: Male  \nAge: 56  \nRace: WHITE  \n\nAdmission 61247890  \n    DRGs:  \n    - APR: SEPSIS DUE TO MRSA INFECTION (Severity 4.0)  \n    - HCFA: MRSA-ASSOCIATED BLOODSTREAM INFECTION WITH ACUTE ORGAN DYSFUNCTION  \n\n    Medications:  \n    - Vancomycin IV 1.25g Q12H (dose-adjusted per trough levels)  \n    - Piperacillin-Tazobactam 4.5g IV Q6H  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV continuous infusion  \n    - Lactated Ringer’s IV bolus 500 mL PRN hypotension  \n    - Heparin 5000 U SC Q8H for DVT prophylaxis  \n\n    Orders:  \n    - Blood cultures ×2 from separate sites before antibiotics, Completed  \n    - Initiate Vancomycin per infectious disease protocol, Completed  \n    - Daily renal function monitoring due to nephrotoxic risk, Completed  \n    - MRSA nasal screening ordered, Completed  \n    - ID consultation ordered, Completed  \n\n    Procedures:  \n    - Central venous catheter placement for IV therapy  \n    - Ultrasound-guided fluid resuscitation  \n    - Serial lactate monitoring  \n\n---\n\nAdmission 64321754  \n    DRGs:  \n    - APR: COMPLICATED MRSA SOFT-TISSUE INFECTION (Severity 3.0)  \n    - HCFA: CELLULITIS AND ABSCESS SECONDARY TO MRSA  \n\n    Medications:  \n    - Linezolid 600 mg PO Q12H  \n    - Vancomycin IV 1g Q12H (discontinued after 48 hrs due to nephrotoxicity)  \n    - Daptomycin 6 mg/kg IV Q24H started after renal function decline  \n    - Ibuprofen 600 mg PO Q8H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Wound culture with MRSA sensitivity panel, Completed  \n    - ID re-consultation for therapy adjustment, Completed  \n    - Switch from vancomycin to daptomycin per nephrology recommendations, Completed  \n    - Daily CBC and CMP monitoring, Completed  \n    - Wound care nurse evaluation, Completed  \n\n    Procedures:  \n    - Surgical incision & drainage (I&D) of left thigh abscess  \n    - Negative pressure wound therapy (VAC dressing)  \n    - Bedside wound debridement performed twice  \n\n---\n\nAdmission 67230987  \n    DRGs:  \n    - APR: RECURRENT MRSA INFECTION — CHRONIC MANAGEMENT (Severity 2.0)  \n    - HCFA: MRSA-RELATED OSTEOARTICULAR INVOLVEMENT  \n\n    Medications:  \n    - Doxycycline 100 mg PO BID × 6 weeks (suppressive therapy)  \n    - Rifampin 600 mg PO daily for biofilm coverage  \n    - Probiotic supplementation PO daily to reduce antibiotic-associated GI effects  \n    - Acetaminophen 500 mg PO Q6H PRN  \n    - Influenza Vaccine Quadrivalent IM once  \n\n    Orders:  \n    - Outpatient infectious disease follow-up scheduled, Completed  \n    - MRI ordered to evaluate for MRSA-associated osteomyelitis, Completed  \n    - PICC line placed for prolonged IV antibiotic therapy, Completed  \n    - Weekly labs for monitoring ESR, CRP, renal function, Completed  \n\n    Procedures:  \n    - PICC line placement for long-term IV antibiotics  \n    - MRI of right ankle showing early MRSA-related osteomyelitis  \n    - Outpatient wound care and physical therapy referral", "pair_text": "Patient 60001288  \nGender: Female  \nAge: 52  \nRace: WHITE  \n\nAdmission 78124561  \n    DRGs:  \n    - APR: AGE-RELATED VISION DISORDERS — PRESBYOPIA (Severity 1.0)  \n    - HCFA: PRESBYOPIA WITH MILD VISUAL FUNCTIONAL IMPAIRMENT  \n\n    Medications:  \n    - Artificial Tears (Polyethylene Glycol 0.4%) — 1 drop OU QID PRN dryness  \n    - Carboxymethylcellulose Eye Drops — 1 drop OU BID  \n    - Omega-3 Fatty Acid Supplements — PO daily  \n    - Multivitamin with Lutein — PO daily  \n\n    Orders:  \n    - Comprehensive eye exam performed, Completed  \n    - Refraction assessment for near vision correction, Completed  \n    - Prescription bifocals provided, Completed  \n    - Patient counseled on the use of progressive lenses vs. separate reading glasses, Completed  \n    - Advised routine ophthalmology follow-up every 12 months  \n\n    Procedures:  \n    - Visual acuity testing  \n    - Autorefraction assessment  \n    - Tonometry screening to rule out elevated intraocular pressure  \n\n---\n\nAdmission 79653482  \n    DRGs:  \n    - APR: PRESBYOPIA WITH COMORBID DRY EYE SYNDROME (Severity 2.0)  \n    - HCFA: DRY EYE-ASSOCIATED AGE-RELATED NEAR-VISION LOSS  \n\n    Medications:  \n    - Restasis (Cyclosporine Ophthalmic 0.05%) — 1 drop OU BID  \n    - Systane Ultra Lubricating Drops — 1 drop OU Q6H PRN  \n    - Vitamin A Supplements — PO daily  \n    - Acetaminophen 500 mg PO Q6H PRN headache  \n\n    Orders:  \n    - Schirmer’s test performed to evaluate tear production, Completed  \n    - Prescription for progressive lenses adjusted, Completed  \n    - Warm compresses advised BID for meibomian gland support, Completed  \n    - Recommended humidifier usage at home to manage dryness, Completed  \n    - Dry eye management plan discussed with patient, Completed  \n\n    Procedures:  \n    - Schirmer tear production testing  \n    - Tear break-up time evaluation  \n    - Optical coherence tomography (OCT) performed to exclude macular pathology  \n\n---\n\nAdmission 80432659  \n    DRGs:  \n    - APR: ROUTINE OPHTHALMOLOGY FOLLOW-UP — PRESBYOPIA MANAGEMENT (Severity 1.0)  \n    - HCFA: STABLE AGE-RELATED VISION CHANGES WITHOUT COMPLICATIONS  \n\n    Medications:  \n    - Refresh Tears (Hypromellose 0.5%) — 1 drop OU QID  \n    - Omega-3 Fish Oil 1000 mg PO daily  \n    - Preservative-Free Artificial Tears — 1 drop OU PRN  \n\n    Orders:  \n    - Annual follow-up for vision reassessment, Completed  \n    - Updated reading glasses prescription, Completed  \n    - Counseling on blue-light filtering lenses, Completed  \n    - Recommended workplace ergonomics adjustments, Completed  \n\n    Procedures:  \n    - Visual acuity re-evaluation  \n    - Digital eye strain assessment  \n    - Intraocular pressure monitoring via non-contact tonometry"}
{"id": "10001289", "pair_id": "20001289", "similarity": 1.0, "text": "Patient 10001289  \nGender: Male  \nAge: 61  \nRace: WHITE  \n\nAdmission 74523816  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH HYPOXEMIA (Severity 3.0)  \n    - HCFA: COMMUNITY-ACQUIRED LOBAR PNEUMONIA, UNSPECIFIED ORGANISM  \n\n    Medications:  \n    - Ceftriaxone 2 g IV Q24H (empiric treatment)  \n    - Azithromycin 500 mg PO day 1, then 250 mg PO daily × 4 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Albuterol Nebulizer 2.5 mg Q6H PRN wheezing  \n    - Sodium Chloride 0.9% IV continuous at 100 mL/hr  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Chest X-ray ordered and completed, confirmed right lower-lobe consolidation  \n    - Sputum and blood cultures drawn, Completed  \n    - Oxygen therapy initiated at 3 L/min nasal cannula, titrated based on SpO₂, Completed  \n    - Pulmonary consult requested, Completed  \n    - Daily BMP and CBC monitoring ordered, Ongoing  \n\n    Procedures:  \n    - Chest radiograph performed and reviewed  \n    - Supplemental oxygen started  \n    - Incentive spirometry instruction provided  \n\n---\n\nAdmission 75218904  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH EXACERBATION OF COPD (Severity 4.0)  \n    - HCFA: PNEUMONIA WITH ACUTE RESPIRATORY DISTRESS  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q6H (broadened coverage due to hypoxia)  \n    - Levofloxacin 750 mg IV Q24H  \n    - Methylprednisolone 40 mg IV Q12H × 3 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - DuoNeb (Albuterol/Ipratropium) inhalation Q6H  \n    - Pantoprazole 40 mg PO daily  \n\n    Orders:  \n    - Chest CT without contrast ordered, Completed — multilobar pneumonia visualized  \n    - Arterial blood gases ordered, Completed — pO₂ 62 mmHg on room air  \n    - Respiratory therapy initiated for airway clearance, Completed  \n    - High-flow nasal cannula started at 40 L/min, Completed  \n    - Daily electrolyte monitoring and aggressive hydration, Ongoing  \n\n    Procedures:  \n    - Chest CT performed  \n    - Bronchodilator treatments provided by respiratory therapy  \n    - High-flow nasal cannula oxygen initiated  \n\n---\n\nAdmission 76954122  \n    DRGs:  \n    - APR: PNEUMONIA WITH POST-INFECTIOUS PLEURAL EFFUSION (Severity 3.0)  \n    - HCFA: LOBAR PNEUMONIA WITH PERSISTENT INFILTRATE  \n\n    Medications:  \n    - Vancomycin IV (dosed per trough levels)  \n    - Cefepime 2 g IV Q8H  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Guaifenesin 600 mg PO BID PRN cough  \n    - Saline Nebulizer 3 mL Q8H  \n\n    Orders:  \n    - Ultrasound-guided thoracentesis ordered and completed  \n    - Pleural fluid analysis sent for culture and cytology, Completed  \n    - Repeat chest X-ray post-procedure showed partial lung re-expansion, Completed  \n    - Infectious disease consultation requested, Completed  \n    - Home oxygen qualification testing ordered, Completed  \n\n    Procedures:  \n    - Ultrasound-guided pleural drainage performed  \n    - Thoracentesis yielded 450 mL serosanguinous fluid  \n    - Post-procedure monitoring for pneumothorax — no complications observed", "pair_text": "Patient 20001289  \nGender: Male  \nAge: 58  \nRace: WHITE  \n\nAdmission 78542103  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH HYPOXEMIA (Severity 3.0)  \n    - HCFA: COMMUNITY-ACQUIRED LOBAR PNEUMONIA, UNSPECIFIED ORGANISM  \n\n    Medications:  \n    - Ceftriaxone 2 g IV Q24H (empiric coverage)  \n    - Azithromycin 500 mg PO day 1, then 250 mg PO daily × 4 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Albuterol Nebulizer 2.5 mg Q6H PRN shortness of breath  \n    - Sodium Chloride 0.9% IV continuous at 125 mL/hr  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Chest X-ray ordered and completed, showing right upper-lobe consolidation  \n    - Blood and sputum cultures obtained, Pending  \n    - Oxygen therapy initiated at 2 L/min via nasal cannula, Completed  \n    - Incentive spirometry ordered, Ongoing  \n    - Daily CBC and CMP ordered for monitoring, Ongoing  \n\n    Procedures:  \n    - Chest radiograph performed  \n    - Oxygen therapy initiated  \n    - Respiratory therapy provided patient education  \n\n---\n\nAdmission 79261452  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH RESPIRATORY FAILURE (Severity 4.0)  \n    - HCFA: PNEUMONIA WITH ACUTE HYPOXIC RESPIRATORY FAILURE  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q6H  \n    - Levofloxacin 750 mg IV Q24H  \n    - Methylprednisolone 40 mg IV Q12H × 3 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - DuoNeb (Albuterol/Ipratropium) inhalation Q6H  \n    - Pantoprazole 40 mg PO daily  \n\n    Orders:  \n    - CT Chest without contrast ordered, Completed — left lower-lobe consolidation confirmed  \n    - Arterial blood gas ordered, Completed — pO₂ 58 mmHg  \n    - Respiratory therapy initiated, Completed  \n    - High-flow nasal cannula oxygen started at 35 L/min, Completed  \n    - Daily renal and liver function panels ordered, Ongoing  \n\n    Procedures:  \n    - CT Chest performed  \n    - Arterial blood gases measured  \n    - High-flow oxygen initiated  \n\n---\n\nAdmission 80429877  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH PLEURAL EFFUSION (Severity 3.0)  \n    - HCFA: PERSISTENT INFILTRATE AND COMPLICATED RECOVERY  \n\n    Medications:  \n    - Vancomycin IV (dosed per trough levels)  \n    - Cefepime 2 g IV Q8H  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Guaifenesin 600 mg PO BID PRN mucus clearance  \n    - Saline Nebulizer 3 mL Q8H  \n\n    Orders:  \n    - Ultrasound-guided thoracentesis performed, Completed  \n    - Pleural fluid cultures sent, Completed  \n    - Post-procedure chest X-ray ordered, Completed  \n    - Infectious disease consultation requested, Completed  \n    - Recommended follow-up chest CT in 6 weeks, Pending  \n\n    Procedures:  \n    - Ultrasound-guided thoracentesis  \n    - Pleural drainage yielded 550 mL serous fluid  \n    - Post-procedure monitoring completed — no pneumothorax noted"}
{"id": "10001289", "pair_id": "30001289", "similarity": 0.75, "text": "Patient 10001289  \nGender: Male  \nAge: 61  \nRace: WHITE  \n\nAdmission 74523816  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH HYPOXEMIA (Severity 3.0)  \n    - HCFA: COMMUNITY-ACQUIRED LOBAR PNEUMONIA, UNSPECIFIED ORGANISM  \n\n    Medications:  \n    - Ceftriaxone 2 g IV Q24H (empiric treatment)  \n    - Azithromycin 500 mg PO day 1, then 250 mg PO daily × 4 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Albuterol Nebulizer 2.5 mg Q6H PRN wheezing  \n    - Sodium Chloride 0.9% IV continuous at 100 mL/hr  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Chest X-ray ordered and completed, confirmed right lower-lobe consolidation  \n    - Sputum and blood cultures drawn, Completed  \n    - Oxygen therapy initiated at 3 L/min nasal cannula, titrated based on SpO₂, Completed  \n    - Pulmonary consult requested, Completed  \n    - Daily BMP and CBC monitoring ordered, Ongoing  \n\n    Procedures:  \n    - Chest radiograph performed and reviewed  \n    - Supplemental oxygen started  \n    - Incentive spirometry instruction provided  \n\n---\n\nAdmission 75218904  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH EXACERBATION OF COPD (Severity 4.0)  \n    - HCFA: PNEUMONIA WITH ACUTE RESPIRATORY DISTRESS  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q6H (broadened coverage due to hypoxia)  \n    - Levofloxacin 750 mg IV Q24H  \n    - Methylprednisolone 40 mg IV Q12H × 3 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - DuoNeb (Albuterol/Ipratropium) inhalation Q6H  \n    - Pantoprazole 40 mg PO daily  \n\n    Orders:  \n    - Chest CT without contrast ordered, Completed — multilobar pneumonia visualized  \n    - Arterial blood gases ordered, Completed — pO₂ 62 mmHg on room air  \n    - Respiratory therapy initiated for airway clearance, Completed  \n    - High-flow nasal cannula started at 40 L/min, Completed  \n    - Daily electrolyte monitoring and aggressive hydration, Ongoing  \n\n    Procedures:  \n    - Chest CT performed  \n    - Bronchodilator treatments provided by respiratory therapy  \n    - High-flow nasal cannula oxygen initiated  \n\n---\n\nAdmission 76954122  \n    DRGs:  \n    - APR: PNEUMONIA WITH POST-INFECTIOUS PLEURAL EFFUSION (Severity 3.0)  \n    - HCFA: LOBAR PNEUMONIA WITH PERSISTENT INFILTRATE  \n\n    Medications:  \n    - Vancomycin IV (dosed per trough levels)  \n    - Cefepime 2 g IV Q8H  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Guaifenesin 600 mg PO BID PRN cough  \n    - Saline Nebulizer 3 mL Q8H  \n\n    Orders:  \n    - Ultrasound-guided thoracentesis ordered and completed  \n    - Pleural fluid analysis sent for culture and cytology, Completed  \n    - Repeat chest X-ray post-procedure showed partial lung re-expansion, Completed  \n    - Infectious disease consultation requested, Completed  \n    - Home oxygen qualification testing ordered, Completed  \n\n    Procedures:  \n    - Ultrasound-guided pleural drainage performed  \n    - Thoracentesis yielded 450 mL serosanguinous fluid  \n    - Post-procedure monitoring for pneumothorax — no complications observed", "pair_text": "Patient 30001289  \nGender: Male  \nAge: 66  \nRace: WHITE  \n\nAdmission 81254901  \n    DRGs:  \n    - APR: PNEUMONIA, UNSPECIFIED ORGANISM WITHOUT COMPLICATIONS (Severity 2.0)  \n    - HCFA: COMMUNITY-ACQUIRED PNEUMONIA, UNSPECIFIED ORGANISM  \n\n    Medications:  \n    - Ceftriaxone 1 g IV Q24H  \n    - Azithromycin 500 mg PO day 1, then 250 mg PO daily × 4 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Guaifenesin 600 mg PO BID PRN cough  \n    - Albuterol Inhaler 2 puffs Q6H PRN shortness of breath  \n    - Sodium Chloride 0.9% IV 100 mL/hr  \n\n    Orders:  \n    - Chest X-ray ordered and completed — right middle lobe consolidation visualized  \n    - Blood and sputum cultures ordered, Completed  \n    - Oxygen therapy initiated at 2 L/min via nasal cannula, Completed  \n    - Incentive spirometry instructed, Ongoing  \n    - Daily CBC, CMP, and inflammatory markers ordered, Ongoing  \n\n    Procedures:  \n    - Chest radiograph performed  \n    - Supplemental oxygen started  \n    - Incentive spirometry education provided  \n\n---\n\nAdmission 82463315  \n    DRGs:  \n    - APR: PNEUMONIA WITH ACUTE HYPOXEMIA (Severity 3.0)  \n    - HCFA: HOSPITAL-ACQUIRED PNEUMONIA, UNSPECIFIED ORGANISM  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q6H  \n    - Levofloxacin 750 mg IV Q24H  \n    - Methylprednisolone 40 mg IV Q12H × 3 days  \n    - DuoNeb (Albuterol/Ipratropium) inhalation Q6H  \n    - Pantoprazole 40 mg PO daily  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n\n    Orders:  \n    - CT Chest ordered, Completed — bilateral infiltrates visualized  \n    - Arterial blood gases performed, Completed — pO₂ 64 mmHg  \n    - Respiratory therapy initiated with bronchodilators and airway clearance, Completed  \n    - High-flow nasal cannula started at 30 L/min, Completed  \n    - Infectious disease consult requested, Completed  \n\n    Procedures:  \n    - CT Chest performed  \n    - High-flow oxygen therapy initiated  \n    - Respiratory therapy-assisted breathing treatments  \n\n---\n\nAdmission 83641227  \n    DRGs:  \n    - APR: PNEUMONIA WITH PERSISTENT COUGH AND SLOW RECOVERY (Severity 2.0)  \n    - HCFA: PNEUMONIA FOLLOW-UP ADMISSION  \n\n    Medications:  \n    - Amoxicillin-Clavulanate 875/125 mg PO BID × 7 days  \n    - Prednisone taper starting at 40 mg PO daily × 5 days  \n    - Guaifenesin 600 mg PO BID PRN cough  \n    - Saline Nebulizer 3 mL Q8H  \n    - Zinc 50 mg PO daily  \n    - Vitamin D 2000 IU PO daily  \n\n    Orders:  \n    - Repeat chest X-ray ordered, Completed — resolving infiltrates noted  \n    - Outpatient pulmonary function testing scheduled, Pending  \n    - Smoking cessation counseling provided, Completed  \n    - Home oxygen evaluation ordered, Completed  \n\n    Procedures:  \n    - Post-treatment chest radiograph  \n    - Pulmonary education sessions completed  \n    - Home oxygen assessment performed"}
{"id": "10001289", "pair_id": "40001289", "similarity": 0.5, "text": "Patient 10001289  \nGender: Male  \nAge: 61  \nRace: WHITE  \n\nAdmission 74523816  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH HYPOXEMIA (Severity 3.0)  \n    - HCFA: COMMUNITY-ACQUIRED LOBAR PNEUMONIA, UNSPECIFIED ORGANISM  \n\n    Medications:  \n    - Ceftriaxone 2 g IV Q24H (empiric treatment)  \n    - Azithromycin 500 mg PO day 1, then 250 mg PO daily × 4 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Albuterol Nebulizer 2.5 mg Q6H PRN wheezing  \n    - Sodium Chloride 0.9% IV continuous at 100 mL/hr  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Chest X-ray ordered and completed, confirmed right lower-lobe consolidation  \n    - Sputum and blood cultures drawn, Completed  \n    - Oxygen therapy initiated at 3 L/min nasal cannula, titrated based on SpO₂, Completed  \n    - Pulmonary consult requested, Completed  \n    - Daily BMP and CBC monitoring ordered, Ongoing  \n\n    Procedures:  \n    - Chest radiograph performed and reviewed  \n    - Supplemental oxygen started  \n    - Incentive spirometry instruction provided  \n\n---\n\nAdmission 75218904  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH EXACERBATION OF COPD (Severity 4.0)  \n    - HCFA: PNEUMONIA WITH ACUTE RESPIRATORY DISTRESS  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q6H (broadened coverage due to hypoxia)  \n    - Levofloxacin 750 mg IV Q24H  \n    - Methylprednisolone 40 mg IV Q12H × 3 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - DuoNeb (Albuterol/Ipratropium) inhalation Q6H  \n    - Pantoprazole 40 mg PO daily  \n\n    Orders:  \n    - Chest CT without contrast ordered, Completed — multilobar pneumonia visualized  \n    - Arterial blood gases ordered, Completed — pO₂ 62 mmHg on room air  \n    - Respiratory therapy initiated for airway clearance, Completed  \n    - High-flow nasal cannula started at 40 L/min, Completed  \n    - Daily electrolyte monitoring and aggressive hydration, Ongoing  \n\n    Procedures:  \n    - Chest CT performed  \n    - Bronchodilator treatments provided by respiratory therapy  \n    - High-flow nasal cannula oxygen initiated  \n\n---\n\nAdmission 76954122  \n    DRGs:  \n    - APR: PNEUMONIA WITH POST-INFECTIOUS PLEURAL EFFUSION (Severity 3.0)  \n    - HCFA: LOBAR PNEUMONIA WITH PERSISTENT INFILTRATE  \n\n    Medications:  \n    - Vancomycin IV (dosed per trough levels)  \n    - Cefepime 2 g IV Q8H  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Guaifenesin 600 mg PO BID PRN cough  \n    - Saline Nebulizer 3 mL Q8H  \n\n    Orders:  \n    - Ultrasound-guided thoracentesis ordered and completed  \n    - Pleural fluid analysis sent for culture and cytology, Completed  \n    - Repeat chest X-ray post-procedure showed partial lung re-expansion, Completed  \n    - Infectious disease consultation requested, Completed  \n    - Home oxygen qualification testing ordered, Completed  \n\n    Procedures:  \n    - Ultrasound-guided pleural drainage performed  \n    - Thoracentesis yielded 450 mL serosanguinous fluid  \n    - Post-procedure monitoring for pneumothorax — no complications observed", "pair_text": "Patient 40001289  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 84521032  \n    DRGs:  \n    - APR: ACUTE BRONCHITIS WITHOUT COMPLICATIONS (Severity 1.0)  \n    - HCFA: COMMUNITY-ACQUIRED BRONCHITIS, UNSPECIFIED ORGANISM  \n\n    Medications:  \n    - Albuterol Inhaler 2 puffs Q6H PRN shortness of breath  \n    - Guaifenesin 600 mg PO BID PRN mucus clearance  \n    - Acetaminophen 650 mg PO Q6H PRN fever or pain  \n    - Dextromethorphan 10 mg PO Q6H PRN cough  \n    - Sodium Chloride 0.9% IV at 75 mL/hr for hydration  \n    - Benzonatate 100 mg PO TID PRN cough suppression  \n\n    Orders:  \n    - Chest X-ray ordered, Completed — no evidence of pneumonia  \n    - COVID-19 and Influenza PCR panel performed, Negative  \n    - Oxygen saturation monitoring ordered, Ongoing  \n    - Encourage fluids and rest, Ongoing  \n    - Outpatient follow-up with primary care physician recommended, Pending  \n\n    Procedures:  \n    - Chest radiograph performed  \n    - Pulse oximetry monitored  \n    - Patient education on hydration and recovery provided  \n\n---\n\nAdmission 85674927  \n    DRGs:  \n    - APR: ACUTE BRONCHITIS WITH BRONCHOSPASM (Severity 2.0)  \n    - HCFA: ACUTE BRONCHITIS WITH ACUTE HYPOXEMIA  \n\n    Medications:  \n    - Prednisone 40 mg PO daily × 5 days  \n    - Albuterol/Ipratropium (DuoNeb) nebulizer Q6H  \n    - Levofloxacin 500 mg PO daily × 7 days  \n    - Guaifenesin-Codeine Syrup 5 mL PO Q6H PRN severe cough  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Pantoprazole 40 mg PO daily  \n\n    Orders:  \n    - Chest X-ray repeated, Completed — mild right lower lobe hyperinflation  \n    - Peak expiratory flow monitoring initiated, Ongoing  \n    - Oxygen therapy started at 2 L/min via nasal cannula, Discontinued after 24 hrs  \n    - Pulmonary therapy initiated for bronchospasm management, Completed  \n    - Daily vitals and respiratory assessments ordered, Ongoing  \n\n    Procedures:  \n    - Nebulizer treatments administered  \n    - Bedside spirometry performed  \n    - Supplemental oxygen initiated and discontinued  \n\n---\n\nAdmission 86732514  \n    DRGs:  \n    - APR: ACUTE BRONCHITIS WITH SECONDARY BACTERIAL INFECTION (Severity 3.0)  \n    - HCFA: ACUTE BRONCHITIS REQUIRING HOSPITALIZATION  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q8H  \n    - Azithromycin 500 mg IV Q24H  \n    - Methylprednisolone 40 mg IV Q12H  \n    - Acetylcysteine Nebulizer 3 mL Q8H  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - High-resolution CT chest ordered, Completed — airway wall thickening noted  \n    - Sputum culture and sensitivity ordered, Completed — E. coli isolated  \n    - Infectious disease consultation requested, Completed  \n    - High-flow nasal cannula oxygen at 35 L/min, Completed  \n    - Discharge planning initiated with 7-day follow-up, Pending  \n\n    Procedures:  \n    - High-resolution CT chest performed  \n    - Sputum sample collected for culture  \n    - High-flow oxygen therapy initiated and discontinued after improvement"}
{"id": "10001289", "pair_id": "50001289", "similarity": 0.25, "text": "Patient 10001289  \nGender: Male  \nAge: 61  \nRace: WHITE  \n\nAdmission 74523816  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH HYPOXEMIA (Severity 3.0)  \n    - HCFA: COMMUNITY-ACQUIRED LOBAR PNEUMONIA, UNSPECIFIED ORGANISM  \n\n    Medications:  \n    - Ceftriaxone 2 g IV Q24H (empiric treatment)  \n    - Azithromycin 500 mg PO day 1, then 250 mg PO daily × 4 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Albuterol Nebulizer 2.5 mg Q6H PRN wheezing  \n    - Sodium Chloride 0.9% IV continuous at 100 mL/hr  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Chest X-ray ordered and completed, confirmed right lower-lobe consolidation  \n    - Sputum and blood cultures drawn, Completed  \n    - Oxygen therapy initiated at 3 L/min nasal cannula, titrated based on SpO₂, Completed  \n    - Pulmonary consult requested, Completed  \n    - Daily BMP and CBC monitoring ordered, Ongoing  \n\n    Procedures:  \n    - Chest radiograph performed and reviewed  \n    - Supplemental oxygen started  \n    - Incentive spirometry instruction provided  \n\n---\n\nAdmission 75218904  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH EXACERBATION OF COPD (Severity 4.0)  \n    - HCFA: PNEUMONIA WITH ACUTE RESPIRATORY DISTRESS  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q6H (broadened coverage due to hypoxia)  \n    - Levofloxacin 750 mg IV Q24H  \n    - Methylprednisolone 40 mg IV Q12H × 3 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - DuoNeb (Albuterol/Ipratropium) inhalation Q6H  \n    - Pantoprazole 40 mg PO daily  \n\n    Orders:  \n    - Chest CT without contrast ordered, Completed — multilobar pneumonia visualized  \n    - Arterial blood gases ordered, Completed — pO₂ 62 mmHg on room air  \n    - Respiratory therapy initiated for airway clearance, Completed  \n    - High-flow nasal cannula started at 40 L/min, Completed  \n    - Daily electrolyte monitoring and aggressive hydration, Ongoing  \n\n    Procedures:  \n    - Chest CT performed  \n    - Bronchodilator treatments provided by respiratory therapy  \n    - High-flow nasal cannula oxygen initiated  \n\n---\n\nAdmission 76954122  \n    DRGs:  \n    - APR: PNEUMONIA WITH POST-INFECTIOUS PLEURAL EFFUSION (Severity 3.0)  \n    - HCFA: LOBAR PNEUMONIA WITH PERSISTENT INFILTRATE  \n\n    Medications:  \n    - Vancomycin IV (dosed per trough levels)  \n    - Cefepime 2 g IV Q8H  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Guaifenesin 600 mg PO BID PRN cough  \n    - Saline Nebulizer 3 mL Q8H  \n\n    Orders:  \n    - Ultrasound-guided thoracentesis ordered and completed  \n    - Pleural fluid analysis sent for culture and cytology, Completed  \n    - Repeat chest X-ray post-procedure showed partial lung re-expansion, Completed  \n    - Infectious disease consultation requested, Completed  \n    - Home oxygen qualification testing ordered, Completed  \n\n    Procedures:  \n    - Ultrasound-guided pleural drainage performed  \n    - Thoracentesis yielded 450 mL serosanguinous fluid  \n    - Post-procedure monitoring for pneumothorax — no complications observed", "pair_text": "Patient 50001289  \nGender: Male  \nAge: 66  \nRace: WHITE  \n\nAdmission 14039821  \n    DRGs:  \n    - APR: SEPSIS WITHOUT ACUTE ORGAN DYSFUNCTION (Severity 2.0)  \n    - HCFA: SEPSIS W/O CC/MCC  \n\n    Medications:  \n    - Piperacillin-Tazobactam (Zosyn) IV  \n    - Vancomycin IV  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Ondansetron IV  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Piperacillin-Tazobactam IV: IV, Discontinued via patient discharge  \n    - Vancomycin IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Blood cultures x2 sets  \n    - Chest X-ray  \n    - Complete blood count with differential  \n    - Serum lactate measurement  \n\nAdmission 14176244  \n    DRGs:  \n    - APR: SEPSIS WITH ACUTE ORGAN DYSFUNCTION (Severity 3.0)  \n    - HCFA: SEPSIS W CC  \n\n    Medications:  \n    - Meropenem IV  \n    - Linezolid IV  \n    - Norepinephrine IV (vasopressor)  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Heparin SC (DVT prophylaxis)  \n    - Ondansetron IV  \n\n    Orders:  \n    - Meropenem IV: IV, Discontinued via patient discharge  \n    - Linezolid IV: IV, Discontinued via patient discharge  \n    - Norepinephrine IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Central venous catheter insertion  \n    - Arterial blood gas (ABG) analysis  \n    - Abdominal ultrasound  \n    - Continuous cardiac monitoring  \n\nAdmission 14309875  \n    DRGs:  \n    - APR: SEVERE SEPTIC SHOCK WITH MULTIPLE ORGAN FAILURE (Severity 4.0)  \n    - HCFA: SEVERE SEPSIS W MCC  \n\n    Medications:  \n    - Cefepime IV  \n    - Metronidazole IV  \n    - Vancomycin IV  \n    - Hydrocortisone IV (stress dose)  \n    - Norepinephrine IV infusion  \n    - Dobutamine IV infusion  \n    - Sodium Bicarbonate IV  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n\n    Orders:  \n    - Cefepime IV: IV, Discontinued via patient discharge  \n    - Metronidazole IV: IV, Discontinued via patient discharge  \n    - Vancomycin IV: IV, Discontinued via patient discharge  \n    - Hydrocortisone IV: IV, Discontinued via patient discharge  \n    - Norepinephrine IV: IV, Discontinued via patient discharge  \n    - Dobutamine IV: IV, Discontinued via patient discharge  \n    - Sodium Bicarbonate IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Endotracheal intubation with mechanical ventilation  \n    - Continuous renal replacement therapy (CRRT)  \n    - Repeat blood cultures  \n    - CT abdomen/pelvis for source identification  \n    - Invasive hemodynamic monitoring via Swan-Ganz catheter"}
{"id": "10001289", "pair_id": "60001289", "similarity": 0.0, "text": "Patient 10001289  \nGender: Male  \nAge: 61  \nRace: WHITE  \n\nAdmission 74523816  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH HYPOXEMIA (Severity 3.0)  \n    - HCFA: COMMUNITY-ACQUIRED LOBAR PNEUMONIA, UNSPECIFIED ORGANISM  \n\n    Medications:  \n    - Ceftriaxone 2 g IV Q24H (empiric treatment)  \n    - Azithromycin 500 mg PO day 1, then 250 mg PO daily × 4 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Albuterol Nebulizer 2.5 mg Q6H PRN wheezing  \n    - Sodium Chloride 0.9% IV continuous at 100 mL/hr  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Chest X-ray ordered and completed, confirmed right lower-lobe consolidation  \n    - Sputum and blood cultures drawn, Completed  \n    - Oxygen therapy initiated at 3 L/min nasal cannula, titrated based on SpO₂, Completed  \n    - Pulmonary consult requested, Completed  \n    - Daily BMP and CBC monitoring ordered, Ongoing  \n\n    Procedures:  \n    - Chest radiograph performed and reviewed  \n    - Supplemental oxygen started  \n    - Incentive spirometry instruction provided  \n\n---\n\nAdmission 75218904  \n    DRGs:  \n    - APR: LOBAR PNEUMONIA WITH EXACERBATION OF COPD (Severity 4.0)  \n    - HCFA: PNEUMONIA WITH ACUTE RESPIRATORY DISTRESS  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q6H (broadened coverage due to hypoxia)  \n    - Levofloxacin 750 mg IV Q24H  \n    - Methylprednisolone 40 mg IV Q12H × 3 days  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - DuoNeb (Albuterol/Ipratropium) inhalation Q6H  \n    - Pantoprazole 40 mg PO daily  \n\n    Orders:  \n    - Chest CT without contrast ordered, Completed — multilobar pneumonia visualized  \n    - Arterial blood gases ordered, Completed — pO₂ 62 mmHg on room air  \n    - Respiratory therapy initiated for airway clearance, Completed  \n    - High-flow nasal cannula started at 40 L/min, Completed  \n    - Daily electrolyte monitoring and aggressive hydration, Ongoing  \n\n    Procedures:  \n    - Chest CT performed  \n    - Bronchodilator treatments provided by respiratory therapy  \n    - High-flow nasal cannula oxygen initiated  \n\n---\n\nAdmission 76954122  \n    DRGs:  \n    - APR: PNEUMONIA WITH POST-INFECTIOUS PLEURAL EFFUSION (Severity 3.0)  \n    - HCFA: LOBAR PNEUMONIA WITH PERSISTENT INFILTRATE  \n\n    Medications:  \n    - Vancomycin IV (dosed per trough levels)  \n    - Cefepime 2 g IV Q8H  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Guaifenesin 600 mg PO BID PRN cough  \n    - Saline Nebulizer 3 mL Q8H  \n\n    Orders:  \n    - Ultrasound-guided thoracentesis ordered and completed  \n    - Pleural fluid analysis sent for culture and cytology, Completed  \n    - Repeat chest X-ray post-procedure showed partial lung re-expansion, Completed  \n    - Infectious disease consultation requested, Completed  \n    - Home oxygen qualification testing ordered, Completed  \n\n    Procedures:  \n    - Ultrasound-guided pleural drainage performed  \n    - Thoracentesis yielded 450 mL serosanguinous fluid  \n    - Post-procedure monitoring for pneumothorax — no complications observed", "pair_text": "Patient 60001289  \nGender: Female  \nAge: 28  \nRace: ASIAN  \n\nAdmission 91234567  \n    DRGs:  \n    - APR: BILATERAL MYOPIA EVALUATION AND MANAGEMENT (Severity 1.0)  \n    - HCFA: REFRACTIVE ERROR MANAGEMENT  \n\n    Medications:  \n    - Artificial Tears 1 drop OU (both eyes) PRN dryness  \n    - Ketotifen 0.025% Ophthalmic Solution 1 drop OU BID PRN allergy-related irritation  \n    - Oral Omega-3 Supplements 1000 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Comprehensive eye exam performed, Completed  \n    - Cycloplegic refraction test ordered, Completed  \n    - Retinal examination performed, Completed  \n    - Patient educated on eye strain prevention and regular breaks, Completed  \n    - Recommended blue-light filter lens usage, Ongoing  \n\n    Procedures:  \n    - Dilated fundus examination  \n    - Corneal topography mapping  \n    - Optical coherence tomography (OCT) scan performed  \n\n---\n\nAdmission 92367842  \n    DRGs:  \n    - APR: MYOPIA WITH SYMPTOMATIC ASTHENOPIA (Severity 2.0)  \n    - HCFA: REFRACTIVE ERROR REQUIRING PRESCRIPTION CHANGE  \n\n    Medications:  \n    - Artificial Tears 1 drop OU TID PRN dryness  \n    - Olopatadine 0.1% Ophthalmic Solution 1 drop OU BID  \n    - Lutein 20 mg PO daily  \n    - Oral Vitamin D3 2000 IU PO daily  \n\n    Orders:  \n    - Updated manifest refraction performed, Completed  \n    - New prescription glasses ordered, Completed  \n    - Discussed potential eligibility for refractive surgery, Completed  \n    - Recommended reducing near work and adjusting computer ergonomics, Ongoing  \n\n    Procedures:  \n    - Visual acuity reassessment performed  \n    - Slit-lamp examination performed  \n    - Binocular vision testing done  \n\n---\n\nAdmission 93542011  \n    DRGs:  \n    - APR: HIGH MYOPIA, BILATERAL (Severity 3.0)  \n    - HCFA: COMPLEX REFRACTIVE ERROR MANAGEMENT  \n\n    Medications:  \n    - Atropine 0.01% Ophthalmic Solution 1 drop OU QHS for progression control  \n    - Lubricating Eye Gel at bedtime OU  \n    - Vitamin A & E Supplementation PO daily  \n    - Omega-3 Fish Oil 1200 mg PO daily  \n\n    Orders:  \n    - Retinal detachment risk counseling provided, Completed  \n    - Ordered prophylactic lattice degeneration screening, Completed  \n    - Scheduled 6-month follow-up for progression monitoring, Pending  \n    - Patient advised on contact lens hygiene and reduced overnight usage, Ongoing  \n\n    Procedures:  \n    - Retinal wide-field imaging performed  \n    - Axial length measurement performed  \n    - High-resolution OCT imaging completed"}
{"id": "10001290", "pair_id": "20001290", "similarity": 1.0, "text": "Patient 10001290  \nGender: Male  \nAge: 49  \nRace: WHITE  \n\nAdmission 77451201  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — INITIAL MANAGEMENT (Severity 2.0)  \n    - HCFA: LUMBAR SPINE DISORDERS WITHOUT NEUROLOGICAL DEFICITS  \n\n    Medications:  \n    - Acetaminophen 650 mg PO Q6H PRN mild pain  \n    - Ibuprofen 600 mg PO Q8H PRN inflammation  \n    - Cyclobenzaprine 5 mg PO TID PRN muscle spasms  \n    - Lidocaine 5% Patch — Apply daily to lumbar region  \n    - Vitamin D3 2000 IU PO daily  \n\n    Orders:  \n    - Lumbar spine MRI ordered, Completed — Modic Type 1 endplate changes  \n    - Physical therapy evaluation initiated, Completed  \n    - Heat therapy recommended for lower back, Ongoing  \n    - Daily pain assessments ordered, Ongoing  \n    - Lifestyle counseling on posture and ergonomic adjustments, Completed  \n\n    Procedures:  \n    - Lumbar spine MRI performed  \n    - Baseline gait and strength assessment done  \n    - Home exercise program demonstrated  \n\n---\n\nAdmission 77451268  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN WITH FUNCTIONAL LIMITATION (Severity 3.0)  \n    - HCFA: CHRONIC LOW BACK PAIN MANAGEMENT  \n\n    Medications:  \n    - Gabapentin 300 mg PO TID for neuropathic pain  \n    - Diclofenac 75 mg PO BID with food  \n    - Baclofen 10 mg PO TID PRN muscle spasms  \n    - Duloxetine 30 mg PO daily for pain modulation  \n    - Calcium + Vitamin D supplementation PO daily  \n\n    Orders:  \n    - Repeat lumbar MRI ordered, Completed — No nerve compression  \n    - Referred to interventional pain specialist, Completed  \n    - Transcutaneous Electrical Nerve Stimulation (TENS) therapy initiated, Completed  \n    - Low-impact aquatic physiotherapy ordered, Ongoing  \n    - Outpatient orthopedic follow-up in 4 weeks, Pending  \n\n    Procedures:  \n    - Trigger point injections with lidocaine performed  \n    - TENS therapy administered in clinic  \n    - Aquatic rehabilitation therapy initiated  \n\n---\n\nAdmission 77451354  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — ADVANCED INTERVENTION (Severity 4.0)  \n    - HCFA: SPINAL STABILITY & PAIN MANAGEMENT  \n\n    Medications:  \n    - Pregabalin 75 mg PO BID  \n    - Tramadol 50 mg PO Q8H PRN breakthrough pain  \n    - Celecoxib 200 mg PO daily  \n    - Methylprednisolone 4 mg PO daily × 7 days  \n    - Omega-3 Supplements 1000 mg PO daily  \n\n    Orders:  \n    - Basivertebral nerve ablation ordered, Completed  \n    - Inpatient rehab referral initiated, Completed  \n    - Pain management consult ordered, Completed  \n    - Pre-procedure labs ordered, Completed  \n    - Follow-up MRI planned for 3 months, Pending  \n\n    Procedures:  \n    - Basivertebral nerve radiofrequency ablation performed under fluoroscopic guidance  \n    - Sedation-assisted outpatient procedure conducted successfully  \n    - Post-op monitoring for complications, Completed", "pair_text": "Patient 20001290  \nGender: Female  \nAge: 52  \nRace: WHITE  \n\nAdmission 88230115  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — INITIAL EVALUATION (Severity 2.0)  \n    - HCFA: LUMBAR SPINE PAIN WITHOUT RADICULOPATHY  \n\n    Medications:  \n    - Acetaminophen 650 mg PO Q6H PRN mild pain  \n    - Ibuprofen 600 mg PO Q8H PRN inflammation  \n    - Methocarbamol 750 mg PO TID PRN muscle spasm  \n    - Lidocaine 5% Topical Patch — Apply to lower back Q24H  \n    - Vitamin D3 1000 IU PO daily  \n\n    Orders:  \n    - Lumbar spine X-ray ordered, Completed  \n    - Physical therapy consult initiated, Completed  \n    - Daily stretching and strengthening program provided, Ongoing  \n    - Heat/ice therapy recommended, Ongoing  \n    - Posture and ergonomic counseling provided, Completed  \n\n    Procedures:  \n    - Lumbar spine X-ray performed  \n    - Initial musculoskeletal exam completed  \n    - Functional mobility assessment done  \n\n---\n\nAdmission 88230188  \n    DRGs:  \n    - APR: CHRONIC VERTEBROGENIC LOW BACK PAIN WITH FUNCTIONAL LIMITATION (Severity 3.0)  \n    - HCFA: SPINAL PAIN MANAGEMENT WITH MEDICATION OPTIMIZATION  \n\n    Medications:  \n    - Naproxen 500 mg PO BID with meals  \n    - Gabapentin 300 mg PO TID for neuropathic pain  \n    - Baclofen 10 mg PO TID PRN muscle spasms  \n    - Duloxetine 30 mg PO daily for chronic pain  \n    - Calcium + Vitamin D PO daily  \n\n    Orders:  \n    - Lumbar MRI ordered, Completed — Modic Type 1 changes at L4-L5  \n    - Referred to pain management specialist, Completed  \n    - Initiated core-strengthening physiotherapy program, Ongoing  \n    - Occupational therapy consult requested, Completed  \n    - Outpatient follow-up scheduled for 6 weeks, Pending  \n\n    Procedures:  \n    - Lumbar MRI performed and reviewed  \n    - TENS (Transcutaneous Electrical Nerve Stimulation) therapy trial initiated  \n    - Ultrasound-guided trigger point injections administered  \n\n---\n\nAdmission 88230257  \n    DRGs:  \n    - APR: ADVANCED VERTEBROGENIC LOW BACK PAIN — INTERVENTIONAL MANAGEMENT (Severity 4.0)  \n    - HCFA: COMPLEX SPINAL PAIN WITH PROCEDURAL INTERVENTION  \n\n    Medications:  \n    - Pregabalin 75 mg PO BID  \n    - Tramadol 50 mg PO Q8H PRN breakthrough pain  \n    - Celecoxib 200 mg PO daily  \n    - Methylprednisolone Dose Pack PO × 6 days  \n    - Omega-3 Fatty Acids 1200 mg PO daily  \n\n    Orders:  \n    - Basivertebral nerve ablation procedure scheduled, Completed  \n    - Pre-procedure bloodwork ordered, Completed  \n    - Pain management care plan updated, Ongoing  \n    - Referral to inpatient rehab for mobility and core recovery, Completed  \n    - Post-procedure MRI planned for 3 months, Pending  \n\n    Procedures:  \n    - Basivertebral nerve ablation performed under fluoroscopic guidance  \n    - Conscious sedation administered, Uneventful recovery  \n    - Discharged with home exercise and post-op pain control instructions"}
{"id": "10001290", "pair_id": "30001290", "similarity": 0.75, "text": "Patient 10001290  \nGender: Male  \nAge: 49  \nRace: WHITE  \n\nAdmission 77451201  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — INITIAL MANAGEMENT (Severity 2.0)  \n    - HCFA: LUMBAR SPINE DISORDERS WITHOUT NEUROLOGICAL DEFICITS  \n\n    Medications:  \n    - Acetaminophen 650 mg PO Q6H PRN mild pain  \n    - Ibuprofen 600 mg PO Q8H PRN inflammation  \n    - Cyclobenzaprine 5 mg PO TID PRN muscle spasms  \n    - Lidocaine 5% Patch — Apply daily to lumbar region  \n    - Vitamin D3 2000 IU PO daily  \n\n    Orders:  \n    - Lumbar spine MRI ordered, Completed — Modic Type 1 endplate changes  \n    - Physical therapy evaluation initiated, Completed  \n    - Heat therapy recommended for lower back, Ongoing  \n    - Daily pain assessments ordered, Ongoing  \n    - Lifestyle counseling on posture and ergonomic adjustments, Completed  \n\n    Procedures:  \n    - Lumbar spine MRI performed  \n    - Baseline gait and strength assessment done  \n    - Home exercise program demonstrated  \n\n---\n\nAdmission 77451268  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN WITH FUNCTIONAL LIMITATION (Severity 3.0)  \n    - HCFA: CHRONIC LOW BACK PAIN MANAGEMENT  \n\n    Medications:  \n    - Gabapentin 300 mg PO TID for neuropathic pain  \n    - Diclofenac 75 mg PO BID with food  \n    - Baclofen 10 mg PO TID PRN muscle spasms  \n    - Duloxetine 30 mg PO daily for pain modulation  \n    - Calcium + Vitamin D supplementation PO daily  \n\n    Orders:  \n    - Repeat lumbar MRI ordered, Completed — No nerve compression  \n    - Referred to interventional pain specialist, Completed  \n    - Transcutaneous Electrical Nerve Stimulation (TENS) therapy initiated, Completed  \n    - Low-impact aquatic physiotherapy ordered, Ongoing  \n    - Outpatient orthopedic follow-up in 4 weeks, Pending  \n\n    Procedures:  \n    - Trigger point injections with lidocaine performed  \n    - TENS therapy administered in clinic  \n    - Aquatic rehabilitation therapy initiated  \n\n---\n\nAdmission 77451354  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — ADVANCED INTERVENTION (Severity 4.0)  \n    - HCFA: SPINAL STABILITY & PAIN MANAGEMENT  \n\n    Medications:  \n    - Pregabalin 75 mg PO BID  \n    - Tramadol 50 mg PO Q8H PRN breakthrough pain  \n    - Celecoxib 200 mg PO daily  \n    - Methylprednisolone 4 mg PO daily × 7 days  \n    - Omega-3 Supplements 1000 mg PO daily  \n\n    Orders:  \n    - Basivertebral nerve ablation ordered, Completed  \n    - Inpatient rehab referral initiated, Completed  \n    - Pain management consult ordered, Completed  \n    - Pre-procedure labs ordered, Completed  \n    - Follow-up MRI planned for 3 months, Pending  \n\n    Procedures:  \n    - Basivertebral nerve radiofrequency ablation performed under fluoroscopic guidance  \n    - Sedation-assisted outpatient procedure conducted successfully  \n    - Post-op monitoring for complications, Completed", "pair_text": "Patient 30001290  \nGender: Male  \nAge: 55  \nRace: WHITE  \n\nAdmission 66121501  \n    DRGs:  \n    - APR: LUMBAR RADICULOPATHY — INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: LUMBAR DISC DISEASE WITH NERVE ROOT INVOLVEMENT WITHOUT SURGERY  \n\n    Medications:  \n    - Ibuprofen 600 mg PO Q8H PRN pain  \n    - Acetaminophen 650 mg PO Q6H PRN  \n    - Methocarbamol 750 mg PO TID PRN muscle spasm  \n    - Prednisone 40 mg PO daily × 5 days  \n    - Lidocaine 5% Patch — Apply daily to lumbar region  \n\n    Orders:  \n    - Lumbar spine MRI ordered, Completed — L5-S1 disc protrusion compressing right L5 nerve root  \n    - Physical therapy consult initiated, Completed  \n    - Activity modification plan initiated, Ongoing  \n    - Patient education on proper lifting techniques, Completed  \n    - Outpatient follow-up scheduled in 4 weeks, Pending  \n\n    Procedures:  \n    - Lumbar spine MRI performed  \n    - Straight leg raise test positive, Completed  \n    - Physical therapy evaluation with home exercise program given  \n\n---\n\nAdmission 66121588  \n    DRGs:  \n    - APR: LUMBAR RADICULOPATHY WITH FUNCTIONAL LIMITATION (Severity 3.0)  \n    - HCFA: SPINAL PAIN MANAGEMENT — MEDICATION OPTIMIZATION  \n\n    Medications:  \n    - Naproxen 500 mg PO BID with meals  \n    - Gabapentin 300 mg PO TID for neuropathic pain  \n    - Baclofen 10 mg PO TID PRN muscle spasms  \n    - Duloxetine 30 mg PO daily for chronic pain  \n    - Calcium + Vitamin D supplementation PO daily  \n\n    Orders:  \n    - Epidural steroid injection ordered, Completed  \n    - Referral to pain management specialist, Completed  \n    - Initiated aquatic therapy program, Ongoing  \n    - Nerve conduction study ordered, Completed  \n    - Return visit in 6 weeks scheduled, Pending  \n\n    Procedures:  \n    - Lumbar transforaminal epidural steroid injection at L5-S1 performed  \n    - Electromyography (EMG) testing completed  \n    - Aquatic physiotherapy initiated  \n\n---\n\nAdmission 66121642  \n    DRGs:  \n    - APR: LUMBAR RADICULOPATHY — SURGICAL MANAGEMENT (Severity 4.0)  \n    - HCFA: SPINAL DECOMPRESSION PROCEDURE WITH OR WITHOUT FUSION  \n\n    Medications:  \n    - Pregabalin 75 mg PO BID  \n    - Tramadol 50 mg PO Q6H PRN post-op pain  \n    - Celecoxib 200 mg PO daily  \n    - Methylprednisolone 4 mg PO × 7 days  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Minimally invasive lumbar microdiscectomy scheduled, Completed  \n    - Pre-op labs and EKG ordered, Completed  \n    - Post-op physiotherapy ordered, Ongoing  \n    - Pain management referral placed, Completed  \n    - Follow-up MRI scheduled for 3 months, Pending  \n\n    Procedures:  \n    - Minimally invasive lumbar microdiscectomy performed at L5-S1  \n    - Intraoperative fluoroscopic guidance used  \n    - Post-op rehabilitation started 48 hours after surgery"}
{"id": "10001290", "pair_id": "40001290", "similarity": 0.5, "text": "Patient 10001290  \nGender: Male  \nAge: 49  \nRace: WHITE  \n\nAdmission 77451201  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — INITIAL MANAGEMENT (Severity 2.0)  \n    - HCFA: LUMBAR SPINE DISORDERS WITHOUT NEUROLOGICAL DEFICITS  \n\n    Medications:  \n    - Acetaminophen 650 mg PO Q6H PRN mild pain  \n    - Ibuprofen 600 mg PO Q8H PRN inflammation  \n    - Cyclobenzaprine 5 mg PO TID PRN muscle spasms  \n    - Lidocaine 5% Patch — Apply daily to lumbar region  \n    - Vitamin D3 2000 IU PO daily  \n\n    Orders:  \n    - Lumbar spine MRI ordered, Completed — Modic Type 1 endplate changes  \n    - Physical therapy evaluation initiated, Completed  \n    - Heat therapy recommended for lower back, Ongoing  \n    - Daily pain assessments ordered, Ongoing  \n    - Lifestyle counseling on posture and ergonomic adjustments, Completed  \n\n    Procedures:  \n    - Lumbar spine MRI performed  \n    - Baseline gait and strength assessment done  \n    - Home exercise program demonstrated  \n\n---\n\nAdmission 77451268  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN WITH FUNCTIONAL LIMITATION (Severity 3.0)  \n    - HCFA: CHRONIC LOW BACK PAIN MANAGEMENT  \n\n    Medications:  \n    - Gabapentin 300 mg PO TID for neuropathic pain  \n    - Diclofenac 75 mg PO BID with food  \n    - Baclofen 10 mg PO TID PRN muscle spasms  \n    - Duloxetine 30 mg PO daily for pain modulation  \n    - Calcium + Vitamin D supplementation PO daily  \n\n    Orders:  \n    - Repeat lumbar MRI ordered, Completed — No nerve compression  \n    - Referred to interventional pain specialist, Completed  \n    - Transcutaneous Electrical Nerve Stimulation (TENS) therapy initiated, Completed  \n    - Low-impact aquatic physiotherapy ordered, Ongoing  \n    - Outpatient orthopedic follow-up in 4 weeks, Pending  \n\n    Procedures:  \n    - Trigger point injections with lidocaine performed  \n    - TENS therapy administered in clinic  \n    - Aquatic rehabilitation therapy initiated  \n\n---\n\nAdmission 77451354  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — ADVANCED INTERVENTION (Severity 4.0)  \n    - HCFA: SPINAL STABILITY & PAIN MANAGEMENT  \n\n    Medications:  \n    - Pregabalin 75 mg PO BID  \n    - Tramadol 50 mg PO Q8H PRN breakthrough pain  \n    - Celecoxib 200 mg PO daily  \n    - Methylprednisolone 4 mg PO daily × 7 days  \n    - Omega-3 Supplements 1000 mg PO daily  \n\n    Orders:  \n    - Basivertebral nerve ablation ordered, Completed  \n    - Inpatient rehab referral initiated, Completed  \n    - Pain management consult ordered, Completed  \n    - Pre-procedure labs ordered, Completed  \n    - Follow-up MRI planned for 3 months, Pending  \n\n    Procedures:  \n    - Basivertebral nerve radiofrequency ablation performed under fluoroscopic guidance  \n    - Sedation-assisted outpatient procedure conducted successfully  \n    - Post-op monitoring for complications, Completed", "pair_text": "Patient 40001290  \nGender: Female  \nAge: 60  \nRace: WHITE  \n\nAdmission 77122401  \n    DRGs:  \n    - APR: LUMBAR SPONDYLOLISTHESIS — INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: LUMBAR SPINE INSTABILITY WITHOUT SURGERY  \n\n    Medications:  \n    - Acetaminophen 650 mg PO Q6H PRN mild pain  \n    - Naproxen 500 mg PO BID with meals  \n    - Cyclobenzaprine 10 mg PO TID PRN muscle spasms  \n    - Calcium + Vitamin D PO daily  \n    - Topical Diclofenac 1% Gel — Apply to lumbar region BID  \n\n    Orders:  \n    - Lumbar spine X-ray ordered, Completed — Grade I anterolisthesis at L4-L5  \n    - Physical therapy consult initiated, Completed  \n    - Provided lumbar stabilization exercise plan, Ongoing  \n    - Weight management counseling recommended, Completed  \n    - Outpatient follow-up scheduled in 4 weeks, Pending  \n\n    Procedures:  \n    - Lumbar spine X-ray performed  \n    - Physical therapy evaluation completed  \n    - Home exercise program issued  \n\n---\n\nAdmission 77122475  \n    DRGs:  \n    - APR: SYMPTOMATIC LUMBAR SPONDYLOLISTHESIS WITH RADICULOPATHY (Severity 3.0)  \n    - HCFA: SPINAL PAIN MANAGEMENT — NON-SURGICAL INTERVENTION  \n\n    Medications:  \n    - Gabapentin 300 mg PO TID for radicular pain  \n    - Ibuprofen 600 mg PO Q8H PRN inflammation  \n    - Baclofen 10 mg PO TID PRN muscle spasms  \n    - Duloxetine 30 mg PO daily for chronic back pain  \n    - Vitamin B12 supplementation PO daily  \n\n    Orders:  \n    - Lumbar spine MRI ordered, Completed — Grade II L4-L5 anterolisthesis with bilateral foraminal narrowing  \n    - Epidural steroid injection ordered, Completed  \n    - Referral to pain management specialist, Completed  \n    - Initiated aquatic therapy program, Ongoing  \n    - Outpatient re-evaluation planned in 6 weeks, Pending  \n\n    Procedures:  \n    - Lumbar spine MRI performed  \n    - Transforaminal epidural steroid injection at L4-L5 performed  \n    - Gait assessment and postural re-training completed  \n\n---\n\nAdmission 77122540  \n    DRGs:  \n    - APR: LUMBAR SPONDYLOLISTHESIS — SURGICAL MANAGEMENT (Severity 4.0)  \n    - HCFA: COMPLEX SPINAL FUSION WITH INSTRUMENTATION  \n\n    Medications:  \n    - Pregabalin 75 mg PO BID  \n    - Tramadol 50 mg PO Q6H PRN post-op pain  \n    - Celecoxib 200 mg PO daily  \n    - Methylprednisolone taper PO × 6 days  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Posterior lumbar interbody fusion (PLIF) scheduled, Completed  \n    - Pre-op labs, EKG, and anesthesia evaluation ordered, Completed  \n    - Post-op rehabilitation and bracing ordered, Ongoing  \n    - Pain management plan reviewed, Ongoing  \n    - Follow-up imaging planned for 3 months, Pending  \n\n    Procedures:  \n    - L4-L5 posterior lumbar interbody fusion performed with pedicle screw instrumentation  \n    - Intraoperative fluoroscopy guidance used  \n    - Discharged with lumbar support brace and home exercise program instructions"}
{"id": "10001290", "pair_id": "50001290", "similarity": 0.25, "text": "Patient 10001290  \nGender: Male  \nAge: 49  \nRace: WHITE  \n\nAdmission 77451201  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — INITIAL MANAGEMENT (Severity 2.0)  \n    - HCFA: LUMBAR SPINE DISORDERS WITHOUT NEUROLOGICAL DEFICITS  \n\n    Medications:  \n    - Acetaminophen 650 mg PO Q6H PRN mild pain  \n    - Ibuprofen 600 mg PO Q8H PRN inflammation  \n    - Cyclobenzaprine 5 mg PO TID PRN muscle spasms  \n    - Lidocaine 5% Patch — Apply daily to lumbar region  \n    - Vitamin D3 2000 IU PO daily  \n\n    Orders:  \n    - Lumbar spine MRI ordered, Completed — Modic Type 1 endplate changes  \n    - Physical therapy evaluation initiated, Completed  \n    - Heat therapy recommended for lower back, Ongoing  \n    - Daily pain assessments ordered, Ongoing  \n    - Lifestyle counseling on posture and ergonomic adjustments, Completed  \n\n    Procedures:  \n    - Lumbar spine MRI performed  \n    - Baseline gait and strength assessment done  \n    - Home exercise program demonstrated  \n\n---\n\nAdmission 77451268  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN WITH FUNCTIONAL LIMITATION (Severity 3.0)  \n    - HCFA: CHRONIC LOW BACK PAIN MANAGEMENT  \n\n    Medications:  \n    - Gabapentin 300 mg PO TID for neuropathic pain  \n    - Diclofenac 75 mg PO BID with food  \n    - Baclofen 10 mg PO TID PRN muscle spasms  \n    - Duloxetine 30 mg PO daily for pain modulation  \n    - Calcium + Vitamin D supplementation PO daily  \n\n    Orders:  \n    - Repeat lumbar MRI ordered, Completed — No nerve compression  \n    - Referred to interventional pain specialist, Completed  \n    - Transcutaneous Electrical Nerve Stimulation (TENS) therapy initiated, Completed  \n    - Low-impact aquatic physiotherapy ordered, Ongoing  \n    - Outpatient orthopedic follow-up in 4 weeks, Pending  \n\n    Procedures:  \n    - Trigger point injections with lidocaine performed  \n    - TENS therapy administered in clinic  \n    - Aquatic rehabilitation therapy initiated  \n\n---\n\nAdmission 77451354  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — ADVANCED INTERVENTION (Severity 4.0)  \n    - HCFA: SPINAL STABILITY & PAIN MANAGEMENT  \n\n    Medications:  \n    - Pregabalin 75 mg PO BID  \n    - Tramadol 50 mg PO Q8H PRN breakthrough pain  \n    - Celecoxib 200 mg PO daily  \n    - Methylprednisolone 4 mg PO daily × 7 days  \n    - Omega-3 Supplements 1000 mg PO daily  \n\n    Orders:  \n    - Basivertebral nerve ablation ordered, Completed  \n    - Inpatient rehab referral initiated, Completed  \n    - Pain management consult ordered, Completed  \n    - Pre-procedure labs ordered, Completed  \n    - Follow-up MRI planned for 3 months, Pending  \n\n    Procedures:  \n    - Basivertebral nerve radiofrequency ablation performed under fluoroscopic guidance  \n    - Sedation-assisted outpatient procedure conducted successfully  \n    - Post-op monitoring for complications, Completed", "pair_text": "Patient 50001290  \nGender: Female  \nAge: 57  \nRace: WHITE  \n\nAdmission 15028763  \n    DRGs:  \n    - APR: LUMBOSACRAL PLEXUS DISORDERS WITHOUT COMPLICATIONS (Severity 2.0)  \n    - HCFA: LUMBOSACRAL PLEXUS NEUROPATHY W/O CC/MCC  \n\n    Medications:  \n    - Gabapentin 300mg PO  \n    - Acetaminophen  \n    - Naproxen 500mg PO  \n    - Sodium Chloride 0.9% Flush  \n    - Cyclobenzaprine 10mg PO  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Gabapentin: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Naproxen: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Cyclobenzaprine: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - MRI lumbosacral spine without contrast  \n    - Electromyography (EMG) and nerve conduction studies  \n    - Physical therapy evaluation  \n\nAdmission 15198244  \n    DRGs:  \n    - APR: LUMBOSACRAL PLEXOPATHY WITH MOTOR DEFICIT (Severity 3.0)  \n    - HCFA: LUMBOSACRAL PLEXUS DISORDERS W CC  \n\n    Medications:  \n    - Pregabalin 75mg PO  \n    - Methylprednisolone IV  \n    - Acetaminophen  \n    - Ketorolac IV  \n    - Sodium Chloride 0.9% Flush  \n    - Heparin SC (DVT prophylaxis)  \n    - Ondansetron IV  \n\n    Orders:  \n    - Pregabalin: PO, Discontinued via patient discharge  \n    - Methylprednisolone: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ketorolac IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT myelogram  \n    - Epidural steroid injection  \n    - Gait and balance testing  \n    - Occupational therapy assessment  \n\nAdmission 15367108  \n    DRGs:  \n    - APR: SEVERE LUMBOSACRAL PLEXUS NEUROPATHY WITH FUNCTIONAL IMPAIRMENT (Severity 4.0)  \n    - HCFA: LUMBOSACRAL PLEXUS DISORDERS W MCC  \n\n    Medications:  \n    - Duloxetine 60mg PO  \n    - Intravenous Immunoglobulin (IVIG)  \n    - Baclofen 10mg PO  \n    - Morphine IV (for severe neuropathic pain)  \n    - Sodium Chloride 0.9% Flush  \n    - Enoxaparin SC  \n    - Lorazepam 1mg PO  \n\n    Orders:  \n    - Duloxetine: PO, Discontinued via patient discharge  \n    - IVIG: IV, Completed  \n    - Baclofen: PO, Discontinued via patient discharge  \n    - Morphine IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Enoxaparin SC: SC, Discontinued via patient discharge  \n    - Lorazepam: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Lumbosacral plexus decompression surgery  \n    - Ultrasound-guided nerve block  \n    - Intensive inpatient rehabilitation therapy  \n    - Neuromuscular ultrasound monitoring"}
{"id": "10001290", "pair_id": "60001290", "similarity": 0.0, "text": "Patient 10001290  \nGender: Male  \nAge: 49  \nRace: WHITE  \n\nAdmission 77451201  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — INITIAL MANAGEMENT (Severity 2.0)  \n    - HCFA: LUMBAR SPINE DISORDERS WITHOUT NEUROLOGICAL DEFICITS  \n\n    Medications:  \n    - Acetaminophen 650 mg PO Q6H PRN mild pain  \n    - Ibuprofen 600 mg PO Q8H PRN inflammation  \n    - Cyclobenzaprine 5 mg PO TID PRN muscle spasms  \n    - Lidocaine 5% Patch — Apply daily to lumbar region  \n    - Vitamin D3 2000 IU PO daily  \n\n    Orders:  \n    - Lumbar spine MRI ordered, Completed — Modic Type 1 endplate changes  \n    - Physical therapy evaluation initiated, Completed  \n    - Heat therapy recommended for lower back, Ongoing  \n    - Daily pain assessments ordered, Ongoing  \n    - Lifestyle counseling on posture and ergonomic adjustments, Completed  \n\n    Procedures:  \n    - Lumbar spine MRI performed  \n    - Baseline gait and strength assessment done  \n    - Home exercise program demonstrated  \n\n---\n\nAdmission 77451268  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN WITH FUNCTIONAL LIMITATION (Severity 3.0)  \n    - HCFA: CHRONIC LOW BACK PAIN MANAGEMENT  \n\n    Medications:  \n    - Gabapentin 300 mg PO TID for neuropathic pain  \n    - Diclofenac 75 mg PO BID with food  \n    - Baclofen 10 mg PO TID PRN muscle spasms  \n    - Duloxetine 30 mg PO daily for pain modulation  \n    - Calcium + Vitamin D supplementation PO daily  \n\n    Orders:  \n    - Repeat lumbar MRI ordered, Completed — No nerve compression  \n    - Referred to interventional pain specialist, Completed  \n    - Transcutaneous Electrical Nerve Stimulation (TENS) therapy initiated, Completed  \n    - Low-impact aquatic physiotherapy ordered, Ongoing  \n    - Outpatient orthopedic follow-up in 4 weeks, Pending  \n\n    Procedures:  \n    - Trigger point injections with lidocaine performed  \n    - TENS therapy administered in clinic  \n    - Aquatic rehabilitation therapy initiated  \n\n---\n\nAdmission 77451354  \n    DRGs:  \n    - APR: VERTEBROGENIC LOW BACK PAIN — ADVANCED INTERVENTION (Severity 4.0)  \n    - HCFA: SPINAL STABILITY & PAIN MANAGEMENT  \n\n    Medications:  \n    - Pregabalin 75 mg PO BID  \n    - Tramadol 50 mg PO Q8H PRN breakthrough pain  \n    - Celecoxib 200 mg PO daily  \n    - Methylprednisolone 4 mg PO daily × 7 days  \n    - Omega-3 Supplements 1000 mg PO daily  \n\n    Orders:  \n    - Basivertebral nerve ablation ordered, Completed  \n    - Inpatient rehab referral initiated, Completed  \n    - Pain management consult ordered, Completed  \n    - Pre-procedure labs ordered, Completed  \n    - Follow-up MRI planned for 3 months, Pending  \n\n    Procedures:  \n    - Basivertebral nerve radiofrequency ablation performed under fluoroscopic guidance  \n    - Sedation-assisted outpatient procedure conducted successfully  \n    - Post-op monitoring for complications, Completed", "pair_text": "Patient 60001290  \nGender: Female  \nAge: 48  \nRace: ASIAN  \n\nAdmission 88131021  \n    DRGs:  \n    - APR: COMPLETE BILATERAL BLINDNESS — INITIAL DIAGNOSIS (Severity 3.0)  \n    - HCFA: VISUAL IMPAIRMENT MANAGEMENT WITHOUT SURGERY  \n\n    Medications:  \n    - Acetazolamide 250 mg PO BID (if elevated intraocular pressure)  \n    - Artificial Tears — Instill 1 drop both eyes QID  \n    - Vitamin A 10,000 IU PO daily  \n    - Lutein-Zeaxanthin supplement PO daily  \n    - Ibuprofen 400 mg PO Q8H PRN mild headache  \n\n    Orders:  \n    - Formal ophthalmology consultation ordered, Completed  \n    - Optical coherence tomography (OCT) performed, Completed  \n    - Visual field testing attempted, Limited due to complete blindness  \n    - Low-vision rehabilitation referral placed, Completed  \n    - Outpatient follow-up scheduled in 6 weeks, Pending  \n\n    Procedures:  \n    - Comprehensive dilated fundus examination performed  \n    - OCT revealed optic nerve atrophy  \n    - Low-vision rehabilitation evaluation initiated  \n\n---\n\nAdmission 88131102  \n    DRGs:  \n    - APR: BILATERAL BLINDNESS WITH FUNCTIONAL ADAPTATION (Severity 4.0)  \n    - HCFA: ADVANCED VISUAL IMPAIRMENT SUPPORT MANAGEMENT  \n\n    Medications:  \n    - Prednisolone Acetate 1% Eye Drops — 1 drop OU QID (short taper trial)  \n    - Brimonidine 0.2% Eye Drops — 1 drop OU BID  \n    - Multivitamin with minerals PO daily  \n    - Omega-3 fish oil 1 g PO daily  \n    - Gabapentin 300 mg PO TID PRN for ocular neuropathic pain  \n\n    Orders:  \n    - Referral to occupational therapy for adaptive skills training, Completed  \n    - Mobility and orientation training ordered, Completed  \n    - Social work consult initiated for disability resources, Completed  \n    - Prescription for voice-assisted screen reader technology issued, Completed  \n    - Psychiatric evaluation for coping and adjustment scheduled, Completed  \n\n    Procedures:  \n    - Adaptive low-vision assessment performed  \n    - White cane mobility training initiated  \n    - Environmental modification consultation for home safety completed  \n\n---\n\nAdmission 88131198  \n    DRGs:  \n    - APR: COMPLETE BLINDNESS — LONG-TERM MANAGEMENT & SUPPORT (Severity 4.0)  \n    - HCFA: VISION LOSS REHABILITATION & HOME ADAPTATION  \n\n    Medications:  \n    - Duloxetine 30 mg PO daily for depression/anxiety  \n    - Melatonin 3 mg PO QHS for sleep regulation  \n    - Calcium + Vitamin D PO daily  \n    - Artificial Tears — Instill 1 drop OU PRN dryness  \n    - Cetirizine 10 mg PO daily for allergic eye irritation  \n\n    Orders:  \n    - Assistive technology integration program initiated, Ongoing  \n    - Blind rehabilitation center referral placed, Completed  \n    - Braille literacy training ordered, Ongoing  \n    - Community support services linked, Completed  \n    - 6-month follow-up with ophthalmology, Pending  \n\n    Procedures:  \n    - Advanced visual rehabilitation performed  \n    - Hands-on Braille literacy training session completed  \n    - Training on tactile navigation tools initiated"}
{"id": "10001291", "pair_id": "20001291", "similarity": 1.0, "text": "Patient 10001291  \nGender: Female  \nAge: 39  \nRace: WHITE  \n\nAdmission 66120450  \n    DRGs:  \n    - APR: CROHN'S DISEASE WITH RECTAL BLEEDING — ACUTE FLARE (Severity 3.0)  \n    - HCFA: CROHN'S DISEASE OF SMALL INTESTINE WITH HEMORRHAGE  \n\n    Medications:  \n    - Methylprednisolone IV 40 mg Q8H for acute inflammation  \n    - Infliximab (Remicade) 5 mg/kg IV infusion — Induction dose  \n    - Mesalamine 2.4 g PO daily  \n    - Pantoprazole 40 mg PO daily for GI protection  \n    - Acetaminophen 650 mg PO Q6H PRN pain/fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - CT enterography ordered, Completed — Severe small bowel inflammation with mucosal thickening  \n    - Colonoscopy scheduled, Completed — Active Crohn’s with terminal ileal ulcerations  \n    - Stool cultures ordered, Completed — Negative for infection  \n    - Nutritional assessment ordered, Completed  \n    - IV hydration protocol initiated, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsies performed  \n    - CT enterography completed  \n    - Peripheral IV placed for biologic therapy  \n\n---\n\nAdmission 66120512  \n    DRGs:  \n    - APR: CROHN'S DISEASE — REFRACTORY FLARE WITH BLEEDING (Severity 4.0)  \n    - HCFA: IMMUNOMODULATOR MANAGEMENT FOR CROHN’S DISEASE  \n\n    Medications:  \n    - Vedolizumab (Entyvio) 300 mg IV infusion — Initiated after poor infliximab response  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Azathioprine 150 mg PO daily  \n    - Ferrous sulfate 325 mg PO BID for iron-deficiency anemia  \n    - Loperamide 2 mg PO PRN for diarrhea  \n\n    Orders:  \n    - MR enterography ordered, Completed — Persistent transmural inflammation in distal ileum  \n    - Small bowel capsule endoscopy scheduled, Completed  \n    - Blood transfusion crossmatch ordered, Completed  \n    - Dietitian consult for low-residue diet, Completed  \n    - Vitamin B12 supplementation initiated, Ongoing  \n\n    Procedures:  \n    - MR enterography completed  \n    - Capsule endoscopy performed  \n    - Iron infusion administered via IV  \n\n---\n\nAdmission 66120604  \n    DRGs:  \n    - APR: CROHN’S DISEASE — SURGICAL MANAGEMENT FOR STRICTURE & BLEEDING (Severity 4.0)  \n    - HCFA: SMALL BOWEL RESECTION WITH PRIMARY ANASTOMOSIS  \n\n    Medications:  \n    - Adalimumab (Humira) 40 mg SC every 2 weeks for maintenance  \n    - Ceftriaxone 2 g IV Q24H (peri-op prophylaxis)  \n    - Metronidazole 500 mg IV Q8H (peri-op prophylaxis)  \n    - Hydromorphone PCA pump for pain control  \n    - Pantoprazole 40 mg PO daily  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Laparoscopic ileocecal resection ordered, Completed  \n    - Pre-op labs, anesthesia clearance, and bowel prep ordered, Completed  \n    - Central line placed for peri-op fluid and biologic administration, Completed  \n    - Post-op physical therapy initiated, Ongoing  \n    - Outpatient follow-up planned for 2 weeks post-surgery, Pending  \n\n    Procedures:  \n    - Laparoscopic-assisted ileocecal resection performed  \n    - Intraoperative endoscopy confirmed hemostasis  \n    - Post-operative recovery supported with TPN for 5 days", "pair_text": "Patient 20001291  \nGender: Male  \nAge: 46  \nRace: WHITE  \n\nAdmission 77450121  \n    DRGs:  \n    - APR: CROHN'S DISEASE WITH ACTIVE BLEEDING — INITIAL PRESENTATION (Severity 3.0)  \n    - HCFA: CROHN’S DISEASE OF SMALL INTESTINE WITH RECTAL BLEEDING  \n\n    Medications:  \n    - IV Methylprednisolone 60 mg daily for acute flare  \n    - Mesalamine 4.8 g PO daily  \n    - Infliximab (Remicade) 5 mg/kg IV infusion — Week 0  \n    - Pantoprazole 40 mg PO daily  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n\n    Orders:  \n    - Colonoscopy ordered, Completed — Multiple ulcerations and active bleeding in ileum  \n    - Stool studies for C. difficile and ova/parasites, Completed — Negative  \n    - CT enterography performed, Completed — Segmental ileal thickening  \n    - CBC and iron panel ordered, Completed — Hemoglobin 9.2 g/dL  \n    - IV hydration protocol initiated, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsy performed  \n    - CT enterography performed  \n    - Peripheral IV line inserted for infusion  \n\n---\n\nAdmission 77450210  \n    DRGs:  \n    - APR: CROHN'S DISEASE — PERSISTENT BLEEDING DESPITE INITIAL THERAPY (Severity 4.0)  \n    - HCFA: CROHN’S FLARE REQUIRING ESCALATED IMMUNOSUPPRESSION  \n\n    Medications:  \n    - Vedolizumab (Entyvio) 300 mg IV infusion — Switched due to Remicade failure  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Azathioprine 150 mg PO daily  \n    - Ferrous sulfate 325 mg PO daily  \n    - Loperamide 2 mg PO PRN diarrhea  \n    - Hydrocodone-Acetaminophen 5/325 mg PO Q6H PRN abdominal pain  \n\n    Orders:  \n    - MR enterography ordered, Completed — Ongoing inflammation in terminal ileum  \n    - Capsule endoscopy performed, Completed — Multifocal ulcerations  \n    - Nutrition consult for low-fiber diet, Completed  \n    - Vitamin B12 and folate supplementation initiated, Ongoing  \n    - Blood transfusion ordered, Completed — 1 unit PRBCs  \n\n    Procedures:  \n    - Capsule endoscopy performed  \n    - MR enterography completed  \n    - IV iron infusion administered  \n\n---\n\nAdmission 77450342  \n    DRGs:  \n    - APR: CROHN'S DISEASE — SURGICAL MANAGEMENT FOR REFRACTORY BLEEDING (Severity 4.0)  \n    - HCFA: SMALL BOWEL RESECTION FOR STRICTURING DISEASE  \n\n    Medications:  \n    - Adalimumab (Humira) 40 mg SC every 2 weeks for long-term maintenance  \n    - Ceftriaxone 2 g IV Q24H peri-op prophylaxis  \n    - Metronidazole 500 mg IV Q8H peri-op prophylaxis  \n    - Morphine PCA for post-op pain control  \n    - Multivitamin with minerals PO daily  \n    - Calcium + Vitamin D supplementation daily  \n\n    Orders:  \n    - Laparoscopic-assisted small bowel resection ordered, Completed  \n    - Post-op TPN initiated for 5 days, Completed  \n    - Central line placed, Completed  \n    - Physical therapy ordered for early ambulation, Ongoing  \n    - Outpatient gastroenterology follow-up scheduled, Pending  \n\n    Procedures:  \n    - Laparoscopic-assisted ileocecal resection performed  \n    - Intraoperative bleeding controlled  \n    - Post-op endoscopy verified anastomosis integrity"}
{"id": "10001291", "pair_id": "30001291", "similarity": 0.75, "text": "Patient 10001291  \nGender: Female  \nAge: 39  \nRace: WHITE  \n\nAdmission 66120450  \n    DRGs:  \n    - APR: CROHN'S DISEASE WITH RECTAL BLEEDING — ACUTE FLARE (Severity 3.0)  \n    - HCFA: CROHN'S DISEASE OF SMALL INTESTINE WITH HEMORRHAGE  \n\n    Medications:  \n    - Methylprednisolone IV 40 mg Q8H for acute inflammation  \n    - Infliximab (Remicade) 5 mg/kg IV infusion — Induction dose  \n    - Mesalamine 2.4 g PO daily  \n    - Pantoprazole 40 mg PO daily for GI protection  \n    - Acetaminophen 650 mg PO Q6H PRN pain/fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - CT enterography ordered, Completed — Severe small bowel inflammation with mucosal thickening  \n    - Colonoscopy scheduled, Completed — Active Crohn’s with terminal ileal ulcerations  \n    - Stool cultures ordered, Completed — Negative for infection  \n    - Nutritional assessment ordered, Completed  \n    - IV hydration protocol initiated, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsies performed  \n    - CT enterography completed  \n    - Peripheral IV placed for biologic therapy  \n\n---\n\nAdmission 66120512  \n    DRGs:  \n    - APR: CROHN'S DISEASE — REFRACTORY FLARE WITH BLEEDING (Severity 4.0)  \n    - HCFA: IMMUNOMODULATOR MANAGEMENT FOR CROHN’S DISEASE  \n\n    Medications:  \n    - Vedolizumab (Entyvio) 300 mg IV infusion — Initiated after poor infliximab response  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Azathioprine 150 mg PO daily  \n    - Ferrous sulfate 325 mg PO BID for iron-deficiency anemia  \n    - Loperamide 2 mg PO PRN for diarrhea  \n\n    Orders:  \n    - MR enterography ordered, Completed — Persistent transmural inflammation in distal ileum  \n    - Small bowel capsule endoscopy scheduled, Completed  \n    - Blood transfusion crossmatch ordered, Completed  \n    - Dietitian consult for low-residue diet, Completed  \n    - Vitamin B12 supplementation initiated, Ongoing  \n\n    Procedures:  \n    - MR enterography completed  \n    - Capsule endoscopy performed  \n    - Iron infusion administered via IV  \n\n---\n\nAdmission 66120604  \n    DRGs:  \n    - APR: CROHN’S DISEASE — SURGICAL MANAGEMENT FOR STRICTURE & BLEEDING (Severity 4.0)  \n    - HCFA: SMALL BOWEL RESECTION WITH PRIMARY ANASTOMOSIS  \n\n    Medications:  \n    - Adalimumab (Humira) 40 mg SC every 2 weeks for maintenance  \n    - Ceftriaxone 2 g IV Q24H (peri-op prophylaxis)  \n    - Metronidazole 500 mg IV Q8H (peri-op prophylaxis)  \n    - Hydromorphone PCA pump for pain control  \n    - Pantoprazole 40 mg PO daily  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Laparoscopic ileocecal resection ordered, Completed  \n    - Pre-op labs, anesthesia clearance, and bowel prep ordered, Completed  \n    - Central line placed for peri-op fluid and biologic administration, Completed  \n    - Post-op physical therapy initiated, Ongoing  \n    - Outpatient follow-up planned for 2 weeks post-surgery, Pending  \n\n    Procedures:  \n    - Laparoscopic-assisted ileocecal resection performed  \n    - Intraoperative endoscopy confirmed hemostasis  \n    - Post-operative recovery supported with TPN for 5 days", "pair_text": "Patient 30001291  \nGender: Female  \nAge: 41  \nRace: WHITE  \n\nAdmission 88210155  \n    DRGs:  \n    - APR: CROHN’S DISEASE WITH STRICTURE & FISTULA FORMATION (Severity 3.0)  \n    - HCFA: CROHN’S SMALL INTESTINE WITH COMPLICATIONS — INITIAL PRESENTATION  \n\n    Medications:  \n    - IV Methylprednisolone 40 mg Q12H for acute inflammation  \n    - Infliximab (Remicade) 5 mg/kg IV induction dose  \n    - Mesalamine 2.4 g PO daily  \n    - Ciprofloxacin 400 mg IV Q12H for suspected fistula infection  \n    - Metronidazole 500 mg IV Q8H for perianal fistula prophylaxis  \n    - Acetaminophen 650 mg PO Q6H PRN abdominal pain  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - MR enterography ordered, Completed — Multiple areas of segmental inflammation  \n    - Colonoscopy ordered, Completed — Terminal ileum stricture identified  \n    - Stool calprotectin ordered, Completed — Significantly elevated  \n    - Small bowel ultrasound ordered, Completed — Complex entero-enteric fistula seen  \n    - Nutrition consult for elemental diet, Completed  \n\n    Procedures:  \n    - MR enterography completed  \n    - Colonoscopy with biopsy performed  \n    - Peripheral IV line placed for infliximab infusion  \n\n---\n\nAdmission 88210227  \n    DRGs:  \n    - APR: CROHN’S DISEASE — REFRACTORY FLARE WITH FISTULA & ABSCESS (Severity 4.0)  \n    - HCFA: CROHN’S FLARE WITH COMPLICATED PERIANAL DISEASE  \n\n    Medications:  \n    - Vedolizumab (Entyvio) 300 mg IV infusion — Switched from infliximab after antibody formation  \n    - Azathioprine 150 mg PO daily  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Piperacillin-Tazobactam 4.5 g IV Q6H for pelvic abscess coverage  \n    - Ferrous sulfate 325 mg PO BID for chronic blood loss anemia  \n    - Loperamide 2 mg PO PRN diarrhea  \n\n    Orders:  \n    - Pelvic MRI ordered, Completed — 3 cm perianal abscess identified  \n    - CT-guided abscess drainage ordered, Completed  \n    - Wound care consult ordered, Completed  \n    - Stool studies ordered, Completed — Negative for infection  \n    - B12 supplementation initiated, Ongoing  \n\n    Procedures:  \n    - CT-guided perianal abscess drainage performed  \n    - Pelvic drain placement completed  \n    - IV antibiotics administered via central line  \n\n---\n\nAdmission 88210392  \n    DRGs:  \n    - APR: CROHN’S DISEASE — SURGICAL MANAGEMENT FOR STRICTURE & FISTULA (Severity 4.0)  \n    - HCFA: ILEOCECAL RESECTION WITH STRICTUROPLASTY  \n\n    Medications:  \n    - Adalimumab (Humira) 40 mg SC every 2 weeks for maintenance therapy  \n    - Ceftriaxone 2 g IV Q24H peri-op prophylaxis  \n    - Metronidazole 500 mg IV Q8H peri-op prophylaxis  \n    - Morphine PCA for post-op pain control  \n    - Multivitamin with minerals PO daily  \n    - Vitamin D3 2000 IU PO daily  \n\n    Orders:  \n    - Ileocecal resection with stricturoplasty ordered, Completed  \n    - Post-op TPN ordered, Completed — 7 days  \n    - Central line placement ordered, Completed  \n    - Physical therapy for early mobilization ordered, Ongoing  \n    - Outpatient follow-up with GI and colorectal surgery scheduled, Pending  \n\n    Procedures:  \n    - Laparoscopic ileocecal resection performed  \n    - Strictureplasty completed  \n    - Post-op endoscopic evaluation confirmed anastomotic healing"}
{"id": "10001291", "pair_id": "40001291", "similarity": 0.5, "text": "Patient 10001291  \nGender: Female  \nAge: 39  \nRace: WHITE  \n\nAdmission 66120450  \n    DRGs:  \n    - APR: CROHN'S DISEASE WITH RECTAL BLEEDING — ACUTE FLARE (Severity 3.0)  \n    - HCFA: CROHN'S DISEASE OF SMALL INTESTINE WITH HEMORRHAGE  \n\n    Medications:  \n    - Methylprednisolone IV 40 mg Q8H for acute inflammation  \n    - Infliximab (Remicade) 5 mg/kg IV infusion — Induction dose  \n    - Mesalamine 2.4 g PO daily  \n    - Pantoprazole 40 mg PO daily for GI protection  \n    - Acetaminophen 650 mg PO Q6H PRN pain/fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - CT enterography ordered, Completed — Severe small bowel inflammation with mucosal thickening  \n    - Colonoscopy scheduled, Completed — Active Crohn’s with terminal ileal ulcerations  \n    - Stool cultures ordered, Completed — Negative for infection  \n    - Nutritional assessment ordered, Completed  \n    - IV hydration protocol initiated, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsies performed  \n    - CT enterography completed  \n    - Peripheral IV placed for biologic therapy  \n\n---\n\nAdmission 66120512  \n    DRGs:  \n    - APR: CROHN'S DISEASE — REFRACTORY FLARE WITH BLEEDING (Severity 4.0)  \n    - HCFA: IMMUNOMODULATOR MANAGEMENT FOR CROHN’S DISEASE  \n\n    Medications:  \n    - Vedolizumab (Entyvio) 300 mg IV infusion — Initiated after poor infliximab response  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Azathioprine 150 mg PO daily  \n    - Ferrous sulfate 325 mg PO BID for iron-deficiency anemia  \n    - Loperamide 2 mg PO PRN for diarrhea  \n\n    Orders:  \n    - MR enterography ordered, Completed — Persistent transmural inflammation in distal ileum  \n    - Small bowel capsule endoscopy scheduled, Completed  \n    - Blood transfusion crossmatch ordered, Completed  \n    - Dietitian consult for low-residue diet, Completed  \n    - Vitamin B12 supplementation initiated, Ongoing  \n\n    Procedures:  \n    - MR enterography completed  \n    - Capsule endoscopy performed  \n    - Iron infusion administered via IV  \n\n---\n\nAdmission 66120604  \n    DRGs:  \n    - APR: CROHN’S DISEASE — SURGICAL MANAGEMENT FOR STRICTURE & BLEEDING (Severity 4.0)  \n    - HCFA: SMALL BOWEL RESECTION WITH PRIMARY ANASTOMOSIS  \n\n    Medications:  \n    - Adalimumab (Humira) 40 mg SC every 2 weeks for maintenance  \n    - Ceftriaxone 2 g IV Q24H (peri-op prophylaxis)  \n    - Metronidazole 500 mg IV Q8H (peri-op prophylaxis)  \n    - Hydromorphone PCA pump for pain control  \n    - Pantoprazole 40 mg PO daily  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Laparoscopic ileocecal resection ordered, Completed  \n    - Pre-op labs, anesthesia clearance, and bowel prep ordered, Completed  \n    - Central line placed for peri-op fluid and biologic administration, Completed  \n    - Post-op physical therapy initiated, Ongoing  \n    - Outpatient follow-up planned for 2 weeks post-surgery, Pending  \n\n    Procedures:  \n    - Laparoscopic-assisted ileocecal resection performed  \n    - Intraoperative endoscopy confirmed hemostasis  \n    - Post-operative recovery supported with TPN for 5 days", "pair_text": "Patient 40001291  \nGender: Female  \nAge: 63  \nRace: WHITE  \n\nAdmission 66743210  \n    DRGs:  \n    - APR: DIVERTICULITIS OF LARGE INTESTINE WITHOUT PERFORATION — INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: ACUTE DIVERTICULITIS WITHOUT ABSCESS OR COMPLICATIONS  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID x10 days  \n    - Metronidazole 500 mg PO TID x10 days  \n    - Acetaminophen 650 mg PO Q6H PRN abdominal pain  \n    - Ondansetron 4 mg PO Q8H PRN nausea  \n    - Polyethylene Glycol 17 g PO daily for bowel regulation  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - CT abdomen/pelvis ordered, Completed — Mild sigmoid diverticulitis, no perforation or abscess  \n    - CBC and CRP ordered, Completed — Mild leukocytosis  \n    - Diet: Clear liquid, advanced to low-fiber diet on day 3, Completed  \n    - Outpatient colonoscopy ordered in 6 weeks, Pending  \n    - GI consult ordered, Completed  \n\n    Procedures:  \n    - Peripheral IV placement  \n    - CT imaging performed  \n\n---\n\nAdmission 66743385  \n    DRGs:  \n    - APR: RECURRENT DIVERTICULITIS WITHOUT PERFORATION OR ABSCESS (Severity 2.0)  \n    - HCFA: RECURRENT UNCOMPLICATED DIVERTICULITIS MANAGEMENT  \n\n    Medications:  \n    - Amoxicillin-Clavulanate 875/125 mg PO BID x10 days  \n    - Acetaminophen 500 mg PO Q6H PRN pain  \n    - Dicyclomine 20 mg PO Q6H PRN abdominal cramps  \n    - Lactobacillus probiotic PO daily  \n    - Ondansetron ODT 4 mg PO Q8H PRN nausea  \n    - Fiber supplement (Psyllium) 5 g PO daily  \n\n    Orders:  \n    - Abdominal ultrasound ordered, Completed — No signs of abscess  \n    - Colonoscopy performed, Completed — Moderate sigmoid diverticulosis, no active bleeding  \n    - Low-residue diet ordered, Completed  \n    - Stool occult blood test ordered, Completed — Negative  \n    - Referral for outpatient nutrition counseling, Completed  \n\n    Procedures:  \n    - Colonoscopy performed  \n    - IV hydration administered  \n\n---\n\nAdmission 66743504  \n    DRGs:  \n    - APR: DIVERTICULITIS WITH SEVERE INFLAMMATION BUT NO PERFORATION OR ABSCESS (Severity 3.0)  \n    - HCFA: INTENSIFIED MANAGEMENT OF ACUTE DIVERTICULITIS  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q8H x5 days  \n    - Metronidazole 500 mg IV Q8H x5 days  \n    - Pantoprazole 40 mg PO daily  \n    - Morphine 2 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Multivitamin + Vitamin D supplementation PO daily  \n\n    Orders:  \n    - CT abdomen with IV contrast ordered, Completed — Significant sigmoid inflammation, no abscess  \n    - IV antibiotics initiated, Completed  \n    - Serial abdominal exams ordered, Ongoing  \n    - Full-liquid diet ordered, Completed  \n    - Outpatient follow-up colonoscopy scheduled in 8 weeks, Pending  \n\n    Procedures:  \n    - CT scan performed  \n    - Peripheral IV access maintained  \n    - IV antibiotics administered"}
{"id": "10001291", "pair_id": "50001291", "similarity": 0.25, "text": "Patient 10001291  \nGender: Female  \nAge: 39  \nRace: WHITE  \n\nAdmission 66120450  \n    DRGs:  \n    - APR: CROHN'S DISEASE WITH RECTAL BLEEDING — ACUTE FLARE (Severity 3.0)  \n    - HCFA: CROHN'S DISEASE OF SMALL INTESTINE WITH HEMORRHAGE  \n\n    Medications:  \n    - Methylprednisolone IV 40 mg Q8H for acute inflammation  \n    - Infliximab (Remicade) 5 mg/kg IV infusion — Induction dose  \n    - Mesalamine 2.4 g PO daily  \n    - Pantoprazole 40 mg PO daily for GI protection  \n    - Acetaminophen 650 mg PO Q6H PRN pain/fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - CT enterography ordered, Completed — Severe small bowel inflammation with mucosal thickening  \n    - Colonoscopy scheduled, Completed — Active Crohn’s with terminal ileal ulcerations  \n    - Stool cultures ordered, Completed — Negative for infection  \n    - Nutritional assessment ordered, Completed  \n    - IV hydration protocol initiated, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsies performed  \n    - CT enterography completed  \n    - Peripheral IV placed for biologic therapy  \n\n---\n\nAdmission 66120512  \n    DRGs:  \n    - APR: CROHN'S DISEASE — REFRACTORY FLARE WITH BLEEDING (Severity 4.0)  \n    - HCFA: IMMUNOMODULATOR MANAGEMENT FOR CROHN’S DISEASE  \n\n    Medications:  \n    - Vedolizumab (Entyvio) 300 mg IV infusion — Initiated after poor infliximab response  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Azathioprine 150 mg PO daily  \n    - Ferrous sulfate 325 mg PO BID for iron-deficiency anemia  \n    - Loperamide 2 mg PO PRN for diarrhea  \n\n    Orders:  \n    - MR enterography ordered, Completed — Persistent transmural inflammation in distal ileum  \n    - Small bowel capsule endoscopy scheduled, Completed  \n    - Blood transfusion crossmatch ordered, Completed  \n    - Dietitian consult for low-residue diet, Completed  \n    - Vitamin B12 supplementation initiated, Ongoing  \n\n    Procedures:  \n    - MR enterography completed  \n    - Capsule endoscopy performed  \n    - Iron infusion administered via IV  \n\n---\n\nAdmission 66120604  \n    DRGs:  \n    - APR: CROHN’S DISEASE — SURGICAL MANAGEMENT FOR STRICTURE & BLEEDING (Severity 4.0)  \n    - HCFA: SMALL BOWEL RESECTION WITH PRIMARY ANASTOMOSIS  \n\n    Medications:  \n    - Adalimumab (Humira) 40 mg SC every 2 weeks for maintenance  \n    - Ceftriaxone 2 g IV Q24H (peri-op prophylaxis)  \n    - Metronidazole 500 mg IV Q8H (peri-op prophylaxis)  \n    - Hydromorphone PCA pump for pain control  \n    - Pantoprazole 40 mg PO daily  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Laparoscopic ileocecal resection ordered, Completed  \n    - Pre-op labs, anesthesia clearance, and bowel prep ordered, Completed  \n    - Central line placed for peri-op fluid and biologic administration, Completed  \n    - Post-op physical therapy initiated, Ongoing  \n    - Outpatient follow-up planned for 2 weeks post-surgery, Pending  \n\n    Procedures:  \n    - Laparoscopic-assisted ileocecal resection performed  \n    - Intraoperative endoscopy confirmed hemostasis  \n    - Post-operative recovery supported with TPN for 5 days", "pair_text": "Patient 50001291  \nGender: Male  \nAge: 68  \nRace: WHITE  \n\nAdmission 16023845  \n    DRGs:  \n    - APR: DIVERTICULOSIS WITH BLEEDING (Severity 2.0)  \n    - HCFA: DIVERTICULOSIS W BLEEDING W/O CC/MCC  \n\n    Medications:  \n    - Pantoprazole IV  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Ondansetron IV  \n    - Ferrous Sulfate 325mg PO  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Pantoprazole IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Ferrous Sulfate 325mg: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Colonoscopy with diagnostic evaluation  \n    - Complete blood count (CBC)  \n    - Fecal occult blood test  \n\nAdmission 16174329  \n    DRGs:  \n    - APR: LOWER GI BLEEDING SECONDARY TO DIVERTICULOSIS (Severity 3.0)  \n    - HCFA: DIVERTICULAR BLEEDING W CC  \n\n    Medications:  \n    - Pantoprazole IV infusion  \n    - Ciprofloxacin IV  \n    - Metronidazole IV  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron IV  \n    - Acetaminophen  \n    - Heparin SC (DVT prophylaxis held during bleeding)  \n\n    Orders:  \n    - Pantoprazole IV infusion: IV, Discontinued via patient discharge  \n    - Ciprofloxacin IV: IV, Discontinued via patient discharge  \n    - Metronidazole IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Heparin SC: SC, Discontinued via patient discharge  \n\n    Procedures:  \n    - Therapeutic colonoscopy with epinephrine injection  \n    - Endoscopic clipping of bleeding diverticulum  \n    - CT angiography abdomen/pelvis to localize source  \n    - Hemoglobin and hematocrit monitoring q6h  \n\nAdmission 16318277  \n    DRGs:  \n    - APR: SEVERE DIVERTICULAR BLEEDING WITH TRANSFUSION (Severity 4.0)  \n    - HCFA: LOWER GI HEMORRHAGE W MCC  \n\n    Medications:  \n    - Pantoprazole continuous IV infusion  \n    - Piperacillin-Tazobactam IV  \n    - Tranexamic Acid IV  \n    - Sodium Chloride 0.9% Flush  \n    - Ondansetron IV  \n    - Acetaminophen  \n    - Packed red blood cells (PRBCs) transfusion  \n\n    Orders:  \n    - Pantoprazole continuous IV: IV, Discontinued via patient discharge  \n    - Piperacillin-Tazobactam IV: IV, Discontinued via patient discharge  \n    - Tranexamic Acid IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - PRBC transfusion: IV, Completed  \n\n    Procedures:  \n    - Colonoscopy with cauterization of active bleeding site  \n    - Interventional radiology-guided mesenteric embolization  \n    - Serial hemoglobin monitoring  \n    - ICU observation for hypotension and volume resuscitation"}
{"id": "10001291", "pair_id": "60001291", "similarity": 0.0, "text": "Patient 10001291  \nGender: Female  \nAge: 39  \nRace: WHITE  \n\nAdmission 66120450  \n    DRGs:  \n    - APR: CROHN'S DISEASE WITH RECTAL BLEEDING — ACUTE FLARE (Severity 3.0)  \n    - HCFA: CROHN'S DISEASE OF SMALL INTESTINE WITH HEMORRHAGE  \n\n    Medications:  \n    - Methylprednisolone IV 40 mg Q8H for acute inflammation  \n    - Infliximab (Remicade) 5 mg/kg IV infusion — Induction dose  \n    - Mesalamine 2.4 g PO daily  \n    - Pantoprazole 40 mg PO daily for GI protection  \n    - Acetaminophen 650 mg PO Q6H PRN pain/fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - CT enterography ordered, Completed — Severe small bowel inflammation with mucosal thickening  \n    - Colonoscopy scheduled, Completed — Active Crohn’s with terminal ileal ulcerations  \n    - Stool cultures ordered, Completed — Negative for infection  \n    - Nutritional assessment ordered, Completed  \n    - IV hydration protocol initiated, Completed  \n\n    Procedures:  \n    - Colonoscopy with biopsies performed  \n    - CT enterography completed  \n    - Peripheral IV placed for biologic therapy  \n\n---\n\nAdmission 66120512  \n    DRGs:  \n    - APR: CROHN'S DISEASE — REFRACTORY FLARE WITH BLEEDING (Severity 4.0)  \n    - HCFA: IMMUNOMODULATOR MANAGEMENT FOR CROHN’S DISEASE  \n\n    Medications:  \n    - Vedolizumab (Entyvio) 300 mg IV infusion — Initiated after poor infliximab response  \n    - Prednisone taper starting at 40 mg PO daily  \n    - Azathioprine 150 mg PO daily  \n    - Ferrous sulfate 325 mg PO BID for iron-deficiency anemia  \n    - Loperamide 2 mg PO PRN for diarrhea  \n\n    Orders:  \n    - MR enterography ordered, Completed — Persistent transmural inflammation in distal ileum  \n    - Small bowel capsule endoscopy scheduled, Completed  \n    - Blood transfusion crossmatch ordered, Completed  \n    - Dietitian consult for low-residue diet, Completed  \n    - Vitamin B12 supplementation initiated, Ongoing  \n\n    Procedures:  \n    - MR enterography completed  \n    - Capsule endoscopy performed  \n    - Iron infusion administered via IV  \n\n---\n\nAdmission 66120604  \n    DRGs:  \n    - APR: CROHN’S DISEASE — SURGICAL MANAGEMENT FOR STRICTURE & BLEEDING (Severity 4.0)  \n    - HCFA: SMALL BOWEL RESECTION WITH PRIMARY ANASTOMOSIS  \n\n    Medications:  \n    - Adalimumab (Humira) 40 mg SC every 2 weeks for maintenance  \n    - Ceftriaxone 2 g IV Q24H (peri-op prophylaxis)  \n    - Metronidazole 500 mg IV Q8H (peri-op prophylaxis)  \n    - Hydromorphone PCA pump for pain control  \n    - Pantoprazole 40 mg PO daily  \n    - Multivitamin with minerals PO daily  \n\n    Orders:  \n    - Laparoscopic ileocecal resection ordered, Completed  \n    - Pre-op labs, anesthesia clearance, and bowel prep ordered, Completed  \n    - Central line placed for peri-op fluid and biologic administration, Completed  \n    - Post-op physical therapy initiated, Ongoing  \n    - Outpatient follow-up planned for 2 weeks post-surgery, Pending  \n\n    Procedures:  \n    - Laparoscopic-assisted ileocecal resection performed  \n    - Intraoperative endoscopy confirmed hemostasis  \n    - Post-operative recovery supported with TPN for 5 days", "pair_text": "Patient 60001291  \nGender: Male  \nAge: 34  \nRace: WHITE  \n\nAdmission 77420115  \n    DRGs:  \n    - APR: EPILEPSY AND SEIZURE DISORDERS — INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: EPILEPSY, UNSPECIFIED — NON-INTRACTABLE, WITHOUT STATUS  \n\n    Medications:  \n    - Levetiracetam (Keppra) 500 mg PO BID  \n    - Lorazepam 2 mg IV PRN seizure >5 minutes  \n    - Acetaminophen 650 mg PO Q6H PRN headache  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Routine EEG ordered, Completed — Abnormal sharp waves, temporal predominance  \n    - MRI brain with contrast ordered, Completed — No acute findings  \n    - CMP + CBC ordered, Completed — Normal results  \n    - Driving restriction counseling provided, Completed  \n    - Outpatient neurology referral placed, Pending  \n\n    Procedures:  \n    - EEG performed  \n    - MRI brain performed  \n\n---\n\nAdmission 77420298  \n    DRGs:  \n    - APR: EPILEPSY — MEDICATION TITRATION AND FOLLOW-UP (Severity 2.0)  \n    - HCFA: FOLLOW-UP MANAGEMENT OF NON-INTRACTABLE EPILEPSY  \n\n    Medications:  \n    - Levetiracetam (Keppra) increased to 750 mg PO BID  \n    - Vitamin B6 50 mg PO daily (for mood stabilization on Keppra)  \n    - Lorazepam 1 mg PO PRN aura or prolonged seizure  \n    - Naproxen 250 mg PO BID PRN post-ictal headaches  \n\n    Orders:  \n    - 48-hour ambulatory EEG ordered, Completed — Decreased seizure frequency, one subclinical event  \n    - Serum Keppra levels ordered, Completed — Within therapeutic range  \n    - Sleep study ordered, Pending — Evaluate nocturnal seizure activity  \n    - Outpatient follow-up with neurology scheduled in 2 weeks, Pending  \n\n    Procedures:  \n    - Ambulatory EEG monitoring performed  \n\n---\n\nAdmission 77420442  \n    DRGs:  \n    - APR: BREAKTHROUGH SEIZURE EPISODE ON MAINTENANCE THERAPY (Severity 3.0)  \n    - HCFA: ACUTE BREAKTHROUGH SEIZURE WITHOUT STATUS  \n\n    Medications:  \n    - Added Lamotrigine (Lamictal) 25 mg PO daily for dual therapy initiation  \n    - Levetiracetam maintained at 750 mg PO BID  \n    - Diazepam nasal spray 10 mg PRN rescue for prolonged seizure  \n    - Pantoprazole 40 mg PO daily for GI protection  \n    - Folic acid 1 mg PO daily  \n\n    Orders:  \n    - Continuous inpatient EEG monitoring ordered, Completed — One electrographic seizure noted  \n    - CT head without contrast ordered, Completed — Negative for acute pathology  \n    - Neuropsychology consult ordered, Completed — Counseling provided on medication adherence  \n    - Seizure safety counseling ordered, Completed — Patient educated on lifestyle modifications  \n\n    Procedures:  \n    - Continuous video EEG monitoring performed  \n    - Rescue therapy administered via nasal diazepam"}
{"id": "10001292", "pair_id": "20001292", "similarity": 1.0, "text": "Patient 10001292  \nGender: Male  \nAge: 45  \nRace: WHITE  \n\nAdmission 78120432  \n    DRGs:  \n    - APR: ACUTE ALCOHOL-INDUCED PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: ALCOHOL-RELATED ACUTE PANCREATITIS — INITIAL EPISODE  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 150 mL/hr  \n    - Hydromorphone 0.5 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Pantoprazole 40 mg IV daily  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - CT abdomen with contrast ordered, Completed — No necrosis, peripancreatic inflammation only  \n    - Serum lipase & amylase ordered, Completed — Lipase 785 U/L (elevated)  \n    - NPO status ordered, Completed  \n    - IV fluids initiated, Completed  \n    - Alcohol cessation counseling ordered, Completed  \n    - Outpatient GI referral placed, Pending  \n\n    Procedures:  \n    - Peripheral IV placement  \n    - Abdominal CT performed  \n\n---\n\nAdmission 78120614  \n    DRGs:  \n    - APR: RECURRENT ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: MANAGEMENT OF RECURRENT ACUTE PANCREATITIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 125 mL/hr  \n    - Morphine 2 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron ODT 4 mg PO Q8H PRN nausea  \n    - Pantoprazole 40 mg PO daily  \n    - Naltrexone 50 mg PO daily for alcohol-use disorder  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Abdominal ultrasound ordered, Completed — No gallstones or ductal obstruction  \n    - Triglycerides level ordered, Completed — Normal  \n    - Diet: NPO → clear liquids → low-fat diet, Completed  \n    - GI consult ordered, Completed  \n    - Alcohol rehabilitation referral placed, Pending  \n\n    Procedures:  \n    - Abdominal ultrasound performed  \n    - IV hydration maintained  \n\n---\n\nAdmission 78120872  \n    DRGs:  \n    - APR: SEVERE ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 4.0)  \n    - HCFA: HIGH-ACUITY PANCREATITIS MANAGEMENT — NO NECROSIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 200 mL/hr  \n    - Hydromorphone PCA pump initiated for pain control  \n    - Ondansetron 4 mg IV Q6H PRN vomiting  \n    - Pantoprazole 40 mg IV daily  \n    - Chlordiazepoxide 25 mg PO Q6H for alcohol withdrawal prophylaxis  \n    - Multivitamin + Thiamine + Folic acid IV daily  \n\n    Orders:  \n    - Repeat CT abdomen ordered, Completed — No necrosis, worsening peripancreatic edema  \n    - Continuous monitoring for SIRS criteria ordered, Ongoing  \n    - Alcohol withdrawal CIWA protocol ordered, Completed  \n    - Nutrition consult ordered, Completed — Recommended low-fat, high-protein diet upon recovery  \n    - Outpatient follow-up with hepatology & addiction medicine, Pending  \n\n    Procedures:  \n    - Repeat abdominal CT scan  \n    - IV PCA management  \n    - Continuous monitoring for alcohol withdrawal", "pair_text": "Patient 20001292  \nGender: Male  \nAge: 48  \nRace: WHITE  \n\nAdmission 78231011  \n    DRGs:  \n    - APR: ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS — INITIAL PRESENTATION (Severity 3.0)  \n    - HCFA: ACUTE PANCREATITIS — ALCOHOL-RELATED, NON-NECROTIZING  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 150 mL/hr  \n    - Morphine 2 mg IV Q4H PRN abdominal pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea/vomiting  \n    - Pantoprazole 40 mg IV daily  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - CT abdomen with contrast ordered, Completed — Diffuse pancreatic swelling, no necrosis  \n    - Lipase/amylase panel ordered, Completed — Lipase 980 U/L, Amylase 400 U/L  \n    - NPO status ordered, Completed  \n    - IV hydration initiated, Completed  \n    - CIWA protocol for alcohol withdrawal initiated, Completed  \n    - Addiction counseling referral placed, Pending  \n\n    Procedures:  \n    - Peripheral IV placement  \n    - Abdominal CT performed  \n\n---\n\nAdmission 78231288  \n    DRGs:  \n    - APR: RECURRENT ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: ACUTE PANCREATITIS READMISSION MANAGEMENT  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 125 mL/hr  \n    - Hydromorphone 0.5 mg IV Q4H PRN pain  \n    - Ondansetron ODT 4 mg PO Q8H PRN nausea  \n    - Pantoprazole 40 mg PO daily  \n    - Naltrexone 50 mg PO daily for alcohol dependence  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Abdominal ultrasound ordered, Completed — No gallstones, normal bile ducts  \n    - Triglyceride panel ordered, Completed — Normal  \n    - Diet: NPO → clear liquids → low-fat diet, Completed  \n    - GI consult ordered, Completed  \n    - Alcohol recovery program referral placed, Pending  \n\n    Procedures:  \n    - Abdominal ultrasound performed  \n    - IV fluid resuscitation maintained  \n\n---\n\nAdmission 78231546  \n    DRGs:  \n    - APR: SEVERE ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 4.0)  \n    - HCFA: COMPLICATED ACUTE PANCREATITIS — INTENSIVE MANAGEMENT  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 200 mL/hr  \n    - Hydromorphone PCA pump initiated for breakthrough pain control  \n    - Ondansetron 4 mg IV Q6H PRN vomiting  \n    - Pantoprazole 40 mg IV daily  \n    - Chlordiazepoxide 25 mg PO Q6H for alcohol withdrawal prophylaxis  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n\n    Orders:  \n    - Repeat CT abdomen ordered, Completed — Increased edema, still no necrosis  \n    - Continuous monitoring for SIRS/sepsis ordered, Ongoing  \n    - Nutrition consult ordered, Completed — Recommended early enteral feeding via low-fat diet once stable  \n    - Counseling for alcohol cessation ordered, Completed  \n    - Follow-up hepatology appointment scheduled, Pending  \n\n    Procedures:  \n    - Repeat CT abdomen performed  \n    - IV PCA pump initiation  \n    - Continuous monitoring for alcohol withdrawal"}
{"id": "10001292", "pair_id": "30001292", "similarity": 0.75, "text": "Patient 10001292  \nGender: Male  \nAge: 45  \nRace: WHITE  \n\nAdmission 78120432  \n    DRGs:  \n    - APR: ACUTE ALCOHOL-INDUCED PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: ALCOHOL-RELATED ACUTE PANCREATITIS — INITIAL EPISODE  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 150 mL/hr  \n    - Hydromorphone 0.5 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Pantoprazole 40 mg IV daily  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - CT abdomen with contrast ordered, Completed — No necrosis, peripancreatic inflammation only  \n    - Serum lipase & amylase ordered, Completed — Lipase 785 U/L (elevated)  \n    - NPO status ordered, Completed  \n    - IV fluids initiated, Completed  \n    - Alcohol cessation counseling ordered, Completed  \n    - Outpatient GI referral placed, Pending  \n\n    Procedures:  \n    - Peripheral IV placement  \n    - Abdominal CT performed  \n\n---\n\nAdmission 78120614  \n    DRGs:  \n    - APR: RECURRENT ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: MANAGEMENT OF RECURRENT ACUTE PANCREATITIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 125 mL/hr  \n    - Morphine 2 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron ODT 4 mg PO Q8H PRN nausea  \n    - Pantoprazole 40 mg PO daily  \n    - Naltrexone 50 mg PO daily for alcohol-use disorder  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Abdominal ultrasound ordered, Completed — No gallstones or ductal obstruction  \n    - Triglycerides level ordered, Completed — Normal  \n    - Diet: NPO → clear liquids → low-fat diet, Completed  \n    - GI consult ordered, Completed  \n    - Alcohol rehabilitation referral placed, Pending  \n\n    Procedures:  \n    - Abdominal ultrasound performed  \n    - IV hydration maintained  \n\n---\n\nAdmission 78120872  \n    DRGs:  \n    - APR: SEVERE ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 4.0)  \n    - HCFA: HIGH-ACUITY PANCREATITIS MANAGEMENT — NO NECROSIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 200 mL/hr  \n    - Hydromorphone PCA pump initiated for pain control  \n    - Ondansetron 4 mg IV Q6H PRN vomiting  \n    - Pantoprazole 40 mg IV daily  \n    - Chlordiazepoxide 25 mg PO Q6H for alcohol withdrawal prophylaxis  \n    - Multivitamin + Thiamine + Folic acid IV daily  \n\n    Orders:  \n    - Repeat CT abdomen ordered, Completed — No necrosis, worsening peripancreatic edema  \n    - Continuous monitoring for SIRS criteria ordered, Ongoing  \n    - Alcohol withdrawal CIWA protocol ordered, Completed  \n    - Nutrition consult ordered, Completed — Recommended low-fat, high-protein diet upon recovery  \n    - Outpatient follow-up with hepatology & addiction medicine, Pending  \n\n    Procedures:  \n    - Repeat abdominal CT scan  \n    - IV PCA management  \n    - Continuous monitoring for alcohol withdrawal", "pair_text": "Patient 30001292  \nGender: Male  \nAge: 51  \nRace: WHITE  \n\nAdmission 79342105  \n    DRGs:  \n    - APR: ALCOHOL-INDUCED ACUTE PANCREATITIS WITH UNINFECTED NECROSIS — INITIAL EPISODE (Severity 4.0)  \n    - HCFA: NECROTIZING ALCOHOLIC PANCREATITIS MANAGEMENT WITHOUT INFECTION  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 250 mL/hr  \n    - Hydromorphone PCA pump for severe abdominal pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea/vomiting  \n    - Pantoprazole 40 mg IV daily  \n    - Ceftriaxone 2 g IV daily (prophylaxis for secondary infection)  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - CT abdomen with contrast ordered, Completed — 35% pancreatic necrosis, no peripancreatic infection  \n    - Lipase/amylase panel ordered, Completed — Lipase 1450 U/L, Amylase 530 U/L  \n    - NPO status ordered, Completed  \n    - NG tube insertion ordered, Completed for gastric decompression  \n    - Addiction medicine consult ordered, Completed  \n    - ICU transfer for close monitoring ordered, Completed  \n\n    Procedures:  \n    - Abdominal CT with contrast performed  \n    - NG tube placement  \n    - ICU admission  \n\n---\n\nAdmission 79342378  \n    DRGs:  \n    - APR: RECURRENT ALCOHOL-INDUCED PANCREATITIS WITH UNINFECTED NECROSIS (Severity 4.0)  \n    - HCFA: PANCREATIC NECROSIS MONITORING — SECONDARY ADMISSION  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 225 mL/hr  \n    - Morphine 2 mg IV Q3H PRN abdominal pain  \n    - Ondansetron ODT 4 mg PO Q8H PRN nausea  \n    - Meropenem 1 g IV Q8H (given due to concern for potential secondary infection)  \n    - Pantoprazole 40 mg PO daily  \n    - Naltrexone 50 mg PO daily for alcohol-use disorder  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Repeat contrast CT ordered, Completed — Stable 35% necrosis, no abscess formation  \n    - Endoscopic ultrasound (EUS) ordered, Completed — Confirmed pancreatic necrosis without fluid collections  \n    - Enteral feeding via NJ tube ordered, Completed  \n    - Addiction counseling ordered, Completed  \n    - Hepatology consult placed, Pending  \n\n    Procedures:  \n    - Repeat abdominal CT performed  \n    - Endoscopic ultrasound performed  \n    - NJ tube placement for enteral feeding  \n\n---\n\nAdmission 79342792  \n    DRGs:  \n    - APR: SEVERE ALCOHOL-INDUCED PANCREATITIS WITH EXTENSIVE UNINFECTED NECROSIS (Severity 4.0)  \n    - HCFA: HIGH-ACUITY MANAGEMENT OF NECROTIZING PANCREATITIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 300 mL/hr  \n    - Hydromorphone PCA pump continued  \n    - Ondansetron 4 mg IV Q6H PRN vomiting  \n    - Piperacillin-tazobactam 4.5 g IV Q8H (prophylactic antibiotic coverage)  \n    - Pantoprazole 40 mg IV daily  \n    - Chlordiazepoxide 25 mg PO Q6H for alcohol withdrawal prophylaxis  \n    - Thiamine 100 mg IV daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Repeat abdominal CT ordered, Completed — Necrosis increased to 45%, still uninfected  \n    - Continuous hemodynamic monitoring ordered, Completed  \n    - Early surgical consult ordered, Completed — Conservative management recommended  \n    - Nutrition consult ordered, Completed — Recommended high-protein, low-fat enteral feeding  \n    - Addiction medicine referral ordered, Completed  \n\n    Procedures:  \n    - Repeat CT abdomen performed  \n    - ICU monitoring maintained  \n    - Initiation of continuous enteral nutrition"}
{"id": "10001292", "pair_id": "40001292", "similarity": 0.5, "text": "Patient 10001292  \nGender: Male  \nAge: 45  \nRace: WHITE  \n\nAdmission 78120432  \n    DRGs:  \n    - APR: ACUTE ALCOHOL-INDUCED PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: ALCOHOL-RELATED ACUTE PANCREATITIS — INITIAL EPISODE  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 150 mL/hr  \n    - Hydromorphone 0.5 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Pantoprazole 40 mg IV daily  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - CT abdomen with contrast ordered, Completed — No necrosis, peripancreatic inflammation only  \n    - Serum lipase & amylase ordered, Completed — Lipase 785 U/L (elevated)  \n    - NPO status ordered, Completed  \n    - IV fluids initiated, Completed  \n    - Alcohol cessation counseling ordered, Completed  \n    - Outpatient GI referral placed, Pending  \n\n    Procedures:  \n    - Peripheral IV placement  \n    - Abdominal CT performed  \n\n---\n\nAdmission 78120614  \n    DRGs:  \n    - APR: RECURRENT ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: MANAGEMENT OF RECURRENT ACUTE PANCREATITIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 125 mL/hr  \n    - Morphine 2 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron ODT 4 mg PO Q8H PRN nausea  \n    - Pantoprazole 40 mg PO daily  \n    - Naltrexone 50 mg PO daily for alcohol-use disorder  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Abdominal ultrasound ordered, Completed — No gallstones or ductal obstruction  \n    - Triglycerides level ordered, Completed — Normal  \n    - Diet: NPO → clear liquids → low-fat diet, Completed  \n    - GI consult ordered, Completed  \n    - Alcohol rehabilitation referral placed, Pending  \n\n    Procedures:  \n    - Abdominal ultrasound performed  \n    - IV hydration maintained  \n\n---\n\nAdmission 78120872  \n    DRGs:  \n    - APR: SEVERE ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 4.0)  \n    - HCFA: HIGH-ACUITY PANCREATITIS MANAGEMENT — NO NECROSIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 200 mL/hr  \n    - Hydromorphone PCA pump initiated for pain control  \n    - Ondansetron 4 mg IV Q6H PRN vomiting  \n    - Pantoprazole 40 mg IV daily  \n    - Chlordiazepoxide 25 mg PO Q6H for alcohol withdrawal prophylaxis  \n    - Multivitamin + Thiamine + Folic acid IV daily  \n\n    Orders:  \n    - Repeat CT abdomen ordered, Completed — No necrosis, worsening peripancreatic edema  \n    - Continuous monitoring for SIRS criteria ordered, Ongoing  \n    - Alcohol withdrawal CIWA protocol ordered, Completed  \n    - Nutrition consult ordered, Completed — Recommended low-fat, high-protein diet upon recovery  \n    - Outpatient follow-up with hepatology & addiction medicine, Pending  \n\n    Procedures:  \n    - Repeat abdominal CT scan  \n    - IV PCA management  \n    - Continuous monitoring for alcohol withdrawal", "pair_text": "Patient 40001292  \nGender: Male  \nAge: 53  \nRace: WHITE  \n\nAdmission 80453212  \n    DRGs:  \n    - APR: ALCOHOLIC HEPATITIS WITHOUT ASCITES — INITIAL PRESENTATION (Severity 3.0)  \n    - HCFA: ACUTE ALCOHOLIC HEPATITIS MANAGEMENT WITHOUT FLUID ACCUMULATION  \n\n    Medications:  \n    - Prednisolone 40 mg PO daily  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n    - Pantoprazole 40 mg PO daily  \n    - Lactulose 20 g PO BID  \n    - Ondansetron 4 mg IV Q8H PRN nausea/vomiting  \n\n    Orders:  \n    - Liver function panel ordered, Completed — AST 280 U/L, ALT 130 U/L, INR 1.6  \n    - Abdominal ultrasound ordered, Completed — Hepatomegaly, no ascites  \n    - Maddrey’s Discriminant Function calculated: 28 → Initiated corticosteroid therapy  \n    - Hepatitis screening ordered, Completed — Negative  \n    - Alcohol cessation counseling ordered, Completed  \n    - Nutrition consult ordered, Completed  \n\n    Procedures:  \n    - Abdominal ultrasound performed  \n    - IV access placement for fluid and vitamin administration  \n\n---\n\nAdmission 80453607  \n    DRGs:  \n    - APR: RECURRENT ALCOHOLIC HEPATITIS WITHOUT ASCITES (Severity 3.0)  \n    - HCFA: SECONDARY ADMISSION FOR HEPATIC FLARE MANAGEMENT  \n\n    Medications:  \n    - Prednisolone 30 mg PO daily  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n    - Naltrexone 50 mg PO daily for alcohol-use disorder  \n    - Pantoprazole 40 mg PO daily  \n    - Ondansetron ODT 4 mg PO Q8H PRN nausea  \n    - Rifaximin 550 mg PO BID  \n\n    Orders:  \n    - Liver ultrasound ordered, Completed — Fatty liver changes, no ascites  \n    - Hepatic function panel ordered, Completed — Mildly worsened bilirubin 3.2 mg/dL  \n    - PT/INR monitoring ordered, Completed  \n    - Referral to outpatient alcohol recovery program, Pending  \n    - Dietitian consult ordered, Completed — High-protein, low-fat, vitamin-rich diet  \n\n    Procedures:  \n    - Abdominal ultrasound performed  \n    - Alcohol cessation counseling session completed  \n\n---\n\nAdmission 80454029  \n    DRGs:  \n    - APR: SEVERE ALCOHOLIC HEPATITIS WITHOUT ASCITES (Severity 4.0)  \n    - HCFA: HIGH-ACUITY MANAGEMENT OF ACUTE HEPATIC INFLAMMATION  \n\n    Medications:  \n    - Prednisolone 40 mg PO daily  \n    - N-acetylcysteine (NAC) 100 mg/kg IV infusion  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n    - Lactulose 30 g PO TID  \n    - Rifaximin 550 mg PO BID  \n    - Piperacillin-tazobactam 4.5 g IV Q8H (prophylaxis due to elevated WBC)  \n    - Ondansetron 4 mg IV Q6H PRN nausea/vomiting  \n\n    Orders:  \n    - Repeat liver function panel ordered, Completed — AST 340 U/L, INR 2.1  \n    - CT abdomen with contrast ordered, Completed — Diffuse hepatic inflammation, no ascites  \n    - Continuous hemodynamic monitoring ordered, Completed  \n    - Alcohol withdrawal prophylaxis via CIWA protocol initiated, Completed  \n    - Hepatology referral ordered, Pending  \n    - Plan for long-term transplant evaluation if hepatic function declines  \n\n    Procedures:  \n    - CT abdomen performed  \n    - NAC infusion initiated  \n    - CIWA monitoring implemented"}
{"id": "10001292", "pair_id": "50001292", "similarity": 0.25, "text": "Patient 10001292  \nGender: Male  \nAge: 45  \nRace: WHITE  \n\nAdmission 78120432  \n    DRGs:  \n    - APR: ACUTE ALCOHOL-INDUCED PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: ALCOHOL-RELATED ACUTE PANCREATITIS — INITIAL EPISODE  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 150 mL/hr  \n    - Hydromorphone 0.5 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Pantoprazole 40 mg IV daily  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - CT abdomen with contrast ordered, Completed — No necrosis, peripancreatic inflammation only  \n    - Serum lipase & amylase ordered, Completed — Lipase 785 U/L (elevated)  \n    - NPO status ordered, Completed  \n    - IV fluids initiated, Completed  \n    - Alcohol cessation counseling ordered, Completed  \n    - Outpatient GI referral placed, Pending  \n\n    Procedures:  \n    - Peripheral IV placement  \n    - Abdominal CT performed  \n\n---\n\nAdmission 78120614  \n    DRGs:  \n    - APR: RECURRENT ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: MANAGEMENT OF RECURRENT ACUTE PANCREATITIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 125 mL/hr  \n    - Morphine 2 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron ODT 4 mg PO Q8H PRN nausea  \n    - Pantoprazole 40 mg PO daily  \n    - Naltrexone 50 mg PO daily for alcohol-use disorder  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Abdominal ultrasound ordered, Completed — No gallstones or ductal obstruction  \n    - Triglycerides level ordered, Completed — Normal  \n    - Diet: NPO → clear liquids → low-fat diet, Completed  \n    - GI consult ordered, Completed  \n    - Alcohol rehabilitation referral placed, Pending  \n\n    Procedures:  \n    - Abdominal ultrasound performed  \n    - IV hydration maintained  \n\n---\n\nAdmission 78120872  \n    DRGs:  \n    - APR: SEVERE ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 4.0)  \n    - HCFA: HIGH-ACUITY PANCREATITIS MANAGEMENT — NO NECROSIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 200 mL/hr  \n    - Hydromorphone PCA pump initiated for pain control  \n    - Ondansetron 4 mg IV Q6H PRN vomiting  \n    - Pantoprazole 40 mg IV daily  \n    - Chlordiazepoxide 25 mg PO Q6H for alcohol withdrawal prophylaxis  \n    - Multivitamin + Thiamine + Folic acid IV daily  \n\n    Orders:  \n    - Repeat CT abdomen ordered, Completed — No necrosis, worsening peripancreatic edema  \n    - Continuous monitoring for SIRS criteria ordered, Ongoing  \n    - Alcohol withdrawal CIWA protocol ordered, Completed  \n    - Nutrition consult ordered, Completed — Recommended low-fat, high-protein diet upon recovery  \n    - Outpatient follow-up with hepatology & addiction medicine, Pending  \n\n    Procedures:  \n    - Repeat abdominal CT scan  \n    - IV PCA management  \n    - Continuous monitoring for alcohol withdrawal", "pair_text": "Patient 50001292  \nGender: Male  \nAge: 45  \nRace: WHITE  \n\nAdmission 17024561  \n    DRGs:  \n    - APR: ALCOHOL ABUSE WITHOUT COMPLICATIONS (Severity 1.0)  \n    - HCFA: ALCOHOL USE DISORDER W/O CC/MCC  \n\n    Medications:  \n    - Thiamine 100mg PO  \n    - Folic Acid 1mg PO  \n    - Multivitamin PO  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Ondansetron PO  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Thiamine 100mg: PO, Discontinued via patient discharge  \n    - Folic Acid 1mg: PO, Discontinued via patient discharge  \n    - Multivitamin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Ondansetron PO: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Basic metabolic panel  \n    - Liver function tests (LFTs)  \n    - Counseling on alcohol cessation and referral to outpatient rehab  \n\nAdmission 17185934  \n    DRGs:  \n    - APR: ALCOHOL USE WITH EARLY WITHDRAWAL SYMPTOMS (Severity 2.0)  \n    - HCFA: ALCOHOL DEPENDENCE W CC  \n\n    Medications:  \n    - Diazepam IV PRN (CIWA protocol)  \n    - Thiamine 100mg PO  \n    - Folic Acid 1mg PO  \n    - Multivitamin PO  \n    - Ondansetron IV  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n\n    Orders:  \n    - Diazepam: IV, Discontinued via patient discharge  \n    - Thiamine: PO, Discontinued via patient discharge  \n    - Folic Acid: PO, Discontinued via patient discharge  \n    - Multivitamin: PO, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - CIWA-Ar scoring and monitoring  \n    - Intravenous fluid resuscitation  \n    - Addiction medicine consult  \n\nAdmission 17349712  \n    DRGs:  \n    - APR: SEVERE ALCOHOL USE WITH WITHDRAWAL AND COMPLICATIONS (Severity 3.0)  \n    - HCFA: ALCOHOL DEPENDENCE W MCC  \n\n    Medications:  \n    - Lorazepam IV continuous infusion  \n    - Phenobarbital IV PRN  \n    - Thiamine 200mg IV  \n    - Folic Acid IV  \n    - Magnesium Sulfate IV  \n    - Sodium Chloride 0.9% Flush  \n    - Multivitamin IV  \n    - Ondansetron IV  \n\n    Orders:  \n    - Lorazepam IV infusion: IV, Discontinued via patient discharge  \n    - Phenobarbital IV: IV, Discontinued via patient discharge  \n    - Thiamine IV: IV, Discontinued via patient discharge  \n    - Folic Acid IV: IV, Discontinued via patient discharge  \n    - Magnesium Sulfate IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Multivitamin IV: IV, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous vital sign and telemetry monitoring  \n    - Arterial blood gas analysis  \n    - ICU admission for alcohol withdrawal management  \n    - Psychiatric evaluation and inpatient rehab referral"}
{"id": "10001292", "pair_id": "60001292", "similarity": 0.0, "text": "Patient 10001292  \nGender: Male  \nAge: 45  \nRace: WHITE  \n\nAdmission 78120432  \n    DRGs:  \n    - APR: ACUTE ALCOHOL-INDUCED PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: ALCOHOL-RELATED ACUTE PANCREATITIS — INITIAL EPISODE  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 150 mL/hr  \n    - Hydromorphone 0.5 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Pantoprazole 40 mg IV daily  \n    - Thiamine 100 mg IV daily  \n    - Folic acid 1 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - CT abdomen with contrast ordered, Completed — No necrosis, peripancreatic inflammation only  \n    - Serum lipase & amylase ordered, Completed — Lipase 785 U/L (elevated)  \n    - NPO status ordered, Completed  \n    - IV fluids initiated, Completed  \n    - Alcohol cessation counseling ordered, Completed  \n    - Outpatient GI referral placed, Pending  \n\n    Procedures:  \n    - Peripheral IV placement  \n    - Abdominal CT performed  \n\n---\n\nAdmission 78120614  \n    DRGs:  \n    - APR: RECURRENT ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 3.0)  \n    - HCFA: MANAGEMENT OF RECURRENT ACUTE PANCREATITIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 125 mL/hr  \n    - Morphine 2 mg IV Q4H PRN severe abdominal pain  \n    - Ondansetron ODT 4 mg PO Q8H PRN nausea  \n    - Pantoprazole 40 mg PO daily  \n    - Naltrexone 50 mg PO daily for alcohol-use disorder  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Abdominal ultrasound ordered, Completed — No gallstones or ductal obstruction  \n    - Triglycerides level ordered, Completed — Normal  \n    - Diet: NPO → clear liquids → low-fat diet, Completed  \n    - GI consult ordered, Completed  \n    - Alcohol rehabilitation referral placed, Pending  \n\n    Procedures:  \n    - Abdominal ultrasound performed  \n    - IV hydration maintained  \n\n---\n\nAdmission 78120872  \n    DRGs:  \n    - APR: SEVERE ALCOHOL-INDUCED ACUTE PANCREATITIS WITHOUT NECROSIS (Severity 4.0)  \n    - HCFA: HIGH-ACUITY PANCREATITIS MANAGEMENT — NO NECROSIS  \n\n    Medications:  \n    - Lactated Ringer’s IV infusion 200 mL/hr  \n    - Hydromorphone PCA pump initiated for pain control  \n    - Ondansetron 4 mg IV Q6H PRN vomiting  \n    - Pantoprazole 40 mg IV daily  \n    - Chlordiazepoxide 25 mg PO Q6H for alcohol withdrawal prophylaxis  \n    - Multivitamin + Thiamine + Folic acid IV daily  \n\n    Orders:  \n    - Repeat CT abdomen ordered, Completed — No necrosis, worsening peripancreatic edema  \n    - Continuous monitoring for SIRS criteria ordered, Ongoing  \n    - Alcohol withdrawal CIWA protocol ordered, Completed  \n    - Nutrition consult ordered, Completed — Recommended low-fat, high-protein diet upon recovery  \n    - Outpatient follow-up with hepatology & addiction medicine, Pending  \n\n    Procedures:  \n    - Repeat abdominal CT scan  \n    - IV PCA management  \n    - Continuous monitoring for alcohol withdrawal", "pair_text": "Patient 60001292  \nGender: Male  \nAge: 66  \nRace: WHITE  \n\nAdmission 76542103  \n    DRGs:  \n    - APR: BENIGN PROSTATIC HYPERPLASIA WITHOUT LOWER URINARY TRACT SYMPTOMS — INITIAL EVALUATION (Severity 1.0)  \n    - HCFA: ELECTIVE ASSESSMENT OF BENIGN PROSTATE ENLARGEMENT WITHOUT OBSTRUCTION  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily  \n    - Finasteride 5 mg PO daily  \n    - Multivitamin PO daily  \n    - Influenza Vaccine Quadrivalent IM yearly  \n\n    Orders:  \n    - PSA test ordered, Completed — PSA: 2.6 ng/mL  \n    - Urinalysis ordered, Completed — Normal findings  \n    - Renal ultrasound ordered, Completed — Mild symmetric enlargement, no obstruction  \n    - Urology consult ordered, Completed  \n    - Lifestyle counseling ordered, Completed — Fluid timing adjustments, alcohol reduction  \n    - Scheduled follow-up in 6 months  \n\n    Procedures:  \n    - Abdominal and pelvic ultrasound performed  \n    - Digital rectal exam (DRE) performed — Smooth, symmetrically enlarged prostate  \n\n---\n\nAdmission 76542612  \n    DRGs:  \n    - APR: BENIGN PROSTATIC HYPERPLASIA — MEDICATION RESPONSE FOLLOW-UP (Severity 1.0)  \n    - HCFA: BPH MANAGEMENT VISIT WITHOUT VOIDING DYSFUNCTION  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily (continued)  \n    - Finasteride 5 mg PO daily (continued)  \n    - Vitamin D3 2000 IU PO daily  \n    - Pravastatin 20 mg PO nightly  \n\n    Orders:  \n    - Repeat PSA test ordered, Completed — PSA: 2.4 ng/mL  \n    - Renal function panel ordered, Completed — Creatinine: 1.0 mg/dL  \n    - Abdominal ultrasound ordered, Completed — Stable prostate volume  \n    - Uroflowmetry ordered, Completed — Peak flow: 18 mL/sec, within normal range  \n    - Counseling for continued medical therapy ordered, Completed  \n    - Follow-up scheduled in 1 year  \n\n    Procedures:  \n    - Uroflowmetry performed  \n    - Bladder scan performed — No post-void residual detected  \n\n---\n\nAdmission 76543145  \n    DRGs:  \n    - APR: BENIGN PROSTATIC HYPERPLASIA — ROUTINE SURVEILLANCE VISIT (Severity 1.0)  \n    - HCFA: LONG-TERM MONITORING OF BPH WITHOUT LUTS  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily  \n    - Finasteride 5 mg PO daily  \n    - Multivitamin PO daily  \n    - Influenza Vaccine Quadrivalent IM yearly  \n\n    Orders:  \n    - Annual PSA test ordered, Completed — PSA: 2.5 ng/mL  \n    - Urology follow-up ordered, Completed — No urinary symptoms  \n    - Counseling ordered, Completed — Maintain hydration, avoid bladder irritants  \n    - Screening for urinary retention ordered, Completed — Negative findings  \n    - Physical activity guidance ordered, Completed — Encouraged moderate exercise  \n\n    Procedures:  \n    - Digital rectal exam performed — Stable size, no nodules  \n    - Post-void bladder ultrasound performed — 20 mL residual, clinically insignificant"}
{"id": "10001293", "pair_id": "20001293", "similarity": 1.0, "text": "Patient 10001293  \nGender: Female  \nAge: 41  \nRace: WHITE  \n\nAdmission 71245980  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: URINARY TRACT INFECTIONS WITH HEMATURIA, NONCOMPLICATED  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Ibuprofen 400 mg PO Q6H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Urinalysis ordered, Completed — Positive nitrites, RBCs present  \n    - Urine culture ordered, Completed — E. coli >100,000 CFU/mL  \n    - Serum creatinine panel ordered, Completed — Normal renal function  \n    - Counseling on hydration and bladder hygiene ordered, Completed  \n    - Follow-up in 2 weeks to reassess hematuria  \n\n    Procedures:  \n    - Straight catheter urine specimen collected  \n    - IV fluids administered for hydration  \n\n---\n\nAdmission 71246321  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — FOLLOW-UP EPISODE (Severity 2.0)  \n    - HCFA: NONCOMPLICATED LOWER URINARY TRACT INFECTION WITH BLEEDING  \n\n    Medications:  \n    - Cefuroxime 500 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO Q6H PRN dysuria  \n    - Probiotic supplement PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Urine culture ordered, Completed — Klebsiella pneumoniae, sensitive to cefuroxime  \n    - Post-treatment urinalysis ordered, Completed — RBCs resolved  \n    - Abdominal and pelvic ultrasound ordered, Completed — No hydronephrosis or obstruction  \n    - Preventive urology referral ordered, Completed  \n    - Education on UTI prevention strategies ordered, Completed  \n\n    Procedures:  \n    - Bladder ultrasound performed  \n    - Urinary catheterization avoided due to intact voiding  \n\n---\n\nAdmission 71247055  \n    DRGs:  \n    - APR: SEVERE CYSTITIS WITH HEMATURIA AND COMPLICATED INFECTION (Severity 3.0)  \n    - HCFA: COMPLICATED LOWER UTI WITH BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-Tazobactam 3.375 g IV Q8H × 5 days  \n    - Ciprofloxacin 500 mg PO BID × 7 days after IV antibiotics  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% IV continuous hydration  \n\n    Orders:  \n    - Blood cultures ordered, Completed — Negative growth  \n    - Urine culture ordered, Completed — E. coli ESBL-positive  \n    - CT abdomen/pelvis ordered, Completed — No renal stones, no obstruction  \n    - Hematuria evaluation via cystoscopy ordered, Completed — Mild bladder mucosal inflammation  \n    - Follow-up plan: Outpatient urology review scheduled in 3 weeks  \n\n    Procedures:  \n    - CT abdomen and pelvis performed  \n    - Diagnostic cystoscopy performed  \n    - IV antibiotics administered via peripheral line", "pair_text": "Patient 20001293  \nGender: Female  \nAge: 54  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 84532710  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL EPISODE (Severity 2.0)  \n    - HCFA: URINARY TRACT INFECTION WITH HEMATURIA, NONCOMPLICATED  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 3 days  \n    - Acetaminophen 650 mg PO Q6H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Urinalysis ordered, Completed — RBCs 25/HPF, positive nitrites  \n    - Urine culture ordered, Completed — E. coli sensitive to nitrofurantoin  \n    - Serum creatinine and BUN ordered, Completed — Normal renal function  \n    - Bladder hydration counseling ordered, Completed  \n    - Scheduled follow-up urinalysis in 2 weeks  \n\n    Procedures:  \n    - IV fluids administered  \n    - Straight catheter specimen collected for culture  \n\n---\n\nAdmission 84533284  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA (Severity 2.0)  \n    - HCFA: LOWER UTI WITH BLEEDING, NONCOMPLICATED  \n\n    Medications:  \n    - Cefuroxime 500 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Ibuprofen 400 mg PO Q6H PRN pelvic discomfort  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Repeat urine culture ordered, Completed — Klebsiella pneumoniae, cefuroxime-sensitive  \n    - Pelvic ultrasound ordered, Completed — No obstruction, bladder wall thickening noted  \n    - Urinalysis ordered, Completed — RBCs resolved post-treatment  \n    - Urology referral ordered, Completed  \n    - Preventive counseling ordered, Completed — Proper hygiene and timed voiding  \n\n    Procedures:  \n    - Bladder ultrasound performed  \n    - No catheterization required  \n\n---\n\nAdmission 84534072  \n    DRGs:  \n    - APR: SEVERE CYSTITIS WITH HEMATURIA AND COMPLICATED INFECTION (Severity 3.0)  \n    - HCFA: COMPLICATED LOWER UTI WITH BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-Tazobactam 3.375 g IV Q8H × 5 days  \n    - Ciprofloxacin 500 mg PO BID × 7 days following IV therapy  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Multivitamin PO daily  \n    - Sodium Chloride 0.9% IV continuous infusion  \n\n    Orders:  \n    - Blood cultures ordered, Completed — No growth  \n    - Urine culture ordered, Completed — E. coli ESBL-positive, switched to IV therapy  \n    - CT urogram ordered, Completed — No stones or obstruction, mild bladder edema  \n    - Cystoscopy ordered, Completed — Small mucosal erythema and hyperemia  \n    - Discharge follow-up with urology ordered, Completed — 3-week follow-up  \n\n    Procedures:  \n    - CT urogram performed  \n    - Diagnostic cystoscopy performed  \n    - IV antibiotics administered via peripheral line"}
{"id": "10001293", "pair_id": "30001293", "similarity": 0.75, "text": "Patient 10001293  \nGender: Female  \nAge: 41  \nRace: WHITE  \n\nAdmission 71245980  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: URINARY TRACT INFECTIONS WITH HEMATURIA, NONCOMPLICATED  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Ibuprofen 400 mg PO Q6H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Urinalysis ordered, Completed — Positive nitrites, RBCs present  \n    - Urine culture ordered, Completed — E. coli >100,000 CFU/mL  \n    - Serum creatinine panel ordered, Completed — Normal renal function  \n    - Counseling on hydration and bladder hygiene ordered, Completed  \n    - Follow-up in 2 weeks to reassess hematuria  \n\n    Procedures:  \n    - Straight catheter urine specimen collected  \n    - IV fluids administered for hydration  \n\n---\n\nAdmission 71246321  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — FOLLOW-UP EPISODE (Severity 2.0)  \n    - HCFA: NONCOMPLICATED LOWER URINARY TRACT INFECTION WITH BLEEDING  \n\n    Medications:  \n    - Cefuroxime 500 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO Q6H PRN dysuria  \n    - Probiotic supplement PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Urine culture ordered, Completed — Klebsiella pneumoniae, sensitive to cefuroxime  \n    - Post-treatment urinalysis ordered, Completed — RBCs resolved  \n    - Abdominal and pelvic ultrasound ordered, Completed — No hydronephrosis or obstruction  \n    - Preventive urology referral ordered, Completed  \n    - Education on UTI prevention strategies ordered, Completed  \n\n    Procedures:  \n    - Bladder ultrasound performed  \n    - Urinary catheterization avoided due to intact voiding  \n\n---\n\nAdmission 71247055  \n    DRGs:  \n    - APR: SEVERE CYSTITIS WITH HEMATURIA AND COMPLICATED INFECTION (Severity 3.0)  \n    - HCFA: COMPLICATED LOWER UTI WITH BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-Tazobactam 3.375 g IV Q8H × 5 days  \n    - Ciprofloxacin 500 mg PO BID × 7 days after IV antibiotics  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% IV continuous hydration  \n\n    Orders:  \n    - Blood cultures ordered, Completed — Negative growth  \n    - Urine culture ordered, Completed — E. coli ESBL-positive  \n    - CT abdomen/pelvis ordered, Completed — No renal stones, no obstruction  \n    - Hematuria evaluation via cystoscopy ordered, Completed — Mild bladder mucosal inflammation  \n    - Follow-up plan: Outpatient urology review scheduled in 3 weeks  \n\n    Procedures:  \n    - CT abdomen and pelvis performed  \n    - Diagnostic cystoscopy performed  \n    - IV antibiotics administered via peripheral line", "pair_text": "Patient 30001293  \nGender: Female  \nAge: 39  \nRace: WHITE  \n\nAdmission 93521840  \n    DRGs:  \n    - APR: ACUTE UNCOMPLICATED CYSTITIS — INITIAL PRESENTATION (Severity 1.0)  \n    - HCFA: ACUTE LOWER URINARY TRACT INFECTION, NONCOMPLICATED  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 5 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Ibuprofen 400 mg PO Q6H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Urinalysis ordered, Completed — Positive leukocyte esterase, negative RBCs  \n    - Urine culture ordered, Completed — E. coli sensitive to nitrofurantoin  \n    - Renal panel ordered, Completed — No renal impairment  \n    - Hydration counseling ordered, Completed  \n    - Follow-up urine dipstick in 10 days ordered, Pending  \n\n    Procedures:  \n    - Straight catheter urine sample collected for culture  \n    - IV fluids administered for mild dehydration  \n\n---\n\nAdmission 93522591  \n    DRGs:  \n    - APR: RECURRENT ACUTE CYSTITIS — SECOND EPISODE (Severity 1.0)  \n    - HCFA: LOWER URINARY TRACT INFECTION WITHOUT BLEEDING  \n\n    Medications:  \n    - Trimethoprim-Sulfamethoxazole DS 1 tab PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Probiotic supplement PO daily × 14 days  \n    - Acetaminophen 650 mg PO Q6H PRN dysuria  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Urine culture ordered, Completed — Klebsiella pneumoniae sensitive to TMP-SMX  \n    - Pelvic ultrasound ordered, Completed — No hydronephrosis, bladder wall normal  \n    - Post-treatment urinalysis ordered, Completed — Leukocytes resolved  \n    - Patient counseling on timed voiding and prevention strategies ordered, Completed  \n    - Urology referral ordered, Completed  \n\n    Procedures:  \n    - Ultrasound of kidneys and bladder performed  \n    - No catheterization performed due to intact spontaneous voiding  \n\n---\n\nAdmission 93523164  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH ANTIBIOTIC RESISTANCE — COMPLICATED CASE (Severity 2.0)  \n    - HCFA: COMPLICATED LOWER UTI REQUIRING IV ANTIBIOTICS  \n\n    Medications:  \n    - Ceftriaxone 1 g IV Q24H × 5 days  \n    - Levofloxacin 500 mg PO daily × 5 days post-IV therapy  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Sodium Bicarbonate PO BID for urine alkalinization  \n    - Sodium Chloride 0.9% IV continuous infusion  \n\n    Orders:  \n    - Urine culture ordered, Completed — E. coli ESBL-positive  \n    - Blood cultures ordered, Completed — Negative  \n    - CT abdomen/pelvis ordered, Completed — No obstruction or calculi  \n    - Foley catheter avoided due to intact voiding  \n    - Urology follow-up appointment ordered, Scheduled for 4 weeks  \n\n    Procedures:  \n    - CT abdomen and pelvis performed  \n    - IV antibiotics administered via peripheral line  \n    - Urine pH monitoring performed during treatment"}
{"id": "10001293", "pair_id": "40001293", "similarity": 0.5, "text": "Patient 10001293  \nGender: Female  \nAge: 41  \nRace: WHITE  \n\nAdmission 71245980  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: URINARY TRACT INFECTIONS WITH HEMATURIA, NONCOMPLICATED  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Ibuprofen 400 mg PO Q6H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Urinalysis ordered, Completed — Positive nitrites, RBCs present  \n    - Urine culture ordered, Completed — E. coli >100,000 CFU/mL  \n    - Serum creatinine panel ordered, Completed — Normal renal function  \n    - Counseling on hydration and bladder hygiene ordered, Completed  \n    - Follow-up in 2 weeks to reassess hematuria  \n\n    Procedures:  \n    - Straight catheter urine specimen collected  \n    - IV fluids administered for hydration  \n\n---\n\nAdmission 71246321  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — FOLLOW-UP EPISODE (Severity 2.0)  \n    - HCFA: NONCOMPLICATED LOWER URINARY TRACT INFECTION WITH BLEEDING  \n\n    Medications:  \n    - Cefuroxime 500 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO Q6H PRN dysuria  \n    - Probiotic supplement PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Urine culture ordered, Completed — Klebsiella pneumoniae, sensitive to cefuroxime  \n    - Post-treatment urinalysis ordered, Completed — RBCs resolved  \n    - Abdominal and pelvic ultrasound ordered, Completed — No hydronephrosis or obstruction  \n    - Preventive urology referral ordered, Completed  \n    - Education on UTI prevention strategies ordered, Completed  \n\n    Procedures:  \n    - Bladder ultrasound performed  \n    - Urinary catheterization avoided due to intact voiding  \n\n---\n\nAdmission 71247055  \n    DRGs:  \n    - APR: SEVERE CYSTITIS WITH HEMATURIA AND COMPLICATED INFECTION (Severity 3.0)  \n    - HCFA: COMPLICATED LOWER UTI WITH BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-Tazobactam 3.375 g IV Q8H × 5 days  \n    - Ciprofloxacin 500 mg PO BID × 7 days after IV antibiotics  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% IV continuous hydration  \n\n    Orders:  \n    - Blood cultures ordered, Completed — Negative growth  \n    - Urine culture ordered, Completed — E. coli ESBL-positive  \n    - CT abdomen/pelvis ordered, Completed — No renal stones, no obstruction  \n    - Hematuria evaluation via cystoscopy ordered, Completed — Mild bladder mucosal inflammation  \n    - Follow-up plan: Outpatient urology review scheduled in 3 weeks  \n\n    Procedures:  \n    - CT abdomen and pelvis performed  \n    - Diagnostic cystoscopy performed  \n    - IV antibiotics administered via peripheral line", "pair_text": "Patient 40001293  \nGender: Male  \nAge: 46  \nRace: WHITE  \n\nAdmission 78120456  \n    DRGs:  \n    - APR: RENAL CALCULUS WITH OBSTRUCTION (Severity 2.0)  \n    - HCFA: KIDNEY STONES WITHOUT MAJOR COMPLICATIONS  \n\n    Medications:  \n    - Ketorolac 15 mg IV Q6H PRN pain  \n    - Tamsulosin 0.4 mg PO daily × 7 days  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n    - Acetaminophen 650 mg PO Q6H PRN mild pain  \n    - Sodium Chloride 0.9% IV continuous infusion  \n\n    Orders:  \n    - Non-contrast CT scan ordered, Completed — 5 mm stone in right proximal ureter  \n    - Urinalysis ordered, Completed — RBCs 10/HPF, negative nitrites  \n    - Basic metabolic panel ordered, Completed — Creatinine 1.1 mg/dL  \n    - Urine straining ordered, Ongoing — Patient instructed to collect passed stones  \n    - Urology consult ordered, Completed — Outpatient follow-up planned  \n\n    Procedures:  \n    - Non-contrast CT abdomen and pelvis performed  \n    - IV hydration administered  \n    - Pain managed with IV ketorolac and oral acetaminophen  \n\n---\n\nAdmission 78121572  \n    DRGs:  \n    - APR: SYMPTOMATIC KIDNEY STONE WITH HYDRONEPHROSIS (Severity 3.0)  \n    - HCFA: URETERAL CALCULUS WITH OBSTRUCTION AND ACUTE PAIN  \n\n    Medications:  \n    - Morphine 2 mg IV Q4H PRN severe pain  \n    - Tamsulosin 0.4 mg PO daily × 10 days  \n    - Ceftriaxone 1 g IV Q24H × 3 days (prophylaxis)  \n    - Ibuprofen 600 mg PO Q6H PRN  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n\n    Orders:  \n    - KUB X-ray ordered, Completed — Confirmed persistence of 7 mm ureteral stone  \n    - Renal ultrasound ordered, Completed — Moderate right hydronephrosis  \n    - Serum creatinine ordered, Completed — 1.4 mg/dL, mild AKI noted  \n    - Pre-op evaluation ordered, Completed — Cleared for procedure  \n    - Urology procedure scheduled, Completed — Ureteroscopy planned  \n\n    Procedures:  \n    - Cystoscopy with ureteroscopy performed  \n    - Stone retrieved via basket extraction  \n    - Temporary ureteral stent placed  \n\n---\n\nAdmission 78122944  \n    DRGs:  \n    - APR: COMPLEX KIDNEY STONE MANAGEMENT WITH STENT (Severity 3.0)  \n    - HCFA: RECURRENT RENAL CALCULI WITH PROCEDURAL INTERVENTION  \n\n    Medications:  \n    - Ciprofloxacin 500 mg PO BID × 7 days (post-procedure prophylaxis)  \n    - Tamsulosin 0.4 mg PO daily × 14 days  \n    - Hydrocodone-Acetaminophen 5-325 mg PO Q6H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Follow-up KUB X-ray ordered, Completed — Stone fragments absent  \n    - Serum creatinine ordered, Completed — Normal at 1.0 mg/dL  \n    - Stent removal scheduled, Completed — Outpatient procedure after 7 days  \n    - 24-hour urine collection ordered, Completed — Elevated calcium levels detected  \n    - Diet modification counseling ordered, Completed — Low-oxalate diet recommended  \n\n    Procedures:  \n    - Ureteral stent successfully removed  \n    - Post-procedure ultrasound performed — No residual stones  \n    - Outpatient dietary counseling session completed"}
{"id": "10001293", "pair_id": "50001293", "similarity": 0.25, "text": "Patient 10001293  \nGender: Female  \nAge: 41  \nRace: WHITE  \n\nAdmission 71245980  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: URINARY TRACT INFECTIONS WITH HEMATURIA, NONCOMPLICATED  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Ibuprofen 400 mg PO Q6H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Urinalysis ordered, Completed — Positive nitrites, RBCs present  \n    - Urine culture ordered, Completed — E. coli >100,000 CFU/mL  \n    - Serum creatinine panel ordered, Completed — Normal renal function  \n    - Counseling on hydration and bladder hygiene ordered, Completed  \n    - Follow-up in 2 weeks to reassess hematuria  \n\n    Procedures:  \n    - Straight catheter urine specimen collected  \n    - IV fluids administered for hydration  \n\n---\n\nAdmission 71246321  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — FOLLOW-UP EPISODE (Severity 2.0)  \n    - HCFA: NONCOMPLICATED LOWER URINARY TRACT INFECTION WITH BLEEDING  \n\n    Medications:  \n    - Cefuroxime 500 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO Q6H PRN dysuria  \n    - Probiotic supplement PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Urine culture ordered, Completed — Klebsiella pneumoniae, sensitive to cefuroxime  \n    - Post-treatment urinalysis ordered, Completed — RBCs resolved  \n    - Abdominal and pelvic ultrasound ordered, Completed — No hydronephrosis or obstruction  \n    - Preventive urology referral ordered, Completed  \n    - Education on UTI prevention strategies ordered, Completed  \n\n    Procedures:  \n    - Bladder ultrasound performed  \n    - Urinary catheterization avoided due to intact voiding  \n\n---\n\nAdmission 71247055  \n    DRGs:  \n    - APR: SEVERE CYSTITIS WITH HEMATURIA AND COMPLICATED INFECTION (Severity 3.0)  \n    - HCFA: COMPLICATED LOWER UTI WITH BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-Tazobactam 3.375 g IV Q8H × 5 days  \n    - Ciprofloxacin 500 mg PO BID × 7 days after IV antibiotics  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% IV continuous hydration  \n\n    Orders:  \n    - Blood cultures ordered, Completed — Negative growth  \n    - Urine culture ordered, Completed — E. coli ESBL-positive  \n    - CT abdomen/pelvis ordered, Completed — No renal stones, no obstruction  \n    - Hematuria evaluation via cystoscopy ordered, Completed — Mild bladder mucosal inflammation  \n    - Follow-up plan: Outpatient urology review scheduled in 3 weeks  \n\n    Procedures:  \n    - CT abdomen and pelvis performed  \n    - Diagnostic cystoscopy performed  \n    - IV antibiotics administered via peripheral line", "pair_text": "Patient 50001293  \nGender: Male  \nAge: 52  \nRace: WHITE  \n\nAdmission 18024317  \n    DRGs:  \n    - APR: ACUTE RENAL COLIC WITHOUT OBSTRUCTION (Severity 2.0)  \n    - HCFA: RENAL CALCULI W/O CC/MCC  \n\n    Medications:  \n    - Ketorolac 30mg IV  \n    - Morphine 2mg IV PRN  \n    - Ondansetron IV  \n    - Tamsulosin 0.4mg PO  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Influenza Vaccine Quadrivalent  \n\n    Orders:  \n    - Ketorolac IV: IV, Discontinued via patient discharge  \n    - Morphine IV: IV, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Tamsulosin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Non-contrast CT abdomen/pelvis  \n    - Urinalysis with microscopy  \n    - Serum creatinine and electrolytes monitoring  \n\nAdmission 18201984  \n    DRGs:  \n    - APR: RENAL COLIC WITH URETERAL OBSTRUCTION (Severity 3.0)  \n    - HCFA: URINARY OBSTRUCTION W CC  \n\n    Medications:  \n    - Ketorolac 30mg IV  \n    - Hydromorphone 0.5mg IV PRN  \n    - Ondansetron IV  \n    - Tamsulosin 0.4mg PO  \n    - Ceftriaxone 1g IV  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n\n    Orders:  \n    - Ketorolac IV: IV, Discontinued via patient discharge  \n    - Hydromorphone IV: IV, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Tamsulosin PO: PO, Discontinued via patient discharge  \n    - Ceftriaxone IV: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT urogram  \n    - Cystoscopy with diagnostic evaluation  \n    - IV hydration and pain management  \n    - Serum creatinine monitoring  \n\nAdmission 18352749  \n    DRGs:  \n    - APR: COMPLICATED RENAL COLIC WITH SEVERE OBSTRUCTION (Severity 4.0)  \n    - HCFA: URETERAL OBSTRUCTION W MCC  \n\n    Medications:  \n    - Hydromorphone 1mg IV  \n    - Ketorolac 30mg IV  \n    - Ondansetron IV  \n    - Cefepime 2g IV  \n    - Tamsulosin 0.4mg PO  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n    - Phenazopyridine 200mg PO  \n\n    Orders:  \n    - Hydromorphone IV: IV, Discontinued via patient discharge  \n    - Ketorolac IV: IV, Discontinued via patient discharge  \n    - Ondansetron IV: IV, Discontinued via patient discharge  \n    - Cefepime IV: IV, Discontinued via patient discharge  \n    - Tamsulosin PO: PO, Discontinued via patient discharge  \n    - Phenazopyridine PO: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Ureteroscopy with laser lithotripsy  \n    - Double-J stent placement  \n    - Ultrasound-guided hydration monitoring  \n    - Follow-up renal ultrasound for resolution of obstruction"}
{"id": "10001293", "pair_id": "60001293", "similarity": 0.0, "text": "Patient 10001293  \nGender: Female  \nAge: 41  \nRace: WHITE  \n\nAdmission 71245980  \n    DRGs:  \n    - APR: ACUTE CYSTITIS WITH HEMATURIA — INITIAL PRESENTATION (Severity 2.0)  \n    - HCFA: URINARY TRACT INFECTIONS WITH HEMATURIA, NONCOMPLICATED  \n\n    Medications:  \n    - Nitrofurantoin 100 mg PO BID × 7 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Ibuprofen 400 mg PO Q6H PRN pain  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Urinalysis ordered, Completed — Positive nitrites, RBCs present  \n    - Urine culture ordered, Completed — E. coli >100,000 CFU/mL  \n    - Serum creatinine panel ordered, Completed — Normal renal function  \n    - Counseling on hydration and bladder hygiene ordered, Completed  \n    - Follow-up in 2 weeks to reassess hematuria  \n\n    Procedures:  \n    - Straight catheter urine specimen collected  \n    - IV fluids administered for hydration  \n\n---\n\nAdmission 71246321  \n    DRGs:  \n    - APR: RECURRENT CYSTITIS WITH HEMATURIA — FOLLOW-UP EPISODE (Severity 2.0)  \n    - HCFA: NONCOMPLICATED LOWER URINARY TRACT INFECTION WITH BLEEDING  \n\n    Medications:  \n    - Cefuroxime 500 mg PO BID × 10 days  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Acetaminophen 650 mg PO Q6H PRN dysuria  \n    - Probiotic supplement PO daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Urine culture ordered, Completed — Klebsiella pneumoniae, sensitive to cefuroxime  \n    - Post-treatment urinalysis ordered, Completed — RBCs resolved  \n    - Abdominal and pelvic ultrasound ordered, Completed — No hydronephrosis or obstruction  \n    - Preventive urology referral ordered, Completed  \n    - Education on UTI prevention strategies ordered, Completed  \n\n    Procedures:  \n    - Bladder ultrasound performed  \n    - Urinary catheterization avoided due to intact voiding  \n\n---\n\nAdmission 71247055  \n    DRGs:  \n    - APR: SEVERE CYSTITIS WITH HEMATURIA AND COMPLICATED INFECTION (Severity 3.0)  \n    - HCFA: COMPLICATED LOWER UTI WITH BLOOD IN URINE  \n\n    Medications:  \n    - Piperacillin-Tazobactam 3.375 g IV Q8H × 5 days  \n    - Ciprofloxacin 500 mg PO BID × 7 days after IV antibiotics  \n    - Phenazopyridine 200 mg PO TID × 2 days  \n    - Lactobacillus probiotic PO daily  \n    - Sodium Chloride 0.9% IV continuous hydration  \n\n    Orders:  \n    - Blood cultures ordered, Completed — Negative growth  \n    - Urine culture ordered, Completed — E. coli ESBL-positive  \n    - CT abdomen/pelvis ordered, Completed — No renal stones, no obstruction  \n    - Hematuria evaluation via cystoscopy ordered, Completed — Mild bladder mucosal inflammation  \n    - Follow-up plan: Outpatient urology review scheduled in 3 weeks  \n\n    Procedures:  \n    - CT abdomen and pelvis performed  \n    - Diagnostic cystoscopy performed  \n    - IV antibiotics administered via peripheral line", "pair_text": "Patient 60001293  \nGender: Female  \nAge: 29  \nRace: ASIAN  \n\nAdmission 88321017  \n    DRGs:  \n    - APR: ATOPIC DERMATITIS FLARE REQUIRING SYSTEMIC THERAPY (Severity 2.0)  \n    - HCFA: ATOPIC DERMATITIS — ACUTE EXACERBATION WITHOUT INFECTION  \n\n    Medications:  \n    - Hydrocortisone 2.5% topical cream BID × 7 days  \n    - Cetirizine 10 mg PO daily PRN itching  \n    - Aquaphor emollient topical BID  \n    - Sodium Chloride 0.9% Flush IV PRN hydration  \n    - Influenza Vaccine Quadrivalent IM  \n\n    Orders:  \n    - Skin hydration protocol ordered, Completed  \n    - Allergy panel testing ordered, Completed — Positive for dust mites and grass pollen  \n    - Topical steroid taper counseling ordered, Completed  \n    - Dermatology follow-up ordered, Scheduled for 2 weeks  \n    - Avoidance education ordered, Completed  \n\n    Procedures:  \n    - Patch testing performed — Negative for contact allergens  \n\n---\n\nAdmission 88321845  \n    DRGs:  \n    - APR: ATOPIC DERMATITIS WITH SECONDARY INFECTION (Severity 3.0)  \n    - HCFA: INFECTED ECZEMA REQUIRING ORAL ANTIBIOTICS  \n\n    Medications:  \n    - Triamcinolone 0.1% topical ointment BID × 10 days  \n    - Cephalexin 500 mg PO Q6H × 7 days  \n    - Diphenhydramine 25 mg PO QHS PRN itching  \n    - Moisturizing barrier cream topical TID  \n    - Ibuprofen 400 mg PO Q6H PRN inflammation  \n\n    Orders:  \n    - Wound culture ordered, Completed — Staphylococcus aureus, methicillin-sensitive  \n    - CBC and CRP ordered, Completed — Elevated CRP, mild leukocytosis  \n    - Dermatology referral ordered, Completed — Telemedicine review performed  \n    - Education on bleach bath protocol ordered, Completed  \n    - Antihistamine counseling ordered, Completed  \n\n    Procedures:  \n    - Wound swab culture obtained  \n    - Wet-wrap therapy initiated for severe lesions  \n\n---\n\nAdmission 88322592  \n    DRGs:  \n    - APR: CHRONIC MODERATE ATOPIC DERMATITIS — SYSTEMIC ESCALATION (Severity 3.0)  \n    - HCFA: REFRACTORY ATOPIC DERMATITIS MANAGEMENT WITH BIOLOGICS  \n\n    Medications:  \n    - Dupilumab 300 mg SC Q2 weeks × 6 months  \n    - Tacrolimus 0.1% topical ointment BID  \n    - Hydroxyzine 25 mg PO QHS for pruritus  \n    - Vitamin D3 supplement 2000 IU daily  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Baseline IgE levels ordered, Completed — Elevated at 520 IU/mL  \n    - Chest X-ray ordered, Completed — Normal, cleared for biologic therapy  \n    - Dupilumab initiation counseling ordered, Completed  \n    - Patient enrolled in eczema biologic registry, Completed  \n    - Follow-up dermatology evaluation ordered, Scheduled at 6 weeks  \n\n    Procedures:  \n    - Subcutaneous Dupilumab loading dose administered  \n    - Biologic injection technique education session completed"}
{"id": "10001294", "pair_id": "20001294", "similarity": 1.0, "text": "Patient 10001294  \nGender: Male  \nAge: 67  \nRace: WHITE  \n\nAdmission 88561432  \n    DRGs:  \n    - APR: ACUTE ON CHRONIC SYSTOLIC HEART FAILURE WITH RESPIRATORY DISTRESS (Severity 3.0)  \n    - HCFA: HEART FAILURE & SHOCK W MCC  \n\n    Medications:  \n    - Furosemide 80 mg IV BID  \n    - Carvedilol 12.5 mg PO BID  \n    - Lisinopril 10 mg PO daily  \n    - Spironolactone 25 mg PO daily  \n    - Potassium Chloride 40 mEq PO daily  \n    - Aspirin 81 mg PO daily  \n    - Atorvastatin 40 mg PO QHS  \n\n    Orders:  \n    - Echocardiogram ordered, Completed — EF 25%, global hypokinesis  \n    - BNP ordered, Completed — Elevated at 2120 pg/mL  \n    - Continuous telemetry ordered, Ongoing  \n    - Daily weights ordered, Ongoing  \n    - Low-sodium diet ordered, Ongoing  \n    - Cardiology consult ordered, Completed  \n\n    Procedures:  \n    - Chest X-ray performed — Pulmonary vascular congestion  \n    - IV diuresis initiated  \n    - Supplemental O₂ via nasal cannula started  \n\n---\n\nAdmission 88562357  \n    DRGs:  \n    - APR: ACUTE DECOMPENSATED HEART FAILURE WITH WORSENING RENAL FUNCTION (Severity 4.0)  \n    - HCFA: HEART FAILURE W CC + ACUTE KIDNEY INJURY  \n\n    Medications:  \n    - Furosemide infusion at 10 mg/hr IV  \n    - Metoprolol Succinate 25 mg PO daily  \n    - Sacubitril/Valsartan 24/26 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Dapagliflozin 10 mg PO daily  \n    - Heparin 5000 units SC Q8H prophylaxis  \n    - Acetaminophen 650 mg PO Q6H PRN  \n\n    Orders:  \n    - Renal panel ordered, Completed — BUN 42, Creatinine 1.8 mg/dL  \n    - Strict intake/output monitoring ordered, Ongoing  \n    - BNP ordered, Completed — Elevated at 3100 pg/mL  \n    - Sleep apnea screening ordered, Completed  \n    - Dietitian consult ordered, Completed — Heart failure diet reinforced  \n\n    Procedures:  \n    - Non-invasive positive pressure ventilation started for acute hypoxia  \n    - Right heart catheterization performed — Elevated pulmonary wedge pressure  \n    - Ultrasound-guided IV line placed  \n\n---\n\nAdmission 88564021  \n    DRGs:  \n    - APR: CHRONIC SYSTOLIC HEART FAILURE EXACERBATION REQUIRING ADVANCED THERAPY (Severity 4.0)  \n    - HCFA: REFRACTORY HEART FAILURE WITH PULMONARY HYPERTENSION  \n\n    Medications:  \n    - Dobutamine infusion at 5 mcg/kg/min IV  \n    - Sacubitril/Valsartan 49/51 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Furosemide 80 mg IV BID  \n    - Ivabradine 5 mg PO BID  \n    - Empagliflozin 10 mg PO daily  \n    - Magnesium Sulfate 2g IV once  \n\n    Orders:  \n    - Cardiac MRI ordered, Completed — Extensive LV remodeling  \n    - Palliative care consult ordered, Completed — Discussed advanced heart failure management  \n    - Evaluation for LVAD candidacy ordered, Completed  \n    - 6-minute walk test ordered, Completed — Marked exercise limitation  \n    - Advanced heart failure clinic follow-up ordered, Scheduled  \n\n    Procedures:  \n    - Dobutamine stress echocardiogram performed — EF remained at 22%  \n    - Swan-Ganz catheter placed for hemodynamic monitoring  \n    - Oxygen therapy escalated to high-flow nasal cannula", "pair_text": "Patient 20001294  \nGender: Male  \nAge: 70  \nRace: BLACK/AFRICAN AMERICAN  \n\nAdmission 89342115  \n    DRGs:  \n    - APR: ACUTE ON CHRONIC SYSTOLIC HEART FAILURE WITH RESPIRATORY DECOMPENSATION (Severity 3.0)  \n    - HCFA: HEART FAILURE & SHOCK W MCC  \n\n    Medications:  \n    - Furosemide 80 mg IV BID  \n    - Carvedilol 6.25 mg PO BID  \n    - Lisinopril 5 mg PO daily  \n    - Spironolactone 25 mg PO daily  \n    - Potassium Chloride 40 mEq PO daily  \n    - Atorvastatin 40 mg PO QHS  \n    - Aspirin 81 mg PO daily  \n\n    Orders:  \n    - Echocardiogram ordered, Completed — EF 30%, global hypokinesis  \n    - BNP ordered, Completed — 1950 pg/mL  \n    - Cardiology consult ordered, Completed  \n    - Continuous telemetry ordered, Ongoing  \n    - Daily weights and strict intake/output monitoring ordered, Ongoing  \n    - 2g sodium restriction and 1.5L fluid restriction ordered  \n\n    Procedures:  \n    - Chest X-ray performed — Cardiomegaly with pulmonary edema  \n    - IV diuresis initiated  \n    - Oxygen therapy started via nasal cannula  \n\n---\n\nAdmission 89342877  \n    DRGs:  \n    - APR: ACUTE DECOMPENSATED HEART FAILURE WITH CONCURRENT RENAL DYSFUNCTION (Severity 4.0)  \n    - HCFA: ACUTE ON CHRONIC HEART FAILURE W CC & KIDNEY IMPAIRMENT  \n\n    Medications:  \n    - Furosemide infusion at 10 mg/hr IV  \n    - Sacubitril/Valsartan 24/26 mg PO BID  \n    - Metoprolol Succinate 25 mg PO daily  \n    - Spironolactone 25 mg PO daily  \n    - Empagliflozin 10 mg PO daily  \n    - Heparin 5000 units SC Q8H prophylaxis  \n    - Acetaminophen 650 mg PO Q6H PRN  \n\n    Orders:  \n    - Renal function panel ordered, Completed — BUN 46, Creatinine 1.9 mg/dL  \n    - BNP ordered, Completed — 2840 pg/mL  \n    - Strict fluid balance and daily labs ordered, Ongoing  \n    - Nephrology consult ordered, Completed  \n    - Heart failure education session ordered, Completed  \n\n    Procedures:  \n    - Right heart catheterization performed — Elevated PCWP 28 mmHg  \n    - Non-invasive positive pressure ventilation started  \n    - IV access upgraded to midline catheter  \n\n---\n\nAdmission 89343520  \n    DRGs:  \n    - APR: ADVANCED SYSTOLIC HEART FAILURE WITH REFRACTORY SYMPTOMS (Severity 4.0)  \n    - HCFA: CHRONIC SYSTOLIC HEART FAILURE WORSENING — LVAD EVALUATION  \n\n    Medications:  \n    - Dobutamine infusion at 5 mcg/kg/min IV  \n    - Sacubitril/Valsartan 49/51 mg PO BID  \n    - Furosemide 80 mg IV TID  \n    - Spironolactone 25 mg PO daily  \n    - Ivabradine 5 mg PO BID  \n    - Empagliflozin 10 mg PO daily  \n    - Magnesium Sulfate 2g IV once  \n\n    Orders:  \n    - Cardiac MRI ordered, Completed — Marked LV dilation, EF 22%  \n    - Evaluation for LVAD candidacy ordered, Completed  \n    - Palliative care consult ordered, Completed  \n    - Dietary sodium restriction reinforced, Ongoing  \n    - 6-minute walk test ordered, Completed — Severe limitation  \n\n    Procedures:  \n    - Dobutamine stress echocardiogram performed — EF remained at 20%  \n    - Swan-Ganz catheter inserted for hemodynamic monitoring  \n    - Oxygen therapy escalated to high-flow nasal cannula"}
{"id": "10001294", "pair_id": "30001294", "similarity": 0.75, "text": "Patient 10001294  \nGender: Male  \nAge: 67  \nRace: WHITE  \n\nAdmission 88561432  \n    DRGs:  \n    - APR: ACUTE ON CHRONIC SYSTOLIC HEART FAILURE WITH RESPIRATORY DISTRESS (Severity 3.0)  \n    - HCFA: HEART FAILURE & SHOCK W MCC  \n\n    Medications:  \n    - Furosemide 80 mg IV BID  \n    - Carvedilol 12.5 mg PO BID  \n    - Lisinopril 10 mg PO daily  \n    - Spironolactone 25 mg PO daily  \n    - Potassium Chloride 40 mEq PO daily  \n    - Aspirin 81 mg PO daily  \n    - Atorvastatin 40 mg PO QHS  \n\n    Orders:  \n    - Echocardiogram ordered, Completed — EF 25%, global hypokinesis  \n    - BNP ordered, Completed — Elevated at 2120 pg/mL  \n    - Continuous telemetry ordered, Ongoing  \n    - Daily weights ordered, Ongoing  \n    - Low-sodium diet ordered, Ongoing  \n    - Cardiology consult ordered, Completed  \n\n    Procedures:  \n    - Chest X-ray performed — Pulmonary vascular congestion  \n    - IV diuresis initiated  \n    - Supplemental O₂ via nasal cannula started  \n\n---\n\nAdmission 88562357  \n    DRGs:  \n    - APR: ACUTE DECOMPENSATED HEART FAILURE WITH WORSENING RENAL FUNCTION (Severity 4.0)  \n    - HCFA: HEART FAILURE W CC + ACUTE KIDNEY INJURY  \n\n    Medications:  \n    - Furosemide infusion at 10 mg/hr IV  \n    - Metoprolol Succinate 25 mg PO daily  \n    - Sacubitril/Valsartan 24/26 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Dapagliflozin 10 mg PO daily  \n    - Heparin 5000 units SC Q8H prophylaxis  \n    - Acetaminophen 650 mg PO Q6H PRN  \n\n    Orders:  \n    - Renal panel ordered, Completed — BUN 42, Creatinine 1.8 mg/dL  \n    - Strict intake/output monitoring ordered, Ongoing  \n    - BNP ordered, Completed — Elevated at 3100 pg/mL  \n    - Sleep apnea screening ordered, Completed  \n    - Dietitian consult ordered, Completed — Heart failure diet reinforced  \n\n    Procedures:  \n    - Non-invasive positive pressure ventilation started for acute hypoxia  \n    - Right heart catheterization performed — Elevated pulmonary wedge pressure  \n    - Ultrasound-guided IV line placed  \n\n---\n\nAdmission 88564021  \n    DRGs:  \n    - APR: CHRONIC SYSTOLIC HEART FAILURE EXACERBATION REQUIRING ADVANCED THERAPY (Severity 4.0)  \n    - HCFA: REFRACTORY HEART FAILURE WITH PULMONARY HYPERTENSION  \n\n    Medications:  \n    - Dobutamine infusion at 5 mcg/kg/min IV  \n    - Sacubitril/Valsartan 49/51 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Furosemide 80 mg IV BID  \n    - Ivabradine 5 mg PO BID  \n    - Empagliflozin 10 mg PO daily  \n    - Magnesium Sulfate 2g IV once  \n\n    Orders:  \n    - Cardiac MRI ordered, Completed — Extensive LV remodeling  \n    - Palliative care consult ordered, Completed — Discussed advanced heart failure management  \n    - Evaluation for LVAD candidacy ordered, Completed  \n    - 6-minute walk test ordered, Completed — Marked exercise limitation  \n    - Advanced heart failure clinic follow-up ordered, Scheduled  \n\n    Procedures:  \n    - Dobutamine stress echocardiogram performed — EF remained at 22%  \n    - Swan-Ganz catheter placed for hemodynamic monitoring  \n    - Oxygen therapy escalated to high-flow nasal cannula", "pair_text": "Patient 30001294  \nGender: Male  \nAge: 73  \nRace: WHITE  \n\nAdmission 77451236  \n    DRGs:  \n    - APR: UNSPECIFIED HEART FAILURE EXACERBATION (Severity 2.0)  \n    - HCFA: HEART FAILURE, UNSPECIFIED W CC  \n\n    Medications:  \n    - Furosemide 40 mg IV BID  \n    - Lisinopril 10 mg PO daily  \n    - Metoprolol Tartrate 25 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Aspirin 81 mg PO daily  \n    - Atorvastatin 20 mg PO QHS  \n    - Potassium Chloride 20 mEq PO daily  \n\n    Orders:  \n    - BNP ordered, Completed — 950 pg/mL  \n    - Echocardiogram ordered, Completed — EF 45%  \n    - Continuous telemetry monitoring ordered, Ongoing  \n    - Daily weights and strict fluid balance monitoring ordered  \n    - 2g sodium restriction and 1.5L fluid restriction ordered  \n    - Cardiology consult ordered, Completed  \n\n    Procedures:  \n    - Chest X-ray performed — Mild pulmonary edema  \n    - IV diuresis initiated  \n    - Oxygen via nasal cannula started  \n\n---\n\nAdmission 77452690  \n    DRGs:  \n    - APR: RECURRENT HEART FAILURE EXACERBATION WITH DYSPNEA (Severity 3.0)  \n    - HCFA: UNSPECIFIED HEART FAILURE WORSENING  \n\n    Medications:  \n    - Furosemide infusion 8 mg/hr IV  \n    - Sacubitril/Valsartan 24/26 mg PO BID  \n    - Metoprolol Succinate 50 mg PO daily  \n    - Spironolactone 25 mg PO daily  \n    - Dapagliflozin 10 mg PO daily  \n    - Heparin 5000 units SC Q8H prophylaxis  \n    - Acetaminophen 650 mg PO Q6H PRN  \n\n    Orders:  \n    - BNP ordered, Completed — 1600 pg/mL  \n    - Basic metabolic panel ordered, Completed — Mild hyponatremia at 131 mmol/L  \n    - Cardiology follow-up ordered, Completed  \n    - 24-hour urine output monitoring ordered, Ongoing  \n    - Low-sodium diet reinforced, Ongoing  \n    - Advanced care planning discussion scheduled, Pending  \n\n    Procedures:  \n    - Non-invasive positive pressure ventilation initiated for dyspnea  \n    - Ultrasound-guided IV line placement performed  \n    - Cardiac stress test ordered, Completed — Ischemia ruled out  \n\n---\n\nAdmission 77453344  \n    DRGs:  \n    - APR: CHRONIC HEART FAILURE WITH MULTIFACTORIAL DECOMPENSATION (Severity 3.0)  \n    - HCFA: UNSPECIFIED HEART FAILURE — PROGRESSIVE SYMPTOMS  \n\n    Medications:  \n    - Furosemide 80 mg IV BID  \n    - Sacubitril/Valsartan 49/51 mg PO BID  \n    - Ivabradine 5 mg PO BID  \n    - Empagliflozin 10 mg PO daily  \n    - Spironolactone 25 mg PO daily  \n    - Magnesium Sulfate 2g IV once  \n    - Aspirin 81 mg PO daily  \n\n    Orders:  \n    - Cardiac MRI ordered, Completed — EF 35%, moderate global hypokinesis  \n    - Advanced heart failure clinic referral ordered, Completed  \n    - Daily weights and input/output monitoring ordered  \n    - Telemetry monitoring ordered, Ongoing  \n    - Education on fluid and sodium management provided  \n\n    Procedures:  \n    - Swan-Ganz catheter inserted for hemodynamic monitoring  \n    - Dobutamine stress echocardiogram performed — EF remained stable  \n    - Oxygen therapy escalated to high-flow nasal cannula"}
{"id": "10001294", "pair_id": "40001294", "similarity": 0.5, "text": "Patient 10001294  \nGender: Male  \nAge: 67  \nRace: WHITE  \n\nAdmission 88561432  \n    DRGs:  \n    - APR: ACUTE ON CHRONIC SYSTOLIC HEART FAILURE WITH RESPIRATORY DISTRESS (Severity 3.0)  \n    - HCFA: HEART FAILURE & SHOCK W MCC  \n\n    Medications:  \n    - Furosemide 80 mg IV BID  \n    - Carvedilol 12.5 mg PO BID  \n    - Lisinopril 10 mg PO daily  \n    - Spironolactone 25 mg PO daily  \n    - Potassium Chloride 40 mEq PO daily  \n    - Aspirin 81 mg PO daily  \n    - Atorvastatin 40 mg PO QHS  \n\n    Orders:  \n    - Echocardiogram ordered, Completed — EF 25%, global hypokinesis  \n    - BNP ordered, Completed — Elevated at 2120 pg/mL  \n    - Continuous telemetry ordered, Ongoing  \n    - Daily weights ordered, Ongoing  \n    - Low-sodium diet ordered, Ongoing  \n    - Cardiology consult ordered, Completed  \n\n    Procedures:  \n    - Chest X-ray performed — Pulmonary vascular congestion  \n    - IV diuresis initiated  \n    - Supplemental O₂ via nasal cannula started  \n\n---\n\nAdmission 88562357  \n    DRGs:  \n    - APR: ACUTE DECOMPENSATED HEART FAILURE WITH WORSENING RENAL FUNCTION (Severity 4.0)  \n    - HCFA: HEART FAILURE W CC + ACUTE KIDNEY INJURY  \n\n    Medications:  \n    - Furosemide infusion at 10 mg/hr IV  \n    - Metoprolol Succinate 25 mg PO daily  \n    - Sacubitril/Valsartan 24/26 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Dapagliflozin 10 mg PO daily  \n    - Heparin 5000 units SC Q8H prophylaxis  \n    - Acetaminophen 650 mg PO Q6H PRN  \n\n    Orders:  \n    - Renal panel ordered, Completed — BUN 42, Creatinine 1.8 mg/dL  \n    - Strict intake/output monitoring ordered, Ongoing  \n    - BNP ordered, Completed — Elevated at 3100 pg/mL  \n    - Sleep apnea screening ordered, Completed  \n    - Dietitian consult ordered, Completed — Heart failure diet reinforced  \n\n    Procedures:  \n    - Non-invasive positive pressure ventilation started for acute hypoxia  \n    - Right heart catheterization performed — Elevated pulmonary wedge pressure  \n    - Ultrasound-guided IV line placed  \n\n---\n\nAdmission 88564021  \n    DRGs:  \n    - APR: CHRONIC SYSTOLIC HEART FAILURE EXACERBATION REQUIRING ADVANCED THERAPY (Severity 4.0)  \n    - HCFA: REFRACTORY HEART FAILURE WITH PULMONARY HYPERTENSION  \n\n    Medications:  \n    - Dobutamine infusion at 5 mcg/kg/min IV  \n    - Sacubitril/Valsartan 49/51 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Furosemide 80 mg IV BID  \n    - Ivabradine 5 mg PO BID  \n    - Empagliflozin 10 mg PO daily  \n    - Magnesium Sulfate 2g IV once  \n\n    Orders:  \n    - Cardiac MRI ordered, Completed — Extensive LV remodeling  \n    - Palliative care consult ordered, Completed — Discussed advanced heart failure management  \n    - Evaluation for LVAD candidacy ordered, Completed  \n    - 6-minute walk test ordered, Completed — Marked exercise limitation  \n    - Advanced heart failure clinic follow-up ordered, Scheduled  \n\n    Procedures:  \n    - Dobutamine stress echocardiogram performed — EF remained at 22%  \n    - Swan-Ganz catheter placed for hemodynamic monitoring  \n    - Oxygen therapy escalated to high-flow nasal cannula", "pair_text": "Patient 40001294  \nGender: Male  \nAge: 68  \nRace: WHITE  \n\nAdmission 67215432  \n    DRGs:  \n    - APR: ATHEROSCLEROTIC HEART DISEASE WITHOUT ANGINA — INITIAL MANAGEMENT (Severity 1.0)  \n    - HCFA: CORONARY ATHEROSCLEROSIS W/O ACUTE CORONARY SYNDROME  \n\n    Medications:  \n    - Atorvastatin 40 mg PO QHS  \n    - Aspirin 81 mg PO daily  \n    - Metoprolol Succinate 25 mg PO daily  \n    - Lisinopril 10 mg PO daily  \n    - Nitroglycerin 0.4 mg SL PRN chest discomfort  \n    - Omega-3 Acid Ethyl Esters 2g PO daily  \n\n    Orders:  \n    - Lipid panel ordered, Completed — LDL 152 mg/dL  \n    - ECG ordered, Completed — Normal sinus rhythm  \n    - Cardiology referral ordered, Completed  \n    - Dietary consult ordered, Completed  \n    - 6-month follow-up stress testing scheduled  \n\n    Procedures:  \n    - Transthoracic echocardiogram performed — EF 55%, no wall motion abnormality  \n    - Carotid duplex ultrasound performed — No significant stenosis  \n\n---\n\nAdmission 67216218  \n    DRGs:  \n    - APR: ATHEROSCLEROSIS WITH HIGH CARDIOVASCULAR RISK FACTORS (Severity 2.0)  \n    - HCFA: CORONARY ATHEROSCLEROSIS W MULTIPLE CO-MORBIDITIES  \n\n    Medications:  \n    - Rosuvastatin 20 mg PO QHS  \n    - Aspirin 81 mg PO daily  \n    - Metoprolol Succinate 50 mg PO daily  \n    - Ezetimibe 10 mg PO daily  \n    - Lisinopril 20 mg PO daily  \n    - Empagliflozin 10 mg PO daily  \n\n    Orders:  \n    - CT coronary calcium scoring ordered, Completed — Agatston score 230  \n    - HbA1c ordered, Completed — 7.1%  \n    - Nutrition counseling for heart-healthy diet provided, Completed  \n    - Smoking cessation program referral ordered, Completed  \n    - Annual cardiology surveillance visit scheduled  \n\n    Procedures:  \n    - Coronary CT angiography performed — Mild diffuse coronary plaque, no obstruction  \n    - Carotid intima-media thickness (IMT) study performed for vascular risk profiling  \n\n---\n\nAdmission 67217893  \n    DRGs:  \n    - APR: ADVANCED ATHEROSCLEROTIC HEART DISEASE MANAGEMENT (Severity 3.0)  \n    - HCFA: CHRONIC CORONARY ARTERY DISEASE — MULTIPLE INTERVENTION PLANNING  \n\n    Medications:  \n    - Rosuvastatin 40 mg PO QHS  \n    - Aspirin 81 mg PO daily  \n    - Clopidogrel 75 mg PO daily  \n    - Metoprolol Succinate 50 mg PO daily  \n    - Lisinopril 20 mg PO daily  \n    - Ezetimibe 10 mg PO daily  \n    - Nitroglycerin 0.4 mg SL PRN  \n\n    Orders:  \n    - Stress echocardiogram ordered, Completed — Mild inferior hypokinesis, no ischemia  \n    - High-sensitivity CRP ordered, Completed — 5.8 mg/L (elevated)  \n    - Repeat coronary risk stratification ordered, Completed  \n    - Education on medication adherence and lifestyle modification provided  \n    - Cardiovascular rehab referral ordered, Completed  \n\n    Procedures:  \n    - Coronary calcium score re-evaluated — Increased to 290  \n    - Non-invasive fractional flow reserve CT performed — No hemodynamically significant lesions  \n    - Exercise treadmill test performed — Low-risk Duke treadmill score"}
{"id": "10001294", "pair_id": "50001294", "similarity": 0.25, "text": "Patient 10001294  \nGender: Male  \nAge: 67  \nRace: WHITE  \n\nAdmission 88561432  \n    DRGs:  \n    - APR: ACUTE ON CHRONIC SYSTOLIC HEART FAILURE WITH RESPIRATORY DISTRESS (Severity 3.0)  \n    - HCFA: HEART FAILURE & SHOCK W MCC  \n\n    Medications:  \n    - Furosemide 80 mg IV BID  \n    - Carvedilol 12.5 mg PO BID  \n    - Lisinopril 10 mg PO daily  \n    - Spironolactone 25 mg PO daily  \n    - Potassium Chloride 40 mEq PO daily  \n    - Aspirin 81 mg PO daily  \n    - Atorvastatin 40 mg PO QHS  \n\n    Orders:  \n    - Echocardiogram ordered, Completed — EF 25%, global hypokinesis  \n    - BNP ordered, Completed — Elevated at 2120 pg/mL  \n    - Continuous telemetry ordered, Ongoing  \n    - Daily weights ordered, Ongoing  \n    - Low-sodium diet ordered, Ongoing  \n    - Cardiology consult ordered, Completed  \n\n    Procedures:  \n    - Chest X-ray performed — Pulmonary vascular congestion  \n    - IV diuresis initiated  \n    - Supplemental O₂ via nasal cannula started  \n\n---\n\nAdmission 88562357  \n    DRGs:  \n    - APR: ACUTE DECOMPENSATED HEART FAILURE WITH WORSENING RENAL FUNCTION (Severity 4.0)  \n    - HCFA: HEART FAILURE W CC + ACUTE KIDNEY INJURY  \n\n    Medications:  \n    - Furosemide infusion at 10 mg/hr IV  \n    - Metoprolol Succinate 25 mg PO daily  \n    - Sacubitril/Valsartan 24/26 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Dapagliflozin 10 mg PO daily  \n    - Heparin 5000 units SC Q8H prophylaxis  \n    - Acetaminophen 650 mg PO Q6H PRN  \n\n    Orders:  \n    - Renal panel ordered, Completed — BUN 42, Creatinine 1.8 mg/dL  \n    - Strict intake/output monitoring ordered, Ongoing  \n    - BNP ordered, Completed — Elevated at 3100 pg/mL  \n    - Sleep apnea screening ordered, Completed  \n    - Dietitian consult ordered, Completed — Heart failure diet reinforced  \n\n    Procedures:  \n    - Non-invasive positive pressure ventilation started for acute hypoxia  \n    - Right heart catheterization performed — Elevated pulmonary wedge pressure  \n    - Ultrasound-guided IV line placed  \n\n---\n\nAdmission 88564021  \n    DRGs:  \n    - APR: CHRONIC SYSTOLIC HEART FAILURE EXACERBATION REQUIRING ADVANCED THERAPY (Severity 4.0)  \n    - HCFA: REFRACTORY HEART FAILURE WITH PULMONARY HYPERTENSION  \n\n    Medications:  \n    - Dobutamine infusion at 5 mcg/kg/min IV  \n    - Sacubitril/Valsartan 49/51 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Furosemide 80 mg IV BID  \n    - Ivabradine 5 mg PO BID  \n    - Empagliflozin 10 mg PO daily  \n    - Magnesium Sulfate 2g IV once  \n\n    Orders:  \n    - Cardiac MRI ordered, Completed — Extensive LV remodeling  \n    - Palliative care consult ordered, Completed — Discussed advanced heart failure management  \n    - Evaluation for LVAD candidacy ordered, Completed  \n    - 6-minute walk test ordered, Completed — Marked exercise limitation  \n    - Advanced heart failure clinic follow-up ordered, Scheduled  \n\n    Procedures:  \n    - Dobutamine stress echocardiogram performed — EF remained at 22%  \n    - Swan-Ganz catheter placed for hemodynamic monitoring  \n    - Oxygen therapy escalated to high-flow nasal cannula", "pair_text": "Patient 50001294  \nGender: Male  \nAge: 58  \nRace: WHITE  \n\nAdmission 19054231  \n    DRGs:  \n    - APR: HYPERLIPIDEMIA WITHOUT COMPLICATIONS (Severity 1.0)  \n    - HCFA: LIPID METABOLISM DISORDERS W/O CC/MCC  \n\n    Medications:  \n    - Atorvastatin 20mg PO  \n    - Aspirin 81mg PO  \n    - Sodium Chloride 0.9% Flush  \n    - Vitamin D3 Supplement  \n    - Influenza Vaccine Quadrivalent  \n    - Acetaminophen  \n\n    Orders:  \n    - Atorvastatin: PO, Discontinued via patient discharge  \n    - Aspirin 81mg: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Vitamin D3 Supplement: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Fasting lipid panel  \n    - HbA1c screening  \n    - Dietitian counseling on low-fat diet  \n\nAdmission 19185762  \n    DRGs:  \n    - APR: MIXED HYPERLIPIDEMIA WITH CARDIOVASCULAR RISK (Severity 2.0)  \n    - HCFA: LIPID METABOLISM DISORDERS W CC  \n\n    Medications:  \n    - Rosuvastatin 10mg PO  \n    - Ezetimibe 10mg PO  \n    - Aspirin 81mg PO  \n    - Fish Oil 1g PO  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n\n    Orders:  \n    - Rosuvastatin: PO, Discontinued via patient discharge  \n    - Ezetimibe: PO, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Fish Oil Supplement: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Echocardiogram for CV risk assessment  \n    - Exercise stress test  \n    - Dietary consultation with cholesterol reduction planning  \n\nAdmission 19309217  \n    DRGs:  \n    - APR: SEVERE HYPERLIPIDEMIA WITH ORGAN COMPLICATIONS (Severity 3.0)  \n    - HCFA: LIPID METABOLISM DISORDERS W MCC  \n\n    Medications:  \n    - Rosuvastatin 20mg PO  \n    - Evolocumab (Repatha) 140mg SC every 2 weeks  \n    - Aspirin 81mg PO  \n    - Omega-3 Fatty Acids 2g PO  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n\n    Orders:  \n    - Rosuvastatin: PO, Discontinued via patient discharge  \n    - Evolocumab: SC, Discontinued via patient discharge  \n    - Aspirin: PO, Discontinued via patient discharge  \n    - Omega-3 Fatty Acids: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Coronary CT angiography  \n    - Carotid Doppler ultrasound for plaque burden  \n    - Advanced lipid fractionation testing  \n    - Referral to lipid specialist for long-term management"}
{"id": "10001294", "pair_id": "60001294", "similarity": 0.0, "text": "Patient 10001294  \nGender: Male  \nAge: 67  \nRace: WHITE  \n\nAdmission 88561432  \n    DRGs:  \n    - APR: ACUTE ON CHRONIC SYSTOLIC HEART FAILURE WITH RESPIRATORY DISTRESS (Severity 3.0)  \n    - HCFA: HEART FAILURE & SHOCK W MCC  \n\n    Medications:  \n    - Furosemide 80 mg IV BID  \n    - Carvedilol 12.5 mg PO BID  \n    - Lisinopril 10 mg PO daily  \n    - Spironolactone 25 mg PO daily  \n    - Potassium Chloride 40 mEq PO daily  \n    - Aspirin 81 mg PO daily  \n    - Atorvastatin 40 mg PO QHS  \n\n    Orders:  \n    - Echocardiogram ordered, Completed — EF 25%, global hypokinesis  \n    - BNP ordered, Completed — Elevated at 2120 pg/mL  \n    - Continuous telemetry ordered, Ongoing  \n    - Daily weights ordered, Ongoing  \n    - Low-sodium diet ordered, Ongoing  \n    - Cardiology consult ordered, Completed  \n\n    Procedures:  \n    - Chest X-ray performed — Pulmonary vascular congestion  \n    - IV diuresis initiated  \n    - Supplemental O₂ via nasal cannula started  \n\n---\n\nAdmission 88562357  \n    DRGs:  \n    - APR: ACUTE DECOMPENSATED HEART FAILURE WITH WORSENING RENAL FUNCTION (Severity 4.0)  \n    - HCFA: HEART FAILURE W CC + ACUTE KIDNEY INJURY  \n\n    Medications:  \n    - Furosemide infusion at 10 mg/hr IV  \n    - Metoprolol Succinate 25 mg PO daily  \n    - Sacubitril/Valsartan 24/26 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Dapagliflozin 10 mg PO daily  \n    - Heparin 5000 units SC Q8H prophylaxis  \n    - Acetaminophen 650 mg PO Q6H PRN  \n\n    Orders:  \n    - Renal panel ordered, Completed — BUN 42, Creatinine 1.8 mg/dL  \n    - Strict intake/output monitoring ordered, Ongoing  \n    - BNP ordered, Completed — Elevated at 3100 pg/mL  \n    - Sleep apnea screening ordered, Completed  \n    - Dietitian consult ordered, Completed — Heart failure diet reinforced  \n\n    Procedures:  \n    - Non-invasive positive pressure ventilation started for acute hypoxia  \n    - Right heart catheterization performed — Elevated pulmonary wedge pressure  \n    - Ultrasound-guided IV line placed  \n\n---\n\nAdmission 88564021  \n    DRGs:  \n    - APR: CHRONIC SYSTOLIC HEART FAILURE EXACERBATION REQUIRING ADVANCED THERAPY (Severity 4.0)  \n    - HCFA: REFRACTORY HEART FAILURE WITH PULMONARY HYPERTENSION  \n\n    Medications:  \n    - Dobutamine infusion at 5 mcg/kg/min IV  \n    - Sacubitril/Valsartan 49/51 mg PO BID  \n    - Spironolactone 25 mg PO daily  \n    - Furosemide 80 mg IV BID  \n    - Ivabradine 5 mg PO BID  \n    - Empagliflozin 10 mg PO daily  \n    - Magnesium Sulfate 2g IV once  \n\n    Orders:  \n    - Cardiac MRI ordered, Completed — Extensive LV remodeling  \n    - Palliative care consult ordered, Completed — Discussed advanced heart failure management  \n    - Evaluation for LVAD candidacy ordered, Completed  \n    - 6-minute walk test ordered, Completed — Marked exercise limitation  \n    - Advanced heart failure clinic follow-up ordered, Scheduled  \n\n    Procedures:  \n    - Dobutamine stress echocardiogram performed — EF remained at 22%  \n    - Swan-Ganz catheter placed for hemodynamic monitoring  \n    - Oxygen therapy escalated to high-flow nasal cannula", "pair_text": "Patient 60001294  \nGender: Male  \nAge: 34  \nRace: WHITE  \n\nAdmission 89342107  \n    DRGs:  \n    - APR: ACUTE APPENDICITIS WITHOUT PERFORATION OR PERITONITIS (Severity 2.0)  \n    - HCFA: SIMPLE APPENDECTOMY W/O COMPLICATIONS  \n\n    Medications:  \n    - Ceftriaxone 2 g IV q24h  \n    - Metronidazole 500 mg IV q8h  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Ondansetron 4 mg IV q8h PRN  \n    - Sodium Chloride 0.9% IV fluids at 100 mL/hr  \n\n    Orders:  \n    - CT Abdomen/Pelvis with contrast ordered, Completed — Findings consistent with acute appendicitis  \n    - NPO status ordered pre-operatively  \n    - Surgical consult ordered, Completed  \n    - Pre-operative labs ordered, Completed — WBC 14.8K  \n    - Sequential compression devices for DVT prophylaxis ordered  \n    - Post-operative pain control with IV acetaminophen and oxycodone ordered  \n\n    Procedures:  \n    - Laparoscopic appendectomy performed successfully  \n    - Pathology confirmed inflamed appendix without perforation  \n    - Post-op wound care provided  \n\n---\n\nAdmission 89343215  \n    DRGs:  \n    - APR: POST-OPERATIVE SURVEILLANCE AND INFECTION PREVENTION (Severity 1.0)  \n    - HCFA: ROUTINE FOLLOW-UP AFTER APPENDECTOMY  \n\n    Medications:  \n    - Amoxicillin-Clavulanate 875 mg PO BID for 5 days  \n    - Acetaminophen 650 mg PO q6h PRN  \n    - Ibuprofen 400 mg PO q8h PRN  \n    - Ondansetron 4 mg PO q8h PRN  \n\n    Orders:  \n    - Follow-up wound inspection scheduled, Completed — No erythema or drainage  \n    - Post-op diet advancement ordered, Completed  \n    - Outpatient follow-up visit scheduled for suture removal in 10 days  \n    - Return-to-work clearance provided after 2 weeks  \n    - Activity restriction order — No lifting >10 lbs for 4 weeks  \n\n    Procedures:  \n    - Suture removal performed at follow-up  \n    - Abdominal ultrasound at 2 weeks — No post-op abscess or fluid collection  \n\n---\n\nAdmission 89344981  \n    DRGs:  \n    - APR: UNCOMPLICATED ABDOMINAL PAIN EVALUATION POST-SURGERY (Severity 1.0)  \n    - HCFA: OBSERVATION FOR POSSIBLE POST-OPERATIVE COMPLICATION  \n\n    Medications:  \n    - IV Fluids: Lactated Ringer’s at 75 mL/hr  \n    - Ondansetron 4 mg IV PRN  \n    - Ketorolac 15 mg IV q6h PRN  \n\n    Orders:  \n    - CT Abdomen ordered, Completed — No intra-abdominal collection, normal post-op changes  \n    - Basic metabolic panel ordered, Completed — Within normal limits  \n    - Observed for 24 hours for possible post-op ileus  \n    - Discharged with instructions to return if fever, worsening pain, or drainage  \n\n    Procedures:  \n    - Repeat abdominal exam performed — Soft, non-tender  \n    - No intervention required"}
{"id": "10001295", "pair_id": "20001295", "similarity": 1.0, "text": "Patient 10001295  \nGender: Female  \nAge: 64  \nRace: WHITE  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY — ACUTE EPISODE MANAGEMENT (Severity 3.0)  \n    - HCFA: METABOLIC DISORDERS W MCC  \n\n    Medications:  \n    - Lactulose 30 mL PO Q6H  \n    - Rifaximin 550 mg PO BID  \n    - Sodium Bicarbonate 50 mEq IV Q8H  \n    - Thiamine 100 mg IV daily  \n    - Potassium Chloride 20 mEq IV PRN hypokalemia  \n    - Furosemide 20 mg IV daily  \n    - Sodium Chloride 0.9% IV fluids at 75 mL/hr  \n    - Insulin regular sliding scale for hyperglycemia  \n\n    Orders:  \n    - Comprehensive metabolic panel ordered, Completed — Ammonia 122 µmol/L, Na+ 128 mmol/L  \n    - Arterial blood gas ordered, Completed — pH 7.28, HCO₃ 17  \n    - Neurology consult ordered, Completed  \n    - Non-contrast CT Head ordered, Completed — No acute intracranial process  \n    - EEG ordered, Completed — Mild generalized slowing consistent with encephalopathy  \n    - Initiate neuro checks q2h  \n    - Strict I/O monitoring and daily weights  \n\n    Procedures:  \n    - Central venous catheter placement for IV medication access  \n    - Non-invasive brain monitoring during acute episode  \n\n---\n\nAdmission 78125912  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY WITH ELECTROLYTE DERANGEMENTS (Severity 2.0)  \n    - HCFA: COMPLICATED METABOLIC DISORDERS W/O RENAL FAILURE  \n\n    Medications:  \n    - Lactulose 30 mL PO TID  \n    - Rifaximin 550 mg PO BID  \n    - Magnesium Sulfate 2g IV PRN  \n    - Vitamin B12 1000 mcg IM weekly  \n    - Sodium Chloride 0.9% IV bolus PRN dehydration  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - Repeat ammonia levels ordered, Completed — Improved to 78 µmol/L  \n    - MRI Brain ordered, Completed — No structural abnormalities  \n    - Glucose monitoring Q6H ordered  \n    - Dietitian consult ordered, Completed  \n    - Liver function panel ordered, Completed — ALT 68, AST 72  \n\n    Procedures:  \n    - Continuous EEG monitoring for 24 hours  \n    - Bedside swallow study performed — Safe for oral intake  \n\n---\n\nAdmission 78127145  \n    DRGs:  \n    - APR: POST-ACUTE FOLLOW-UP OF METABOLIC ENCEPHALOPATHY (Severity 1.0)  \n    - HCFA: OBSERVATION AND COGNITIVE RECOVERY MANAGEMENT  \n\n    Medications:  \n    - Lactulose 20 mL PO BID  \n    - Rifaximin 550 mg PO daily  \n    - Thiamine 100 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Neurocognitive testing ordered, Completed — Mild residual short-term memory impairment  \n    - Discharge referral to outpatient neurology ordered, Completed  \n    - Sleep hygiene counseling provided, Completed  \n    - Diet modified to low-protein regimen per hepatology recommendations  \n\n    Procedures:  \n    - Outpatient EEG follow-up performed — Normalized background activity  \n    - Repeat cognitive evaluation performed at 3 weeks", "pair_text": "Patient 20001295  \nGender: Male  \nAge: 68  \nRace: WHITE  \n\nAdmission 77483210  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY WITH ACUTE ORGAN DYSFUNCTION (Severity 4.0)  \n    - HCFA: METABOLIC DISORDERS W MCC  \n\n    Medications:  \n    - Lactulose 30 mL PO Q6H  \n    - Rifaximin 550 mg PO BID  \n    - Sodium Bicarbonate 50 mEq IV Q8H  \n    - Potassium Chloride 20 mEq IV PRN hypokalemia  \n    - Thiamine 100 mg IV daily  \n    - Furosemide 20 mg IV daily  \n    - Sodium Chloride 0.9% IV fluids at 75 mL/hr  \n    - Insulin regular sliding scale for hyperglycemia  \n    - Ceftriaxone 1 g IV Q24H (empiric for possible infection)  \n\n    Orders:  \n    - Comprehensive metabolic panel ordered, Completed — Ammonia 135 µmol/L, Na+ 124 mmol/L, Creatinine 1.8 mg/dL  \n    - Arterial blood gas ordered, Completed — pH 7.25, HCO₃ 15  \n    - Non-contrast CT Head ordered, Completed — No acute intracranial process  \n    - EEG ordered, Completed — Generalized slowing, consistent with encephalopathy  \n    - Blood cultures ordered, Completed — Negative  \n    - Initiate neuro checks q1h during acute phase  \n    - Strict I/O monitoring, Foley catheter placed  \n    - Cardiology consult ordered, Completed — Ruled out cardiogenic contribution  \n\n    Procedures:  \n    - Central venous catheter placed for IV access  \n    - Non-invasive brain monitoring performed  \n    - Nasogastric tube inserted for lactulose administration  \n\n---\n\nAdmission 77484592  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY WITH ELECTROLYTE DERANGEMENTS (Severity 3.0)  \n    - HCFA: METABOLIC DISORDERS W/O RESPIRATORY FAILURE  \n\n    Medications:  \n    - Lactulose 30 mL PO TID  \n    - Rifaximin 550 mg PO BID  \n    - Magnesium Sulfate 2g IV PRN  \n    - Vitamin B12 1000 mcg IM weekly  \n    - Sodium Chloride 0.9% IV bolus PRN dehydration  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n    - Metoprolol 25 mg PO BID for rate control  \n\n    Orders:  \n    - Repeat ammonia levels ordered, Completed — Improved to 88 µmol/L  \n    - MRI Brain ordered, Completed — No acute ischemia  \n    - Glucose monitoring Q6H ordered  \n    - Dietitian consult ordered, Completed  \n    - Liver function panel ordered, Completed — ALT 54, AST 62  \n    - Sodium correction protocol initiated, Completed  \n\n    Procedures:  \n    - Continuous EEG monitoring for 36 hours  \n    - Bedside swallow study performed — Cleared for soft solids  \n\n---\n\nAdmission 77486104  \n    DRGs:  \n    - APR: POST-ACUTE FOLLOW-UP FOR METABOLIC ENCEPHALOPATHY (Severity 2.0)  \n    - HCFA: COGNITIVE RECOVERY MANAGEMENT AND MONITORING  \n\n    Medications:  \n    - Lactulose 20 mL PO BID  \n    - Rifaximin 550 mg PO daily  \n    - Thiamine 100 mg PO daily  \n    - Multivitamin PO daily  \n    - Zinc Sulfate 220 mg PO daily  \n\n    Orders:  \n    - Neurocognitive testing ordered, Completed — Mild residual attention deficits  \n    - Discharge referral to outpatient neurology ordered, Completed  \n    - Sleep optimization and circadian hygiene counseling ordered, Completed  \n    - Protein-restricted diet ordered per hepatology recommendations  \n    - Physical therapy consult ordered for strength and balance evaluation  \n\n    Procedures:  \n    - Outpatient EEG follow-up performed — Normalized electrical activity  \n    - Repeat ammonia level at 3-week follow-up — Stable at 42 µmol/L  \n    - Cognitive rehabilitation therapy initiated"}
{"id": "10001295", "pair_id": "30001295", "similarity": 0.75, "text": "Patient 10001295  \nGender: Female  \nAge: 64  \nRace: WHITE  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY — ACUTE EPISODE MANAGEMENT (Severity 3.0)  \n    - HCFA: METABOLIC DISORDERS W MCC  \n\n    Medications:  \n    - Lactulose 30 mL PO Q6H  \n    - Rifaximin 550 mg PO BID  \n    - Sodium Bicarbonate 50 mEq IV Q8H  \n    - Thiamine 100 mg IV daily  \n    - Potassium Chloride 20 mEq IV PRN hypokalemia  \n    - Furosemide 20 mg IV daily  \n    - Sodium Chloride 0.9% IV fluids at 75 mL/hr  \n    - Insulin regular sliding scale for hyperglycemia  \n\n    Orders:  \n    - Comprehensive metabolic panel ordered, Completed — Ammonia 122 µmol/L, Na+ 128 mmol/L  \n    - Arterial blood gas ordered, Completed — pH 7.28, HCO₃ 17  \n    - Neurology consult ordered, Completed  \n    - Non-contrast CT Head ordered, Completed — No acute intracranial process  \n    - EEG ordered, Completed — Mild generalized slowing consistent with encephalopathy  \n    - Initiate neuro checks q2h  \n    - Strict I/O monitoring and daily weights  \n\n    Procedures:  \n    - Central venous catheter placement for IV medication access  \n    - Non-invasive brain monitoring during acute episode  \n\n---\n\nAdmission 78125912  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY WITH ELECTROLYTE DERANGEMENTS (Severity 2.0)  \n    - HCFA: COMPLICATED METABOLIC DISORDERS W/O RENAL FAILURE  \n\n    Medications:  \n    - Lactulose 30 mL PO TID  \n    - Rifaximin 550 mg PO BID  \n    - Magnesium Sulfate 2g IV PRN  \n    - Vitamin B12 1000 mcg IM weekly  \n    - Sodium Chloride 0.9% IV bolus PRN dehydration  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - Repeat ammonia levels ordered, Completed — Improved to 78 µmol/L  \n    - MRI Brain ordered, Completed — No structural abnormalities  \n    - Glucose monitoring Q6H ordered  \n    - Dietitian consult ordered, Completed  \n    - Liver function panel ordered, Completed — ALT 68, AST 72  \n\n    Procedures:  \n    - Continuous EEG monitoring for 24 hours  \n    - Bedside swallow study performed — Safe for oral intake  \n\n---\n\nAdmission 78127145  \n    DRGs:  \n    - APR: POST-ACUTE FOLLOW-UP OF METABOLIC ENCEPHALOPATHY (Severity 1.0)  \n    - HCFA: OBSERVATION AND COGNITIVE RECOVERY MANAGEMENT  \n\n    Medications:  \n    - Lactulose 20 mL PO BID  \n    - Rifaximin 550 mg PO daily  \n    - Thiamine 100 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Neurocognitive testing ordered, Completed — Mild residual short-term memory impairment  \n    - Discharge referral to outpatient neurology ordered, Completed  \n    - Sleep hygiene counseling provided, Completed  \n    - Diet modified to low-protein regimen per hepatology recommendations  \n\n    Procedures:  \n    - Outpatient EEG follow-up performed — Normalized background activity  \n    - Repeat cognitive evaluation performed at 3 weeks", "pair_text": "Patient 30001295  \nGender: Male  \nAge: 56  \nRace: WHITE  \n\nAdmission 80431210  \n    DRGs:  \n    - APR: ANOXIC BRAIN DAMAGE — ACUTE CRITICAL CARE MANAGEMENT (Severity 4.0)  \n    - HCFA: RESPIRATORY FAILURE W MCC  \n\n    Medications:  \n    - Mannitol 20% 100 mL IV Q6H (for cerebral edema)  \n    - Levetiracetam 1 g IV Q12H (seizure prophylaxis)  \n    - Midazolam infusion 2 mg/hr IV (sedation)  \n    - Fentanyl infusion 50 mcg/hr IV (analgesia)  \n    - Norepinephrine 0.05 mcg/kg/min IV (for blood pressure support)  \n    - Sodium Chloride 3% IV continuous (hypertonic therapy for ICP control)  \n    - Pantoprazole 40 mg IV daily (stress ulcer prophylaxis)  \n    - Heparin 5000 U SC Q12H (DVT prophylaxis)  \n    - Acetaminophen 650 mg PO/NG Q6H PRN fever  \n\n    Orders:  \n    - Non-contrast CT Head ordered, Completed — Diffuse hypoxic-ischemic injury noted  \n    - Arterial blood gas ordered, Completed — pO₂ 42 mmHg pre-intubation  \n    - EEG ordered, Completed — Burst-suppression pattern, consistent with severe injury  \n    - Intubation performed, mechanical ventilation initiated  \n    - Intracranial pressure monitoring ordered, Ongoing  \n    - Neurology and critical care consultations ordered, Completed  \n    - Serum lactate monitoring Q6H ordered  \n    - Maintain strict normothermia: Cooling blanket initiated  \n\n    Procedures:  \n    - Endotracheal intubation performed emergently  \n    - Placement of intracranial pressure (ICP) monitor  \n    - Central venous catheter insertion for vasoactive medications  \n    - Therapeutic hypothermia initiated for 24 hours post-cardiac arrest  \n\n---\n\nAdmission 80432477  \n    DRGs:  \n    - APR: POST-ACUTE CARE — ANOXIC BRAIN DAMAGE WITH SEVERE FUNCTIONAL IMPAIRMENT (Severity 3.0)  \n    - HCFA: NEUROLOGICAL DISORDERS W CC  \n\n    Medications:  \n    - Levetiracetam 750 mg PO BID  \n    - Baclofen 10 mg PO TID (for spasticity)  \n    - Gabapentin 300 mg PO BID (neuropathic pain control)  \n    - Amantadine 100 mg PO BID (neurostimulant for recovery)  \n    - Enoxaparin 40 mg SC daily (DVT prophylaxis)  \n    - Polyethylene Glycol 17g PO daily (bowel regimen)  \n\n    Orders:  \n    - MRI Brain ordered, Completed — Diffuse cortical atrophy, chronic hypoxic changes  \n    - Speech and swallow evaluation ordered, Completed — PEG tube recommended  \n    - Nutrition consult ordered, Completed — Initiated tube feeding formula  \n    - Physical therapy evaluation ordered, Completed — Minimal voluntary motor recovery  \n    - Occupational therapy evaluation ordered, Completed  \n    - Neurobehavioral testing ordered, Completed — Profound deficits with minimal responsiveness  \n\n    Procedures:  \n    - Percutaneous endoscopic gastrostomy (PEG) tube placement  \n    - Tracheostomy performed for prolonged ventilatory support  \n    - Bedside bronchoscopy for secretion clearance  \n\n---\n\nAdmission 80433902  \n    DRGs:  \n    - APR: LONG-TERM NEUROLOGICAL REHABILITATION AFTER ANOXIC INJURY (Severity 2.0)  \n    - HCFA: REHABILITATION AND COGNITIVE RECOVERY FOLLOW-UP  \n\n    Medications:  \n    - Levetiracetam 500 mg PO BID  \n    - Baclofen 5 mg PO BID  \n    - Amantadine 100 mg PO daily  \n    - Multivitamin daily  \n    - Omega-3 fatty acids 2 g PO daily  \n\n    Orders:  \n    - Neurocognitive rehabilitation program ordered, Ongoing  \n    - Outpatient EEG ordered, Completed — Slow background activity persists  \n    - Pulmonary rehabilitation consult ordered, Completed  \n    - Social work and palliative care consultations ordered, Completed  \n    - Caregiver training ordered for family  \n\n    Procedures:  \n    - Wheelchair mobility assessment performed  \n    - Repeat brain MRI performed — Stable chronic injury  \n    - Assistive communication device evaluation completed"}
{"id": "10001295", "pair_id": "40001295", "similarity": 0.5, "text": "Patient 10001295  \nGender: Female  \nAge: 64  \nRace: WHITE  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY — ACUTE EPISODE MANAGEMENT (Severity 3.0)  \n    - HCFA: METABOLIC DISORDERS W MCC  \n\n    Medications:  \n    - Lactulose 30 mL PO Q6H  \n    - Rifaximin 550 mg PO BID  \n    - Sodium Bicarbonate 50 mEq IV Q8H  \n    - Thiamine 100 mg IV daily  \n    - Potassium Chloride 20 mEq IV PRN hypokalemia  \n    - Furosemide 20 mg IV daily  \n    - Sodium Chloride 0.9% IV fluids at 75 mL/hr  \n    - Insulin regular sliding scale for hyperglycemia  \n\n    Orders:  \n    - Comprehensive metabolic panel ordered, Completed — Ammonia 122 µmol/L, Na+ 128 mmol/L  \n    - Arterial blood gas ordered, Completed — pH 7.28, HCO₃ 17  \n    - Neurology consult ordered, Completed  \n    - Non-contrast CT Head ordered, Completed — No acute intracranial process  \n    - EEG ordered, Completed — Mild generalized slowing consistent with encephalopathy  \n    - Initiate neuro checks q2h  \n    - Strict I/O monitoring and daily weights  \n\n    Procedures:  \n    - Central venous catheter placement for IV medication access  \n    - Non-invasive brain monitoring during acute episode  \n\n---\n\nAdmission 78125912  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY WITH ELECTROLYTE DERANGEMENTS (Severity 2.0)  \n    - HCFA: COMPLICATED METABOLIC DISORDERS W/O RENAL FAILURE  \n\n    Medications:  \n    - Lactulose 30 mL PO TID  \n    - Rifaximin 550 mg PO BID  \n    - Magnesium Sulfate 2g IV PRN  \n    - Vitamin B12 1000 mcg IM weekly  \n    - Sodium Chloride 0.9% IV bolus PRN dehydration  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - Repeat ammonia levels ordered, Completed — Improved to 78 µmol/L  \n    - MRI Brain ordered, Completed — No structural abnormalities  \n    - Glucose monitoring Q6H ordered  \n    - Dietitian consult ordered, Completed  \n    - Liver function panel ordered, Completed — ALT 68, AST 72  \n\n    Procedures:  \n    - Continuous EEG monitoring for 24 hours  \n    - Bedside swallow study performed — Safe for oral intake  \n\n---\n\nAdmission 78127145  \n    DRGs:  \n    - APR: POST-ACUTE FOLLOW-UP OF METABOLIC ENCEPHALOPATHY (Severity 1.0)  \n    - HCFA: OBSERVATION AND COGNITIVE RECOVERY MANAGEMENT  \n\n    Medications:  \n    - Lactulose 20 mL PO BID  \n    - Rifaximin 550 mg PO daily  \n    - Thiamine 100 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Neurocognitive testing ordered, Completed — Mild residual short-term memory impairment  \n    - Discharge referral to outpatient neurology ordered, Completed  \n    - Sleep hygiene counseling provided, Completed  \n    - Diet modified to low-protein regimen per hepatology recommendations  \n\n    Procedures:  \n    - Outpatient EEG follow-up performed — Normalized background activity  \n    - Repeat cognitive evaluation performed at 3 weeks", "pair_text": "Patient 40001295  \nGender: Female  \nAge: 42  \nRace: WHITE  \n\nAdmission 68341210  \n    DRGs:  \n    - APR: SEIZURE DISORDERS — ACUTE MANAGEMENT (Severity 3.0)  \n    - HCFA: EPILEPSY & CONVULSIONS W CC  \n\n    Medications:  \n    - Lorazepam 2 mg IV PRN seizure activity  \n    - Levetiracetam 1 g IV loading dose, then 500 mg PO BID  \n    - Phenytoin 100 mg IV Q8H (bridging until levetiracetam stabilized)  \n    - Sodium Chloride 0.9% IV fluids at 75 mL/hr  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Heparin 5000 U SC Q12H (DVT prophylaxis)  \n\n    Orders:  \n    - EEG ordered, Completed — Abnormal with focal epileptiform discharges  \n    - Non-contrast CT Head ordered, Completed — No acute hemorrhage  \n    - Basic metabolic panel ordered, Completed — Na+ 138 mmol/L, Glucose 104 mg/dL  \n    - Serum phenytoin levels ordered, Completed — 12 mcg/mL  \n    - Initiate seizure precautions: padded bedrails, neuro checks Q1H  \n    - Neurology consult ordered, Completed  \n    - Continuous cardiac monitoring initiated  \n\n    Procedures:  \n    - Video EEG monitoring performed for 24 hours  \n    - Peripheral IV line placed for anti-epileptic infusions  \n\n---\n\nAdmission 68342879  \n    DRGs:  \n    - APR: ELECTIVE SEIZURE CONTROL OPTIMIZATION (Severity 2.0)  \n    - HCFA: SEIZURE DISORDERS W/O MCC  \n\n    Medications:  \n    - Levetiracetam 750 mg PO BID  \n    - Lamotrigine 25 mg PO daily, titrated to BID after week 2  \n    - Folic Acid 1 mg PO daily  \n    - Vitamin D 2000 IU PO daily  \n    - Melatonin 3 mg PO HS (for sleep hygiene)  \n\n    Orders:  \n    - Ambulatory EEG ordered, Completed — Improved baseline, no generalized seizure activity  \n    - MRI Brain with contrast ordered, Completed — No structural abnormalities  \n    - Patient education session ordered, Completed — Medication adherence and seizure triggers  \n    - Driving restriction counseling ordered, Completed  \n    - Sleep study referral ordered, Completed — Evaluated for possible nocturnal seizures  \n\n    Procedures:  \n    - Neurocognitive evaluation performed to assess memory and processing  \n    - Outpatient seizure diary tracking initiated  \n\n---\n\nAdmission 68344520  \n    DRGs:  \n    - APR: LONG-TERM FOLLOW-UP FOR EPILEPSY MANAGEMENT (Severity 1.0)  \n    - HCFA: CHRONIC NEUROLOGICAL CARE W/O MCC  \n\n    Medications:  \n    - Levetiracetam 500 mg PO BID  \n    - Lamotrigine 50 mg PO BID  \n    - Multivitamin PO daily  \n    - Omega-3 fatty acids 1 g PO daily  \n\n    Orders:  \n    - Neurology follow-up ordered, Completed — Stable seizure control  \n    - Routine EEG ordered, Completed — Occasional focal discharges, no seizure correlation  \n    - Psychiatric consult ordered, Completed — No depression, cleared for continued therapy  \n    - Transition plan to outpatient epilepsy clinic ordered, Completed  \n\n    Procedures:  \n    - Outpatient EEG performed — Stable background activity  \n    - Cognitive behavioral therapy initiated for stress-related seizure triggers"}
{"id": "10001295", "pair_id": "50001295", "similarity": 0.25, "text": "Patient 10001295  \nGender: Female  \nAge: 64  \nRace: WHITE  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY — ACUTE EPISODE MANAGEMENT (Severity 3.0)  \n    - HCFA: METABOLIC DISORDERS W MCC  \n\n    Medications:  \n    - Lactulose 30 mL PO Q6H  \n    - Rifaximin 550 mg PO BID  \n    - Sodium Bicarbonate 50 mEq IV Q8H  \n    - Thiamine 100 mg IV daily  \n    - Potassium Chloride 20 mEq IV PRN hypokalemia  \n    - Furosemide 20 mg IV daily  \n    - Sodium Chloride 0.9% IV fluids at 75 mL/hr  \n    - Insulin regular sliding scale for hyperglycemia  \n\n    Orders:  \n    - Comprehensive metabolic panel ordered, Completed — Ammonia 122 µmol/L, Na+ 128 mmol/L  \n    - Arterial blood gas ordered, Completed — pH 7.28, HCO₃ 17  \n    - Neurology consult ordered, Completed  \n    - Non-contrast CT Head ordered, Completed — No acute intracranial process  \n    - EEG ordered, Completed — Mild generalized slowing consistent with encephalopathy  \n    - Initiate neuro checks q2h  \n    - Strict I/O monitoring and daily weights  \n\n    Procedures:  \n    - Central venous catheter placement for IV medication access  \n    - Non-invasive brain monitoring during acute episode  \n\n---\n\nAdmission 78125912  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY WITH ELECTROLYTE DERANGEMENTS (Severity 2.0)  \n    - HCFA: COMPLICATED METABOLIC DISORDERS W/O RENAL FAILURE  \n\n    Medications:  \n    - Lactulose 30 mL PO TID  \n    - Rifaximin 550 mg PO BID  \n    - Magnesium Sulfate 2g IV PRN  \n    - Vitamin B12 1000 mcg IM weekly  \n    - Sodium Chloride 0.9% IV bolus PRN dehydration  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - Repeat ammonia levels ordered, Completed — Improved to 78 µmol/L  \n    - MRI Brain ordered, Completed — No structural abnormalities  \n    - Glucose monitoring Q6H ordered  \n    - Dietitian consult ordered, Completed  \n    - Liver function panel ordered, Completed — ALT 68, AST 72  \n\n    Procedures:  \n    - Continuous EEG monitoring for 24 hours  \n    - Bedside swallow study performed — Safe for oral intake  \n\n---\n\nAdmission 78127145  \n    DRGs:  \n    - APR: POST-ACUTE FOLLOW-UP OF METABOLIC ENCEPHALOPATHY (Severity 1.0)  \n    - HCFA: OBSERVATION AND COGNITIVE RECOVERY MANAGEMENT  \n\n    Medications:  \n    - Lactulose 20 mL PO BID  \n    - Rifaximin 550 mg PO daily  \n    - Thiamine 100 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Neurocognitive testing ordered, Completed — Mild residual short-term memory impairment  \n    - Discharge referral to outpatient neurology ordered, Completed  \n    - Sleep hygiene counseling provided, Completed  \n    - Diet modified to low-protein regimen per hepatology recommendations  \n\n    Procedures:  \n    - Outpatient EEG follow-up performed — Normalized background activity  \n    - Repeat cognitive evaluation performed at 3 weeks", "pair_text": "Patient 50001295  \nGender: Female  \nAge: 34  \nRace: WHITE  \n\nAdmission 20018745  \n    DRGs:  \n    - APR: ACUTE HYPERAMMONEMIA SECONDARY TO UREA CYCLE DISORDER (Severity 3.0)  \n    - HCFA: INBORN ERRORS OF METABOLISM W CC  \n\n    Medications:  \n    - Sodium Benzoate IV  \n    - Arginine HCl IV  \n    - Lactulose PO  \n    - Levocarnitine PO  \n    - Rifaximin PO  \n    - Sodium Phenylbutyrate PO  \n    - Ondansetron IV  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n\n    Orders:  \n    - Sodium Benzoate: IV infusion, Discontinued via patient discharge  \n    - Arginine HCl: IV infusion, Discontinued via patient discharge  \n    - Lactulose: PO, Discontinued via patient discharge  \n    - Levocarnitine: PO, Discontinued via patient discharge  \n    - Rifaximin: PO, Discontinued via patient discharge  \n    - Sodium Phenylbutyrate: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Plasma ammonia level monitoring every 6 hours  \n    - Venous blood gas analysis  \n    - High-protein restriction with calorie supplementation via NG tube  \n\nAdmission 20094362  \n    DRGs:  \n    - APR: UREA CYCLE DEFICIENCY WITH MODERATE CRISIS (Severity 2.0)  \n    - HCFA: GENETIC DISORDERS OF METABOLISM W/O MCC  \n\n    Medications:  \n    - Sodium Phenylbutyrate PO  \n    - Glycerol Phenylbutyrate PO  \n    - L-Citrulline PO  \n    - Levocarnitine PO  \n    - Ondansetron IV  \n    - Lactulose PO  \n    - Sodium Chloride 0.9% Flush  \n    - Acetaminophen  \n\n    Orders:  \n    - Sodium Phenylbutyrate: PO, Discontinued via patient discharge  \n    - Glycerol Phenylbutyrate: PO, Discontinued via patient discharge  \n    - L-Citrulline: PO, Discontinued via patient discharge  \n    - Levocarnitine: PO, Discontinued via patient discharge  \n    - Ondansetron: IV, Discontinued via patient discharge  \n    - Lactulose: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Serial plasma amino acid monitoring  \n    - MRI brain for metabolic encephalopathy  \n    - Dietary consult with low-protein plan  \n\nAdmission 20164781  \n    DRGs:  \n    - APR: SEVERE UREA CYCLE CRISIS WITH HYPERAMMONEMIC ENCEPHALOPATHY (Severity 4.0)  \n    - HCFA: INBORN ERRORS OF METABOLISM W MCC  \n\n    Medications:  \n    - Sodium Phenylbutyrate IV  \n    - Sodium Benzoate IV  \n    - Arginine HCl IV  \n    - Levocarnitine PO  \n    - Lactulose PO  \n    - Mannitol IV  \n    - Ondansetron IV  \n    - Sodium Chloride 0.9% Flush  \n\n    Orders:  \n    - Sodium Phenylbutyrate: IV, Discontinued via patient discharge  \n    - Sodium Benzoate: IV, Discontinued via patient discharge  \n    - Arginine HCl: IV, Discontinued via patient discharge  \n    - Levocarnitine: PO, Discontinued via patient discharge  \n    - Lactulose: PO, Discontinued via patient discharge  \n    - Mannitol: IV, Discontinued via patient discharge  \n    - Ondansetron: IV, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n\n    Procedures:  \n    - Continuous renal replacement therapy (CRRT) for ammonia clearance  \n    - PICC line placement for long-term medication infusion  \n    - Genetic panel confirmation of OTC gene mutation  \n    - Neurocognitive evaluation for metabolic encephalopathy"}
{"id": "10001295", "pair_id": "60001295", "similarity": 0.0, "text": "Patient 10001295  \nGender: Female  \nAge: 64  \nRace: WHITE  \n\nAdmission 78124560  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY — ACUTE EPISODE MANAGEMENT (Severity 3.0)  \n    - HCFA: METABOLIC DISORDERS W MCC  \n\n    Medications:  \n    - Lactulose 30 mL PO Q6H  \n    - Rifaximin 550 mg PO BID  \n    - Sodium Bicarbonate 50 mEq IV Q8H  \n    - Thiamine 100 mg IV daily  \n    - Potassium Chloride 20 mEq IV PRN hypokalemia  \n    - Furosemide 20 mg IV daily  \n    - Sodium Chloride 0.9% IV fluids at 75 mL/hr  \n    - Insulin regular sliding scale for hyperglycemia  \n\n    Orders:  \n    - Comprehensive metabolic panel ordered, Completed — Ammonia 122 µmol/L, Na+ 128 mmol/L  \n    - Arterial blood gas ordered, Completed — pH 7.28, HCO₃ 17  \n    - Neurology consult ordered, Completed  \n    - Non-contrast CT Head ordered, Completed — No acute intracranial process  \n    - EEG ordered, Completed — Mild generalized slowing consistent with encephalopathy  \n    - Initiate neuro checks q2h  \n    - Strict I/O monitoring and daily weights  \n\n    Procedures:  \n    - Central venous catheter placement for IV medication access  \n    - Non-invasive brain monitoring during acute episode  \n\n---\n\nAdmission 78125912  \n    DRGs:  \n    - APR: METABOLIC ENCEPHALOPATHY WITH ELECTROLYTE DERANGEMENTS (Severity 2.0)  \n    - HCFA: COMPLICATED METABOLIC DISORDERS W/O RENAL FAILURE  \n\n    Medications:  \n    - Lactulose 30 mL PO TID  \n    - Rifaximin 550 mg PO BID  \n    - Magnesium Sulfate 2g IV PRN  \n    - Vitamin B12 1000 mcg IM weekly  \n    - Sodium Chloride 0.9% IV bolus PRN dehydration  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n\n    Orders:  \n    - Repeat ammonia levels ordered, Completed — Improved to 78 µmol/L  \n    - MRI Brain ordered, Completed — No structural abnormalities  \n    - Glucose monitoring Q6H ordered  \n    - Dietitian consult ordered, Completed  \n    - Liver function panel ordered, Completed — ALT 68, AST 72  \n\n    Procedures:  \n    - Continuous EEG monitoring for 24 hours  \n    - Bedside swallow study performed — Safe for oral intake  \n\n---\n\nAdmission 78127145  \n    DRGs:  \n    - APR: POST-ACUTE FOLLOW-UP OF METABOLIC ENCEPHALOPATHY (Severity 1.0)  \n    - HCFA: OBSERVATION AND COGNITIVE RECOVERY MANAGEMENT  \n\n    Medications:  \n    - Lactulose 20 mL PO BID  \n    - Rifaximin 550 mg PO daily  \n    - Thiamine 100 mg PO daily  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Neurocognitive testing ordered, Completed — Mild residual short-term memory impairment  \n    - Discharge referral to outpatient neurology ordered, Completed  \n    - Sleep hygiene counseling provided, Completed  \n    - Diet modified to low-protein regimen per hepatology recommendations  \n\n    Procedures:  \n    - Outpatient EEG follow-up performed — Normalized background activity  \n    - Repeat cognitive evaluation performed at 3 weeks", "pair_text": "Patient 60001295  \nGender: Female  \nAge: 28  \nRace: ASIAN  \n\nAdmission 74589231  \n    DRGs:  \n    - APR: FULL-TERM UNCOMPLICATED VAGINAL DELIVERY (Severity 1.0)  \n    - HCFA: NORMAL LABOR & DELIVERY W/O COMPLICATIONS  \n\n    Medications:  \n    - Oxytocin 20 units in 1,000 mL NS IV infusion (for labor augmentation)  \n    - Fentanyl 50 mcg IV PRN during early labor  \n    - Lidocaine 1% 10 mL epidural (for anesthesia)  \n    - Acetaminophen 650 mg PO Q6H PRN pain  \n    - Ibuprofen 600 mg PO Q6H PRN postpartum cramping  \n    - Sodium Chloride 0.9% Flush IV PRN line maintenance  \n    - Prenatal vitamins PO daily  \n    - Rh immune globulin 300 mcg IM (administered if Rh-negative)  \n\n    Orders:  \n    - Non-stress test (NST) ordered, Completed — Reactive  \n    - CBC and type & screen ordered, Completed — WNL  \n    - Continuous fetal monitoring ordered, Ongoing  \n    - Group B strep screen ordered, Completed — Negative  \n    - Initiate spontaneous vaginal delivery protocol, Completed  \n    - Skin-to-skin initiation immediately after delivery  \n    - Breastfeeding consultation ordered, Completed  \n\n    Procedures:  \n    - Vaginal delivery performed — Full-term, healthy infant  \n    - Delayed cord clamping performed  \n    - Perineal inspection performed — First-degree laceration repaired with 3-0 Vicryl  \n    - Immediate postpartum fundal massage performed  \n\n---\n\nAdmission 74590852  \n    DRGs:  \n    - APR: POSTPARTUM OBSERVATION FOLLOWING VAGINAL DELIVERY (Severity 1.0)  \n    - HCFA: ROUTINE POST-DELIVERY CARE W/O COMPLICATIONS  \n\n    Medications:  \n    - Ibuprofen 600 mg PO Q6H PRN uterine cramping  \n    - Docusate sodium 100 mg PO BID PRN constipation  \n    - Acetaminophen 650 mg PO Q6H PRN discomfort  \n    - Ferrous sulfate 325 mg PO daily (for mild postpartum anemia)  \n    - Prenatal vitamins PO daily  \n    - Influenza vaccine IM prior to discharge  \n\n    Orders:  \n    - Vital signs Q4H ordered, Ongoing  \n    - Fundal assessment ordered, Ongoing — Firm, midline  \n    - Lactation consultation ordered, Completed — Breastfeeding established  \n    - Postpartum education ordered, Completed — Safe sleep, bleeding precautions, pelvic rest  \n    - Discharge instructions provided, Completed  \n\n    Procedures:  \n    - Postpartum perineal care performed  \n    - Screening for postpartum depression initiated  \n    - Infant car seat fit evaluation completed  \n\n---\n\nAdmission 74601327  \n    DRGs:  \n    - APR: OUTPATIENT FOLLOW-UP FOR POSTPARTUM CARE (Severity 1.0)  \n    - HCFA: ROUTINE MATERNAL CHECK, 6-WEEK POSTPARTUM VISIT  \n\n    Medications:  \n    - Prenatal vitamins PO daily  \n    - Ibuprofen 400 mg PO PRN mild discomfort  \n    - Norethindrone 0.35 mg PO daily (progestin-only contraception started)  \n\n    Orders:  \n    - Postpartum depression screening ordered, Completed — Negative  \n    - Breast examination ordered, Completed — No masses, breastfeeding continues  \n    - Blood pressure monitoring ordered, Completed — Stable  \n    - Family planning counseling ordered, Completed  \n    - Clearance to resume normal activities, Completed  \n\n    Procedures:  \n    - Routine pelvic exam performed — Uterus involuted, healing complete  \n    - Pap smear performed per screening guidelines  \n    - Infant weight check performed — Healthy growth"}
{"id": "10001296", "pair_id": "20001296", "similarity": 1.0, "text": "Patient 10001296  \nGender: Male  \nAge: 57  \nRace: WHITE  \n\nAdmission 61278345  \n    DRGs:  \n    - APR: OBSTRUCTIVE UROPATHY WITH HYDRONEPHROSIS (Severity 3.0)  \n    - HCFA: KIDNEY & URINARY TRACT OBSTRUCTION W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q8H (empiric coverage for urinary obstruction infection risk)  \n    - Tamsulosin 0.4 mg PO daily (to improve urinary flow)  \n    - Ketorolac 15 mg IV Q6H PRN flank pain  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV fluids 125 mL/hr  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n    - Enoxaparin 40 mg SC daily (DVT prophylaxis)  \n\n    Orders:  \n    - CT Abdomen/Pelvis without contrast ordered, Completed — Right-sided severe hydronephrosis with proximal obstruction  \n    - Renal ultrasound ordered, Completed — Confirmed obstruction at ureteropelvic junction  \n    - Serum creatinine ordered, Completed — Elevated at 2.1 mg/dL  \n    - Insert Foley catheter ordered, Completed — Initial drainage of 600 mL  \n    - Urology consult ordered, Completed — Recommended urgent decompression  \n    - IV antibiotics initiated before intervention  \n    - NPO status ordered pre-procedure, Completed  \n\n    Procedures:  \n    - Right percutaneous nephrostomy tube placed for decompression  \n    - Cystoscopic evaluation performed — Identified obstruction at ureteropelvic junction  \n\n---\n\nAdmission 61280192  \n    DRGs:  \n    - APR: ELECTIVE UROLOGICAL STENT PLACEMENT (Severity 2.0)  \n    - HCFA: URETERAL STENT INSERTION W/O MCC  \n\n    Medications:  \n    - Ciprofloxacin 400 mg IV Q12H (perioperative prophylaxis)  \n    - Tamsulosin 0.4 mg PO daily  \n    - Acetaminophen 650 mg PO Q6H PRN  \n    - Oxycodone 5 mg PO Q4H PRN post-procedure pain  \n    - Docusate sodium 100 mg PO BID PRN constipation  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Ureteral stent insertion ordered, Completed — Successful placement of double-J stent  \n    - Post-stent urine culture ordered, Completed — No growth  \n    - Serum electrolytes ordered, Completed — Normalized after decompression  \n    - Foley catheter discontinued after stent placement  \n    - Outpatient urology follow-up ordered, Scheduled at 2 weeks  \n    - Patient education ordered, Completed — Instructions on stent care and follow-up  \n\n    Procedures:  \n    - Ureteral stent placement under fluoroscopic guidance  \n    - Intraoperative retrograde pyelogram performed  \n\n---\n\nAdmission 61281745  \n    DRGs:  \n    - APR: FOLLOW-UP FOR OBSTRUCTIVE UROPATHY (Severity 1.0)  \n    - HCFA: ROUTINE UROLOGY VISIT FOR STENT REMOVAL  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ibuprofen 400 mg PO Q8H PRN mild discomfort  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Ureteral stent removal ordered, Completed — Procedure tolerated well  \n    - Repeat renal ultrasound ordered, Completed — Resolution of hydronephrosis  \n    - Serum creatinine ordered, Completed — Improved to 1.0 mg/dL  \n    - Urinalysis ordered, Completed — No hematuria, no infection  \n    - Patient counseling ordered, Completed — Hydration, stone prevention, and monitoring plan  \n\n    Procedures:  \n    - Outpatient ureteral stent removal performed  \n    - Ultrasound-guided renal assessment confirmed resolution", "pair_text": "Patient 20001296  \nGender: Female  \nAge: 63  \nRace: HISPANIC  \n\nAdmission 78124567  \n    DRGs:  \n    - APR: SEVERE HYDRONEPHROSIS WITH OBSTRUCTIVE UROPATHY (Severity 3.0)  \n    - HCFA: URINARY TRACT OBSTRUCTION W CC  \n\n    Medications:  \n    - Ceftriaxone 1 g IV Q24H (empiric antibiotic for UTI risk)  \n    - Tamsulosin 0.4 mg PO daily (to facilitate drainage)  \n    - Ketorolac 15 mg IV Q6H PRN flank pain  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV fluids 100 mL/hr  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Enoxaparin 40 mg SC daily (DVT prophylaxis)  \n\n    Orders:  \n    - Non-contrast CT abdomen/pelvis ordered, Completed — Left-sided moderate hydronephrosis with distal ureteral obstruction  \n    - Renal ultrasound ordered, Completed — Confirms obstruction  \n    - Urinalysis and urine culture ordered, Completed — Positive for E. coli  \n    - Foley catheter insertion ordered, Completed — 450 mL drained  \n    - Urology consult ordered, Completed — Recommended urgent stent placement  \n    - IV antibiotics initiated pre-procedure  \n    - NPO status ordered before intervention  \n\n    Procedures:  \n    - Left retrograde ureteral stent placed to relieve obstruction  \n    - Bladder irrigation performed post-procedure  \n\n---\n\nAdmission 78126210  \n    DRGs:  \n    - APR: UROLOGICAL STONE MANAGEMENT WITH OBSTRUCTION (Severity 2.0)  \n    - HCFA: URETEROSCOPIC STONE EXTRACTION W/O MCC  \n\n    Medications:  \n    - Levofloxacin 500 mg PO daily x 5 days (post-op prophylaxis)  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ibuprofen 600 mg PO Q8H PRN post-procedure pain  \n    - Acetaminophen 650 mg PO Q6H PRN  \n    - Docusate sodium 100 mg PO BID PRN constipation  \n    - Sodium Chloride 0.9% Flush IV PRN line care  \n\n    Orders:  \n    - Ureteroscopic laser lithotripsy ordered, Completed — 8 mm distal stone successfully fragmented and removed  \n    - Ureteral stent exchanged during procedure  \n    - Serum creatinine ordered, Completed — Improved to 1.2 mg/dL  \n    - Post-op urine culture ordered, Completed — Negative  \n    - Urology follow-up ordered, Scheduled in 3 weeks  \n    - Patient education ordered, Completed — Hydration and dietary modifications  \n\n    Procedures:  \n    - Ureteroscopic stone removal with laser fragmentation  \n    - Ureteral stent exchanged intraoperatively  \n\n---\n\nAdmission 78128395  \n    DRGs:  \n    - APR: POST-STENT REMOVAL FOLLOW-UP (Severity 1.0)  \n    - HCFA: ROUTINE UROLOGY VISIT, NO COMPLICATIONS  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily (continued temporarily)  \n    - Multivitamin PO daily  \n    - Ibuprofen 400 mg PO Q8H PRN mild discomfort  \n\n    Orders:  \n    - Ureteral stent removal ordered, Completed — No complications  \n    - Renal ultrasound ordered, Completed — Normalized renal pelvis diameter  \n    - Serum electrolytes ordered, Completed — Stable  \n    - Urinalysis ordered, Completed — Clear, no hematuria or infection  \n    - Patient counseling ordered, Completed — Kidney stone prevention and regular follow-up plan  \n\n    Procedures:  \n    - Outpatient ureteral stent removal performed  \n    - Post-procedure ultrasound confirmed full resolution of hydronephrosis"}
{"id": "10001296", "pair_id": "30001296", "similarity": 0.75, "text": "Patient 10001296  \nGender: Male  \nAge: 57  \nRace: WHITE  \n\nAdmission 61278345  \n    DRGs:  \n    - APR: OBSTRUCTIVE UROPATHY WITH HYDRONEPHROSIS (Severity 3.0)  \n    - HCFA: KIDNEY & URINARY TRACT OBSTRUCTION W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q8H (empiric coverage for urinary obstruction infection risk)  \n    - Tamsulosin 0.4 mg PO daily (to improve urinary flow)  \n    - Ketorolac 15 mg IV Q6H PRN flank pain  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV fluids 125 mL/hr  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n    - Enoxaparin 40 mg SC daily (DVT prophylaxis)  \n\n    Orders:  \n    - CT Abdomen/Pelvis without contrast ordered, Completed — Right-sided severe hydronephrosis with proximal obstruction  \n    - Renal ultrasound ordered, Completed — Confirmed obstruction at ureteropelvic junction  \n    - Serum creatinine ordered, Completed — Elevated at 2.1 mg/dL  \n    - Insert Foley catheter ordered, Completed — Initial drainage of 600 mL  \n    - Urology consult ordered, Completed — Recommended urgent decompression  \n    - IV antibiotics initiated before intervention  \n    - NPO status ordered pre-procedure, Completed  \n\n    Procedures:  \n    - Right percutaneous nephrostomy tube placed for decompression  \n    - Cystoscopic evaluation performed — Identified obstruction at ureteropelvic junction  \n\n---\n\nAdmission 61280192  \n    DRGs:  \n    - APR: ELECTIVE UROLOGICAL STENT PLACEMENT (Severity 2.0)  \n    - HCFA: URETERAL STENT INSERTION W/O MCC  \n\n    Medications:  \n    - Ciprofloxacin 400 mg IV Q12H (perioperative prophylaxis)  \n    - Tamsulosin 0.4 mg PO daily  \n    - Acetaminophen 650 mg PO Q6H PRN  \n    - Oxycodone 5 mg PO Q4H PRN post-procedure pain  \n    - Docusate sodium 100 mg PO BID PRN constipation  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Ureteral stent insertion ordered, Completed — Successful placement of double-J stent  \n    - Post-stent urine culture ordered, Completed — No growth  \n    - Serum electrolytes ordered, Completed — Normalized after decompression  \n    - Foley catheter discontinued after stent placement  \n    - Outpatient urology follow-up ordered, Scheduled at 2 weeks  \n    - Patient education ordered, Completed — Instructions on stent care and follow-up  \n\n    Procedures:  \n    - Ureteral stent placement under fluoroscopic guidance  \n    - Intraoperative retrograde pyelogram performed  \n\n---\n\nAdmission 61281745  \n    DRGs:  \n    - APR: FOLLOW-UP FOR OBSTRUCTIVE UROPATHY (Severity 1.0)  \n    - HCFA: ROUTINE UROLOGY VISIT FOR STENT REMOVAL  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ibuprofen 400 mg PO Q8H PRN mild discomfort  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Ureteral stent removal ordered, Completed — Procedure tolerated well  \n    - Repeat renal ultrasound ordered, Completed — Resolution of hydronephrosis  \n    - Serum creatinine ordered, Completed — Improved to 1.0 mg/dL  \n    - Urinalysis ordered, Completed — No hematuria, no infection  \n    - Patient counseling ordered, Completed — Hydration, stone prevention, and monitoring plan  \n\n    Procedures:  \n    - Outpatient ureteral stent removal performed  \n    - Ultrasound-guided renal assessment confirmed resolution", "pair_text": "Patient 30001296  \nGender: Male  \nAge: 61  \nRace: WHITE  \n\nAdmission 71546281  \n    DRGs:  \n    - APR: HYDRONEPHROSIS WITH RENAL & URETERAL CALCULOUS OBSTRUCTION (Severity 3.0)  \n    - HCFA: KIDNEY & URETERAL STONES WITH OBSTRUCTION W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q8H (empiric therapy due to possible obstruction-related infection)  \n    - Tamsulosin 0.4 mg PO daily (to relax ureteral smooth muscle)  \n    - Ketorolac 15 mg IV Q6H PRN severe flank pain  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV fluids 125 mL/hr  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Enoxaparin 40 mg SC daily (DVT prophylaxis)  \n\n    Orders:  \n    - CT Abdomen/Pelvis ordered, Completed — Right-sided hydronephrosis with 9 mm proximal ureteral stone  \n    - Urinalysis ordered, Completed — Moderate hematuria, positive leukocyte esterase  \n    - Urine culture ordered, Completed — No significant growth  \n    - Foley catheter insertion ordered, Completed — Initial drainage 350 mL  \n    - Urology consult ordered, Completed — Recommended urgent stent placement  \n    - IV fluids ordered, Started  \n    - NPO status ordered pre-procedure, Completed  \n\n    Procedures:  \n    - Right retrograde ureteral stent insertion under fluoroscopic guidance  \n    - Intraoperative cystoscopic evaluation performed  \n\n---\n\nAdmission 71547293  \n    DRGs:  \n    - APR: URETEROSCOPIC STONE EXTRACTION WITH LASER (Severity 2.0)  \n    - HCFA: URETEROSCOPIC CALCULI REMOVAL W/O MCC  \n\n    Medications:  \n    - Cefazolin 1 g IV perioperative  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ibuprofen 600 mg PO Q8H PRN post-op pain  \n    - Acetaminophen 650 mg PO Q6H PRN  \n    - Oxycodone 5 mg PO Q6H PRN severe pain  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Ureteroscopic laser lithotripsy ordered, Completed — 9 mm stone fragmented successfully  \n    - Post-op urine culture ordered, Completed — No bacterial growth  \n    - Serum creatinine ordered, Completed — Improved to 1.1 mg/dL  \n    - Foley catheter removed post-procedure, Completed  \n    - Outpatient urology follow-up ordered, Scheduled at 2 weeks  \n\n    Procedures:  \n    - Ureteroscopic laser lithotripsy  \n    - Stone fragments retrieved and sent for compositional analysis  \n\n---\n\nAdmission 71549024  \n    DRGs:  \n    - APR: POST-STENT REMOVAL & RECOVERY (Severity 1.0)  \n    - HCFA: ROUTINE UROLOGY FOLLOW-UP  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily  \n    - Multivitamin PO daily  \n    - Ibuprofen 400 mg PO Q8H PRN mild flank discomfort  \n\n    Orders:  \n    - Ureteral stent removal ordered, Completed — No complications  \n    - Renal ultrasound ordered, Completed — Resolution of hydronephrosis  \n    - Serum electrolytes ordered, Completed — Within normal limits  \n    - Urinalysis ordered, Completed — Clear urine, no hematuria  \n    - Patient counseling ordered, Completed — Stone prevention, hydration, and low-oxalate dietary guidance  \n\n    Procedures:  \n    - Outpatient ureteral stent removal performed  \n    - Ultrasound-guided renal assessment confirmed recovery"}
{"id": "10001296", "pair_id": "40001296", "similarity": 0.5, "text": "Patient 10001296  \nGender: Male  \nAge: 57  \nRace: WHITE  \n\nAdmission 61278345  \n    DRGs:  \n    - APR: OBSTRUCTIVE UROPATHY WITH HYDRONEPHROSIS (Severity 3.0)  \n    - HCFA: KIDNEY & URINARY TRACT OBSTRUCTION W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q8H (empiric coverage for urinary obstruction infection risk)  \n    - Tamsulosin 0.4 mg PO daily (to improve urinary flow)  \n    - Ketorolac 15 mg IV Q6H PRN flank pain  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV fluids 125 mL/hr  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n    - Enoxaparin 40 mg SC daily (DVT prophylaxis)  \n\n    Orders:  \n    - CT Abdomen/Pelvis without contrast ordered, Completed — Right-sided severe hydronephrosis with proximal obstruction  \n    - Renal ultrasound ordered, Completed — Confirmed obstruction at ureteropelvic junction  \n    - Serum creatinine ordered, Completed — Elevated at 2.1 mg/dL  \n    - Insert Foley catheter ordered, Completed — Initial drainage of 600 mL  \n    - Urology consult ordered, Completed — Recommended urgent decompression  \n    - IV antibiotics initiated before intervention  \n    - NPO status ordered pre-procedure, Completed  \n\n    Procedures:  \n    - Right percutaneous nephrostomy tube placed for decompression  \n    - Cystoscopic evaluation performed — Identified obstruction at ureteropelvic junction  \n\n---\n\nAdmission 61280192  \n    DRGs:  \n    - APR: ELECTIVE UROLOGICAL STENT PLACEMENT (Severity 2.0)  \n    - HCFA: URETERAL STENT INSERTION W/O MCC  \n\n    Medications:  \n    - Ciprofloxacin 400 mg IV Q12H (perioperative prophylaxis)  \n    - Tamsulosin 0.4 mg PO daily  \n    - Acetaminophen 650 mg PO Q6H PRN  \n    - Oxycodone 5 mg PO Q4H PRN post-procedure pain  \n    - Docusate sodium 100 mg PO BID PRN constipation  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Ureteral stent insertion ordered, Completed — Successful placement of double-J stent  \n    - Post-stent urine culture ordered, Completed — No growth  \n    - Serum electrolytes ordered, Completed — Normalized after decompression  \n    - Foley catheter discontinued after stent placement  \n    - Outpatient urology follow-up ordered, Scheduled at 2 weeks  \n    - Patient education ordered, Completed — Instructions on stent care and follow-up  \n\n    Procedures:  \n    - Ureteral stent placement under fluoroscopic guidance  \n    - Intraoperative retrograde pyelogram performed  \n\n---\n\nAdmission 61281745  \n    DRGs:  \n    - APR: FOLLOW-UP FOR OBSTRUCTIVE UROPATHY (Severity 1.0)  \n    - HCFA: ROUTINE UROLOGY VISIT FOR STENT REMOVAL  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ibuprofen 400 mg PO Q8H PRN mild discomfort  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Ureteral stent removal ordered, Completed — Procedure tolerated well  \n    - Repeat renal ultrasound ordered, Completed — Resolution of hydronephrosis  \n    - Serum creatinine ordered, Completed — Improved to 1.0 mg/dL  \n    - Urinalysis ordered, Completed — No hematuria, no infection  \n    - Patient counseling ordered, Completed — Hydration, stone prevention, and monitoring plan  \n\n    Procedures:  \n    - Outpatient ureteral stent removal performed  \n    - Ultrasound-guided renal assessment confirmed resolution", "pair_text": "Patient 40001296  \nGender: Female  \nAge: 58  \nRace: ASIAN  \n\nAdmission 67124821  \n    DRGs:  \n    - APR: CALCULUS OF KIDNEY WITH OBSTRUCTIVE UROPATHY (Severity 2.0)  \n    - HCFA: KIDNEY STONE W/O COMPLICATIONS  \n\n    Medications:  \n    - Ketorolac 15 mg IV Q6H PRN renal colic  \n    - Tamsulosin 0.4 mg PO daily (facilitates stone passage)  \n    - Ceftriaxone 1 g IV Q24H (prophylactic, given mild hydronephrosis)  \n    - Ondansetron 4 mg IV Q6H PRN nausea  \n    - Acetaminophen 650 mg PO Q6H PRN mild pain  \n    - Sodium Chloride 0.9% IV fluids 100 mL/hr  \n    - Enoxaparin 40 mg SC daily for DVT prophylaxis  \n\n    Orders:  \n    - Non-contrast CT ordered, Completed — Left kidney 6 mm non-obstructing stone with mild hydronephrosis  \n    - Renal ultrasound ordered, Completed — Confirms mild obstruction  \n    - Urinalysis ordered, Completed — Trace blood, no infection  \n    - Strain urine ordered, Completed — Stone fragments collected  \n    - Urology consult ordered, Completed — Recommended conservative management  \n    - IV hydration initiated, Completed  \n    - Patient education ordered — Low-sodium, high-fluid diet to prevent recurrence  \n\n    Procedures:  \n    - None performed; stone expected to pass spontaneously  \n\n---\n\nAdmission 67126504  \n    DRGs:  \n    - APR: URETEROSCOPIC REMOVAL OF PERSISTENT KIDNEY STONE (Severity 2.0)  \n    - HCFA: STONE EXTRACTION W/O MCC  \n\n    Medications:  \n    - Levofloxacin 500 mg PO daily x 5 days post-op prophylaxis  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ibuprofen 600 mg PO Q8H PRN post-op discomfort  \n    - Acetaminophen 650 mg PO Q6H PRN mild fever  \n    - Sodium Chloride 0.9% Flush IV PRN line care  \n    - Docusate sodium 100 mg PO BID PRN constipation  \n\n    Orders:  \n    - Ureteroscopic laser lithotripsy ordered, Completed — 6 mm left renal stone fragmented successfully  \n    - Ureteral stent inserted, Completed  \n    - Serum creatinine ordered, Completed — Stable at 0.9 mg/dL  \n    - Post-procedure urinalysis ordered, Completed — No hematuria  \n    - Stone composition analysis ordered, Completed — Calcium oxalate monohydrate  \n    - Outpatient follow-up ordered, Scheduled in 3 weeks  \n\n    Procedures:  \n    - Ureteroscopic laser lithotripsy with stent placement  \n    - Stone fragments removed endoscopically  \n\n---\n\nAdmission 67128977  \n    DRGs:  \n    - APR: STENT REMOVAL FOLLOW-UP (Severity 1.0)  \n    - HCFA: ROUTINE UROLOGY FOLLOW-UP  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily (continued temporarily)  \n    - Ibuprofen 400 mg PO Q8H PRN  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Ureteral stent removal ordered, Completed  \n    - Renal ultrasound ordered, Completed — No hydronephrosis  \n    - Urinalysis ordered, Completed — Negative for blood and infection  \n    - Dietary counseling ordered, Completed — Advised low-oxalate, high-fluid regimen  \n    - Follow-up ordered, Completed — Annual monitoring for stone recurrence  \n\n    Procedures:  \n    - Outpatient ureteral stent removal  \n    - Renal ultrasound performed, confirming full recovery"}
{"id": "10001296", "pair_id": "50001296", "similarity": 0.25, "text": "Patient 10001296  \nGender: Male  \nAge: 57  \nRace: WHITE  \n\nAdmission 61278345  \n    DRGs:  \n    - APR: OBSTRUCTIVE UROPATHY WITH HYDRONEPHROSIS (Severity 3.0)  \n    - HCFA: KIDNEY & URINARY TRACT OBSTRUCTION W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q8H (empiric coverage for urinary obstruction infection risk)  \n    - Tamsulosin 0.4 mg PO daily (to improve urinary flow)  \n    - Ketorolac 15 mg IV Q6H PRN flank pain  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV fluids 125 mL/hr  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n    - Enoxaparin 40 mg SC daily (DVT prophylaxis)  \n\n    Orders:  \n    - CT Abdomen/Pelvis without contrast ordered, Completed — Right-sided severe hydronephrosis with proximal obstruction  \n    - Renal ultrasound ordered, Completed — Confirmed obstruction at ureteropelvic junction  \n    - Serum creatinine ordered, Completed — Elevated at 2.1 mg/dL  \n    - Insert Foley catheter ordered, Completed — Initial drainage of 600 mL  \n    - Urology consult ordered, Completed — Recommended urgent decompression  \n    - IV antibiotics initiated before intervention  \n    - NPO status ordered pre-procedure, Completed  \n\n    Procedures:  \n    - Right percutaneous nephrostomy tube placed for decompression  \n    - Cystoscopic evaluation performed — Identified obstruction at ureteropelvic junction  \n\n---\n\nAdmission 61280192  \n    DRGs:  \n    - APR: ELECTIVE UROLOGICAL STENT PLACEMENT (Severity 2.0)  \n    - HCFA: URETERAL STENT INSERTION W/O MCC  \n\n    Medications:  \n    - Ciprofloxacin 400 mg IV Q12H (perioperative prophylaxis)  \n    - Tamsulosin 0.4 mg PO daily  \n    - Acetaminophen 650 mg PO Q6H PRN  \n    - Oxycodone 5 mg PO Q4H PRN post-procedure pain  \n    - Docusate sodium 100 mg PO BID PRN constipation  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Ureteral stent insertion ordered, Completed — Successful placement of double-J stent  \n    - Post-stent urine culture ordered, Completed — No growth  \n    - Serum electrolytes ordered, Completed — Normalized after decompression  \n    - Foley catheter discontinued after stent placement  \n    - Outpatient urology follow-up ordered, Scheduled at 2 weeks  \n    - Patient education ordered, Completed — Instructions on stent care and follow-up  \n\n    Procedures:  \n    - Ureteral stent placement under fluoroscopic guidance  \n    - Intraoperative retrograde pyelogram performed  \n\n---\n\nAdmission 61281745  \n    DRGs:  \n    - APR: FOLLOW-UP FOR OBSTRUCTIVE UROPATHY (Severity 1.0)  \n    - HCFA: ROUTINE UROLOGY VISIT FOR STENT REMOVAL  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ibuprofen 400 mg PO Q8H PRN mild discomfort  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Ureteral stent removal ordered, Completed — Procedure tolerated well  \n    - Repeat renal ultrasound ordered, Completed — Resolution of hydronephrosis  \n    - Serum creatinine ordered, Completed — Improved to 1.0 mg/dL  \n    - Urinalysis ordered, Completed — No hematuria, no infection  \n    - Patient counseling ordered, Completed — Hydration, stone prevention, and monitoring plan  \n\n    Procedures:  \n    - Outpatient ureteral stent removal performed  \n    - Ultrasound-guided renal assessment confirmed resolution", "pair_text": "Patient 50001296  \nGender: Male  \nAge: 62  \nRace: WHITE  \n\nAdmission 30124781  \n    DRGs:  \n    - APR: HEMATURIA WITHOUT MAJOR COMPLICATIONS (Severity 1.0)  \n    - HCFA: DISORDERS OF URINARY TRACT W/O CC/MCC  \n\n    Medications:  \n    - Phenazopyridine PO  \n    - Ciprofloxacin PO  \n    - Sodium Chloride 0.9% Flush IV  \n    - Acetaminophen PO  \n    - Influenza Vaccine Quadrivalent  \n    - Tamsulosin PO  \n\n    Orders:  \n    - Phenazopyridine: PO, Discontinued via patient discharge  \n    - Ciprofloxacin: PO, Discontinued via patient discharge  \n    - Tamsulosin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n    - Influenza Vaccine Quadrivalent: IM, Discontinued via patient discharge  \n\n    Procedures:  \n    - Urinalysis with microscopy  \n    - Urine culture and sensitivity  \n    - Renal ultrasound  \n\nAdmission 30291453  \n    DRGs:  \n    - APR: HEMATURIA WITH ASSOCIATED UPPER URINARY TRACT INFECTION (Severity 2.0)  \n    - HCFA: KIDNEY/URINARY TRACT INFECTIONS W CC  \n\n    Medications:  \n    - Ceftriaxone IV  \n    - Phenazopyridine PO  \n    - Tamsulosin PO  \n    - Acetaminophen PO  \n    - Sodium Chloride 0.9% Flush  \n    - Probiotic Supplement PO  \n\n    Orders:  \n    - Ceftriaxone: IV, Discontinued via patient discharge  \n    - Phenazopyridine: PO, Discontinued via patient discharge  \n    - Tamsulosin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Probiotic Supplement: PO, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - Cystoscopy with bladder evaluation  \n    - Non-contrast CT urogram  \n    - Foley catheter placement for urine output monitoring  \n\nAdmission 30547862  \n    DRGs:  \n    - APR: SEVERE HEMATURIA WITH OBSTRUCTIVE UROPATHY (Severity 3.0)  \n    - HCFA: MAJOR URINARY TRACT DISORDERS W MCC  \n\n    Medications:  \n    - Piperacillin-Tazobactam IV  \n    - Phenazopyridine PO  \n    - Tamsulosin PO  \n    - Oxybutynin PO  \n    - Sodium Chloride 0.9% Flush IV  \n    - Acetaminophen PO  \n    - Hydromorphone IV  \n\n    Orders:  \n    - Piperacillin-Tazobactam: IV, Discontinued via patient discharge  \n    - Phenazopyridine: PO, Discontinued via patient discharge  \n    - Tamsulosin: PO, Discontinued via patient discharge  \n    - Oxybutynin: PO, Discontinued via patient discharge  \n    - Sodium Chloride 0.9% Flush: IV, Discontinued via patient discharge  \n    - Hydromorphone: IV, Discontinued via patient discharge  \n    - Acetaminophen: PO, Discontinued via patient discharge  \n\n    Procedures:  \n    - CT abdomen and pelvis with contrast  \n    - Retrograde pyelogram  \n    - Ureteral stent placement  \n    - Bladder irrigation via three-way catheter"}
{"id": "10001296", "pair_id": "60001296", "similarity": 0.0, "text": "Patient 10001296  \nGender: Male  \nAge: 57  \nRace: WHITE  \n\nAdmission 61278345  \n    DRGs:  \n    - APR: OBSTRUCTIVE UROPATHY WITH HYDRONEPHROSIS (Severity 3.0)  \n    - HCFA: KIDNEY & URINARY TRACT OBSTRUCTION W CC  \n\n    Medications:  \n    - Piperacillin-Tazobactam 4.5 g IV Q8H (empiric coverage for urinary obstruction infection risk)  \n    - Tamsulosin 0.4 mg PO daily (to improve urinary flow)  \n    - Ketorolac 15 mg IV Q6H PRN flank pain  \n    - Acetaminophen 650 mg PO Q6H PRN fever  \n    - Sodium Chloride 0.9% IV fluids 125 mL/hr  \n    - Ondansetron 4 mg IV Q8H PRN nausea  \n    - Enoxaparin 40 mg SC daily (DVT prophylaxis)  \n\n    Orders:  \n    - CT Abdomen/Pelvis without contrast ordered, Completed — Right-sided severe hydronephrosis with proximal obstruction  \n    - Renal ultrasound ordered, Completed — Confirmed obstruction at ureteropelvic junction  \n    - Serum creatinine ordered, Completed — Elevated at 2.1 mg/dL  \n    - Insert Foley catheter ordered, Completed — Initial drainage of 600 mL  \n    - Urology consult ordered, Completed — Recommended urgent decompression  \n    - IV antibiotics initiated before intervention  \n    - NPO status ordered pre-procedure, Completed  \n\n    Procedures:  \n    - Right percutaneous nephrostomy tube placed for decompression  \n    - Cystoscopic evaluation performed — Identified obstruction at ureteropelvic junction  \n\n---\n\nAdmission 61280192  \n    DRGs:  \n    - APR: ELECTIVE UROLOGICAL STENT PLACEMENT (Severity 2.0)  \n    - HCFA: URETERAL STENT INSERTION W/O MCC  \n\n    Medications:  \n    - Ciprofloxacin 400 mg IV Q12H (perioperative prophylaxis)  \n    - Tamsulosin 0.4 mg PO daily  \n    - Acetaminophen 650 mg PO Q6H PRN  \n    - Oxycodone 5 mg PO Q4H PRN post-procedure pain  \n    - Docusate sodium 100 mg PO BID PRN constipation  \n    - Sodium Chloride 0.9% Flush IV PRN  \n\n    Orders:  \n    - Ureteral stent insertion ordered, Completed — Successful placement of double-J stent  \n    - Post-stent urine culture ordered, Completed — No growth  \n    - Serum electrolytes ordered, Completed — Normalized after decompression  \n    - Foley catheter discontinued after stent placement  \n    - Outpatient urology follow-up ordered, Scheduled at 2 weeks  \n    - Patient education ordered, Completed — Instructions on stent care and follow-up  \n\n    Procedures:  \n    - Ureteral stent placement under fluoroscopic guidance  \n    - Intraoperative retrograde pyelogram performed  \n\n---\n\nAdmission 61281745  \n    DRGs:  \n    - APR: FOLLOW-UP FOR OBSTRUCTIVE UROPATHY (Severity 1.0)  \n    - HCFA: ROUTINE UROLOGY VISIT FOR STENT REMOVAL  \n\n    Medications:  \n    - Tamsulosin 0.4 mg PO daily  \n    - Ibuprofen 400 mg PO Q8H PRN mild discomfort  \n    - Multivitamin PO daily  \n\n    Orders:  \n    - Ureteral stent removal ordered, Completed — Procedure tolerated well  \n    - Repeat renal ultrasound ordered, Completed — Resolution of hydronephrosis  \n    - Serum creatinine ordered, Completed — Improved to 1.0 mg/dL  \n    - Urinalysis ordered, Completed — No hematuria, no infection  \n    - Patient counseling ordered, Completed — Hydration, stone prevention, and monitoring plan  \n\n    Procedures:  \n    - Outpatient ureteral stent removal performed  \n    - Ultrasound-guided renal assessment confirmed resolution", "pair_text": "Patient 60001296  \nGender: Female  \nAge: 55  \nRace: WHITE  \n\nAdmission 78456219  \n    DRGs:  \n    - APR: AGE-RELATED VISION CHANGES — PRESBYOPIA (Severity 1.0)  \n    - HCFA: OPHTHALMIC DISORDERS W/O MCC  \n\n    Medications:  \n    - Carboxymethylcellulose 0.5% Eye Drops — 1 drop OU PRN dryness  \n    - Artificial Tears — 1 drop OU QID PRN  \n    - Multivitamin with Lutein — 1 tablet PO daily  \n    - Omega-3 Fatty Acid Supplement — 1 g PO daily  \n\n    Orders:  \n    - Comprehensive eye exam ordered, Completed — Confirmed presbyopia  \n    - Visual acuity test ordered, Completed — 20/40 near vision  \n    - Refraction test ordered, Completed — Recommended +1.50 reading glasses  \n    - Intraocular pressure check ordered, Completed — Normal (14 mmHg)  \n    - Patient counseling ordered, Completed — Discussed age-related lens rigidity and need for corrective lenses  \n    - Prescription for reading glasses issued, Completed  \n\n    Procedures:  \n    - None required; diagnosis managed conservatively  \n\n---\n\nAdmission 78457502  \n    DRGs:  \n    - APR: REFRACTIVE ERROR FOLLOW-UP (Severity 1.0)  \n    - HCFA: ROUTINE OPHTHALMOLOGY EXAM  \n\n    Medications:  \n    - Carboxymethylcellulose 0.5% Eye Drops — 1 drop OU PRN dryness  \n    - Preservative-free Artificial Tears — 1 drop OU QID PRN  \n\n    Orders:  \n    - Follow-up visual acuity testing ordered, Completed — Stable at 20/40 near vision  \n    - Updated refraction test ordered, Completed — Glasses strength increased to +1.75  \n    - Patient education ordered, Completed — Guidance on computer-related eye strain and blue-light filter recommendations  \n    - Annual comprehensive ophthalmology follow-up ordered, Scheduled  \n\n    Procedures:  \n    - Dilated fundus examination performed — No signs of diabetic or hypertensive retinopathy  \n    - Updated optical prescription issued  \n\n---\n\nAdmission 78458834  \n    DRGs:  \n    - APR: ANNUAL OPHTHALMIC WELLNESS VISIT (Severity 1.0)  \n    - HCFA: ROUTINE EYE EXAM W/O COMPLICATIONS  \n\n    Medications:  \n    - Same as prior regimen — Artificial tears and multivitamin continued  \n\n    Orders:  \n    - Comprehensive ophthalmologic examination ordered, Completed — No progression beyond expected presbyopia  \n    - Optical coherence tomography (OCT) scan ordered, Completed — Normal macular and optic nerve findings  \n    - Patient counseling ordered, Completed — Recommended bifocals for smoother distance/near transitions  \n    - Follow-up ordered, Scheduled — Annual monitoring unless vision changes occur  \n\n    Procedures:  \n    - OCT imaging performed  \n    - Visual field testing performed — Normal results"}